Sentence,class,file
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007491).,Non-OADS,/arxiv_data1/oa_pdf/ef/93/bmjopen-2014-007491.PMC4480030.pdf
http://www.washingtonpost.,Non-OADS,/arxiv_data1/oa_pdf/ef/93/bmjopen-2014-007491.PMC4480030.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007172).,Non-OADS,/arxiv_data1/oa_pdf/54/39/bmjopen-2014-007172.PMC4480033.pdf
2012. http://www.csep.ca/guidelines 16.,Non-OADS,/arxiv_data1/oa_pdf/54/39/bmjopen-2014-007172.PMC4480033.pdf
"Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.j01v0 Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/72/34/bmjopen-2014-007421.PMC4480034.pdf
http://kosis.kr/statHtml/ statHtml.do?orgId=101&tblId=DT_1B34E01&vw_cd=&list_id=&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=E1 (accessed Jun 2015).,OADS,/arxiv_data1/oa_pdf/72/34/bmjopen-2014-007421.PMC4480034.pdf
2010. http://www.who.int/classifications/icd/en/ 3.,OADS,/arxiv_data1/oa_pdf/5b/60/bmjopen-2014-006969.PMC4480036.pdf
2012. https://www.gov.uk/ government/publications/national-diet-and-nutrition-survey-headline-results-from-years-1-2-and-3-combined-of-the-rolling-programme-200809-201011 8.,Non-OADS,/arxiv_data1/oa_pdf/5b/60/bmjopen-2014-006969.PMC4480036.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006778).,Non-OADS,/arxiv_data1/oa_pdf/f8/c5/bmjopen-2014-006778.PMC4480039.pdf
2008. http://www.who.int/mental_health/mhgap/en/ 5. WHO.,OADS,/arxiv_data1/oa_pdf/f8/c5/bmjopen-2014-006778.PMC4480039.pdf
2004. http://www.who.int/ healthinfo/global_burden_disease/2004_report_update/en/ (accessed Oct 2013).,OADS,/arxiv_data1/oa_pdf/f8/c5/bmjopen-2014-006778.PMC4480039.pdf
2008. http://www.who.int/mental_health/policy/services/integratingmhintoprimarycare/en/ 10.,Non-OADS,/arxiv_data1/oa_pdf/f8/c5/bmjopen-2014-006778.PMC4480039.pdf
http://rwanda.unfpa.org/2011/08/24/3764/should_rwanda_be_concerned_by_the_rapid_increase_of_its_population/ (accessed Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/f8/c5/bmjopen-2014-006778.PMC4480039.pdf
"Department of Mental Health and Substance Abuse, World Health Organization, 2011. http://www.who.int/mental_health/evidence/atlas/profiles/rwa_mh_profile.pdf?ua=1 (accessed May 2014).",OADS,/arxiv_data1/oa_pdf/f8/c5/bmjopen-2014-006778.PMC4480039.pdf
2005http://www.moh.gov.rw/fileadmin/templates/Docs/Posted-National-Mental-health-Policy-1.pdf 27.,Non-OADS,/arxiv_data1/oa_pdf/f8/c5/bmjopen-2014-006778.PMC4480039.pdf
http://www.svri.org/Questionnaire.pdf (accessed May 2014).,Non-OADS,/arxiv_data1/oa_pdf/f8/c5/bmjopen-2014-006778.PMC4480039.pdf
"36, Supplement 1, S254–S296 doi:10.1093/carcin/bgv039 Review S254 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/c2/bgv039.PMC4480130.pdf
http://www.epa.gov/ncct/toxcast/data.html .,OADS,/arxiv_data1/oa_pdf/8a/c2/bgv039.PMC4480130.pdf
http://www.epa.gov/ iris/subst/0249.htm .,OADS,/arxiv_data1/oa_pdf/8a/c2/bgv039.PMC4480130.pdf
"https://www.sciencemag.org/content/330/  6009/1338/reply  (7 May 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/8a/c2/bgv039.PMC4480130.pdf
"CAS: 117-81-7. http://www.nicnas.gov.au/communications/publica- tions/information-sheets/existing-chemical-info-sheets/diethyl - hexyl-phthalate-dehp-factsheet  (7 May 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/8a/c2/bgv039.PMC4480130.pdf
"Developmental  Cognitive  Neuroscience  16  (2015)  183–190 Contents  lists  available  at  ScienceDirect Developmental Cognitive  Neuroscience j  our na l  ho  me  pag  e:  http://www.elsevier.com/locate/dcn Adolescent  rats  are  resistant  to  forming  ethanol  seeking habits Hannah  Serlin,  Mary  M.  Torregrossa∗ Department of Psychiatry,  University  of  Pittsburgh,  Pittsburgh,  PA  15219,  United  States a r t i c l  e  i  n  f  o Article  history: Received  11  August  2014 Received  in  revised  form  3  December  2014 Accepted  16  December  2014 Available  online 24 December 2014 Keywords:AlcoholAdolescentHabitGoal-directedContingency degradation Self-administrationa b s t r  a  c  t Early  age  of  onset  alcohol  drinking  is  signiﬁcantly  more  likely  to  lead  to  alcohol  use  disorders (AUDs) than alcohol drinking that begins  after  the  age  of  18.",Non-OADS,/arxiv_data1/oa_pdf/62/1b/main.PMC4480209.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/1b/main.PMC4480209.pdf
A  stimulus–response  habit  is  deﬁned  as  an  action  or behavior  that  is  insensitive  to  changes  in  the  value  of  the http://dx.doi.org/10.1016/j.dcn.2014.12.002 1878-9293/©  2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/1b/main.PMC4480209.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/1b/main.PMC4480209.pdf
"Biol.,  http://dx.doi.org/10.1111/adb.12131 .",OADS,/arxiv_data1/oa_pdf/62/1b/main.PMC4480209.pdf
"Neurosci., http://dx.doi.org/10.1016/j.dcn.2014.09.003 .",OADS,/arxiv_data1/oa_pdf/62/1b/main.PMC4480209.pdf
Detailed information on the NHMRC fund- ing and review schemes is available online via the NHMRC website: http://www.nhmrc.,Non-OADS,/arxiv_data1/oa_pdf/b6/1b/ANS0972-7531-22-58.PMC4480255.pdf
"This isan Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/e8/civ279.PMC4480264.pdf
Available at: http://www.iom.edu/~/media/ Files/Report%20Files /2015/MECF S/MECFS cliniciansguide.pdf .,Non-OADS,/arxiv_data1/oa_pdf/92/e8/civ279.PMC4480264.pdf
"Key Words:  Fogarty balloon, Thrombosis, Vascular access, Thrombectomy Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/89/vsi-31-25.PMC4480287.pdf
Vasc Spec Int 2015;31(1):25-31  • http://dx.doi.org/10.5758/vsi.2015.31.1.25,Non-OADS,/arxiv_data1/oa_pdf/20/89/vsi-31-25.PMC4480287.pdf
27 http://dx.doi.org/10.5758/vsi.2015.31.1.25 Hybrid Procedure Using the Adherent Clot Catheter 2) Surgical thrombectomy with AC catheter Surgical thrombectomy with the AC catheter is similar  to the procedure performed using the Fogarty balloon  catheter except for the manner in which the equipment  is handled.,Non-OADS,/arxiv_data1/oa_pdf/20/89/vsi-31-25.PMC4480287.pdf
"29 http://dx.doi.org/10.5758/vsi.2015.31.1.25 Hybrid Procedure Using the Adherent Clot Catheter vs. 63.2% at 3 months, 40.7% vs. 47.1% at 6 months, and  17.9% vs. 19.1% at 12 months, respectively.",Non-OADS,/arxiv_data1/oa_pdf/20/89/vsi-31-25.PMC4480287.pdf
"31 http://dx.doi.org/10.5758/vsi.2015.31.1.25 Hybrid Procedure Using the Adherent Clot Catheter H, Islam MS, Robino C, Declemy S, et  al.",Non-OADS,/arxiv_data1/oa_pdf/20/89/vsi-31-25.PMC4480287.pdf
"Key Words:  Arteriovenous fistula, Angioplasty, Vascular patency Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/8d/vsi-31-20.PMC4480288.pdf
Vasc Spec Int 2015;31(1):20-24  • http://dx.doi.org/10.5758/vsi.2015.31.1.20,Non-OADS,/arxiv_data1/oa_pdf/8d/8d/vsi-31-20.PMC4480288.pdf
21 http://dx.doi.org/10.5758/vsi.2015.31.1.20 Postoperative Angioplasty of Native AVF analyzed during the follow-up period.,Non-OADS,/arxiv_data1/oa_pdf/8d/8d/vsi-31-20.PMC4480288.pdf
23 http://dx.doi.org/10.5758/vsi.2015.31.1.20 Postoperative Angioplasty of Native AVF There was only one case of operation site hematoma but  was not related with the anastomosis.,Non-OADS,/arxiv_data1/oa_pdf/8d/8d/vsi-31-20.PMC4480288.pdf
"Key Words:  Chronic cerebrospinal venous insufficiency, Multiple sclerosis, Libera - tion procedure Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/18/vsi-31-11.PMC4480289.pdf
Vasc Spec Int 2015;31(1):11-14  • http://dx.doi.org/10.5758/vsi.2015.31.1.11,Non-OADS,/arxiv_data1/oa_pdf/e0/18/vsi-31-11.PMC4480289.pdf
13 http://dx.doi.org/10.5758/vsi.2015.31.1.11 Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept double-blinded; subjects were blinded to the treatment and  investigators evaluating response to treatment were also  blinded to the treatment that the subject received.,Non-OADS,/arxiv_data1/oa_pdf/e0/18/vsi-31-11.PMC4480289.pdf
"Key Words:  Kissing stents, Aortic bifurcation, Aortoiliac occlusive disease Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/45/vsi-31-15.PMC4480290.pdf
Vasc Spec Int 2015;31(1):15-19  • http://dx.doi.org/10.5758/vsi.2015.31.1.15,Non-OADS,/arxiv_data1/oa_pdf/80/45/vsi-31-15.PMC4480290.pdf
17 http://dx.doi.org/10.5758/vsi.2015.31.1.15 Usefulness of Self-Expandable Kissing Stents index (ABI) was 0.53 and post-treatment ABI was 0.81.,OADS,/arxiv_data1/oa_pdf/80/45/vsi-31-15.PMC4480290.pdf
19 http://dx.doi.org/10.5758/vsi.2015.31.1.15 Usefulness of Self-Expandable Kissing Stents REFERENCES technique in the management of aor - toiliac obstructive disease.,Non-OADS,/arxiv_data1/oa_pdf/80/45/vsi-31-15.PMC4480290.pdf
"Key Words:  Aorta, Aneurysm, Animal model, Research Copyright © 2015, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/0a/vsi-31-01.PMC4480291.pdf
Vasc Spec Int 2015;31(1):1-10  • http://dx.doi.org/10.5758/vsi.2015.31.1.1,Non-OADS,/arxiv_data1/oa_pdf/82/0a/vsi-31-01.PMC4480291.pdf
"3 http://dx.doi.org/10.5758/vsi.2015.31.1.1 Recent Advances in Animal Models for Aortic Aneurysm Research strains has been widely employed, generating data of  mechanistic and pharmacologic relevance [31-33].",Non-OADS,/arxiv_data1/oa_pdf/82/0a/vsi-31-01.PMC4480291.pdf
5 http://dx.doi.org/10.5758/vsi.2015.31.1.1 Recent Advances in Animal Models for Aortic Aneurysm Research cidence of aneurysm formation in animal model is an  essential factor.,Non-OADS,/arxiv_data1/oa_pdf/82/0a/vsi-31-01.PMC4480291.pdf
"7 http://dx.doi.org/10.5758/vsi.2015.31.1.1 Recent Advances in Animal Models for Aortic Aneurysm Research in these animal models will provide an understanding  of signaling systems at the cellular and molecular levels  that are associated with the occurrence of human aortic  aneurysms, along with predictions for the risk of rupture.ACKNOWLEDGEMENTS  This study was supported by research fund from Chosun  University, 2013.",OADS,/arxiv_data1/oa_pdf/82/0a/vsi-31-01.PMC4480291.pdf
9 http://dx.doi.org/10.5758/vsi.2015.31.1.1 Recent Advances in Animal Models for Aortic Aneurysm Research angiotensin II- infused ApoE-defi - cient mice.,Non-OADS,/arxiv_data1/oa_pdf/82/0a/vsi-31-01.PMC4480291.pdf
Vasc Spec Int 2014;30(3):91-93 • http://dx.doi.org/10.5758/vsi.2014.30.3.91,Non-OADS,/arxiv_data1/oa_pdf/e2/92/vsi-30-91.PMC4480292.pdf
93 http://dx.doi.org/10.5758/vsi.2014.30.3.91 Hypogastric Artery Transposition harvest the vein.,Non-OADS,/arxiv_data1/oa_pdf/e2/92/vsi-30-91.PMC4480292.pdf
Vasc Spec Int 2014;30(3):87-90 • http://dx.doi.org/10.5758/vsi.2014.30.3.87,Non-OADS,/arxiv_data1/oa_pdf/8c/34/vsi-30-87.PMC4480293.pdf
89 http://dx.doi.org/10.5758/vsi.2014.30.3.87 Common Iliac Artery Aneurysm Treated by Iliac Branched Device minutes.,Non-OADS,/arxiv_data1/oa_pdf/8c/34/vsi-30-87.PMC4480293.pdf
Vasc Spec Int 2014;30(3):94-97 • http://dx.doi.org/10.5758/vsi.2014.30.3.94 Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/d1/vsi-30-94.PMC4480294.pdf
95 http://dx.doi.org/10.5758/vsi.2014.30.3.94 Mycotic Popliteal Aneurysm (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/d1/vsi-30-94.PMC4480294.pdf
"97 http://dx.doi.org/10.5758/vsi.2014.30.3.94 Mycotic Popliteal Aneurysm 1) Killeen SD, O’Brien N, O’Sullivan  MJ, Karr G, Redmond HP, Fulton GJ.",Non-OADS,/arxiv_data1/oa_pdf/c7/d1/vsi-30-94.PMC4480294.pdf
Vasc Spec Int 2014;30(3):81-86 • http://dx.doi.org/10.5758/vsi.2014.30.3.81,Non-OADS,/arxiv_data1/oa_pdf/09/9b/vsi-30-81.PMC4480295.pdf
83 http://dx.doi.org/10.5758/vsi.2014.30.3.81 Surgical Repair of Juxtarenal Aortic Occlusion and thromboendarterectomy of the pararenal aorta and  renal artery ostia was performed.,Non-OADS,/arxiv_data1/oa_pdf/09/9b/vsi-30-81.PMC4480295.pdf
85 http://dx.doi.org/10.5758/vsi.2014.30.3.81 Surgical Repair of Juxtarenal Aortic Occlusion surgical procedure.,Non-OADS,/arxiv_data1/oa_pdf/09/9b/vsi-30-81.PMC4480295.pdf
Vasc Spec Int 2014;30(3):102-104 • http://dx.doi.org/10.5758/vsi.2014.30.3.102,Non-OADS,/arxiv_data1/oa_pdf/e8/fe/vsi-30-102.PMC4480296.pdf
"103 http://dx.doi.org/10.5758/vsi.2014.30.3.102 The Remodeling of the GSV 2 Years after Endovenous Cryoablation could be observed some years after the treatment that may  cause recurrent varicosity with symptoms [1,2,4,5].",Non-OADS,/arxiv_data1/oa_pdf/e8/fe/vsi-30-102.PMC4480296.pdf
Vasc Spec Int 2014;30(3):98-101 • http://dx.doi.org/10.5758/vsi.2014.30.3.98 Fig.,Non-OADS,/arxiv_data1/oa_pdf/6a/e9/vsi-30-98.PMC4480297.pdf
99 http://dx.doi.org/10.5758/vsi.2014.30.3.98 Endometrial Stromal Sarcoma with IVC Extension Fig.,Non-OADS,/arxiv_data1/oa_pdf/6a/e9/vsi-30-98.PMC4480297.pdf
"101 http://dx.doi.org/10.5758/vsi.2014.30.3.98 Endometrial Stromal Sarcoma with IVC Extension Most cases of LGESS have favorable outcomes, with a  5-year survival rate of 80%-90% after curative resection.",Non-OADS,/arxiv_data1/oa_pdf/6a/e9/vsi-30-98.PMC4480297.pdf
Vasc Spec Int 2014;30(1):33-37  • http://dx.doi.org/10.5758/vsi.2014.30.1.33,Non-OADS,/arxiv_data1/oa_pdf/36/e8/vsi-30-33.PMC4480298.pdf
"35 http://dx.doi.org/10.5758/vsi.2014.30.1.33Successful Access Rate and Risk Factor of Vascular Access Surgery the follow up period, 347 patients had patent AVFs, 16  patients had undergone kidney transplantation, 18 patients had other AVF operations, and 31 patients died (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/36/e8/vsi-30-33.PMC4480298.pdf
37 http://dx.doi.org/10.5758/vsi.2014.30.1.33Successful Access Rate and Risk Factor of Vascular Access Surgery S137-S181.,Non-OADS,/arxiv_data1/oa_pdf/36/e8/vsi-30-33.PMC4480298.pdf
Vasc Spec Int 2014;30(1):26-32  • http://dx.doi.org/10.5758/vsi.2014.30.1.26,Non-OADS,/arxiv_data1/oa_pdf/2a/a1/vsi-30-26.PMC4480299.pdf
27 http://dx.doi.org/10.5758/vsi.2014.30.1.26Analysis of Intermediate Term Results of Short Vein Bypass Graft by Mann-Whitney U test.,Non-OADS,/arxiv_data1/oa_pdf/2a/a1/vsi-30-26.PMC4480299.pdf
29 http://dx.doi.org/10.5758/vsi.2014.30.1.26Analysis of Intermediate Term Results of Short Vein Bypass Graft patients in the LVB group.,Non-OADS,/arxiv_data1/oa_pdf/2a/a1/vsi-30-26.PMC4480299.pdf
31 http://dx.doi.org/10.5758/vsi.2014.30.1.26Analysis of Intermediate Term Results of Short Vein Bypass Graft reported a lack of intergroup differences in would healing  time.,Non-OADS,/arxiv_data1/oa_pdf/2a/a1/vsi-30-26.PMC4480299.pdf
Vasc Spec Int 2014;30(1):11-18  • http://dx.doi.org/10.5758/vsi.2014.30.1.11,Non-OADS,/arxiv_data1/oa_pdf/ba/4b/vsi-30-11.PMC4480300.pdf
"13 http://dx.doi.org/10.5758/vsi.2014.30.1.11Muscle-derived Stem Cell’s Fate PA, USA) and the mean value was calculated.",OADS,/arxiv_data1/oa_pdf/ba/4b/vsi-30-11.PMC4480300.pdf
"15 http://dx.doi.org/10.5758/vsi.2014.30.1.11Muscle-derived Stem Cell’s Fate In this study, the high affinity of these cells to implant  in blood vessels may partially explain for the increase in angiogenic activity.",Non-OADS,/arxiv_data1/oa_pdf/ba/4b/vsi-30-11.PMC4480300.pdf
"17 http://dx.doi.org/10.5758/vsi.2014.30.1.11Muscle-derived Stem Cell’s Fate also important in determining the fate of stem cells, since  the conditions these cells are immediately exposed to and the pattern of distribution may be different.",Non-OADS,/arxiv_data1/oa_pdf/ba/4b/vsi-30-11.PMC4480300.pdf
Vasc Spec Int 2014;30(1):38-42  • http://dx.doi.org/10.5758/vsi.2014.30.1.38,Non-OADS,/arxiv_data1/oa_pdf/3b/f1/vsi-30-38.PMC4480301.pdf
"39 http://dx.doi.org/10.5758/vsi.2014.30.1.38Reversed Iliac Leg Stent-Graft Vascular Plug II (AGA Medical, Golden Valley, MN, USA)  via contralateral left transfemoral approach.",Non-OADS,/arxiv_data1/oa_pdf/3b/f1/vsi-30-38.PMC4480301.pdf
41 http://dx.doi.org/10.5758/vsi.2014.30.1.38Reversed Iliac Leg Stent-Graft Patients with IIA aneurysm have variable iliac artery  diameters due to ectatic characteristics of the arterial wa-lls.,Non-OADS,/arxiv_data1/oa_pdf/3b/f1/vsi-30-38.PMC4480301.pdf
Vasc Spec Int 2014;30(1):1-4  • http://dx.doi.org/10.5758/vsi.2014.30.1.1,Non-OADS,/arxiv_data1/oa_pdf/ed/a1/vsi-30-01.PMC4480302.pdf
"3 http://dx.doi.org/10.5758/vsi.2014.30.1.Rupture of AAA after EVAR OUTCOMES  The reported operative mortality rates for post-EVAR  rAAA range widely from 15% to 67% [7,16,20,23,28-33].",Non-OADS,/arxiv_data1/oa_pdf/ed/a1/vsi-30-01.PMC4480302.pdf
Vasc Spec Int 2014;30(1):19-25  • http://dx.doi.org/10.5758/vsi.2014.30.1.19,Non-OADS,/arxiv_data1/oa_pdf/74/82/vsi-30-19.PMC4480303.pdf
21 http://dx.doi.org/10.5758/vsi.2014.30.1.19Experiences of Surgical Treatment for Juxtarenal Aortic Occlusion performed.,Non-OADS,/arxiv_data1/oa_pdf/74/82/vsi-30-19.PMC4480303.pdf
"23 http://dx.doi.org/10.5758/vsi.2014.30.1.19Experiences of Surgical Treatment for Juxtarenal Aortic Occlusion DISCUSSION  Occlusive disease of the infrarenal aorta, which may  affect in varying degrees and extent to involve the bifurcation and the common iliac arteries, entails clau-dication or critical limb ischemia, and is also typically asso-ciated with absent or diminished peripheral pulses, and with erectile dysfunction in men.",Non-OADS,/arxiv_data1/oa_pdf/74/82/vsi-30-19.PMC4480303.pdf
25 http://dx.doi.org/10.5758/vsi.2014.30.1.19Experiences of Surgical Treatment for Juxtarenal Aortic Occlusion soned approach to diagnosis and ma- nagement.,Non-OADS,/arxiv_data1/oa_pdf/74/82/vsi-30-19.PMC4480303.pdf
Vasc Spec Int 2014;30(1):5-10  • http://dx.doi.org/10.5758/vsi.2014.30.1.5,Non-OADS,/arxiv_data1/oa_pdf/f7/4d/vsi-30-05.PMC4480304.pdf
7 http://dx.doi.org/10.5758/vsi.2014.30.1.5Neointimal Cell Response to Imatinib and Rapamycin the animals were allowed to recover from anesthesia and to  access freely to water and food.,Non-OADS,/arxiv_data1/oa_pdf/f7/4d/vsi-30-05.PMC4480304.pdf
"9 http://dx.doi.org/10.5758/vsi.2014.30.1.5Neointimal Cell Response to Imatinib and Rapamycin In this study, neointimal cells from the injured carotid  artery were more susceptible to the antiproliferative effects of imatinib and rapamycin in terms of proliferation and viability.",Non-OADS,/arxiv_data1/oa_pdf/f7/4d/vsi-30-05.PMC4480304.pdf
"Vasc Spec Int 2014;30(2):43-48  • http://dx.doi.org/10.5758/vsi.2014.30.2.43Corresponding author:  Young-Wook Kim Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTel: 82-2-3410-3461, Fax: 82-2-3410-0040, E-mail: ywkim@skku.eduYoung-Wook Kim President of KSVS (2012-2013) Professor of Surgery, Sungkyunkwan University School of Medicine,  Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Seoul, Korea",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/vsi-30-43.PMC4480305.pdf
45 http://dx.doi.org/10.5758/vsi.2014.30.2.43Presidental Address of the 58th Annual Meeting of KSVS that 76% of all strokes were attributed to ischemic stroke  and 36% of them to large artery atherosclerosis [7].,Non-OADS,/arxiv_data1/oa_pdf/4e/1c/vsi-30-43.PMC4480305.pdf
"47 http://dx.doi.org/10.5758/vsi.2014.30.2.43Presidental Address of the 58th Annual Meeting of KSVS Among these issues, I’d like to describe the operation  fee issue first.",Non-OADS,/arxiv_data1/oa_pdf/4e/1c/vsi-30-43.PMC4480305.pdf
Vasc Spec Int 2014;30(2):76-79  • http://dx.doi.org/10.5758/vsi.2014.30.2.76,Non-OADS,/arxiv_data1/oa_pdf/fd/b9/vsi-30-76.PMC4480306.pdf
77 http://dx.doi.org/10.5758/vsi.2014.30.2.76Colon Ischemia after Huge Aorto-iliac Aneurysm Repair its distal stump was very deeply located after exclusion  of its aneurysm.,Non-OADS,/arxiv_data1/oa_pdf/fd/b9/vsi-30-76.PMC4480306.pdf
79 http://dx.doi.org/10.5758/vsi.2014.30.2.76Colon Ischemia after Huge Aorto-iliac Aneurysm Repair aortic aneurysm.,Non-OADS,/arxiv_data1/oa_pdf/fd/b9/vsi-30-76.PMC4480306.pdf
Vasc Spec Int 2014;30(2):49-55  • http://dx.doi.org/10.5758/vsi.2014.30.2.49,Non-OADS,/arxiv_data1/oa_pdf/3b/91/vsi-30-49.PMC4480307.pdf
51 http://dx.doi.org/10.5758/vsi.2014.30.2.49Venous Thromboembolism after Coloretal Cancer Surgery Table 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/91/vsi-30-49.PMC4480307.pdf
53 http://dx.doi.org/10.5758/vsi.2014.30.2.49Venous Thromboembolism after Coloretal Cancer Surgery Table 1).,Non-OADS,/arxiv_data1/oa_pdf/3b/91/vsi-30-49.PMC4480307.pdf
"55 http://dx.doi.org/10.5758/vsi.2014.30.2.49Venous Thromboembolism after Coloretal Cancer Surgery 13) Alcalay A, Wun T, Khatri V, Chew HK,  Harvey D, Zhou H, et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/91/vsi-30-49.PMC4480307.pdf
Vasc Spec Int 2014;30(2):62-67  • http://dx.doi.org/10.5758/vsi.2014.30.2.62,Non-OADS,/arxiv_data1/oa_pdf/4d/01/vsi-30-62.PMC4480308.pdf
"63 http://dx.doi.org/10.5758/vsi.2014.30.2.62Cephalic Vein Transposition for Brachiocephalic Arteriovenous Fistula per manent vascular access dysfunction (239 for native  ar teriovenous fistulas; 160 for prosthetic arteriovenous  fistulas) at Kyungpook National University Hospital, Daegu, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4d/01/vsi-30-62.PMC4480308.pdf
65 http://dx.doi.org/10.5758/vsi.2014.30.2.62Cephalic Vein Transposition for Brachiocephalic Arteriovenous Fistula revision were thrombotic occlusion in 1 1 patients (85%)  and AVF dysfunction with difficulty in hemostasis after removal of dialysis needle in the remaining 2 patients.,Non-OADS,/arxiv_data1/oa_pdf/4d/01/vsi-30-62.PMC4480308.pdf
67 http://dx.doi.org/10.5758/vsi.2014.30.2.62Cephalic Vein Transposition for Brachiocephalic Arteriovenous Fistula 232:508-515.,Non-OADS,/arxiv_data1/oa_pdf/4d/01/vsi-30-62.PMC4480308.pdf
Vasc Spec Int 2014;30(2):72-75  • http://dx.doi.org/10.5758/vsi.2014.30.2.72,Non-OADS,/arxiv_data1/oa_pdf/dd/9e/vsi-30-72.PMC4480309.pdf
73 http://dx.doi.org/10.5758/vsi.2014.30.2.72Aortic Reconstruction for Post-EVAR Infection entirely.,Non-OADS,/arxiv_data1/oa_pdf/dd/9e/vsi-30-72.PMC4480309.pdf
"75 http://dx.doi.org/10.5758/vsi.2014.30.2.72Aortic Reconstruction for Post-EVAR Infection 4) Taylor LM Jr, Deitz DM, McConnell  DB, Porter JM.",Non-OADS,/arxiv_data1/oa_pdf/dd/9e/vsi-30-72.PMC4480309.pdf
Vasc Spec Int 2014;30(2):68-71  • http://dx.doi.org/10.5758/vsi.2014.30.2.68,Non-OADS,/arxiv_data1/oa_pdf/06/61/vsi-30-68.PMC4480310.pdf
69 http://dx.doi.org/10.5758/vsi.2014.30.2.68Hybrid Treatment of RAA and AAA mid-axillary line.,Non-OADS,/arxiv_data1/oa_pdf/06/61/vsi-30-68.PMC4480310.pdf
71 http://dx.doi.org/10.5758/vsi.2014.30.2.68Hybrid Treatment of RAA and AAA uncommon condition.,Non-OADS,/arxiv_data1/oa_pdf/06/61/vsi-30-68.PMC4480310.pdf
Vasc Spec Int 2014;30(2):56-61  • http://dx.doi.org/10.5758/vsi.2014.30.2.56,Non-OADS,/arxiv_data1/oa_pdf/56/1f/vsi-30-56.PMC4480311.pdf
"57 http://dx.doi.org/10.5758/vsi.2014.30.2.56Laterality of Deep Vein Thrombosis and applied the Thrombus Scoring System (TSS) score,  which was obtained by dividing the lower extremity venous system into 11 segments for each side based on the anatomical venous system.",Non-OADS,/arxiv_data1/oa_pdf/56/1f/vsi-30-56.PMC4480311.pdf
59 http://dx.doi.org/10.5758/vsi.2014.30.2.56Laterality of Deep Vein Thrombosis Table 3.,Non-OADS,/arxiv_data1/oa_pdf/56/1f/vsi-30-56.PMC4480311.pdf
"61 http://dx.doi.org/10.5758/vsi.2014.30.2.56Laterality of Deep Vein Thrombosis 1) Labropoulos N, Bekelis K, Leon LR Jr.  Thrombosis in unusual sites of the lo wer extremity veins.",Non-OADS,/arxiv_data1/oa_pdf/56/1f/vsi-30-56.PMC4480311.pdf
Vasc Spec Int 2014;30(4):144-150 • http://dx.doi.org/10.5758/vsi.2014.30.4.144,Non-OADS,/arxiv_data1/oa_pdf/fe/52/vsi-30-144.PMC4480312.pdf
145 http://dx.doi.org/10.5758/vsi.2014.30.4.144 Thrombolysis in Central Venous Catheter Management performed in aseptic conditions in an operation room.,Non-OADS,/arxiv_data1/oa_pdf/fe/52/vsi-30-144.PMC4480312.pdf
"147 http://dx.doi.org/10.5758/vsi.2014.30.4.144 Thrombolysis in Central Venous Catheter Management coughing, and flushing with normal saline.",Non-OADS,/arxiv_data1/oa_pdf/fe/52/vsi-30-144.PMC4480312.pdf
149 http://dx.doi.org/10.5758/vsi.2014.30.4.144 Thrombolysis in Central Venous Catheter Management and the RA.,Non-OADS,/arxiv_data1/oa_pdf/fe/52/vsi-30-144.PMC4480312.pdf
Vasc Spec Int 2014;30(4):155-158 • http://dx.doi.org/10.5758/vsi.2014.30.4.155,Non-OADS,/arxiv_data1/oa_pdf/2d/3f/vsi-30-155.PMC4480313.pdf
"157 http://dx.doi.org/10.5758/vsi.2014.30.4.155 Thrombectomy and Direct Thrombolysis in PVT included protein C and S activity, protein C and S Ag,  anticardiolipin immunoglobulin A (IgA), IgM, and IgG, tissue plasminogen activator, homocysteine, and factor V Leiden revealed protein C and S deficiency in the patient.",OADS,/arxiv_data1/oa_pdf/2d/3f/vsi-30-155.PMC4480313.pdf
Vasc Spec Int 2014;30(4):139-143 • http://dx.doi.org/10.5758/vsi.2014.30.4.139,Non-OADS,/arxiv_data1/oa_pdf/0e/6c/vsi-30-139.PMC4480314.pdf
141 http://dx.doi.org/10.5758/vsi.2014.30.4.139 Management of Acute Deep Vein Thrombosis vascular surgery departments.,Non-OADS,/arxiv_data1/oa_pdf/0e/6c/vsi-30-139.PMC4480314.pdf
143 http://dx.doi.org/10.5758/vsi.2014.30.4.139 Management of Acute Deep Vein Thrombosis Leiden mutation and the prothrombin  G20210A mutation was not found in  Japanese patients with pulmonary  thromboembolism.,Non-OADS,/arxiv_data1/oa_pdf/0e/6c/vsi-30-139.PMC4480314.pdf
Vasc Spec Int 2014;30(4):113-119 • http://dx.doi.org/10.5758/vsi.2014.30.4.113,Non-OADS,/arxiv_data1/oa_pdf/93/cc/vsi-30-113.PMC4480315.pdf
"115 http://dx.doi.org/10.5758/vsi.2014.30.4.113 Clinical Implications of MTHFR Mutations and Plasma Homocystein 3) MTHFR gene test The samples were obtained from whole blood in all of  the patients, and the MTHFR polymorphism was classified  into a homozygous normal genotype (CC), a heterozygous genotype (CT), or a homozygous mutant genotype (TT) with real-time polymerase chain reactions with an AccuPower MTHFR C677T genotyping kit (Bioneer Co., Daejeon, Korea).",Non-OADS,/arxiv_data1/oa_pdf/93/cc/vsi-30-113.PMC4480315.pdf
"117 http://dx.doi.org/10.5758/vsi.2014.30.4.113 Clinical Implications of MTHFR Mutations and Plasma Homocystein thylation step in which methionine is resynthesized into  homocysteine, causes severe hyperhomocysteinemia [18] and can result in severe clinical outcomes, such as coronary artery disease, deep vein thrombosis, peripheral arterial occlusive disease, and cerebral infarction [2-5].",Non-OADS,/arxiv_data1/oa_pdf/93/cc/vsi-30-113.PMC4480315.pdf
"119 http://dx.doi.org/10.5758/vsi.2014.30.4.113 Clinical Implications of MTHFR Mutations and Plasma Homocystein 26) Abbate R, Sardi I, Pepe G, Marcucci  R, Brunelli T, Prisco D, et al.",Non-OADS,/arxiv_data1/oa_pdf/93/cc/vsi-30-113.PMC4480315.pdf
Vasc Spec Int 2014;30(4):133-138 • http://dx.doi.org/10.5758/vsi.2014.30.4.133,Non-OADS,/arxiv_data1/oa_pdf/2b/16/vsi-30-133.PMC4480316.pdf
135 http://dx.doi.org/10.5758/vsi.2014.30.4.133 Retrieval Rate of Vena Cava Filter RESULTS 1) Patient demographics  IVCF placement was done in 115 cases (113 patients).,Non-OADS,/arxiv_data1/oa_pdf/2b/16/vsi-30-133.PMC4480316.pdf
"137 http://dx.doi.org/10.5758/vsi.2014.30.4.133 Retrieval Rate of Vena Cava Filter The filter retrieval rate in our center was 59%, and the  mean implantation time of the retrieved filters was 21  days, which was much better than those of other reports indicating retrieval rates of 5%-40%.",OADS,/arxiv_data1/oa_pdf/2b/16/vsi-30-133.PMC4480316.pdf
Vasc Spec Int 2014;30(4):125-132 • http://dx.doi.org/10.5758/vsi.2014.30.4.125,Non-OADS,/arxiv_data1/oa_pdf/15/54/vsi-30-125.PMC4480317.pdf
"127 http://dx.doi.org/10.5758/vsi.2014.30.4.125 Peripheral Neuropathy in Peripheral Arterial Occlusive Disease potential, and were analyzed for amplitude, duration,  latencies and conduction velocity.",OADS,/arxiv_data1/oa_pdf/15/54/vsi-30-125.PMC4480317.pdf
"129 http://dx.doi.org/10.5758/vsi.2014.30.4.125 Peripheral Neuropathy in Peripheral Arterial Occlusive Disease 4) Diabetic peripheral neuropathy Of the 30 total diabetic limbs, diabetic peripheral neuro - pathy was identified in 22 limbs (73.3%) (Table 3).",OADS,/arxiv_data1/oa_pdf/15/54/vsi-30-125.PMC4480317.pdf
"131 http://dx.doi.org/10.5758/vsi.2014.30.4.125 Peripheral Neuropathy in Peripheral Arterial Occlusive Disease complications, affecting up two-thirds of patients with  DM [21-23].",Non-OADS,/arxiv_data1/oa_pdf/15/54/vsi-30-125.PMC4480317.pdf
Vasc Spec Int 2014;30(4):105-112 • http://dx.doi.org/10.5758/vsi.2014.30.4.105,Non-OADS,/arxiv_data1/oa_pdf/f4/c9/vsi-30-105.PMC4480318.pdf
107 http://dx.doi.org/10.5758/vsi.2014.30.4.105 Consensus for the Treatment of Varicose Vein with RFA not consider the venous diameter [11].,Non-OADS,/arxiv_data1/oa_pdf/f4/c9/vsi-30-105.PMC4480318.pdf
109 http://dx.doi.org/10.5758/vsi.2014.30.4.105 Consensus for the Treatment of Varicose Vein with RFA most patients [31].,Non-OADS,/arxiv_data1/oa_pdf/f4/c9/vsi-30-105.PMC4480318.pdf
111 http://dx.doi.org/10.5758/vsi.2014.30.4.105 Consensus for the Treatment of Varicose Vein with RFA 2014;26:548-550.,Non-OADS,/arxiv_data1/oa_pdf/f4/c9/vsi-30-105.PMC4480318.pdf
Vasc Spec Int 2014;30(4):120-124 • http://dx.doi.org/10.5758/vsi.2014.30.4.120,Non-OADS,/arxiv_data1/oa_pdf/68/48/vsi-30-120.PMC4480319.pdf
121 http://dx.doi.org/10.5758/vsi.2014.30.4.120 Transcatheter Arterial Embolization of Splenic Artery Aneurysms additional injection of N-butyl-2-cyanoacrylate (Histoacryl).,Non-OADS,/arxiv_data1/oa_pdf/68/48/vsi-30-120.PMC4480319.pdf
123 http://dx.doi.org/10.5758/vsi.2014.30.4.120 Transcatheter Arterial Embolization of Splenic Artery Aneurysms again within 1 month but access site complications did  not occur.,Non-OADS,/arxiv_data1/oa_pdf/68/48/vsi-30-120.PMC4480319.pdf
Vasc Spec Int 2014;30(4):151-154 • http://dx.doi.org/10.5758/vsi.2014.30.4.151,Non-OADS,/arxiv_data1/oa_pdf/7e/ba/vsi-30-151.PMC4480320.pdf
153 http://dx.doi.org/10.5758/vsi.2014.30.4.151 Antegrade Debranching with EVAR Fig.,Non-OADS,/arxiv_data1/oa_pdf/7e/ba/vsi-30-151.PMC4480320.pdf
"A second FD assay was also used, designed to the 23S rRNA, and available in kit form from OptiGene Ltd (http://www.optigene.co.uk).",Non-OADS,/arxiv_data1/oa_pdf/28/43/ppa0064-0286.PMC4480326.pdf
[http://www.eppo.int/DATABASES/pqr/pqr.htm].Accessed 10 March 2014.,OADS,/arxiv_data1/oa_pdf/28/43/ppa0064-0286.PMC4480326.pdf
Susceptibility data for this species is presented and we review the literature on thetreatment and outcomes after ocular infections from Colleto- trichum species.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.06.001 2211-7539/ &2015 International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/5c/23/main.PMC4480352.pdf
"Normal conjunctiva was obtained  from the superior temporal part while the conjunctival Molecular Vision  2015; 21:711-717 <http://www.molvis.org/molvis/v 21/711> Received 12 December 2014 | Accepted 23 June 2015 | Published 25 June 2015© 2015 Molecular Vision 711Expression of WW domain–containing oxidoreductase WWOX in  pterygium Yi-Hsun Huang,1,2 Nan-Shan Chang,3 Sung-Huei Tseng2 1Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University,  Tainan, Taiwan; 2Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National  Cheng Kung University, Tainan, Taiwan; 3Institute of Molecular Medicine, National Cheng Kung University Hospital, College of  Medicine, National Cheng Kung University, Tainan, Taiwan Purpose:  Pterygium was traditionally regarded as a degenerative disease, but certain characteristics suggest that pte - rygium is probably premalignant tissue.",Non-OADS,/arxiv_data1/oa_pdf/d1/c4/mv-v21-711.PMC4480446.pdf
Molecular Vision  2015; 21:711-717 <http://www.molvis.org/molvis/v 21/711> © 2015 Molecular Vision  712autograft was harvested.,Non-OADS,/arxiv_data1/oa_pdf/d1/c4/mv-v21-711.PMC4480446.pdf
"Molecular Vision  2015; 21:711-717 <http://www.molvis.org/molvis/v 21/711> © 2015 Molecular Vision  713By using specific antibodies, we found that WOX1 and other  family proteins are expressed in the cytoplasm of epithelial  cells, and the expression is increased in intensity toward  the superficial layers (Figure 1A).",Non-OADS,/arxiv_data1/oa_pdf/d1/c4/mv-v21-711.PMC4480446.pdf
Molecular Vision  2015; 21:711-717 <http://www.molvis.org/molvis/v 21/711> © 2015 Molecular Vision  714preformed immunohistochemistry (IHC)for p-WOX1 (Figure  1B).,Non-OADS,/arxiv_data1/oa_pdf/d1/c4/mv-v21-711.PMC4480446.pdf
"Molecular Vision  2015; 21:711-717 <http://www.molvis.org/molvis/v 21/711> © 2015 Molecular Vision  715WOX1 labeling and Tyr 33 phosphorylation also showed a  positive correlation with pterygium status; that is, WOX1  expression was highly present in recurrent pterygium and  lower in primary pterygium.",Non-OADS,/arxiv_data1/oa_pdf/d1/c4/mv-v21-711.PMC4480446.pdf
Molecular Vision  2015; 21:711-717 <http://www.molvis.org/molvis/v 21/711> © 2015 Molecular Vision  716needed to provide a clearer pathway regarding WWOX and  p53 in pterygium.,Non-OADS,/arxiv_data1/oa_pdf/d1/c4/mv-v21-711.PMC4480446.pdf
Molecular Vision  2015; 21:711-717 <http://www.molvis.org/molvis/v 21/711> © 2015 Molecular Vision  717and its involvement in multiple myeloma translocations.,Non-OADS,/arxiv_data1/oa_pdf/d1/c4/mv-v21-711.PMC4480446.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/copd-10-1191.PMC4480584.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1191–1197International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1191OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8250 9Small airway dysfunction and flow and volume  bronchodilator responsiveness in patients with  chronic obstructive pulmonary disease roberta Pisi1 Marina aiello1 andrea Zanini2 Panagiota Tzani1 Davide Paleari3 emilio Marangio1 antonio spanevello2,4 gabriele nicolini5 alfredo Chetta1 1Department of Clinical and  experimental Medicine, University  of Parma, Parma, 2Division of  Pneumology, I rCCs rehabilitation  Institute of Tradate, salvatore  Maugeri Foundation, Tradate, 3Medical  Department, Chiesi Farmaceutici spa,   Parma, 4Department of Clinical and  experimental Medicine, University  of Insubria, Varese, 5Corporate  Clinical Development, Chiesi  Farmaceutici spa, Parma, ItalyBackground:  We investigated whether a relationship between small airways dysfunction and  bronchodilator responsiveness exists in patients with chronic obstructive pulmonary disease  (COPD).",Non-OADS,/arxiv_data1/oa_pdf/9a/42/copd-10-1191.PMC4480584.pdf
"Keywords:  bronchodilator responsiveness, small airways, COPD Introduction Small airways are considered the major sites of airflow limitation in patients with  chronic obstructive pulmonary disease (COPD).1 Structural and inflammatory changes  in distal airways increase with more severe bronchial obstruction in COPD.1 Further - more, association of distal airway impairment with mortality has been also observed  in patients with COPD.2 However, the understanding of the exact role of small airway  dysfunction in the clinical features and progression of the disease is still limited.3 One  of the reasons for this fact is that, though pulmonary function testing is the gold stan - dard to diagnose and manage COPD, there is little agreement on the most useful lung  function parameter to assess the small airways.3 The ability of spirometry to indicate small airway obstruction is still debated.4 On the  other hand, the forced oscillation technique has been successfully used as a measure of  the airway resistance heterogeneity and gas trapping.5 Notably, the impulse oscillometry Correspondence: alfredo Chetta Dipartimento di Medicina Clinica  e sperimentale, Unità di Malattie  respiratorie e Funzionalità Polmonare,  Università di Parma, Padiglione rasori, via  g rasori 10, 43100 Parma, Italy Tel +39 0521 703 475 Fax +39 0521 292 615 email chetta@unipr.i t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Pisi et al Running head recto: Small airway dysfunction and bronchodilator response in COPD DOI: http://dx.doi.org/10.2147/COPD.S82509",Non-OADS,/arxiv_data1/oa_pdf/9a/42/copd-10-1191.PMC4480584.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/copd-10-1191.PMC4480584.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/copd-10-1191.PMC4480584.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/da/ott-8-1511.PMC4480585.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1511–1521OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1511Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8324 3evaluation of the pathological response and  prognosis following neoadjuvant chemotherapy  in molecular subtypes of breast cancer Yue Zhao1 Xiaoqiu Dong2 rongguo li1 Xiao Ma1 Jian song1 Yingjie li3 Dongwei Zhang1 1Department of general surgery,   second affiliated hospital of harbin  Medical University, 2Department of  Ultrasonography, Fourth affiliated  hospital of harbin Medical University,   3Department of Pathology, second  affiliated hospital of harbin Medical  University, harbin, People’s republic  of chinaBackground:  The pathological complete response of neoadjuvant chemotherapy for breast  cancer correlates with the prognosis for survival.",Non-OADS,/arxiv_data1/oa_pdf/00/da/ott-8-1511.PMC4480585.pdf
"Patients who achieve a pathological complete  response have a better prognosis than those who do not.2 Higher rates of pathological correspondence: Dongwei Zhang Department of general surgery,  Second Affiliated Hospital of Harbin  Medical University, 246 Xuefu road,  nangang District, harbin 150086,  People’s republic of china Tel +86 135 0484 5465 email mugong0@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhao et al Running head recto: Molecular subtypes and chemotherapy in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S83243",Non-OADS,/arxiv_data1/oa_pdf/00/da/ott-8-1511.PMC4480585.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/00/da/ott-8-1511.PMC4480585.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/da/ott-8-1511.PMC4480585.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/78/oajsm-6-191.PMC4480586.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 191–199Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  191OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S8229 5relationship between performance test and body  composition/physical strength characteristic   in sprint canoe and kayak paddlers Saki hamano1 eisuke Ochi2 Y osuke Tsuchiya3 erina Muramatsu4 Kazuhiro Suzukawa5 Shoji igawa1 1Department of Sports nutrition,   nippon Sport Science University,   Y okohama, Kanagawa, 2graduate  School of education, Okayama  University, Okayama, 3laboratory  of health and Sports Sciences,   Meiji gakuin University, Y okohama,   Kanagawa, 4Department of natural  Sciences, nippon Sport Science  University, Setagaya, T okyo,   5laboratory of Preventive Medicine  and Public health, nippon Sport  Science University, Setagaya, T okyo,   Japan correspondence: eisuke Ochi   graduate School of education,   Okayama University, 3-1-1, Tsushimanaka,  Kita, Okayama 700-8530, Japan   Tel +81 86 251 7750   Fax +81 86 251 7750   email eisukeochi@cc.okayama-u.ac.j pObjective:  Canoe sprint is divided into canoe and kayak.",Non-OADS,/arxiv_data1/oa_pdf/32/78/oajsm-6-191.PMC4480586.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/32/78/oajsm-6-191.PMC4480586.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/78/oajsm-6-191.PMC4480586.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/7b/ijn-10-4059.PMC4480588.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4059–4069International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4059OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8390 6Optimized zein nanospheres for improved oral  bioavailability of atorvastatin Fahima M hashem1 Majid M al-sawahli2 Mohamed Nasr1 Osama aa ahmed3,4 1Department of Pharmaceutics  and Industrial Pharmacy, Faculty  of Pharmacy, helwan University,    cairo, 2holding company for  Biological Products and Vaccines,   giza, egypt; 3Department of  Pharmaceutics and Industrial  Pharmacy, Faculty of Pharmacy, King  abdulaziz University, Jeddah, saudi  arabia; 4Department of Pharmaceutics  and Industrial Pharmacy, Faculty  of Pharmacy, Minia University,   Minia,  egyptBackground:  This work focuses on the development of atorvastatin utilizing zein, a natural,  safe, and biocompatible polymer, as a nanosized formulation in order to overcome the poor  oral bioavailability (12%) of the drug.",Non-OADS,/arxiv_data1/oa_pdf/16/7b/ijn-10-4059.PMC4480588.pdf
"ATR also increases high-density lipoprotein cholesterol levels in the treatment  of hyperlipidemia and dysbetalipoproteinemia (type III hyperlipoproteinemia).3 ATR  has a unique crystalline structure, undergoes hepatic first-pass metabolism, and has  very good intestinal permeability and better low-density lipoprotein-lowering potency  compared with other HMG-CoA reductase inhibitors.4 ATR belongs to Biopharmaceutics Classification System class II, showing low oral  bioavailability (12%) due to low aqueous solubility (0.1 mg/mL), high presystemic  clearance in the gastrointestinal mucosa ( 80%), and extensive hepatic first-pass correspondence: Osama aa ahmed Department of Pharmaceutics and  Industrial Pharmacy, Faculty of Pharmacy,  King abdulaziz University, PO Box 80260,   Jeddah 21589, saudi arabia Tel +96 612 640 0000 extension 22251 email oaahmed@kau.edu.s a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Hashem et al Running head recto: Nanostructured atorvastatin–zein formulation DOI: http://dx.doi.org/10.2147/IJN.S83906",Non-OADS,/arxiv_data1/oa_pdf/16/7b/ijn-10-4059.PMC4480588.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/16/7b/ijn-10-4059.PMC4480588.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/7b/ijn-10-4059.PMC4480588.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c1/db/ijn-10-4043.PMC4480589.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 4043–4057International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4043OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7904 5The therapeutic effect of methotrexate- conjugated Pluronic-based polymeric micelles  on the folate receptor-rich tumors treatment Yanzuo chen1–3 Wei Zhang2,4 YuKun huang1 Feng gao1 Xianyi sha2 Kaiyan lou1 Xiaoling Fang2 1Department of Pharmaceutics, school  of Pharmacy, east china University  of science and T echnology, 2Key  laboratory of smart Drug Delivery,   Ministry of education and P la,   Department of Pharmaceutics, school  of Pharmacy, 3state Key laboratory  of Molecular engineering of Polymers,   Department of Macromolecular  science, Fudan University, shanghai,   People’s republic of china;   4cONraD, Department of Obstetrics  and gynecology, eastern Virginia  Medical school, arlington, V a, UsaAbstract:  The therapeutic effect of methotrexate (MTX)-conjugated Pluronic-based polymeric  mixed micelles (F127/P105-MTX) on the folate receptor-overexpressing tumors treatment was  investigated in this study.",Non-OADS,/arxiv_data1/oa_pdf/c1/db/ijn-10-4043.PMC4480589.pdf
"The  narrow size range is similar to those of viruses and lipoproteins and natural mesoscopic- scaled vehicle systems, and has been considered as a crucial factor in determining  their in vivo disposition, especially when enhanced permeation and retention (EPR)  effect is involved.2 In our previous studies, polymeric micelles prepared with Pluronic  F127 and P105 have been demonstrated to enhance anticancer efficacy of docetaxel  and methotrexate (MTX) against multidrug-resistant (MDR) cancer cells in vitro and  in vivo.3–5 Pluronic P105 is presented as PEO37–PPO56–PEO37 triblock copolymer  with high MDR tumor-sensitizing ability, and Pluronic F127 is presented as PEO100– PPO65–PEO100 triblock copolymer with long poly(ethylene oxide) (PEO) hydrophilic correspondence: Yanzuo chen Department of Pharmaceutics, school  of Pharmacy, east china University  of science and Technology, lane 130,  Meilong road, shanghai 200237,   People’s republic of china email chenyz@ecust.edu.c n  Xiaoling Fang Key laboratory of smart Drug Delivery,  Ministry of education and Pla,  Department of Pharmaceutics, school of  Pharmacy, Fudan University, lane 826,  Zhangheng road, shanghai 201203,  People’s republic of china email xlfang@shmu.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chen et al Running head recto: Methotrexate-conjugated micelles for folate receptor-rich cancer therapy DOI: http://dx.doi.org/10.2147/IJN.S79045",Non-OADS,/arxiv_data1/oa_pdf/c1/db/ijn-10-4043.PMC4480589.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c1/db/ijn-10-4043.PMC4480589.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/db/ijn-10-4043.PMC4480589.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/30/copd-10-1199.PMC4480590.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1199–1205International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1199OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8291 0Influence of pulmonary emphysema on COPD  assessment test-oriented categorization in gOlD  document T oshio Suzuki1 Yuji Tada1 Naoko Kawata1 Jun Ikari1 Yasunori Kasahara1 Y oriko Sakurai1 Ken Iesato1 Rintaro Nishimura1 James West2 Koichiro Tatsumi1 1Department of Respirology,   Graduate School of Medicine, Chiba  University, Chiba, Japan; 2Department  of Medicine, Vanderbilt University  Medical Center, Nashville, TN, USABackground:  The COPD assessment test (CAT) score is a key component of the multifactorial  assessment of COPD in the Global initiative for chronic Obstructive Lung Disease (GOLD)  guidelines of 2014.",Non-OADS,/arxiv_data1/oa_pdf/a3/30/copd-10-1199.PMC4480590.pdf
"Correspondence: Yuji Tada Department of Respirology, Graduate  School of Medicine, Chiba University,  1-8-1 Inohana Chuo-ku, Chiba 260-8670,  Japan Tel +81 43 222 7171 Fax +81 43 226 2176 email ytada@faculty.chiba-u.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Suzuki et al Running head recto: Emphysema on CAT-oriented categorization DOI: http://dx.doi.org/10.2147/COPD.S82910",Non-OADS,/arxiv_data1/oa_pdf/a3/30/copd-10-1199.PMC4480590.pdf
"Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report_2014_Jun11.pd f. Accessed February 12,  2015.",OADS,/arxiv_data1/oa_pdf/a3/30/copd-10-1199.PMC4480590.pdf
Avail - able from: http://www.thoracic.org/clinical/copd-guidelines/resources/ copddoc.pdf#search =%2713.,Non-OADS,/arxiv_data1/oa_pdf/a3/30/copd-10-1199.PMC4480590.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a3/30/copd-10-1199.PMC4480590.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/30/copd-10-1199.PMC4480590.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/ceor-7-357.PMC4480591.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 357–367ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  357ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8226 7association of persistent and transient worsening  renal function with mortality risk, readmissions  risk, length of stay, and costs in patients  hospitalized with acute heart failure Jacqueline B Palmer1 howard s Friedman2 Katherine Waltman  Johnson1 Prakash navaratnam2 stephen s gottlieb3 1novartis Pharmaceuticals  Corporation, East hanover, nJ, Usa;   2DataMed solutions, llC, new York,  nY, Usa;  3Department of Medicine,  University of Maryland school of  Medicine, Baltimore, MD, Usa Correspondence: stephen s gottlieb   Department of Medicine, University of  Maryland school of Medicine,  110 south  Paca street, Baltimore, MD  21201, Usa   Tel +1 410 328 8788  Fax +1 410 328 1048  Email sgottlie@medicine.umaryland.ed uBackground:  Data comparing effects of transient worsening renal function (WRFt) and per - sistent WRF (WRFp) on outcomes in patients hospitalized with acute heart failure (AHF) are  lacking.",Non-OADS,/arxiv_data1/oa_pdf/26/f5/ceor-7-357.PMC4480591.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/26/f5/ceor-7-357.PMC4480591.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/ceor-7-357.PMC4480591.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/e5/ott-8-1503.PMC4480592.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1503–1509OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1503Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8063 4Prognostic role of urokinase plasminogen activator  receptor in gastric and colorectal cancer: a  systematic review and meta-analysis Hong Guo1,2 Chun Ling1 Yun-yun Ma1 Lan-xia Zhou1 Li Zhao2 1The First Clinical Medical College,  Lanzhou University, Lanzhou, 2The First  Hospital, Lanzhou University, Lanzhou,  People’s Republic of ChinaPurpose:  Although the urokinase plasminogen activator receptor (uPAR) is expressed in gastric  cancer (GC) and colorectal cancer (CRC), its evaluation as a prognostic biomarker remains  controversial.",Non-OADS,/arxiv_data1/oa_pdf/78/e5/ott-8-1503.PMC4480592.pdf
"Urokinase plasminogen activator (uPA) is a serine protease that is first secreted as  a proenzyme, and then activated by proteolytic cleavage after binding to its specific  cell-surface receptor, urokinase plasminogen activator receptor (uPAR).4 In many Correspondence: Li Zhao The First Hospital of Lanzhou University,  No 1, Donggang west Road, Lanzhou  730000, Gansu, People’s Republic of  China email gszhaoli66@163.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Guo et al Running head recto: Prognostic role of uPAR in GC and CRC DOI: http://dx.doi.org/10.2147/OTT.S80634",Non-OADS,/arxiv_data1/oa_pdf/78/e5/ott-8-1503.PMC4480592.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/78/e5/ott-8-1503.PMC4480592.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/e5/ott-8-1503.PMC4480592.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/65/oajsm-6-181.PMC4480593.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 181–189Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  181OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S8467 1reliability and validity of a dual-task test for  skill proficiency in roundhouse kicks in elite  taekwondo athletes Chung-Yu Chen1  Jing Dai2  I-Fan Chen3  Kuei-Ming Chou4  Chen-Kang Chang5 1Department of Physical Education,   2Department of Sport Performance,   National Taiwan University of Sport,   Taichung, Taiwan;  3graduate institute  of Sport Coaching Science, Chinese  Culture University, Taipei, Taiwan;   4Department of Combat Sport,    5Sport Science Research Center,   national Taiwan University of   Sport, Taichung, Taiwan Correspondence: Chen-Kang Chang   Sport Science Research Center, National  Taiwan University of Sport,  16, Section  1,  Shuan-Shih Road, Taichung  404, Taiwan   Tel +886 4 222 13108  ext 2235  Fax +886 4 222 32463   email wspahn@seed.net.t wAbstract:  The dual-task methodology, conducting two tasks simultaneously, may provide better  validity than the traditional single-task tests in the environment that is closely related to real sport  competitions.",Non-OADS,/arxiv_data1/oa_pdf/7a/65/oajsm-6-181.PMC4480593.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/7a/65/oajsm-6-181.PMC4480593.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/65/oajsm-6-181.PMC4480593.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/1c/ppa-9-821.PMC4480594.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 821–830Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  821OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8196 3reasons for not initiating osteoporosis therapy  among a managed care population Jingbo Yu1 susan K Brenneman2 Vasilisa sazonov1 Ankita Modi1 1center for Observational and  real-World evidence, Merck & co.,   inc., Kenilworth, nJ, UsA; 2health  economics and Outcomes research,   Optum, eden Prairie, M n, UsABackground:  Many women with osteoporosis do not initiate osteoporosis treatment.",Non-OADS,/arxiv_data1/oa_pdf/f0/1c/ppa-9-821.PMC4480594.pdf
"The National Osteoporosis Foundation recommends bone mineral density  (BMD) testing be considered for all women aged 65 years and older irrespective of correspondence: Ankita Modi center for Observational and real- World evidence, Merck & co., inc.,  2000 galloping hill rd, Kenilworth,  nJ 07033, UsA Tel +1 908 236 4563 Fax +1 908 236 4089 email ankita.modi@merck.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Yu et al Running head recto: Reasons for not initiating osteoporosis therapy DOI: http://dx.doi.org/10.2147/PPA.S81963",Non-OADS,/arxiv_data1/oa_pdf/f0/1c/ppa-9-821.PMC4480594.pdf
"Available from: http://nof.org/files/nof/public/content/file/2791/ upload/919.pd f. Accessed January 12, 2015.",OADS,/arxiv_data1/oa_pdf/f0/1c/ppa-9-821.PMC4480594.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f0/1c/ppa-9-821.PMC4480594.pdf
"Available from: http://data.bls.gov/cgi-bin/surveymos t. Accessed  January 12, 2015.",OADS,/arxiv_data1/oa_pdf/f0/1c/ppa-9-821.PMC4480594.pdf
"Available at: http://www.ecdc.europa.eu/en/healthtopics/ escherichia_coli/basic_facts/Pages/basic_facts.aspx (accessedon November 14, 2013).",Non-OADS,/arxiv_data1/oa_pdf/75/95/apa0103-1192.PMC4480659.pdf
"Graphical abstract Keywords Enediyne polyketide synthase; Biosynthetic gene cluster; Genome mining; ADC payload; Natural  products The enediyne natural products are the most cytotoxic molecules in existence today, and their  use as anticancer drugs has been demonstrated clinically.1–6 The natural enediynes have  seen limited use as clinical drugs mainly because of substantial toxicity, however, various  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/6b/8f/nihms701638.PMC4480864.pdf
"Developmental  Cognitive  Neuroscience  13  (2015)  68–74 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience jo  ur  nal  ho  me  pag  e:  http://www.elsevier.com/locate/dcn The  direct segment of  the  arcuate  fasciculus  is  predictive of  longitudinal reading change Margaret  M.  Gullick∗,  James  R.  Booth1 Roxelyn  and  Richard  Pepper  Department  of  Communication  Sciences  and  Disorders,  Northwestern  University,  2240  Campus  Drive,  Evanston,  IL  60208,  USA a  r  t  i  c  l  e  i  n  f  o Article  history: Received  5 November 2014 Received in  revised  form  30  April  2015 Accepted  4 May  2015 Available online  13  May  2015 Keywords:Magnetic resonance  imaging Diffusion  tensor  imaging Arcuate  fasciculus Superior  longitudinal  fasciculus LongitudinalReading developmenta  b  s  t  r  a  c  t Structural  coherence  across  the  arcuate  fasciculus  has  previously  been  related  to  reading  skill,  but  the arcuate may  be  divisible  into  distinct  subtracts  which  support  different  functions.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Further,  signiﬁcant  differences  in  arcuate connectivity  have  been  found  between  reading-skill  groups:  both http://dx.doi.org/10.1016/j.dcn.2015.05.002 1878-9293/© 2015  Published  by  Elsevier  Ltd.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.dcn.2015.05.002 References Beaulieu,  C.,  Plewes,  C.,  Paulson,  L.A.,  Roy,  D.,  Snook,  L.,  Concha,  L.,  Phillips,  L.,  2005.",OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Neuroimage 25 (4),  1266–1271,  http://dx.doi.org/10.1016/J.Neuroimage.2004.12.053 Catani,  M.,  Jones,  D.K.,  Ffytche,  D.H.,  2005.",OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Annals  of  Neurology  57  (1),  8–16,  http://dx.doi.org/10.1002/Ana.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Neuropsychologia  46 (4),  927–934,  http://dx.doi.org/10.1016/j.neuropsychologia.2007.10.025 Eden, G.F., Jones, K.M.,  Cappell,  K.,  Gareau,  L.,  Wood,  F.B.,  Zefﬁro,  T.A.,  Flowers,  D.L., 2004.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Neuron  44  (3),  411–422,  http://dx.doi.org/10.1016/j.neuron.2004.10.019 Friederici,  A.D.,  2009.",OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Trends in Cognitive Sciences 13 (4), 175–181,  http://dx.doi.org/10.1016/j.tics.2009.01.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Cerebral Cortex  18  (11),  2471–2482,  http://dx.doi.org/10.1093/cercor/ bhn011 Gold,  B.T.,  Powell,  D.K.,  Xuan,  L.,  Jiang,  Y.,  Hardy,  P.A.,  2007.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Neuropsychologia  45  (11),  2439–2446, http://dx.doi.org/10.1016/J.Neuropsychologia.2007.04.011 Gullick,  M.M.,  Booth,  J.,  2014.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Journal  of  Cognitive Neuroscience  26  (7),  1331–1346,  http://dx.doi.org/10.1162/jocn  a  00581Hoeft,  F.,  McCandliss,  B.D.,  Black,  J.M.,  Gantman,  A.,  Zakerani,  N.,  Hulme,  C., Gabrieli,  J.D.E.,  2011.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Proceedings  of  the  National  Academy  of  Sciences  of  the  United  States  of  America 108 (1),  361–366,  http://dx.doi.org/10.1073/Pnas.1008950108 Makris,  N.,  Kennedy,  D.N.,  McInerney,  S.,  Sorensen,  A.G.,  Wang,  R.,  Caviness,  V.S., Pandya,  D.N.,  2005.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Cerebral  Cortex 15  (6), 854–869, http://dx.doi.org/10.1093/cercor/bhh186 Myers,  C.A.,  Vandermosten,  M.,  Farris,  E.A.,  Hancock,  R.,  Gimenez,  P.,  Black,  J.M., Hoeft, F.,  2014.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Psychological  Science  25  (10),  1870–1883,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Jour- nal  of  Cognitive  Neuroscience  16  (7),  1227–1233,  http://dx.doi.org/10.1162/ 0898929041920441 Richlan,  F.,  Kronbichler,  M.,  Wimmer,  H.,  2009.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Human Brain  Mapping  30  (10),  3299–3308,  http://dx.doi.org/10.1002/Hbm.20752 Roberts, R.E.,  Anderson,  E.J.,  Husain,  M.,  2013.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Neuroscientist  19  (1),  8–15,  http://dx.doi.org/10.1177/ 1073858411421218 Saygin,  Z.M.,  Norton,  E.S.,  Osher,  D.E.,  Beach,  S.D.,  Cyr,  A.B.,  Ozernov-Palchik,  O., Gabrieli, J.D.E.,  2013.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Journal  of  Neuroscience  33  (33),  13251–13258, http://dx.doi.org/10.1523/Jneurosci.4383-12.2013 Thiebaut de  Schotten,  M.,  Cohen,  L.,  Amemiya,  E.,  Braga,  L.W.,  Dehaene,  S.,  2014.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Cerebral  Cortex 24  (4),  989–995,  http://dx.doi.org/10.1093/cercor/bhs383 Vandermosten, M.,  Boets,  B.,  Poelmans,  H.,  Sunaert,  S.,  Wouters,  J.,  Ghesquiere,  P., 2012a.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Brain  135,  935–948,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Neuroscience and  Biobehavioral  Reviews  36  (6),  1532–1552,  http://dx.doi.org/ 10.1016/J.Neubiorev.2012.04.002 Wagner,  R.K.,  Torgesen,  J.K.,  Rashotte,  C.A.,  1999.",OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Neuroimage  36  (3),  630–644,  http://dx.doi.org/10.1016/ J.Neuroimage.2007.02.049 Wechsler, D., 1999.",OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
"Journal  of  Cognitive  Neuro- science  23  (11),  3304–3317,  http://dx.doi.org/10.1162/jocn  a  00061 .",Non-OADS,/arxiv_data1/oa_pdf/57/74/main.PMC4480913.pdf
" Annals of Surgical Treatment and Research 1pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.1.1 Annals of Surgical Treatment and ResearchREVIEW ARTICLE Pivotal role of vascular endothelial growth factor  pathway in tumor angiogenesis Sang Hun Lee1,2, Dongjun Jeong3, Yong-Seok Han1, Moo Jun Baek4 1Medical Science Research Institute, Soonchunhyang University Seoul Hospital, Seoul, Departments of 2Biochemistry, 3Pathology,  and 4Surgery, Soonchunhyang University College of Medicine, Cheonan, Korea INTRODUCTION The formation of new blood vessels from pre-existing  vessels, known as angiogenesis, is an essential process in  malignant tumor growth.",Non-OADS,/arxiv_data1/oa_pdf/6c/eb/astr-89-1.PMC4481026.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/eb/astr-89-1.PMC4481026.pdf
" Annals of Surgical Treatment and Research 17pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.1.17 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The effects of ventilation with high density oxygen on   the strength of gastrointestinal anastomosis Tevfik Eker, Volkan Genc, Yusuf Sevim1, Ozge Cumaogullari2, Menekse Ozcelik3, Akin Firat Kocaay,   Cemal Özben Ensari4, Ozge Tugce Pasaoglu5 Department of General Surgery, Ankara University Medical School, Ankara, 1Department of General Surgery, Ankara Penal  Institution Campus State Hospital, Ankara, 2Ankara University Biotechnology Institute, Ankara, 3Department of Anesthesiology   and Reanimation, Ankara University Medical School, Ankara, 4Department of General Surgery, Antalya Education and Training  Hospital, Antalya, 5Department of Medical Biochemistry, Gazi University Medical School, Ankara, Turkey INTRODUCTION Anastomotic leak (AL) is the most distressing early com­ plication of gastrointestinal anastomosis; it also requires  frequent reoperation.",Non-OADS,/arxiv_data1/oa_pdf/ca/cb/astr-89-17.PMC4481027.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/cb/astr-89-17.PMC4481027.pdf
" Annals of Surgical Treatment and Research 23pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.1.23 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Oncologic outcomes in rectal cancer with close distal  resection margins: a retrospective analysis Kyung Sook Hong, Nara Moon, Soon Sup Chung, Ryung-Ah Lee, Kwang Ho Kim Department of Surgery, Ewha Womans University School of Medicine, Seoul, Korea INTRODUCTION Achieving a clear resection margin and performing  en bloc  resection are crucial in rectal cancer surgery.",Non-OADS,/arxiv_data1/oa_pdf/68/70/astr-89-23.PMC4481028.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/70/astr-89-23.PMC4481028.pdf
"30pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.1.30 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Outcomes of retrievable inferior vena cava filters in  patients with deep vein thrombosis and transient contraindication for anticoagulation Hyung-Kee Kim, Incheol Song, Ji-Hoon Jang, Chang-Wug Oh1, Jong-Min Lee2, Seung Huh Division of Vascular Surgery, Department of Surgery, Departments of 1Orthopedic Surgery and 2Radiology, Kyungpook National  University School of Medicine, Daegu, Korea INTRODUCTION Pulmonary embolism (PE) is a major preventable cause of  death in hospitalized patients [1].",Non-OADS,/arxiv_data1/oa_pdf/88/74/astr-89-30.PMC4481029.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/74/astr-89-30.PMC4481029.pdf
" Annals of Surgical Treatment and Research 37pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.1.37 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Heterogeneous living donor hepatic fat distribution on  MRI chemical shift imaging YoungRok Choi, Jeong Min Lee1, Nam-Joon Yi2, Hyeyoung Kim2, Min-Su Park2, Geun Hong2, Tae Yoo2,   Suk-Won Suh2, Hae Won Lee2, Kwang-Woong Lee2, Kyung-Suk Suh2 Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Departments of 1Radiology and 2Surgery, Seoul  National University College of Medicine, Seoul, Korea INTRODUCTION Nonalcoholic fatty liver disease affects 10%–30% of adults  and 13% of children in the general population [1,2].",Non-OADS,/arxiv_data1/oa_pdf/8f/51/astr-89-37.PMC4481030.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/51/astr-89-37.PMC4481030.pdf
" Annals of Surgical Treatment and Research 43pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.1.43 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Clinical characteristics of ceftriaxone plus metronidazole  in complicated intra-abdominal infection Jung Min Bae Department of Surgery, Yeungnam University College of Medicine, Daegu, Korea INTRODUCTION Empirical antibiotics in complicated intra-abdominal  infection (c-IAI), such as secondary peritonitis are a very im - p ortant first step of treatment.",Non-OADS,/arxiv_data1/oa_pdf/6f/2b/astr-89-43.PMC4481031.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/2b/astr-89-43.PMC4481031.pdf
"48pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.1.48 Annals of Surgical Treatment and ResearchCASE REPORT Renal autotransplantation in open surgical repair of  suprarenal abdominal aortic aneurysm Eun-Ki Min, Young Hoon Kim1, Duck Jong Han1, Youngjin Han1, Hyunwook Kwon1, Byung Hyun Choi1,   Hojong Park2, Ji Yoon Choi1, Tae-Won Kwon1, Yong-Pil Cho1 Yonsei University College of Medicine, Seoul, 1Department of Surgery, Asan Medical Center, University of Ulsan College of  Medicine, Seoul, 2Department of Surgery, Ulsan University Hospital, Ulsan, Korea INTRODUCTION Although endovascular aneurysm repair (EVAR) has been  replacing open surgical repair (OSR) in the treatment of  standard infrarenal abdominal aortic aneurysms (AAAs) over the last 10 years, OSR has remained the standard of care for patients with complex aneurysms involving the visceral arteries and for patients unsuitable for EVAR [1,2].",Non-OADS,/arxiv_data1/oa_pdf/bd/de/astr-89-48.PMC4481032.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/de/astr-89-48.PMC4481032.pdf
" Annals of Surgical Treatment and Research 51pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.1.51 Annals of Surgical Treatment and ResearchCASE REPORT Use of cryopreserved cadaveric arterial allograft as a  vascular conduit for peripheral arterial graft infection Hyojeong Kwon, Hyunwook Kwon1, Joon Pio Hong2, Youngjin Han1, Hojong Park3, Gi-Won Song1,   Tae-Won Kwon1, Yong-Pil Cho1 Gachon University of Medicine and Science, Incheon, Departments of 1Surgery and 2Plastic Surgery, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, 3Department of Surgery, Ulsan University Hospital, Ulsan, Korea INTRODUCTION Major peripheral graft infection in patients with severe  underlying peripheral arterial occlusive disease is associated  with high operative mortality, recurrent infection, and am­putation rates, especially when autologous conduits are unavailable or unsuitable [1 ­3 ].",Non-OADS,/arxiv_data1/oa_pdf/ef/21/astr-89-51.PMC4481033.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/21/astr-89-51.PMC4481033.pdf
" Annals of Surgical Treatment and Research 9pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.1.9 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE CD44 expression in patients with combined  hepatocellular cholangiocarcinoma Ryounggo Kim, Sang Bum Kim, Eung-Ho Cho, Sun Hoo Park1, Sung Bae Park2, Seong Kweon Hong2,   Gibong Chae2 Departments of Surgery and 1Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences, Seoul,  2Department of Surgery, Kangwon National University Hospital, Chuncheon, Korea INTRODUCTION Combined hepatocellular cholangiocarcinoma (ChC) is a rare  subtype of primary liver cancer.",Non-OADS,/arxiv_data1/oa_pdf/10/9f/astr-89-9.PMC4481034.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/9f/astr-89-9.PMC4481034.pdf
"159 http://dx.doi.org/10.3345/kjp.2015.58.5.159Korean J Pediatr 2015;58(5):159-164 Approaches to the diagnosis and management  of chronic urticaria in children Sun Hee Choi, MD, PhD1, Hey Sung Baek, MD, PhD2 1Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, 2Department of Pediatrics, Gangdong  Sacred Heart Hospital, Hallym University School of Medicine, Seoul, Korea Most guidelines for chronic urticaria (CU) in infants and children are based on limited pediatric  evidence.",Non-OADS,/arxiv_data1/oa_pdf/fc/2f/kjped-58-159.PMC4481035.pdf
"Corresponding author: Sun Hee Choi, MD, PhD Department of Pediatrics, Kyung Hee University  Hospital at Gangdong, 892 Dongnam-ro, Gang - dong-gu, Seoul 134-727, Korea Tel: +82-2-440-6278 Fax: +82-2-440-6295 E-mail: chsh0414@naver.com Received: 9 October, 2014 Accepted: 17 March, 2015 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2015;58(5):159-164 http://dx.doi.org/10.3345/kjp.2015.58.5.159 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/fc/2f/kjped-58-159.PMC4481035.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.159Choi SH and Baek HS  • Chronic urticaria in childhood  160Definition and classification of urticaria and its  severity Urticaria manifests as wheals, angioedema, or both.",Non-OADS,/arxiv_data1/oa_pdf/fc/2f/kjped-58-159.PMC4481035.pdf
161 http://dx.doi.org/10.3345/kjp.2015.58.5.159Korean J Pediatr 2015;58(5):159-164 conditions should be considered for spontaneous CU cases.,Non-OADS,/arxiv_data1/oa_pdf/fc/2f/kjped-58-159.PMC4481035.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.159Choi SH and Baek HS  • Chronic urticaria in childhood  162gy to diagnose these underlying autoimmune diseases (such as  connective tissue disease) is not warranted in an initial evalua - tion of CU in the absence of additional features suggesting con - comitant autoimmune disease1,25-27).",Non-OADS,/arxiv_data1/oa_pdf/fc/2f/kjped-58-159.PMC4481035.pdf
163 http://dx.doi.org/10.3345/kjp.2015.58.5.159Korean J Pediatr 2015;58(5):159-164 used (step 2) for patients who do not respond to monotherapy  with a second-generation antihistamine.,Non-OADS,/arxiv_data1/oa_pdf/fc/2f/kjped-58-159.PMC4481035.pdf
http://dx.doi.org/10.3345/kjp.2015.58.5.159Choi SH and Baek HS  • Chronic urticaria in childhood  164References  1.,Non-OADS,/arxiv_data1/oa_pdf/fc/2f/kjped-58-159.PMC4481035.pdf
"165 http://dx.doi.org/10.3345/kjp.2015.58.5.165Korean J Pediatr 2015;58(5):165-171 Association between serum alanine amino­ transferase level and obesity indices in Korean  adolescents Moon Bae Ahn, MD1, Woo Ri Bae, MD1, Kyung Do Han2, Won Kyoung Cho, MD3, Kyoung Soon Cho, MD1, So Hyun Park, MD4, Min Ho  Jung, MD5, Byung Kyu Suh, MD3 1Department of Pediatrics, Bucheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Buchoen, 2Department of Biostatistics, The Catholic  University of Korea College of Medicine, Seoul, 3Department of Pediatrics, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul,  4Department of Pediatrics, St. Vincent Hospital, The Catholic University of Korea College of Medicine, Suwon, 5Department of Pediatrics, Yeouido St. Mary's Hospital,  The Catholic University of Korea College of Medicine, Seoul, Korea Purpose:  To analyze the correlation between serum alanine aminotransferase (ALT) and obesity  indices including body mass index (BMI), body fat percentage (BFP), total fat mass (FM), truncal fat  mass (TFM), waist circumference (WC), and waist-to-height ratio (WHtR) in Korean adolescents.",Non-OADS,/arxiv_data1/oa_pdf/e8/e0/kjped-58-165.PMC4481036.pdf
"According to a study conducted by  Loomba et al.2), the prevalence of NAFLD in the pediatric population ranged from 3% to Corresponding author: Kyoung Soon Cho, MD Department of Pediatrics, Bucheon St. Mary’s  Hospital, The Catholic University of Korea College  of Medicine, 327 Sosa-ro 327beon-gil, Wonmi-gu,  Bucheon 420-717, Korea Tel: +82-32-340-7065 Fax: +82-32-340-2673 E-mail: soon926@catholic.ac.kr Received: 17 July, 2014 Revised: 5 September, 2014 Accepted: 2 October, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(5):165­171 http://dx.doi.org/10.3345/kjp.2015.58.5.165 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/e8/e0/kjped-58-165.PMC4481036.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.165Ahn MB, et al.",OADS,/arxiv_data1/oa_pdf/e8/e0/kjped-58-165.PMC4481036.pdf
167 http://dx.doi.org/10.3345/kjp.2015.58.5.165Korean J Pediatr 2015;58(5):165-171 obesity indices was calculated based on sex and age.,OADS,/arxiv_data1/oa_pdf/e8/e0/kjped-58-165.PMC4481036.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.165Ahn MB, et al.",OADS,/arxiv_data1/oa_pdf/e8/e0/kjped-58-165.PMC4481036.pdf
"169 http://dx.doi.org/10.3345/kjp.2015.58.5.165Korean J Pediatr 2015;58(5):165-171 whole-body DXA, bioelectrical impedance analysis, or skinfold  measurements to assess body fat composition and diagnose  obesity.",Non-OADS,/arxiv_data1/oa_pdf/e8/e0/kjped-58-165.PMC4481036.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.165Ahn MB, et al.",OADS,/arxiv_data1/oa_pdf/e8/e0/kjped-58-165.PMC4481036.pdf
171 http://dx.doi.org/10.3345/kjp.2015.58.5.165Korean J Pediatr 2015;58(5):165-171 53:99-105.,Non-OADS,/arxiv_data1/oa_pdf/e8/e0/kjped-58-165.PMC4481036.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.172Kim EK, et al.",OADS,/arxiv_data1/oa_pdf/76/4c/kjped-58-172.PMC4481037.pdf
"Corresponding author: Kyung-Yil Lee, MD Department of Pediatrics, The Catholic University of  Korea, Daejeon St. Mary’s Hospital, 64 Daeheung- ro, Jung-gu, Daejeon 301-723, Korea Tel: +82-42-220-9541  Fax: +82-42-221-2925   E-mail: leekyungyil@catholic.ac.kr Received: 8 August, 2014 Revised: 12 September, 2014 Accepted: 25 September, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(5):172-177 http://dx.doi.org/10.3345/kjp.2015.58.5.172 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/76/4c/kjped-58-172.PMC4481037.pdf
"173 http://dx.doi.org/10.3345/kjp.2015.58.5.172Korean J Pediatr 2015;58(5):172-177 In this study, we evaluated patients with MP pneumonia for the  decade from 2003 to 2012 and compared epidemiological data  from 3 MP pneumonia epidemics during the study period with  more than 100 patients a year.",Non-OADS,/arxiv_data1/oa_pdf/76/4c/kjped-58-172.PMC4481037.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.172Kim EK, et al.",OADS,/arxiv_data1/oa_pdf/76/4c/kjped-58-172.PMC4481037.pdf
"175 http://dx.doi.org/10.3345/kjp.2015.58.5.172Korean J Pediatr 2015;58(5):172-177 infections differ according to pathogen, and seasonal influenza  is most prevalent from January to April in Korea [unpublished  observation].",Non-OADS,/arxiv_data1/oa_pdf/76/4c/kjped-58-172.PMC4481037.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.172Kim EK, et al.",OADS,/arxiv_data1/oa_pdf/76/4c/kjped-58-172.PMC4481037.pdf
177 http://dx.doi.org/10.3345/kjp.2015.58.5.172Korean J Pediatr 2015;58(5):172-177 of M. pneumoniae clinical strains.,Non-OADS,/arxiv_data1/oa_pdf/76/4c/kjped-58-172.PMC4481037.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.178Son BR and Kim JY  • Regulatory T cells and childhood chronic ITP 178 Association of CD4+CD25+FoxP3+ regulatory T  cells with natural course of childhood chronic  immune thrombocytopenic purpura Bo Ra Son, MD1, Ji Yoon Kim, MD2,3 1Department of Laboratory Medicine, Chungbuk National University College of Medicine, Cheongju, 2Department of Pediatrics, Kyungpook National University  School of Medicine, Daegu, 3Department of Pediatric Hematology-Oncology, Kyungpook National University Children’s Hospital, Kyungpook National University  Medical Center, Daegu, Korea Purpose: The purpose of this study was to determine the frequency of CD4+CD25+FoxP3+ regulatory  T cells (Treg) in the peripheral blood of patients with childhood chronic immune thrombocytopenic  purpura (ITP) exhibiting thrombocytopenia and spontaneous remission.",OADS,/arxiv_data1/oa_pdf/2e/5e/kjped-58-178.PMC4481038.pdf
"Childhood ITP is usually a self­limiting disease and is typically normalized within Corresponding author: Ji Yoon Kim, MD Department of Pediatric Hematology-Oncology,  Kyungpook National University Children’s Hospital,  Kyungpook National University Medical Center, 807  Hoguk-ro, Buk-gu, Daegu 702-210, Korea Tel: +82-53-200-5704 Fax: +82-53-425-6683 E-mail: phojyk@gmail.com  Received: 20 April, 2015 Revised: 29 April, 2015 Accepted: 7 May, 2015 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(5):178-182 http://dx.doi.org/10.3345/kjp.2015.58.5.178 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/2e/5e/kjped-58-178.PMC4481038.pdf
179 http://dx.doi.org/10.3345/kjp.2015.58.5.178Korean J Pediatr 2015;58(5):178-182 several months.,Non-OADS,/arxiv_data1/oa_pdf/2e/5e/kjped-58-178.PMC4481038.pdf
http://dx.doi.org/10.3345/kjp.2015.58.5.178Son BR and Kim JY  • Regulatory T cells and childhood chronic ITP 180sex ratio of all enrolled patients were not significantly different  from the total chronic ITP patients.,OADS,/arxiv_data1/oa_pdf/2e/5e/kjped-58-178.PMC4481038.pdf
"181 http://dx.doi.org/10.3345/kjp.2015.58.5.178Korean J Pediatr 2015;58(5):178-182 after the critical diagnosis; therefore, invasive therapy should  be delayed.",Non-OADS,/arxiv_data1/oa_pdf/2e/5e/kjped-58-178.PMC4481038.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.178Son BR and Kim JY  • Regulatory T cells and childhood chronic ITP 182the loss of immune tolerance for maintaining the platelet count,  and recovery from the impairment of Tregs to normal level is as ­ sociated with the spontaneous remission.",Non-OADS,/arxiv_data1/oa_pdf/2e/5e/kjped-58-178.PMC4481038.pdf
"183 http://dx.doi.org/10.3345/kjp.2015.58.5.183Korean J Pediatr 2015;58(5):183-189 Validity of bag urine culture for predicting  urinary tract infections in febrile infants: a paired  comparison of urine collection methods Geun-A Kim, MD, Ja-Wook Koo, MD, PhD Department of Pediatrics, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea Purpose:  Catheter urine (CATH-U) and suprapubic aspiration (SPA) are reliable urine collection  methods for confirming urinary tract infections (UTI) in infants.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/kjped-58-183.PMC4481039.pdf
"Transurethral catheterization is a less painful method that Corresponding author: Ja-Wook Koo, MD, PhD  Department of Pediatrics, Inje University Sanggye  Paik Hospital, Inje University College of Medicine,  1342 Dongil-ro, Nowon-gu, Seoul 139-707, Korea Tel: +82-2-950-1074 Fax: +82-2-950-1246 E-mail: koojw9@paik.ac.kr Received: 14 July, 2014 Revised: 17 August, 2014 Accepted: 24 September, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(5):183-189 http://dx.doi.org/10.3345/kjp.2015.58.5.183 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/kjped-58-183.PMC4481039.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.183Kim GA and Koo JW  • Validity of bag urine culture in febrile infants 184has comparable sensitivity and specificity as SPA, making it  more routinely used2,6).",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/kjped-58-183.PMC4481039.pdf
"185 http://dx.doi.org/10.3345/kjp.2015.58.5.183Korean J Pediatr 2015;58(5):183-189 13 received antibacterial agents before urine collection, 6 were  circumcised male infants, and 2 patients had CBU cultures  positive for CNS.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/kjped-58-183.PMC4481039.pdf
http://dx.doi.org/10.3345/kjp.2015.58.5.183Kim GA and Koo JW  • Validity of bag urine culture in febrile infants 186levels were higher in the UTI groups than in the non-UTI group.,OADS,/arxiv_data1/oa_pdf/cd/0c/kjped-58-183.PMC4481039.pdf
187 http://dx.doi.org/10.3345/kjp.2015.58.5.183Korean J Pediatr 2015;58(5):183-189 is more difficult because SPA is a more invasive and painful urine  collection method than CATH-U9).,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/kjped-58-183.PMC4481039.pdf
http://dx.doi.org/10.3345/kjp.2015.58.5.183Kim GA and Koo JW  • Validity of bag urine culture in febrile infants 188materials.,OADS,/arxiv_data1/oa_pdf/cd/0c/kjped-58-183.PMC4481039.pdf
189 http://dx.doi.org/10.3345/kjp.2015.58.5.183Korean J Pediatr 2015;58(5):183-189  7.,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/kjped-58-183.PMC4481039.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.190Shim JE, et al.",OADS,/arxiv_data1/oa_pdf/64/d3/kjped-58-190.PMC4481040.pdf
"Here, we report an unusual case of seropositive ABPA in a 10-year-old Korean girl without  previous history of asthma.Corresponding author: Jung Yeon Shim, MD, PhD Division of Pediatric Allergy & Pulmonology, Depart - ment of Pediatrics, Kangbuk Samsung Hospital,  Sungkyunkwan University School of Medicine, 29  Saemunan-ro, Jongno-gu, Seoul 110-746, Korea Tel: +82-2-2001-2484 Fax: +82-2-2001-2199 E-mail: jy7.shim@samsung.com Received: 12 July, 2013 Revised: 3 September, 2013 Accepted: 4 November, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2015;58(5):190-193 http://dx.doi.org/10.3345/kjp.2015.58.5.190 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/64/d3/kjped-58-190.PMC4481040.pdf
191 http://dx.doi.org/10.3345/kjp.2015.58.5.190Korean J Pediatr 2015;58(5):190-193 Case report A 10-year-old girl presented with a 4-month history of intrac - table cough and purulent rhinorrhea without fever.,Non-OADS,/arxiv_data1/oa_pdf/64/d3/kjped-58-190.PMC4481040.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.190Shim JE, et al.",OADS,/arxiv_data1/oa_pdf/64/d3/kjped-58-190.PMC4481040.pdf
193 http://dx.doi.org/10.3345/kjp.2015.58.5.190Korean J Pediatr 2015;58(5):190-193 Conflict of interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/64/d3/kjped-58-190.PMC4481040.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.194Chang SJ, et al.",OADS,/arxiv_data1/oa_pdf/62/e9/kjped-58-194.PMC4481041.pdf
"The main criteria include (1) progressive or relapsing motor and sensory Corresponding author: Hoon-Chul Kang, MD, PhD Division of Pediatric Neurology, Department of  Pediatrics, Severance Children's Hospital, Yonsei  University College of Medicine, 50 Yonsei-ro,  Seodaemun-gu, Seoul 120-752, Korea Tel: +82-2-2228-2050 Fax: +82-2-393-9118 E-mail: hipo0207@yuhs.ac Received: 14 June, 2013 Revised: 26 September, 2014 Accepted: 21 November, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2015;58(5):194­198 http://dx.doi.org/10.3345/kjp.2015.58.5.194 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/62/e9/kjped-58-194.PMC4481041.pdf
"195 http://dx.doi.org/10.3345/kjp.2015.58.5.194Korean J Pediatr 2015;58(4):194-198 dysfunction of more than limbs of a peripheral nerve nature,  developing over at least 2 months; and (2) electrophysiological  evidence of acquired demyelination.",Non-OADS,/arxiv_data1/oa_pdf/62/e9/kjped-58-194.PMC4481041.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.194Chang SJ, et al.",OADS,/arxiv_data1/oa_pdf/62/e9/kjped-58-194.PMC4481041.pdf
"197 http://dx.doi.org/10.3345/kjp.2015.58.5.194Korean J Pediatr 2015;58(4):194-198 corticosteroids, and plasmapheresis and have a more favorable  long-term outcome than CIDP in adults1,2).",Non-OADS,/arxiv_data1/oa_pdf/62/e9/kjped-58-194.PMC4481041.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.5.194Chang SJ, et al.",OADS,/arxiv_data1/oa_pdf/62/e9/kjped-58-194.PMC4481041.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2015, 5: 27060 - http://dx.doi.org/10.3402/iee.v5.27060 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
"The poor infrastructure in the slum can be a barrier for improvement, but at the same timetargeted interventions for safer water and better sanitationCarl-Johan Neiderud 2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27060 - http://dx.doi.org/10.3402/iee.v5.27060",Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
"It is estimated that 300,000 individuals in the United States are infected (27) and the most affectedcountry in Europe, Spain, is thought to have 45,000 /C167,000Epidemiology of emerging infectious diseases Citation: Infection Ecology and Epidemiology 2015, 5: 27060 - http://dx.doi.org/10.3402/iee.v5.27060 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
"It shows for a vector-borne disease to have a successful transmission cycle several different factorsneed to be in place to affect the human population.Carl-Johan Neiderud 4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27060 - http://dx.doi.org/10.3402/iee.v5.27060",Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
"The expected rise of travel makes it critical for the future global health and the possibility to react in time for possible threats.Epidemiology of emerging infectious diseases Citation: Infection Ecology and Epidemiology 2015, 5: 27060 - http://dx.doi.org/10.3402/iee.v5.27060 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
"However,whether it was the increased urbanization that led to aCarl-Johan Neiderud 6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27060 - http://dx.doi.org/10.3402/iee.v5.27060",Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
"Surveillance is of primary importance to monitor the burden of disease and will give both localauthorities and the global community a chance for aquick response to public health threats.Epidemiology of emerging infectious diseases Citation: Infection Ecology and Epidemiology 2015, 5: 27060 - http://dx.doi.org/10.3402/iee.v5.27060 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
Available from: http://pubs.iied.,Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
Available from: http://who.int/social_determinants/publications/urbanization/factﬁle/en/ [cited 16 December 2014].,Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
"Host-seeking heights, host-seeking activityCarl-Johan Neiderud 8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27060 - http://dx.doi.org/10.3402/iee.v5.27060",OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
Available from: http://dtxtq4w60xqpw.cloudfront.,Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
"Int J Biomed Sci 2011; 7: 295 /C1303.Epidemiology of emerging infectious diseases Citation: Infection Ecology and Epidemiology 2015, 5: 27060 - http://dx.doi.org/10.3402/iee.v5.27060 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/71/07/IEE-5-27060.PMC4481042.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2015, 5: 27094 - http://dx.doi.org/10.3402/iee.v5.27094 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27094 - http://dx.doi.org/10.3402/iee.v5.27094",Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
"Available at: www.whocc.no/atc_ ddd_index/Evaluation of antibiotic prescription Citation: Infection Ecology and Epidemiology 2015, 5: 27094 - http://dx.doi.org/10.3402/iee.v5.27094 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27094 - http://dx.doi.org/10.3402/iee.v5.27094",Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
Available from: http://www.who.int/medicines/areas/policy/ world_medicines_situation/en/ [cited April 2015].,OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
Available from: http://www.idsociety.org/Organ_System/[cited April 2015].,OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
"doi: 10.1136/bmjopen-2011-000795.Evaluation of antibiotic prescription Citation: Infection Ecology and Epidemiology 2015, 5: 27094 - http://dx.doi.org/10.3402/iee.v5.27094 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27094 - http://dx.doi.org/10.3402/iee.v5.27094",Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
"1 day 22 (53.7%) 19 (46.3%) 0.012 2 days 37 (64.9%) 20 (35.1%)3 days 25 (75.8%) 8 (24.2%) 1 week 8 (88.9%) 1 (11.1%) Laboratory culture Yes 34 (63%) 20 (37%) 0.931 No 134 (62.3%) 81 (37.7%)Evaluation of antibiotic prescription Citation: Infection Ecology and Epidemiology 2015, 5: 27094 - http://dx.doi.org/10.3402/iee.v5.27094 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
"8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27094 - http://dx.doi.org/10.3402/iee.v5.27094",Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
"1 day 11 (26.8%) 30 (73.2%) 0.107 2 days 23 (40.4%) 34 (59.6%)3 days 15 (45.5%) 18 (54.5%) 1 week 4 (44.4%) 5 (55.6%) Laboratory culture Yes 21 (38.9%) 33 (61.1%) 0.981 No 84 (39.1%) 131 (60.9%)Evaluation of antibiotic prescription Citation: Infection Ecology and Epidemiology 2015, 5: 27094 - http://dx.doi.org/10.3402/iee.v5.27094 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
"10 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27094 - http://dx.doi.org/10.3402/iee.v5.27094",Non-OADS,/arxiv_data1/oa_pdf/87/f0/IEE-5-27094.PMC4481048.pdf
Trial registration: ISRCTN register; http://www.controlled-trials.com.,Non-OADS,/arxiv_data1/oa_pdf/16/bc/keu444.PMC4481374.pdf
"Published by Oxford University Press on behalf of the British Society for Rheumatology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/bc/keu444.PMC4481374.pdf
"http://www.who.int/dietphysicalactivity/factsheet_adults/en/index.html (21 March 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/16/bc/keu444.PMC4481374.pdf
"http://www.nhs.uk/Livewell/fitness/Pages/phys- ical-activity-guidelines-for-adults.aspx (21 March 2014,date last accessed).3 Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/16/bc/keu444.PMC4481374.pdf
"http://www.cdc.gov/physicalactivity/everyone/guidelines/adults.html (21 March 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/16/bc/keu444.PMC4481374.pdf
"Introduction Stains from medicinal plants may be used to define  and examine bulk tissue and cell populations and to  Original article Key Words autodock, DT-diaphorase, hydrogen peroxide, lawsone,  NADPH, THNISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[2]:007-018 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.010    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
"Tel: +0091-9433098372  Fax: +0091-33- 2837-1078  E-mail: subhashmandal@yahoo.com ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acPharmacognosy and Phytotherapy Research Laboratory, Division of Pharmacognosy, Department of Pharmaceutical Technology, Jadav- pur University, Kolkata, India Received: Feb 25, 2015    Reviewed: May 12, 2015    Accepted: May 13, 2015",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
008  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):007-018 classify different blood cells or organelles within individu- al cells [1].,Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
"http://www.journal.ac009  Journal of Pharmacopuncture 2015;18(2):007-018 loaded in increasing order of energy; then, the play option  was selected to visualize the conformation.",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
010  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):007-018 Figure 2  Docking interactions of lawsone; different views of the lawsone interactions involved at the active sites in hydrogen peroxide.,Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
"http://www.journal.ac011  Journal of Pharmacopuncture 2015;18(2):007-018 Figure 5  Docking interactions of 1,2,4-trihydroxynaphthalen (THN); different views of the THN interactions involved at the active sites in  nitric oxide synthase.",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
012  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):007-018 Figure 9  Docking interactions of THN; different views of the THN interactions involved at the active sites in glutathione.,Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
http://www.journal.ac013  Journal of Pharmacopuncture 2015;18(2):007-018 Figure 13  Docking interactions of THN; different views of the THN interactions involved at the active sites in glucose 6-phosphate dehydroge- nase.,Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
See our FAQ and do not hesitate to provide feedback or contact us by email!Molinspiration miSMILES Oc2cc(=O)c1ccccc1c2=OmiLogP          TPSA           natoms  MW  nON   nOHNH  nviolationsnrotb  volume GPCRligand                Ion channel modulator Kinase inhibitorNuclear receptor ligand Protease inhibitor   Enzyme inhibitor -1.00 -0.37 -0.49-0.92 -1.09 -0.071.376 54.37 13.0 174.155 3 1 00 146.603http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):007-018 Figure 16  Molinspiration computational evaluations of the molecular properties and the bioactivity of lawsone.,Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
http://www.journal.ac015 Molinspiration bioactivity score v2011.06 Get data as text (for copy / paste).,OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
"016  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):007-018 bindings through oxygen were found to be 2.9, 3.5 and 3.6  kcal/mol-1.",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
http://www.journal.ac017  Journal of Pharmacopuncture 2015;18(2):007-018 cule of hydrogen peroxidase as a substrate electron donor  and another molecule of H 2O2 as an oxidant or electron ac - ceptor.,Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
"Available from:  http://ec.europa.eu/health/archive/ph_risk/commit - tees/sccp/documents/out254_en.pdf.Munday R, Smith BL, Fowke EA.",Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
Available from: http://www.rcsb.org/pdb/home/home.do.,Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
018  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):007-018 gressive interstitial renal fibrosis in young women: as - sociation with slimming regimen including Chinese  herbs.,Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
Available from: http://www.molinspira- tion.com/cgi-bin/properties.,Non-OADS,/arxiv_data1/oa_pdf/ed/f1/2093-6966-v18-n02-007.PMC4481394.pdf
"The continuous processes of ECM turnover  accelerated by tumor derived proteases, along with the  abundance of remodeled ECM, pave the way for neo- Original article Key Words benzo(a)pyrene, capsaicin, collagen, glycosaminogly- cans, lung cancer, matrix metalloproteases ISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[2]:019-025 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.011    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e0/2093-6966-v18-n02-019.PMC4481395.pdf
"*Corresponding Author Pandi Anandakumar, Department of Biomedical Sciences, College of Health Sciences, Arsi University, Asella, Ethiopia.Tel: +251 223317975 Fax: +251 223317524 E-mail: winanand07@gmail.com ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1Department of Biochemistry, University of Madras, Guindy Campus, Chennai, India 2Department of Medical Biochemistry, University of Madras, Taramani Campus, Chennai, India Received: Mar 29, 2015   Reviewed: May 12, 2015   Accepted: May 13, 2015",Non-OADS,/arxiv_data1/oa_pdf/19/e0/2093-6966-v18-n02-019.PMC4481395.pdf
020  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):019-025 vascularization.,Non-OADS,/arxiv_data1/oa_pdf/19/e0/2093-6966-v18-n02-019.PMC4481395.pdf
http://www.journal.ac021  Journal of Pharmacopuncture 2015;18(2):019-025 tion of 1 : 2000 overnight at 4oC.,Non-OADS,/arxiv_data1/oa_pdf/19/e0/2093-6966-v18-n02-019.PMC4481395.pdf
022  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):019-025 when compared with the normal control animals of group  I.,Non-OADS,/arxiv_data1/oa_pdf/19/e0/2093-6966-v18-n02-019.PMC4481395.pdf
"http://www.journal.ac023  Journal of Pharmacopuncture 2015;18(2):019-025 that chondroitin sulfate levels are also markedly increased  during cancerous conditions [36], and that corroborates  our present findings.",Non-OADS,/arxiv_data1/oa_pdf/19/e0/2093-6966-v18-n02-019.PMC4481395.pdf
024  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):019-025 leviates the imbalance in xenobiotic metabolizing en- zymes and tumor markers during experimental lung  tumorigenesis.,Non-OADS,/arxiv_data1/oa_pdf/19/e0/2093-6966-v18-n02-019.PMC4481395.pdf
"http://www.journal.ac025  Journal of Pharmacopuncture 2015;18(2):019-025 Jia XL, Li SY, Dang SS, Cheng YA, Zhang X, Wang WJ, et  al.",Non-OADS,/arxiv_data1/oa_pdf/19/e0/2093-6966-v18-n02-019.PMC4481395.pdf
"Although cancer treatment including surgery, radi- Original articleISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[2]:026-032 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.012    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/70/2093-6966-v18-n02-026.PMC4481396.pdf
"ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acDivision of Longevity and Biofunctional Medicine, Healthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan  National University, Busan, Korea Received: Feb 09, 2015    Reviewed: Mar 03, 2015    Accepted: Mar 04, 2015",Non-OADS,/arxiv_data1/oa_pdf/3b/70/2093-6966-v18-n02-026.PMC4481396.pdf
"http://www.journal.ac027 ation therapy and chemotherapy has advanced in recent  years, these therapies have many limitations because of  low response and poor survival [4].",Non-OADS,/arxiv_data1/oa_pdf/3b/70/2093-6966-v18-n02-026.PMC4481396.pdf
028  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):026-032 lysed in the supplied lysis buffer.,Non-OADS,/arxiv_data1/oa_pdf/3b/70/2093-6966-v18-n02-026.PMC4481396.pdf
http://www.journal.ac029 tosis in both the intrinsic and the extrinsic pathways.,Non-OADS,/arxiv_data1/oa_pdf/3b/70/2093-6966-v18-n02-026.PMC4481396.pdf
030  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):026-032 Figure 5   Effects of a specific inhibitor of MAPK on MERL induced cell death in AGS cells.,Non-OADS,/arxiv_data1/oa_pdf/3b/70/2093-6966-v18-n02-026.PMC4481396.pdf
http://www.journal.ac031 ity.,Non-OADS,/arxiv_data1/oa_pdf/3b/70/2093-6966-v18-n02-026.PMC4481396.pdf
http://orcid.org/0000-0001-8835-9103.,Non-OADS,/arxiv_data1/oa_pdf/3b/70/2093-6966-v18-n02-026.PMC4481396.pdf
032  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):026-032 1999;79(1):143-80.,Non-OADS,/arxiv_data1/oa_pdf/3b/70/2093-6966-v18-n02-026.PMC4481396.pdf
"HB is a Korean culture related  syndrome related to a deep expression of feeling, i.e.,  deep sorrow ( 恨), and is included in the Diagnostic  and Statistical Manual of Mental Disorders, 4th edition  Original articleISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[2]:033-041 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.013    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
"Department of Korean Internal Medicine, Sangji University Korean Med-icine Hospital, 283, Woosan-dong, Wonju, Kangwon 220-955, Korea.Tel: +82-33-741-9209  Fax: +82-33-732-2124  E-mail: sunguy2001@hanmail.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Neuropsychiatry, College of Korean Medicine, Sangji University, Wonju, Korea 2 Department of Internal Medicine, College of Korean Medicine, Sangji University, Wonju, Korea Received: Jan 09, 2015    Reviewed: Feb 23, 2015    Accepted: Mar 19, 2015",Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
"Needle insertions  with depths of less than 3 mm depth were done at 6 cm  superior and 3 cm lateral of PC3, 6 cm superior and 3 cm  Figure 1 Simpo-jeongkyeok of Sa-am acupuncture.1$ 1$-3,*034 http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):033-041",Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
"http://www.journal.ac035  Journal of Pharmacopuncture 2015;18(2):033-041 medial of PC3, 6 cm inferior and 3 cm posterior of KI10,  and 6 cm inferior and 3 cm posterior of GB34.",Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
"036 /WV\VWROLF%3&RQWUR O 5WV\VWROLF%3&RQWUR O /WV\VWROLF7 UHDWPHQW 5WV\VWROLF7 UHDWPHQWhttp://www.journal.ac Journal of Pharmacopuncture 2015;18(2):033-041 /WV\VWROLF%3&RQWUR O 5WV\VWROLF%3&RQWUR O /WV\VWROLF7 UHDWPHQW 5WV\VWROLF7 UHDWPHQW Figure 3 Systolic Blood Pressure at each visit: AT1, first treatment; AT2, second treatment; AT3, third treatment; AT4, fourth treatment; F/U5,  follow-up visit 2 weeks after the end of all treatment; BP , blood pressure; Rt, right; Lt, left.",Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
http://www.journal.ac037  Journal of Pharmacopuncture 2015;18(2):033-041 third visit of the control group (Figs.,Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
"038  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):033-041 without an antihypertensive drug had decreased BP com- pared to the normal range of BPs, but that effect was not  maintained.",Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
"http://www.journal.ac039  Journal of Pharmacopuncture 2015;18(2):033-041 Table 3 Pulse rate differences between pre-treatment and post-treatment for the control and the treatment groups Table 4 Body temperature difference between pre-treatment and post-treatment at various acupoints for the control and the treatment  groups*Man-Whitney U test, †P < 0.05, ‡P < 0.01.",Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
"040  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):033-041 Kim JW, Kim SY.",Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
http://orcid.org/0000-0002-0668-9131.,Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
http://www.journal.ac041  Journal of Pharmacopuncture 2015;18(2):033-041 puncture.,Non-OADS,/arxiv_data1/oa_pdf/45/86/2093-6966-v18-n02-033.PMC4481397.pdf
"Pharmacopuncture is categorized as  Original articleISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[2]:042-050 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.014    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/67/2093-6966-v18-n02-042.PMC4481398.pdf
"Korean Pharmacopuncture Institute, 4F, Association of Korean Oriental Medicine B/D 26-27, Gayang-dong, Gangseo-gu, Seoul 157-200, Korea.Tel: +82-33-744-9304  Fax: +82-33-744-9305  E-mail: drkwon5031@daum.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Internal Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 2 Department of Preventive Medicine, College of Korean Medicine, Daejeon University, Daejeon, Korea 3 Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 4 Department of Sasang Constitutional Medicine, College of Korean Medicine, Sangji University, Wonju, Korea  5 Department of Ophthalmology, Otolaryngology, and Dermatology, Korean Medicine Hospital, Pusan National University, Yangsan, Korea 6 Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea Received: Nov 27, 2014    Reviewed: Dec 21, 2014    Accepted: Jan 14, 2015",Non-OADS,/arxiv_data1/oa_pdf/92/67/2093-6966-v18-n02-042.PMC4481398.pdf
"http://www.journal.ac043 meridian field pharmacopuncture (MFP), eight principle  pharmacopuncture (EPP), animal based pharmacopunc - ture (ABP) and mountain ginseng pharmacopuncture (MGP).",Non-OADS,/arxiv_data1/oa_pdf/92/67/2093-6966-v18-n02-042.PMC4481398.pdf
044  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):042-050 injection.,Non-OADS,/arxiv_data1/oa_pdf/92/67/2093-6966-v18-n02-042.PMC4481398.pdf
"http://www.journal.ac045 impotence, and leukorrhea due to deficiencies of vital  functions caused by chronic diseases [7, 8].",Non-OADS,/arxiv_data1/oa_pdf/92/67/2093-6966-v18-n02-042.PMC4481398.pdf
046  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):042-050 Figure 1   Body weights in male Sprague-Dawley rats.,Non-OADS,/arxiv_data1/oa_pdf/92/67/2093-6966-v18-n02-042.PMC4481398.pdf
http://www.journal.ac047  Journal of Pharmacopuncture 2015;18(2):042-050 Table 5  Summary of histopathological findings Sex Male Female Organ / FindingsGroup G1 G3 G1 G3 Dose (mL/kg)Saline DHRP Saline DHRP 20 20 20 20 No.,Non-OADS,/arxiv_data1/oa_pdf/92/67/2093-6966-v18-n02-042.PMC4481398.pdf
http://www.journal.ac048  Journal of Pharmacopuncture 2015;18(2):042-050 Figure 3   Histopathological observations (hematoxylin & eosin staining × 200).ControlLiver Brain Kidney Spinal cordExperiment,Non-OADS,/arxiv_data1/oa_pdf/92/67/2093-6966-v18-n02-042.PMC4481398.pdf
http://www.journal.ac049  Journal of Pharmacopuncture 2015;18(2):042-050 Korean Pharmacopuncture Insitute.,Non-OADS,/arxiv_data1/oa_pdf/92/67/2093-6966-v18-n02-042.PMC4481398.pdf
http://www.journal.ac050  Journal of Pharmacopuncture 2015;18(2):042-050 japonicus on the NC/nga atopy model].,Non-OADS,/arxiv_data1/oa_pdf/92/67/2093-6966-v18-n02-042.PMC4481398.pdf
"Original articleISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[2]:051-059 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.015    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
"Department of Acupuncture & Moxibution, College of Korean Med-icine, Dong-Eui University, San 45-1, Yangjung 2-Dong, Busanjin-Gu, Busan 614-710, Korea.Tel: +82-51-850-8613  Fax: +82-51-867-5162E-mail: kmdkch@deu.ac.kr ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Acupuncture & Moxibustion Meridian & Acupoint, College of Oriental Medicine, Dong-Eui University, Busan, Korea Received: Jan 10, 2015    Reviewed: Jan 30, 2015    Accepted: Jan 31, 2015",Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
Table 1  Groups of animals GroupDose (mL/animal)Injection (mL/animal)Number of animals (serial numbers) Male Female G1: Control group  0 0.5 5 (1101 -  1105) 5 (2101 - 2105) G2: Low-dose group 0.125 0.125 5 (1201 -  1205) 5 (2201 - 2205) G3: Mid-dose group  0.25 0.25 5 (1301 -  1305) 5 (2301 -  2305) G4: High-dose group 0.5 0.5 5 (1401 -  1405) 5 (2401 -  2405)052 http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):051-059,Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
"http://www.journal.ac053  Journal of Pharmacopuncture 2015;18(2):051-059 Table 2  Hematologic examination Table 3  Coagulation test Table 4  Blood chemical testMeasurement Unit Measuring method Erythrocyte count (RBC) × 106 cells/μL Flow cytometry Hemoglobin (HGB) g/mLFlow cytometry, Cyanmethemoglobin Hematocrit (HCT) % Calculated Mean corpuscular volume (MCV) fL Flow cytometry Mean corpuscular hemoglobin (MCH) Pg Calculated Mean corpuscular hemoglobin  concentration (MCHC)g/dL Platelet (PLT) × 103 cells/μL Flow cytometry Leucocyte count (WBC) × 103 cells/μL Flow cytometry, Peroxidase stainWBC differential counting %Neutrophils (NEU) Lymphocytes (LYM) Monocytes (MONO)Eosinophils (EOS) Basophils (BASO) Reticulocytes (Reti) % Flow cytometry, RNA stain Measurement Unit Measuring method Prothrombin test (PT) Second Coagulation time methodActivated partial thromboplastin time (APTT) Second  Measurement Unit Measuring method Prothrombin test (PT) U/L JSCC (UV Kinetic) Activated partial thromboplastin time (APTT) U/L JSCC (UV Kinetic) Alkaline phosphatase (ALP) U/L 4-nitrophenyl-phosphate, 2Na (JSCC Transferable) Gamma glutamyltranspeptidase (GGT) U/L International federation of clinical chemistr (IFCC) Blood urea nitrogen (BUN) mg/dL Urease  Glutamate dehydrogenase (GLDH) Creatinine (Crea) mg/dL Jaffe Total bilirubin (T-Bili) mg/dL Vanadate oxidation Total protein (TP) g/dL Biuret Albumin (Alb) g/dL Brom cresol green (BCG) Albumin/globulin ratio (A/G ratio) - Calculated Total cholesterol (T-Chol) mg/dL Cholesterol oxidase-HMMPS Triglycerides (TG) mg/dL GPO-HMMPS glycerol blanking Phosphorus (P) mg/dL Fiske subbarow Glucose (Glu) mg/dL Hexokinase-G6PDH Calcium (Ca) mg/dL Orthocresolphthalein complexone (OCPC) Chloride (Cl) mmol/L Ion selective electrode Sodium (Na) mmol/L Potassium (K) mmol/L HMMPS, N-(3-sulfopropyl)-3-methoxy-5methylaniline; G6PDH, Glucose-6-phosphate dehydrogenase.",Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
054 http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):051-059 Table 5  Body weights (g) GroupDose (mL/animal)SexMean S.D.,Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
http://www.journal.ac055  Journal of Pharmacopuncture 2015;18(2):051-059 GroupDose (mL/ animal)SexMean S.D.,Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
"056  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):051-059 S.D., standard deviation; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV , mean corpuscular cell volume; MCH, mean  corpuscular hemoglobin; MCHC, mean corpuscular cell hemoglobin concentration; PLT, platelet; Reti, reticulocytes; WBC, white blood cell; NEU, neutrophils; LYM, lymphocytes; MONO, monocytes; EOS, Eosinophils; BASO, basophils; PT, prothrombin time; APTT, active  partial thromboplastin time.G3 0.25MaleMean 8.58 12.5 84.2 1.6 0.5 0.2 17.6 14.9 S.D.",Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
http://www.journal.ac057  Journal of Pharmacopuncture 2015;18(2):051-059 GroupDose (mL/ animal)SexMean S.D.,Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
http://www.journal.ac058  Journal of Pharmacopuncture 2015;18(2):051-059 Figure 1   Body weights in male Sprague-Dawley rats.,Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
http://orcid.org/0000-0003-2058-0762.,Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
http://www.journal.ac059  Journal of Pharmacopuncture 2015;18(2):051-059 3.,Non-OADS,/arxiv_data1/oa_pdf/9c/d6/2093-6966-v18-n02-051.PMC4481399.pdf
"Original articleISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[2]:060-066 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.016    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/81/2093-6966-v18-n02-060.PMC4481400.pdf
"Department of Ophthalmology, Otolaryngology and Dermatology, School of Korean Medicine, Pusan National University, 49, Busandaehak-ro, Mulge-um-eup, Yangsan-si, Gyeongnam, Korea.Tel: +82-10-2470-2985  Fax: +82-55-360-5689  E-mail: aran99@pusan.ac.kr ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1  Department of Ophthalmology, Otolaryngology, and Dermatology, Korean Medicine Hospital, Pusan National University, Yangsan, Korea 2    Department of Acupuncture and Moxibustion, Sangji University College of Korean Medicine, Wonju, Korea Received: Mar 20, 2015    Reviewed: May 14, 2015    Accepted: May 14, 2015",Non-OADS,/arxiv_data1/oa_pdf/e2/81/2093-6966-v18-n02-060.PMC4481400.pdf
http://www.journal.ac 061 2.,Non-OADS,/arxiv_data1/oa_pdf/e2/81/2093-6966-v18-n02-060.PMC4481400.pdf
"062  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):060-066 Weights and hematology and blood biochemistry data  were analyzed by using statistical analysis system (SAS,  version 9.3, SAS Institute Inc., U.S.A.).",OADS,/arxiv_data1/oa_pdf/e2/81/2093-6966-v18-n02-060.PMC4481400.pdf
"http://www.journal.ac063  Journal of Pharmacopuncture 2015;18(2):060-066 Group/dose  (mL/animal)RBC (×106  cell/μL)HGB (g/dL) HCT (%)RBC  indices PLT  (×103 cell/μL)Reti (%) MCV (fL)MCH (pg)MCHC  (g/dL) G1/1.0 (NS) 7.24 ± 0.15 14.4 ± 0.3 41.3 ± 0.7 57.1 ± 0.7 19.9 ± 0.2 34.8 ± 0.3 1146 ± 55 4.7 ± 0.4 G2/0.25 (SP) 7.24 ± 0.26 14.8 ± 0.6 41.6 ± 1.4 57.5 ± 0.9 20.4 ± 0.1 35.5 ± 0.6 1166 ± 55 4.7 ± 1.0 G3/0.5 (SP) 7.13 ± 0.45 14.5 ± 0.6 41.3 ± 1.5 58.0 ± 2.4 20.4 ± 1.0 35.1 ± 0.5 1179 ± 95 4.7 ± 0.8 G4/1.0 (SP) 6.99 ± 0.15 14.6 ± 0.5 41.3 ± 1.0 59.2 ± 1.2 20.9 ± 0.6 35.3 ± 0.5 1181 ± 52 4.6 ± 0.5Table 2 Summary of hematological data (male) Table 3 Summary of hematological data (female)NS, normal saline; SP , samjeong pharmacopuncture; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV , mean corpuscular  volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelet; Reti, reticulocytes; WBC, white blood cell; NEU, neutrophils; LYM, lymphocytes; MONO, monocytes; EOS, Eosinophils; BASO, basophils; PT, prothrombin time; APTT, activated partial thromboplastin time.",Non-OADS,/arxiv_data1/oa_pdf/e2/81/2093-6966-v18-n02-060.PMC4481400.pdf
"064  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):060-066 Table 4 Summary of blood biochemistry data (male) Table 5 Summary of blood biochemistry data (female)NS, normal saline; SP , samjeong pharmacopuncture; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP , alkaline  phosphatase; GGT, gamma glutamyl transpeptidase; Glu, glucose; BUN, blood urea nitrogen; Crea, creatinine; T-Bil, total bilirubin; T-Chol, total cholesterol; TG, triglycerides; TP , total protein; Alb, albumin; A/G ratio, albumin/globulin ratio; P , phosphorus; Ca, calci-um; Na, sodium; K, potassium; Cl, chloride.",Non-OADS,/arxiv_data1/oa_pdf/e2/81/2093-6966-v18-n02-060.PMC4481400.pdf
"http://www.journal.ac065  Journal of Pharmacopuncture 2015;18(2):060-066 Table 6 Summary of necropsy findings Table 7 Summary of histopathological findingsNS, normal saline; SP , samjeong pharmacopuncture.",Non-OADS,/arxiv_data1/oa_pdf/e2/81/2093-6966-v18-n02-060.PMC4481400.pdf
http://www.journal.ac 066 Korean Pharmacopuncture Institute.,Non-OADS,/arxiv_data1/oa_pdf/e2/81/2093-6966-v18-n02-060.PMC4481400.pdf
http://orcid.org/0000-0003-2410-4704.,Non-OADS,/arxiv_data1/oa_pdf/e2/81/2093-6966-v18-n02-060.PMC4481400.pdf
"These were extracted at low temperature and low  Original articleISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[2]:067-075 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.017    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
"Department of Acupuncture & Moxibustion Medicine, Wonkwang Uni-versity Gwangju Korean Medical Hospital, 543-8 Juweol 1-dong, Nam-gu, Gwangju 503-310, Korea.Tel: +82-62-670-6441  Fax: +82-62-670-6767  E-mail: kscndl@hanmail.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1  Department of Acupuncture & Moxibustion Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 2    Nervous & Muscular System Disease Clinical Research Center of Wonkwang University Gwangju Korean Medical Hospital, Gwangju,  Korea Received: Mar 12, 2015    Reviewed: May 13, 2015    Accepted: May 20, 2015",Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
068  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):067-075 pressure in an aseptic room at the Korean Pharmacopunc - ture Institute (KPI).,Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
"http://www.journal.ac069 ments were analyzed by using a statistical analysis system  (SAS, version 9.3, SAS Institute Inc., U.S.A.).",OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
070  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):067-075 tivity [10].,Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
http://www.journal.ac071  Journal of Pharmacopuncture 2015;18(2):067-075 Table 5 Mean hematology parameters (continued)GroupDose  (mL/ animal)SexMean  S. D.  NRBC  (×106  cells/ μL)HGB  (g/dL)HCT  (%)RBC Indices PLT  (×103  cells/  μL)Reti (%)MCV  (fL)MCH  (pg)MCHC  (g/dL) G1 0MaleMean 7.04 14.6 41.0 58.4 20.7 35.5 1102 4.55 S. D. 0.54 0.5 1.7 2.2 0.9 0.5 107 0.81 N 5 5 5 5 5 5 5 5 FemaleMean 7.45 15.0 41.5 55.7 20.2 36.3 1141 2.59 S. D. 0.37 0.7 1.4 1.2 0.4 0.6 82 0.60 N 5 5 5 5 5 5 5 5 G2 0.25MaleMean 7.09 14.9 41.8 59.0 21.1 35.7 1131 4.78 S. D. 0.28 0.4 1.3 1.9 0.8 0.5 61 0.77 N 5 5 5 5 5 5 5 5 FemaleMean 7.29 14.9 41.1 56.4 20.5 36.3 1207 2.51 S. D. 0.18 0.3 0.9 0.7 0.3 0.4 151 0.24 N 5 5 5 5 5 5 5 5 G3 0.5MaleMean 7.29 14.5 41.7 57.3 19.8 34.7 1076 4.56 S. D. 0.44 0.7 1.8 1.6 0.5 0.9 161 1.26 N 4*4*4*4*4*4*4*4* FemaleMean 7.35 15.0 41.3 56.2 20.4 36.3 1170 2.43 S. D. 0.26 0.6 1.3 0.9 0.4 0.5 86 0.49 N 5 5 5 5 5 5 5 5 G4 1.0MaleMean 7.41 15.1 42.5 57.5 20.4 35.5 1161 4.06 S. D. 0.35 0.3 1.0 1.8 0.7 0.3 101 0.77 N 5 5 5 5 5 5 5 5 FemaleMean 7.29 14.9 40.8 56.1 20.4 36.4 1178 2.56 S. D. 0.37 0.4 1.4 1.8 0.8 0.3 119 0.36 N 5 5 5 5 5 5 5 5 GroupDose  (mL/ animal)SexMean  S. D.  NWBC  (×103  cells/ μL)WBC Differential Count (%) PT  (sec)APTT  (sec) NEU LYM MONO EOS BASO G1 0MaleMean 6.23 15.5 81.7 1.6 0.6 0.1 16.6 17.2 S. D. 1.98 4.1 4.3 0.2 0.1 0.0 0.6 1.7 N 5 5 5 5 5 5 5 5 FemaleMean 4.65 15.2 81.8 1.3 0.9 0.1 18.5 15.0 S. D. 1.58 4.4 4.8 0.5 0.2 0.1 0.5 0.4 N 5 5 5 5 5 5 5 5 G2 0.25MaleMean 7.99 17.1 79.7 1.7 0.4 0.1 16.4 16.0 S. D. 2.43 6.5 6.8 0.1 0.2 0.1 0.5 1.3 N 5 5 5 5 5 5 5 5 FemaleMean 4.89 12.8 84.3 1.3 0.8 0.2 18.9 16.0 S. D. 2.53 2.2 2.6 0.4 0.2 0.1 0.4 1.4 N 5 5 5 5 5 5 5 5,Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
072  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):067-075 *Datum was excluded because animal (1303) was not fasted.,Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
http://www.journal.ac073  Journal of Pharmacopuncture 2015;18(2):067-075 *Datum was excluded because animal (1303) was not fasted.,Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
http://www.journal.ac074  Journal of Pharmacopuncture 2015;18(2):067-075 Yook TH.,Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
http://orcid.org/0000-0003-3580-5290.,Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
http://www.journal.ac075  Journal of Pharmacopuncture 2015;18(2):067-075 rhizoma  herbal-acupuncture at KI(10) on LPS-induced  nephritis in rats.,Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
Available from: http://www.mfds.go.kr/.20.,Non-OADS,/arxiv_data1/oa_pdf/2b/0c/2093-6966-v18-n02-067.PMC4481401.pdf
"Original articleISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[2]:076-085 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.018    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
"Tel: +82-33-744-9304  Fax: +82-33-744-9305  E-mail: drkwon5031@daum.net  ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Sasang Constitutional Medicine, Sangji University College of Korean Medicine, Wonju, Korea 2 Department of Acupuncture and Moxibustion, Sangji University College of Korean Medicine, Wonju, Korea 3 Department of Internal Medicine, Sangji University College of Korean Medicine, Wonju, Korea 4 Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea Received: Jan 02, 2015    Reviewed: Jan 10, 2015    Accepted: Feb 04, 2015",Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
http://www.journal.ac077 Panax ginseng (Korean ginseng) has been used as a tra- ditional medicine for boosting Qi energy and tonifying the  spleen and lungs [2].,Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
078  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):076-085 Figure 2 Body weights in male Sprague-Dawley rats.,Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
"http://www.journal.ac079  Journal of Pharmacopuncture 2015;18(2):076-085 Table 2 Summary of mortality GP , ginseng pharmacopuncture.GroupGP Injection (mL/animal)Number of animals Male Female G1: Control group 0 5 5 G2: Low-dose group 0.1 5 5 G3: Mid-dose group 0.5 5 5 G4: High-dose group 1.0 5 5 CP3202S system (Sartorius, Germany).",Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
"080  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):076-085 Table 3 Summary of clinical signs NOA, no observable abnormality.SexGroup/Dose (mL/animal)No.",Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
"http://www.journal.ac081  Journal of Pharmacopuncture 2015;18(2):076-085 Table 4 Mean body weights Table 5 Mean hematology parameters in male, female Sprague-Dawley rats (male) (female) *Significantly different from control by Steel test: P  < 0.05.",Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
"082  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):076-085 Table 6 Mean clinical chemistry in male, female Sprague-Dawley rats (male) (female) *Significantly different from control by Steel test: P  < 0.05.",Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
http://www.journal.ac083  Journal of Pharmacopuncture 2015;18(2):076-085 Figure 4 The tissue of the liver from an intramuscular single-dose toxicity study of ginseng pharmacopuncture in Sprague-Dawley rats.,Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
"084  http://www.journal.ac Journal of Pharmacopuncture 2015;18(2):076-085 Kim JD, Kang DI.",Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
http://www.journal.ac085 side components in the process of red ginseng].,Non-OADS,/arxiv_data1/oa_pdf/26/87/2093-6966-v18-n02-076.PMC4481402.pdf
"Ethanolic Extract of Marsdenia  condurango  Ameliorates Benzo[a]pyrene-induced Lung Cancer of  Rats Sourav Sikdar, Avinaba Mukherjee, Anisur Rahman Khuda-Bukhsh*-Condurango Ameliorates BaP-induced Lung Cancer in Rats- Key Words apoptosis, caspase-3, complementary and alternative  medicine (CAM), Condurango, lung cancer, reactive ox - ygen species (ROS) The original article Ethanolic Extract of Marsdenia con- durango Ameliorates Benzo[a]pyrene-induced Lung  Cancer of Rats (J Pharmacopuncture 2014;17(2):7-17,  DOI: http://dx.doi.org/10.3831/KPI.2014.17.011) by  Sourav Sikdar, Avinaba Mukherjee, and, Anisur Rahman  Khuda-Bukhsh, was published with an incorrect meth- od in abstract due to a production error.",Non-OADS,/arxiv_data1/oa_pdf/74/1b/2093-6966-v18-n02-086.PMC4481403.pdf
"Results: A histological study revealed gradual progress  in lung tissue-repair activity in Condurango-fed can- cer-bearing rats, showing gradual tissue recovery after  CorrectionISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[2]:086-087 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.019    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/1b/2093-6966-v18-n02-086.PMC4481403.pdf
"Tel:+91-33-2582-8750 Fax: +91-33-2582-8282 Email: prof_arkb@yahoo.co.in ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acReceived: Apr 11, 2014    Reviewed: May 29, 2014    Accepted: Jun 09, 2014Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India",Non-OADS,/arxiv_data1/oa_pdf/74/1b/2093-6966-v18-n02-086.PMC4481403.pdf
http://www.journal.ac 087 three months of drug administration.,Non-OADS,/arxiv_data1/oa_pdf/74/1b/2093-6966-v18-n02-086.PMC4481403.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/07/main.PMC4481417.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/07/main.PMC4481417.pdf
URL: www.ksu.edu.sa http://dx.doi.org/10.1016/j.jsha.2015.03.003Production and hosting by Elsevier,OADS,/arxiv_data1/oa_pdf/69/07/main.PMC4481417.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/59/main.PMC4481418.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2014.12.001 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/fc/59/main.PMC4481418.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2014.07.001 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/1e/30/main.PMC4481419.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/e7/main.PMC4481420.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/e7/main.PMC4481420.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.02.004 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/a6/e7/main.PMC4481420.pdf
Angiology 2014. http://dx.doi.org/ 10.1177/0003319714535970 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/a6/e7/main.PMC4481420.pdf
Clin Appl ThrombHemost 2014. http://dx.doi.org/10.1177/1076029613519851 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/a6/e7/main.PMC4481420.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/a4/main.PMC4481421.pdf
"Received April 23, 2015 /C15Revision received April 27, 2015 /C15Accepted April 30, 2015 /C15Available online 14 May 2015 http://dx.doi.org/10.1016/j.molmet.2015.04.006 Brief communication MOLECULAR METABOLISM 4 (2015) 537 e542/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/45/a4/main.PMC4481421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/a4/main.PMC4481421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/a4/main.PMC4481421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/a4/main.PMC4481421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/a4/main.PMC4481421.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/45/a4/main.PMC4481421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/a4/main.PMC4481421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/a4/main.PMC4481421.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/b8/main.PMC4481422.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.04.002 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/88/b8/main.PMC4481422.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/50/main.PMC4481423.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/50/main.PMC4481423.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2014.11.003 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/5a/50/main.PMC4481423.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/c4/main.PMC4481425.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/c4/main.PMC4481425.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2014.11.001 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/a6/c4/main.PMC4481425.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
"Received April 11, 2015 /C15Revision received April 18, 2015 /C15Accepted April 22, 2015 /C15Available online 1 May 2015 http://dx.doi.org/10.1016/j.molmet.2015.04.003 Original article MOLECULAR METABOLISM 4 (2015) 507 e518/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ab/main.PMC4481426.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/00/main.PMC4481427.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/00/main.PMC4481427.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.02.005 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/89/00/main.PMC4481427.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/05/main.PMC4481428.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.03.006 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/63/05/main.PMC4481428.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
"Received April 6, 2015 /C15Revision received April 21, 2015 /C15Accepted April 24, 2015 /C15Available online 2 May 2015 http://dx.doi.org/10.1016/j.molmet.2015.04.004 Brief communication MOLECULAR METABOLISM 4 (2015) 543 e550/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/92/main.PMC4481462.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2014.09.004 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/85/62/main.PMC4481463.pdf
< http://www.saudigazette.,Non-OADS,/arxiv_data1/oa_pdf/85/62/main.PMC4481463.pdf
"AnnEpidemiol 2014, pii: S1047-2797(14)00375-5. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/85/62/main.PMC4481463.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/1d/main.PMC4481464.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/1d/main.PMC4481464.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.02.002 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/f7/1d/main.PMC4481464.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
"Abbreviations: AMPK, AMP-activated protein kinase; BMI, body mass index; C/EBP- a, CCAAT/enhancer-binding protein- a; CIDEA, cell death-inducing DNA fragmentation factor-like effector a; ERK, extracellular signal-regulated kinase; FGF, ﬁbroblast growth factor; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; hasc, human abdominal subcutaneous; IL-6, interleukin-6; MHO, metabolically healthy obesity; MUHO, metabolically unhealthy obesity; qPCR, quantitative polymerase c hain reaction; PGC-1 a, PPAR-gcoactivator-1 a; PPAR- g, peroxisome proliferator-activated receptor- g; rh, recombinant human; UCP-1, uncoupling protein-1 Received March 27, 2015 /C15Revision received April 20, 2015 /C15Accepted April 23, 2015 /C15Available online 1 May 2015 http://dx.doi.org/10.1016/j.molmet.2015.04.002 Original article MOLECULAR METABOLISM 4 (2015) 519 e527/C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
"In addition, Ingenuity Pathway Software (http://www.ingenuity.com ) was used to identify enriched pathways.",OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/da/main.PMC4481465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/22/main.PMC4481509.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/22/main.PMC4481509.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.03.005 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/36/22/main.PMC4481509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/a7/main.PMC4481511.pdf
This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/a7/main.PMC4481511.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2014.11.005 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/c0/a7/main.PMC4481511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/51/main.PMC4481512.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/51/main.PMC4481512.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.02.001 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/24/51/main.PMC4481512.pdf
http://www.nimh.nih.,Non-OADS,/arxiv_data1/oa_pdf/cb/b4/ANS0972-7531-22-127.PMC4481554.pdf
BMJ 2000;321:588. http://www.pubmedcentral.nih.gov/arti- clerender.fcgi?artid=1118489&tool=pm centrez&rendertype=abstract (accessed  12 Feb2015).,OADS,/arxiv_data1/oa_pdf/cb/b4/ANS0972-7531-22-127.PMC4481554.pdf
Evid Based  Med 2009;1–8.http://www.chnri.org/re - sources/2.,OADS,/arxiv_data1/oa_pdf/cb/b4/ANS0972-7531-22-127.PMC4481554.pdf
2006;:1–4.http://resources.civilservice.,Non-OADS,/arxiv_data1/oa_pdf/cb/b4/ANS0972-7531-22-127.PMC4481554.pdf
2014. http://www.equator-network.org/ (ac- cessed 12 Feb2015).,Non-OADS,/arxiv_data1/oa_pdf/cb/b4/ANS0972-7531-22-127.PMC4481554.pdf
2014.http://alltrials.net 26.,Non-OADS,/arxiv_data1/oa_pdf/cb/b4/ANS0972-7531-22-127.PMC4481554.pdf
"A detailed composition of hESCs  used in this study their derivatives, methods of use, and meth- ods of preparation are available at http://patentscope.wipo.int/ search/en/WO2007141657).",OADS,/arxiv_data1/oa_pdf/c4/df/ANS0972-7531-22-132.PMC4481559.pdf
Ltd (http://www.knowledgeisotopes.com)  for writing support.,Non-OADS,/arxiv_data1/oa_pdf/c4/df/ANS0972-7531-22-132.PMC4481559.pdf
"Available from:  http://www.bizjournals.com/sanfrancisco/blog/biotech/2014/08/   embryonic-stem-cells-asterias-geron-spinal-cord.html; accessed on  17th September, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c4/df/ANS0972-7531-22-132.PMC4481559.pdf
"Available at: http://icmr.nic.in/ethical_guidelines.pdf; assessed on 7  November, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c4/df/ANS0972-7531-22-132.PMC4481559.pdf
"The only guidelines that were available are from Indian Council of Medical Research (ICMR) on their website and are issued every year (available at http://icmr.nic.in/ethical_guidelines.pdf).Few points to consider here are: For every patient that we recruited, we informed and reported to regulatory authority.",Non-OADS,/arxiv_data1/oa_pdf/c4/df/ANS0972-7531-22-132.PMC4481559.pdf
Available from:  http://www.health.bih.nic.in/Docs/Guidelines/Guidelines‑NPCDCS.,Non-OADS,/arxiv_data1/oa_pdf/76/fd/IJEM-19-443.PMC4481648.pdf
Available from:  http://www.icmr.nic.in/guidelines_diabetes/guide_diabetes.htm.,Non-OADS,/arxiv_data1/oa_pdf/76/fd/IJEM-19-443.PMC4481648.pdf
Available from:  http://www.health.mp.gov.in/drug/druglist‑2008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/fd/IJEM-19-443.PMC4481648.pdf
Available from: http://www.mciindia.org/ InformationDesk/CollegesCoursesSearch.aspx?N=92.,Non-OADS,/arxiv_data1/oa_pdf/b2/c0/IJEM-19-448.PMC4481649.pdf
Available from: http://www.cetss.,Non-OADS,/arxiv_data1/oa_pdf/b2/c0/IJEM-19-448.PMC4481649.pdf
Available from: http://www.endocrinesocietyindia.,Non-OADS,/arxiv_data1/oa_pdf/b2/c0/IJEM-19-448.PMC4481649.pdf
Available from: http://www.endocrinesocietyindia.org/ node/109.,OADS,/arxiv_data1/oa_pdf/b2/c0/IJEM-19-448.PMC4481649.pdf
These growth charts can be downloaded  from the IAP website: http://www.iapinidia.org.,OADS,/arxiv_data1/oa_pdf/89/b9/IJEM-19-470.PMC4481652.pdf
http://www.iofbonehealth.org/sites/ default/files/PDFs/Audit%20Asia/Asian_regional_audit_2009.,Non-OADS,/arxiv_data1/oa_pdf/92/ff/IJEM-19-483.PMC4481654.pdf
For more details log  on to http://www.cdi.org.in/index.php/outreach.,Non-OADS,/arxiv_data1/oa_pdf/5f/53/IJEM-19-507.PMC4481658.pdf
"Available from: http://www.fssai.gov.in/Portals/0/Pdf/ Food%20safety%20and%20standards%20(Prohibition%20 and%20Restrction%20on%20sales)%20regulation,%202011.pdf.",Non-OADS,/arxiv_data1/oa_pdf/85/77/IJEM-19-511.PMC4481659.pdf
Available  at: http://press.endocrine.org/doi/abs/10.1210/endo‑meetings.,Non-OADS,/arxiv_data1/oa_pdf/ee/2e/IJEM-19-524.PMC4481661.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ ucm446845.htm.,Non-OADS,/arxiv_data1/oa_pdf/ee/2e/IJEM-19-524.PMC4481661.pdf
Available from: http://www.adips.org/downloads/2014ADIPSGDM GuidelinesV18.11.2014_000.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/d2/IJEM-19-529.PMC4481662.pdf
Available from: http://www.japi.org/ august2006/DIPSI‑622.htm.,Non-OADS,/arxiv_data1/oa_pdf/b5/d2/IJEM-19-529.PMC4481662.pdf
"1929 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/57/btv103.PMC4481699.pdf
"i258 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/15/btv233.PMC4481700.pdf
"Our new methods are implemented in our software,FISHtrees, for which C þþsource code and two datasets are avail- able at ftp://ftp.ncbi.nlm.nih.gov/pub/FISHtrees.",OADS,/arxiv_data1/oa_pdf/9a/15/btv233.PMC4481700.pdf
Copenhagen: Laegeforeningers Forlag; 2003. http://www.ph3c.,Non-OADS,/arxiv_data1/oa_pdf/b5/36/JMH-6-51.PMC4481739.pdf
Retrieved from:  http://www.ph3c.org/PH3C/docs/27/000284/0000439.pdf  [Last accessed on 2015 Jun 6].REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/36/JMH-6-51.PMC4481739.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/13/98/JMH-6-66.PMC4481742.pdf
Available form: http://www.iofbonehealth.org/ patients-public/about-osteoporis [Last assessed on 2013 Apr 08].,Non-OADS,/arxiv_data1/oa_pdf/61/75/JMH-6-70.PMC4481743.pdf
Available from: http://www.sportsmed.,Non-OADS,/arxiv_data1/oa_pdf/5e/79/IJA-59-335.PMC4481750.pdf
"Medical College, Kangra, TANDA (HP) Organising Chairman:  Dr. Sudarshan Kumar Name of the conference: 7th Central Zone Conference & 29th MP State  Conference 2015 Date:  3rd to 4th October 2015 Venue:  Motel Shiraz, MP Nagar, Bhopal Organising Secretary:  Dr. Surendra Raikwar Contact:  +91 94065 33300, +91 89591 13801 E-mail: mpisaconcentzone2015@gmail.com, drskraikwar@gmail.com,  centralzonempisacon2015@gmail.com Website: www.isampchapter.com Name of the conference: ISA JAC 25th East Zone Conference Date:  6th to 8th November 2015 Venue:  Hotel The Stadel, Kolkatta Organising Secretary:  Dr. Subhendu Sarkar Contact:  +91 98311 71162 E-mail: subhendusarkar757@gmail.com, sarkar_subhendu@yahoo.com Name of the conference: 7th Annual Conference of ICA Date:  13th to 15th November 2015 Venue:  Hotel Savera, Dr. Radhakrishnan Road, Chennai 600004 Organising Secretary:  Dr. K. Balakrishnan Contact:  +91 98410 29259  E-mail: ica2015@gmail.com (visit isaweb.in ISA > ICACON2015) Name of the conference: KISACON2015, 31st Annual Conference of Indian  Society of Anaesthesiologists, Karnataka State Chapter Date:  9th to 11th October 2015 Venue:  S N Medical College, Bagalkot  Organising Secretary:  Dr. Ramesh KoppalContact:  +91 98455 04515 E-mail: rameshkoppaldr@gmail.com Website: www.kisacon2015.com Name of the conference: 48th Gujarat State Conference of Indian Society of  Anaesthesiologists 2015 (GISACON 2015) Date:  9th to 11th October 2015 Venue:  Shanku’s Water World Resort (Ahmedabad-Mehsana Highway) Organising Chairman:  Dr. R G Agrawal Organising Secretary:  Dr. H G Bhavsar Contact:  +91 98242 33694 E-mail: info@gisacon2015.com Website: www.gisacon2015.com Name of the conference: ukisacon 2015 Uttrakhand State ISA Conference 2015 Date:  27th to 29th November 2015 Venue:  Max Hospital, Dehradun Organising Secretary:  Dr. Sanjeev Nivargi Contact:  +91 78959 00714 E-mail: sanjeev.nivargi@maxhealthcare.com Name of the conference: 28th Assam State Branch ISA Conference ABISACON  2015 Date:  3rd to 4th October 2015 Venue:  NEDFi Building, Guwahati Organising Secretary:  Dr. Jogendra Narayan Goswami Contact:  +91 98640 23709 E-mail: jogengo74@gmail.com Name of the conference: 6th National Airway Conference 2015 (NAC 2015) Date:  18th to 20th September 2015 Venue:  Workshop: Srinagar, Conference: Gulmarg (J&K) Organising Secretary:  Dr. Zulfiqar Ali Contact:  +91 94190 86761 E-mail: nacsrinagar2015@gmail.com Website: http://aidiaa.org/NAC2015/NAC_home.html Name of the conference: AORA2015 5th National Conference of Academy of  Regional Anaesthesia of India Date:  25th to 27th September 2015 Venue:  J N Tata Auditorium, Near IISC, Bengalur Organising Secretary:  Dr. Kumar M V Contact:  +91 98450 25236 E-mail: aoraindia2015@gmail.com Website: http://www.aora2015.com Name of the conference: AOACON Date:  11th to 13th September 2015 Venue:  Hotel Marriot, Hyderabad Organising Secretary:  Dr. Sunil T Pandya Contact:  +91 98483 10000, +91 98487 42426 E-mail: aoahyderabad2015@gmail.com, suniltp05@gmail.com Website: http://www.prernaanaesthesia.comAnnouncement",Non-OADS,/arxiv_data1/oa_pdf/39/97/IJA-59-342.PMC4481752.pdf
Available from: https://www.painpolicy.wordpress.,Non-OADS,/arxiv_data1/oa_pdf/8d/45/IJA-59-385.PMC4481762.pdf
Available from: https://www.painpolicy.wordpress.,Non-OADS,/arxiv_data1/oa_pdf/ed/74/IJA-59-386.PMC4481763.pdf
Availability and implementation : Freely available on the web at http://www.vivanbioinfo.org Contact : nshomron@post.tau.ac.il Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/52/1b/btv101.PMC4481840.pdf
"2141 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/1b/btv101.PMC4481840.pdf
"We anticipate that LCR-eXXXplorer will be a useful starting point in research efforts for the elucida- tion of the structure, function and evolution of proteins with LCRs.Availability and implementation: LCR-eXXXplorer is freely available at the URL http://repeat.biol.",OADS,/arxiv_data1/oa_pdf/a0/db/btv115.PMC4481844.pdf
"2208 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/db/btv115.PMC4481844.pdf
"Furthermore, users may initiate BLASTP searchesagainst the sequence databases hosted at the NCBI web servers(http://www.ncbi.nlm.nih.gov/) using as input query the currentlydisplayed sequence; several options of applying masking using anycombination of amino acid residue types and detection algorithm are available.",OADS,/arxiv_data1/oa_pdf/a0/db/btv115.PMC4481844.pdf
"2182 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/btv130.PMC4481854.pdf
"Experimental protocols, analyt- ical workﬂows, tools and data are available throughpublic repositories ( http://lumc.github.io/ribosome- proﬁling-analysis-framework/ ).INTRODUCTION Myogenesis, the formation and maintenance of skeletal muscles, occurs during embryogenesis and muscle regen- eration.",OADS,/arxiv_data1/oa_pdf/34/c7/gkv281.PMC4482065.pdf
Wiggle files are available athttp://gwips.ucc.ie/ .,OADS,/arxiv_data1/oa_pdf/34/c7/gkv281.PMC4482065.pdf
"Paired end RNAseq reads were aligned to RefSeq RNA sequences ( ftp://ftp.ncbi.nlm.nih.gov/refseq/M musculus/ mRNAProt/) using Bowtie2 ( 45), with the following parameters: -N1–norc.",OADS,/arxiv_data1/oa_pdf/34/c7/gkv281.PMC4482065.pdf
Usinga custom PHP script the merged wiggle files were converted to a format suitable for the Batch PositionConverter In- terface in Mutalyzer ( 46) 2.0.beta-32 ( https://mutalyzer.nl/ batch-jobs?job type=position-converter ).,OADS,/arxiv_data1/oa_pdf/34/c7/gkv281.PMC4482065.pdf
"Peaks located 5 kb downstream of the annotated start codon (counted as transcript positions, not genome) were not consideredfordownstreamanalysis.Thebackgroundnoiseinthesere- gions was higher, likely because the ribosomes were not al- lowed sufficient time to finish the translation of transcriptsonwhichtheyhadalreadyengagedintheelongationphase atthestartoftheharringtonintreatment.Wigglefilesshow- ingallthemappedfootprintsareavailableandvisualizedathttp://gwips.ucc.ie/ .",Non-OADS,/arxiv_data1/oa_pdf/34/c7/gkv281.PMC4482065.pdf
Differential expres- sion analysis was performed at gene level after summingreads mapped to Refseq sequences ( ftp://ftp.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/34/c7/gkv281.PMC4482065.pdf
"The model wasfitted using R Bioconductor package lme4.0 (R version 2.15.1,http://cran.r-project.org/web/packages/lme4/index.",OADS,/arxiv_data1/oa_pdf/34/c7/gkv281.PMC4482065.pdf
Amino acid sequences for 24665 MusMusculus proteins were retrieved from UniProt ( http://www.uniprot.org/uniprot/?query= organism%3A%22mus+musculus%22+AND+reviewed% 3Ayes+AND+keyword%3A1185&sort=score )i nf a s t a format and used as background reference.,OADS,/arxiv_data1/oa_pdf/34/c7/gkv281.PMC4482065.pdf
"HAIs are common complications of hos- pitalization and it is postulated that these infections cause over 2 million cases, and at least 23 000 deaths per yearin the United States ( http://www.cdc.gov/drugresistance/ threat-report-2013/ ).",Non-OADS,/arxiv_data1/oa_pdf/ec/d3/gkv321.PMC4482077.pdf
An auto- mated step-finding method (from http://bio.physics.illinois.,Non-OADS,/arxiv_data1/oa_pdf/e3/e9/gkv361.PMC4482088.pdf
"Oligonucleotides and siRNAs PCRprimersweredesignedusing‘qPCR’settingsinPrimer 3 Plus (http://www.bioinformatics.nl/cgi-bin/primer3plus/ primer3plus.cgi , i.e.",OADS,/arxiv_data1/oa_pdf/a0/ef/gkv386.PMC4482092.pdf
"Statisticalanalysis Pvalues (two-tailed) from unpaired Student’s t-tests and Fisher’s exact tests were calculated using GraphPad on-line (http://www.graphpad.com ), and were considered sig- nificantwhen <0.05.Pearson’scorrelationcoefficientswere calculated inMS Excel.",OADS,/arxiv_data1/oa_pdf/a0/ef/gkv386.PMC4482092.pdf
The following sgRNAs were designed us- ing the http://tools.genome-engineering.org online tool: ‘dR2-For’:GCAATTCAGGTGATGGGAAG;‘dR2-Rev’: AAAGACACAGACTTAATTTG; ‘eR9-For’: CTTTGC- CCGGACGGTCTAGG; ‘eR9-Rev’: GTCACTTCA-CATGCAGCCCC; ‘x3-For’: TATCACTCTGCAGGT- CAAGA; ‘x3-Rev’: AGAGAGAAGAACATGGACTC.,OADS,/arxiv_data1/oa_pdf/a0/ef/gkv386.PMC4482092.pdf
The prevailing theory to explain this Open AccessL Ulrich and others Cervical haemorrhage of a parathyroid adenomaID: 15-0034; May 2015 DOI: 10.1530/EDM-15-0034 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/eb/e9/edmcr-2015-150034.PMC4482155.pdf
L Ulrich and others Cervical haemorrhage of a parathyroid adenomaID: 15-0034; May 2015 DOI: 10.1530/EDM-15-0034 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/eb/e9/edmcr-2015-150034.PMC4482155.pdf
L Ulrich and others Cervical haemorrhage of a parathyroid adenomaID: 15-0034; May 2015 DOI: 10.1530/EDM-15-0034 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/eb/e9/edmcr-2015-150034.PMC4482155.pdf
L Ulrich and others Cervical haemorrhage of a parathyroid adenomaID: 15-0034; May 2015 DOI: 10.1530/EDM-15-0034 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/eb/e9/edmcr-2015-150034.PMC4482155.pdf
2008.1.1.46 ) Received in ﬁnal form 26 April 2015 Accepted 28 April 2015 L Ulrich and others Cervical haemorrhage of a parathyroid adenomaID: 15-0034; May 2015 DOI: 10.1530/EDM-15-0034 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/eb/e9/edmcr-2015-150034.PMC4482155.pdf
"Hyperparathyroidism occurs as the ﬁrst and foremost manifestation in 90% of the cases, Open AccessS Birla and others Impact of a novel 14 bp MEN1 deletionID: 15-0011; May 2015 DOI: 10.1530/EDM-15-0011 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd",Non-OADS,/arxiv_data1/oa_pdf/70/54/edmcr-2015-150011.PMC4482156.pdf
S Birla and others Impact of a novel 14 bp MEN1 deletionID: 15-0011; May 2015 DOI: 10.1530/EDM-15-0011 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/70/54/edmcr-2015-150011.PMC4482156.pdf
S Birla and others Impact of a novel 14 bp MEN1 deletionID: 15-0011; May 2015 DOI: 10.1530/EDM-15-0011 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/70/54/edmcr-2015-150011.PMC4482156.pdf
Clinical characteristics Values 1 Age at presentation/sex 35 years/female 2 Family history Negative3 Duration of disease (years) 5 years 4 Serum gastrin (pg/ml) 3043 5 Tumour location Pancreas and duodenum6 Surgery performed Pancreaticoduodenectomy 7 Number of tumors Multiple 8 Metastasis Lymph nodes and Liver S Birla and others Impact of a novel 14 bp MEN1 deletionID: 15-0011; May 2015 DOI: 10.1530/EDM-15-0011 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/70/54/edmcr-2015-150011.PMC4482156.pdf
( doi:10.3748/wjg.v17.i10.1343 ) Received in ﬁnal form 25 April 2015 Accepted 29 April 2015 S Birla and others Impact of a novel 14 bp MEN1 deletionID: 15-0011; May 2015 DOI: 10.1530/EDM-15-0011 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/70/54/edmcr-2015-150011.PMC4482156.pdf
She was a known case of type 2 diabetes mellitus (T2DM) for the Open AccessS Mukherjee and others Spontaneous diabetic myonecrosisID: 15-0003; May 2015 DOI: 10.1530/EDM-15-0003 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/17/ae/edmcr-2015-150003.PMC4482157.pdf
S Mukherjee and others Spontaneous diabetic myonecrosisID: 15-0003; May 2015 DOI: 10.1530/EDM-15-0003 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/17/ae/edmcr-2015-150003.PMC4482157.pdf
S Mukherjee and others Spontaneous diabetic myonecrosisID: 15-0003; May 2015 DOI: 10.1530/EDM-15-0003 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/17/ae/edmcr-2015-150003.PMC4482157.pdf
Parameters Patient 1 Patient 2 Patient 3 Patient 4 Gender F F F F Age (years) 42 48 51 43 Diabetes Type 2 Type 2 Type 2 Type 2Duration (years) 11 24 12 9 Nephropathy CCC C Retinopathy CCC C Nephropathy CCC C Comorbities HTN HypothyroidismHTN HTN HypothyroidismHTN Muscle group Right calf Anterolateral group of muscle of both thigh Medial group of muscle of left thigh Anterolateral group of muscle of left legAnteromedial group of muscle in right thigh Medial group of muscle in left thighAnterolateral group of muscle of right thigh MRI s/o myonecrosis s/o myonecrosis s/o myonecrosis s/o myonecrosis Treatment for DMN Paracetamol and tramadol (6 weeks)Codeine and paracetamol (6 weeks)Paracetamol and tramadol (6 weeks)Paracetamol and tramadol (6 weeks) Outcome Improved Improved Improved Improved S Mukherjee and others Spontaneous diabetic myonecrosisID: 15-0003; May 2015 DOI: 10.1530/EDM-15-0003 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/17/ae/edmcr-2015-150003.PMC4482157.pdf
S Mukherjee and others Spontaneous diabetic myonecrosisID: 15-0003; May 2015 DOI: 10.1530/EDM-15-0003 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/17/ae/edmcr-2015-150003.PMC4482157.pdf
2001.19961 ) Received in ﬁnal form 2 March 2015 Accepted 22 April 2015 S Mukherjee and others Spontaneous diabetic myonecrosisID: 15-0003; May 2015 DOI: 10.1530/EDM-15-0003 http://www.edmcasereports.com 6,Non-OADS,/arxiv_data1/oa_pdf/17/ae/edmcr-2015-150003.PMC4482157.pdf
Much of what is known has been derived from studies of in toto pituitaries obtained at Open AccessS M C De Sousa and others Pituitary hyperplasia ID: 15-0017; May 2015 DOI: 10.1530/EDM-15-0017 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/b0/03/edmcr-2015-150017.PMC4482158.pdf
S M C De Sousa and others Pituitary hyperplasia ID: 15-0017; May 2015 DOI: 10.1530/EDM-15-0017 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/b0/03/edmcr-2015-150017.PMC4482158.pdf
S M C De Sousa and others Pituitary hyperplasia ID: 15-0017; May 2015 DOI: 10.1530/EDM-15-0017 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/b0/03/edmcr-2015-150017.PMC4482158.pdf
S M C De Sousa and others Pituitary hyperplasia ID: 15-0017; May 2015 DOI: 10.1530/EDM-15-0017 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/b0/03/edmcr-2015-150017.PMC4482158.pdf
S M C De Sousa and others Pituitary hyperplasia ID: 15-0017; May 2015 DOI: 10.1530/EDM-15-0017 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/b0/03/edmcr-2015-150017.PMC4482158.pdf
S M C De Sousa and others Pituitary hyperplasia ID: 15-0017; May 2015 DOI: 10.1530/EDM-15-0017 http://www.edmcasereports.com 6,Non-OADS,/arxiv_data1/oa_pdf/b0/03/edmcr-2015-150017.PMC4482158.pdf
( doi:10.1530/ERC-11-0059 ) Received in ﬁnal form 12 February 2015 Accepted 6 May 2015 S M C De Sousa and others Pituitary hyperplasia ID: 15-0017; May 2015 DOI: 10.1530/EDM-15-0017 http://www.edmcasereports.com 7,Non-OADS,/arxiv_data1/oa_pdf/b0/03/edmcr-2015-150017.PMC4482158.pdf
"(1), the all-cause mortality Open AccessA Khanna and others Management of adrenocortical insufﬁciencyID: 15-0005; May 2015 DOI: 10.1530/EDM-15-0005 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd",Non-OADS,/arxiv_data1/oa_pdf/76/d8/edmcr-2015-150005.PMC4482159.pdf
PatientStarting rate of hydro- cortisone (mg/h)Mean serum cortisol (nmol//l)Adjusted rate of hydrocortisone (mg/h)Subsequent mean serum cortisol (nmol/l) Patient 1 (TDD 20 mg in 3DD) 0400–0900 1.1 – 1.1 – 0900–1400 0.9 430 0.9 357 1400–1800 0.8 385 0.8 272 1800–2200 0.6 344 0.6 251 2200–0400 0.7 – 0.6 –Total over 24 h (mg) 19.8 – 19.2 – Patient 2 (TDD 30 mg in 3DD) 0400–0900 1 – 1.3 –0900–1400 0.7 – 1 – 1400–1800 0.6 – 0.9 – 1800–2200 0.4 – 0.7 – 2200–0400 0.5 – 0.8 – Total over 24 h (mg) 15.5 – 23.6 – Patient 3 (TDD 20 mg in 3DD) 0400–0900 1 – 1 – 0900–1400 0.7 400 0.8 – 1400–1800 0.6 292 0.7 –1800–2200 0.4 163 0.5 – 2200–0400 0.5 91 0.6 – Total over 24 h (mg) 15.5 – 17.4 – A Khanna and others Management of adrenocortical insufﬁciencyID: 15-0005; May 2015 DOI: 10.1530/EDM-15-0005 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/76/d8/edmcr-2015-150005.PMC4482159.pdf
A Khanna and others Management of adrenocortical insufﬁciencyID: 15-0005; May 2015 DOI: 10.1530/EDM-15-0005 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/76/d8/edmcr-2015-150005.PMC4482159.pdf
A Khanna and others Management of adrenocortical insufﬁciencyID: 15-0005; May 2015 DOI: 10.1530/EDM-15-0005 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/76/d8/edmcr-2015-150005.PMC4482159.pdf
"( doi:10.1210/jc.2007-1134 ) 6 Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J & Chatterjee VK 2000 Improvement in mood and fatigue afterdehydroepiandrosterone replacement in Addison’s disease in a A Khanna and others Management of adrenocortical insufﬁciencyID: 15-0005; May 2015 DOI: 10.1530/EDM-15-0005 http://www.edmcasereports.com 5",Non-OADS,/arxiv_data1/oa_pdf/76/d8/edmcr-2015-150005.PMC4482159.pdf
81.7.2468 ) Received in ﬁnal form 13 March 2015 Accepted 27 April 2015 A Khanna and others Management of adrenocortical insufﬁciencyID: 15-0005; May 2015 DOI: 10.1530/EDM-15-0005 http://www.edmcasereports.com 6,Non-OADS,/arxiv_data1/oa_pdf/76/d8/edmcr-2015-150005.PMC4482159.pdf
More than 1000 QTLs on plant height have been mapped in rice chromosomes (http://www.gramene.org/qtl).,OADS,/arxiv_data1/oa_pdf/00/89/65_192.PMC4482168.pdf
At least 1011 QTLs for PH in rice have been saved in  Gramene QTL Database (http://www.gramene.org/qtl/).,OADS,/arxiv_data1/oa_pdf/00/89/65_192.PMC4482168.pdf
The location of each marker was based on the genomic sequence of the cultivar  Nipponbare in IRGSP build 5 in RAP-DB (http://rgp.dna.affrc.go.jp/E/IRGSP/Build5/build5.html).,OADS,/arxiv_data1/oa_pdf/0b/9a/65_201.PMC4482169.pdf
"QTLs involved in WCR, AC, and PC detected in the DHL population Trait Chromosome Position of nearest QTL markeraMarker interval LOD PVE (%)bAec WCR  3 22,664,880 ac30537*–aa30290 3.23 11.8 0.06 11 24,664,880 RM4601*–aa115083 2.86 10.3 0.06 AC  9 1,689,083 ac90004-aa90002* 29.23 67.9 0.25 PC  2 1,389,486 –ab20002* 2.53 9.3 –0.20  3 28,715,718 Ac30633–aa302391* 3.42 12.9 0.25 a Position of nearest marker based on location of the start of simple sequence repeat in IRGSP build 5 in RAP-DB (http://rgp.dna.affrc.go.jp/E/IRGSP/Build5/build5.html).",OADS,/arxiv_data1/oa_pdf/0b/9a/65_201.PMC4482169.pdf
"(http://statgen.ncsu.edu/qtlcart/WQTLCart.htm) Yamakawa, H., T. Ebitani and T. Terao (2008) Comparison between lo- cations of QTLs for grain chalkiness and genes responsive to high  temperature during grain filling on the rice chromosome map.",OADS,/arxiv_data1/oa_pdf/4c/63/65_216.PMC4482171.pdf
"From September to the following May (the autumn, winter and spring seasons of the Northern Hemisphere), the light condition at Hainan Province is in short-day period, which induces rice to flower much earlier than that of normal growing time (from April to October) in Zhejiang Province (located in the semitropi - cal region of China) (http://www.weather.com.cn/html/weather/101210301.shtml).",Non-OADS,/arxiv_data1/oa_pdf/48/a9/65_233.PMC4482173.pdf
The introgression of a favorable allele found in a diverse Asian rice population into Japanese rice cultivars has been widely used to improve elite Japanese cultivars (http://www.naro.affrc.go.jp/genome/database/ine/index.html).,Non-OADS,/arxiv_data1/oa_pdf/27/66/65_249.PMC4482175.pdf
PCR duplicates were  removed by using version 1.6.3 of the Picard software (http://picard.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/27/66/65_249.PMC4482175.pdf
"2011, http://www.brassicadb.org), the forward  primer (FAEF1: 5′-ATTCTCCGACACACACACTG-3′) and the reverse primer (FAER1: 5′-AGAGAAACATCGTAGCC ATCA-3′) were designed to isolate the CDS of F AE1.",OADS,/arxiv_data1/oa_pdf/a8/ae/65_257.PMC4482176.pdf
"A melting curve cycle followed the amplification cycle to confirm PCR product specificity: 94°C for 1 min, 58°C for 1 min, and acquisition of a melting curve from  55°C to 95°C with temperature change values of 0.5°C and a dwell time of 30 s. Statistical analysis Box plots of erucic acid contents in F2 individuals  grouped by F AE1 genotypes were drawn and the differences  in the erucic acid contents among different genotypes were tested using R software Version 3.11 for Windows (http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/a8/ae/65_257.PMC4482176.pdf
"napus import volume (k ton) Import volume from Canada (%) Year Year 2006 2007 2008 2009 2010 2011 2006 2007 2008 2009 2010 2011  1 Kashima 199 183 166 164 195 180 95 96 100 100 100 100  2 Chiba 367 365 352 351 346 322 94 100 100 100 100 100  3 Yokohama 348 363 354 377 349 368 95 99 99 90 99 99  4 Shimizu 157 201 196 190 220 216 100 100 100 100 100 100  5 Nagoya 287 253 226 278 260 318 92 88 95 96 95 97  6 Yokkaichi 145 116 103 93 95 131 52 82 100 92 92 99  7 Osaka 6 2 5 6 5 7 0 0 0 0 0 0  8 Kobe 430 426 433 466 500 494 75 89 95 83 91 94  9 Mizushima 188 160 159 152 190 160 93 83 100 63 91 92 10 Uno 25 23 23 15 16 19 94 95 100 100 100 100 11 Hakata 114 126 110 118 130 139 88 89 88 90 95 96 12 Tobata 3 0 0 0 0 0 49 – – – – – Total 2270 2218 2127 2211 2307 2353 87 93 97 91 96 97 Data are from Trade Statistics of Japan, MOF (Ministry of Finance Japan); http://www.customs.go.jp/toukei/info/index.htm (2015).",Non-OADS,/arxiv_data1/oa_pdf/53/c3/65_265.PMC4482177.pdf
"Department of the Environment, Transport and Regions, http://www.defra.gov.uk/environment/gm/research/reports.htm (accessed on 2009/6/15).",Non-OADS,/arxiv_data1/oa_pdf/53/c3/65_265.PMC4482177.pdf
"ISAAA (International Service for the Acquisition of Agribiotech Ap- plications) (2013) ISAAA Briefs 46-2013, http://www.isaaa.org/ (accessed on 2015/3/25).J-BCH (Japan Biosafety Clearing-House) (2012) Approved LMOs in  2012, http://www.bch.biodic.go.jp/english/lmo.html (accessed on 2014/1/6).",Non-OADS,/arxiv_data1/oa_pdf/53/c3/65_265.PMC4482177.pdf
"MAFF (Ministry of Agriculture, Forestry and Fisheries) (2012) The  list of genetically modified crops of safety inspection, http://www.maff.go.jp/j/syouan/nouan/carta/c_list/pdf/list01_20131031.pdf (accessed on 2014/1/6).",Non-OADS,/arxiv_data1/oa_pdf/53/c3/65_265.PMC4482177.pdf
"MHLW (Ministry of Health, Labour and Welfare) (2012) The list  of genetically modified foods and additives after procedure of safety inspection, http://www.mhlw.go.jp/topics/idenshi/dl/list.pdf (accessed on 2014/1/6).",Non-OADS,/arxiv_data1/oa_pdf/53/c3/65_265.PMC4482177.pdf
"MOF (Ministry of Finance Japan) (2015) Trade Statistics of Japan,  http://www.customs.go.jp/toukei/info/index.htm (accessed on 2015/   3/10).",OADS,/arxiv_data1/oa_pdf/53/c3/65_265.PMC4482177.pdf
"7, p. 16, http://www.oecd.org/science/biotrack/  (accessed on 2008/12/15).",Non-OADS,/arxiv_data1/oa_pdf/53/c3/65_265.PMC4482177.pdf
"ISBN 3-900051-07-0, http://www.R-project.org/ (accessed on 2013/3/25).",Non-OADS,/arxiv_data1/oa_pdf/53/c3/65_265.PMC4482177.pdf
"Thereafter, sequence reads were assessed for their quality using a FASTX toolkit (http://hannonlab.cshl.edu/fastx_toolkit/commandline.html).",OADS,/arxiv_data1/oa_pdf/f5/fe/65_276.PMC4482178.pdf
"For BLASTN searching, the genome sequence of rice (IRGSP-1.0_genome.fasta), a model plant for monocots including pineapple, was down-loaded from the rice annotation project database (http://rapdb.dna.affrc.go.jp/download/irgsp1.html) and used as a database.",OADS,/arxiv_data1/oa_pdf/f5/fe/65_276.PMC4482178.pdf
BOX server (https://www.box.com/) was used for data storage in this study.Results The concept of WIPPER WIPPER is a new field phenotyping system that is aided  by wireless communications for data recording and storage as described in Fig.,OADS,/arxiv_data1/oa_pdf/3d/9a/65_285.PMC4482179.pdf
"This is an Open Access articledistributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/4.0/), whichpermits non-commercialreproduction and distribution ofthe work, in any medium, providedthe original work is not altered ortransformed in any way, and thatthe work is properly cited.DOI: 10.1093/asj/sju114 www.aestheticsurgeryjournal.com",Non-OADS,/arxiv_data1/oa_pdf/fa/9d/sju114.PMC4482213.pdf
"This is an Open Access articledistributed under the terms of theCreative Commons AttributionNon-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), whichpermits non-commercial re-use,distribution, and reproduction inany medium, provided the originalwork is properly cited.DOI: 10.1093/asj/sjv050www.aestheticsurgeryjournal.com",Non-OADS,/arxiv_data1/oa_pdf/d3/f7/sjv050.PMC4482214.pdf
"Trial Registration Clinicaltrials.gov Identifier: NCT00170248 http://clinicaltrials.gov/ct2/show/NCT00170248?term ¼Asthma &spons¼McGillþUniversity&state1 ¼NA%3ACA%3AQC&rank ¼2 ............................................................................................................................... ..................... Keywords : out-of-control, computer decision support, MOXXI, personalized medicine, RCT, asthma Correspondence to Robyn Tamblyn, PhD, McGill University, Morrice House, 1140 Pine Ave West, Montreal Quebec, Canada, H3A 1A3; robyn.tamblyn@mcgil l.ca; tel: (514) 934-1934 ext.",OADS,/arxiv_data1/oa_pdf/d5/ab/ocu009.PMC4482273.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/ab/ocu009.PMC4482273.pdf
2014. http://www.ginasthma.org/local/uploads/files/ GINA_Report_2014_Aug12.pdf .,OADS,/arxiv_data1/oa_pdf/d5/ab/ocu009.PMC4482273.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/2d/ocu014.PMC4482274.pdf
"21 Utilization of health care resources for each category of ADE was reported in 2009 British pounds by Karnon et al.22These figures were converted to Australian dollars using the 2009 purchasing power par- ity of A$2.18 to UK£1 ( http://stats.oecd.org/Index.aspx?datasetcode ) and uprated to 2013 values using the health inflation index.23As these cost estimates do not reflect Australian health care costs and prac- tices, we also undertook an alternative estimation of cost savings re- sulting from the reduction in ADEs and the subsequent reduction inlength of stay (LOS) for each ADE category, 22,24–26which is multiplied by the cost of a bed day (A$472.5) obtained from the hospital account- ing records.",Non-OADS,/arxiv_data1/oa_pdf/73/2d/ocu014.PMC4482274.pdf
NSW Public Health System Awards and Determinations; http://www.health.nsw.gov.au/careers/conditions/Awards/hsu_he_phar- macists.pdf ; http://www.health.nsw.gov.au/careers/conditions/Awards/ hsu_health_managers.pdf .,Non-OADS,/arxiv_data1/oa_pdf/73/2d/ocu014.PMC4482274.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/7f/ocv013.PMC4482275.pdf
http://assets.fiercemarkets.com/public/healthit/medtechact.,Non-OADS,/arxiv_data1/oa_pdf/ff/7f/ocv013.PMC4482275.pdf
http://www.healthit.gov/sites/default/files/fdasia_healthitreport_ final.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ff/7f/ocv013.PMC4482275.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/f1/ocv024.PMC4482276.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.For commercial re-use, please contact journals.permissions@oup.comFor numbered affiliations see end of article.PERSPECTIVE 921Hripcsak G, et al.",Non-OADS,/arxiv_data1/oa_pdf/51/05/ocv035.PMC4482277.pdf
"Washington, DC: Department of Health and Human Services; 2008. http://www.health.gov/paguidelines/report/pdf/ committeereport.pdf .",Non-OADS,/arxiv_data1/oa_pdf/51/05/ocv035.PMC4482277.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/55/euu388.PMC4482286.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/2a/euu412.PMC4482287.pdf
"London: NICE, 2010. http://guidance.nice.org.uk/CG109/NICEGuidance/pdf/ English (29 Nov 2010, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/1d/2a/euu412.PMC4482287.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"78–80In Japan, the Japanese Stroke Databank is a patient oriented, academically con- trolled database aimed at establishing rigorous evidence for the quality improvement of stroke care ( http://cvddb.med.shimane-u.",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"2014. http://www.who.int/mediacentre/factsheets/fs310/en/index.html (6 January 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"2014. http://www.nice.org.uk/guidance/CG180 (6 January 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"2012. http://www.scottishmedicines.org.uk/ﬁles/ advice/rivaroxaban_Xarelto_for_AF_FINAL_Jan_2012_for_website.pdf (6 January 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"2013. http://www.neneccg.nhs.uk/resources/uploads/ﬁles/ implementation-of-nice-tas-249-256-and-275-dabigatran-rivaroxaban-and-apixaban- april-2013-ﬁnal.pdf (6 January 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"2014. http://www.dorsetccg.nhs.uk/Downloads/aboutus/ medicines-management/Other%20Guidelines/NOACs%20in%20AF.pdf (Decem- ber 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
2012. http://www.aemps.gob.es/ medicamentosUsoHumano/informesPublicos/docs/criterios-anticoagulantes-orales.,Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"2012. http://www.nice.org.uk/ta261 (26 January 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"2012. http://www.nice.org.uk/ta256 (6 January 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"2012. http://www.nice.org.uk/ta249 (6 January 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"2013. http://www.nice.org.uk/guidance/TA275 (6 January 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
"2012. http://www.rcplondon.ac.uk/sites/default/ﬁles/sinap-comprehensive- public-report-2012.pdf (6 January 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/33/d0/euv068.PMC4482288.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/e9/nss-7-063.PMC4482367.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pNature and Science of Sleep 2015:7 63–72Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  63OrigiNal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NSS.S8288 8Sleep deprivation does not affect neuronal  susceptibility to mild traumatic brain injury   in the rat aimee M caron richard Stephenson Department of cell and Systems  Biology, University of T oronto,   T oronto, ON, canada correspondence: richard Stephenson   Department of cell and Systems Biology,  University of Toronto, ramsay Wright  laboratories,  25 harbord Street,  Toronto, ON, canada M5S  3g5  Tel +1 416 978 3491  email richard.stephenson@utoronto.c aAbstract:  Mild and moderate traumatic brain injuries (TBIs) (and concussion) occur frequently  as a result of falls, automobile accidents, and sporting activities, and are a major cause of acute  and chronic disability.",Non-OADS,/arxiv_data1/oa_pdf/d4/e9/nss-7-063.PMC4482367.pdf
"For each ROI, the number of neurons of each type was  counted using the ImageJ manual cell counter plugin (Java- based open-source software, http://rsbweb.nih.gov/ij /).",OADS,/arxiv_data1/oa_pdf/d4/e9/nss-7-063.PMC4482367.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/d4/e9/nss-7-063.PMC4482367.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/e9/nss-7-063.PMC4482367.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/13/ijn-10-4099.PMC4482368.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4099–4109International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4099OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7899 5Targeted tumor imaging of anti-cD20-polymeric  nanoparticles developed for the diagnosis of   B-cell malignancies sara capolla1 chiara garrovo2 sonia Zorzet1 andrea lorenzon3 enrico rampazzo4 ruben spretz5 gabriele Pozzato6 luis Núñez7 claudio Tripodo8 Paolo Macor1,9 stefania Biffi2 1Department of life sciences,   University of Trieste, 2Institute  for Maternal and child health –  Irccs “Burlo garofolo”, Trieste,   3animal care Unit, cluster in  Biomedicine (cBM scrl), Trieste,   Italy; 4Department of chemistry “ g.   ciamician”, University of Bologna,   Bologna, Italy; 5lNK chemsolutions  llc, lincoln, N e, Usa; 6Department  of Medical, surgery and health  sciences, University of Trieste, Trieste,   Italy; 7Bio-Target, Inc., University  of chicago, chicago, Il, Usa;   8Department of human Pathology,   University of Palermo, Palermo, Italy;   9callerio Foundation Onlus, Institutes  of Biological researches, Trieste, ItalyAbstract:  The expectations of nanoparticle (NP)-based targeted drug delivery systems in cancer,  when compared with convectional therapeutic methods, are greater efficacy and reduced drug  side effects due to specific cellular-level interactions.",Non-OADS,/arxiv_data1/oa_pdf/43/13/ijn-10-4099.PMC4482368.pdf
"Keywords:  active targeting, optical imaging, tumor accumulation Introduction Nanomedicine for cancer therapy is advantageous over conventional medicine1 because  it has the potential to enable the preferential delivery of drugs to tumors owing to the  enhanced permeability and retention (EPR) effect, and the delivery of more than one  therapeutic agent for combination therapy.2 Moreover, the engineering of a targeting  ligand onto the nanoparticles’ (NPs’) surface can result in prolonged and localized drug  delivery, which should translate into greater efficacy and reduced drug side effects.3–5 Cancer treatment stands to benefit from targeted drug delivery, as tumor cells  express many molecules on their surface that distinguish them from normal cells.6  Although there are expectations of improved efficacy of targeted NPs derived from  specific cellular-level interactions, there are conflicting literature reports on tumor  accumulation of targeted NPs: previous reports suggest that a tumor-targeting ligand  does not increase NP accumulation in tumors, but the targeting antibody may increase  tumor cell internalization.3,7 The results of these studies suggest that the tumor local - ization of NPs is independent of the ligand and primarily relies on the EPR effect.8  These reports are in contrast, however, to others, which suggest that the attachment  of tumor-targeting antibody on NPs enhances total accumulation in solid tumor.9–11  One difference might be the presence or absence of polyethylene glycol (PEG) in the  complex and its impact on the EPR effect.12 In fact, the increased circulation time Correspondence: Stefania Biffi Institute for Maternal and child  health – Irccs “Burlo garofolo”,  via dell’Istria, 65/1, 34137 Trieste, Italy Tel +39 040 378 5478 Fax +39 040 378 5210 email stefania.biffi@burlo.trieste.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Capolla et al Running head recto: Targeted tumor imaging of anti-CD20 polymeric nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S78995",Non-OADS,/arxiv_data1/oa_pdf/43/13/ijn-10-4099.PMC4482368.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/43/13/ijn-10-4099.PMC4482368.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/13/ijn-10-4099.PMC4482368.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/76/dddt-9-3153.PMC4482369.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 3153–3162Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3153Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8191 1histone demethylase lsD1-mediated repression  of GATA-2  is critical for erythroid differentiation Yidi guo1 Xueqi Fu1,2 Yue Jin1 Jing sun1 Ye liu1 Bo huo1 Xiang li1 Xin hu1–3 1school of life sciences, Jilin  University, 2Key laboratory  for Molecular enzymology  and engineering of Ministry of  education, Jilin University, 3national  engineering laboratory of aiDs  Vaccine, school of life sciences,   Jilin University, changchun, People’s  republic of chinaBackground:  The transcription factor GATA-2  is predominantly expressed in hematopoietic  stem and progenitor cells and counteracts the erythroid-specific transcription factor GATA-1 ,  to modulate the proliferation and differentiation of hematopoietic cells.",Non-OADS,/arxiv_data1/oa_pdf/4d/76/dddt-9-3153.PMC4482369.pdf
"While the 1G promoter and 1S  promoter are mainly located in hematopoietic and progenitor tissues.9,10 At the early  stage of erythroid differentiation, GATA-2  binds to five GATA motifs in the GATA-2   locus (−77 kb, −3.9 kb, −2.8 kb, −1.8 kb, and +9.5 kb from the 1S promoter) and pro - motes its own expression.11–13 At the late stage of erythroid differentiation, GATA-1  replaces GATA-2  and binds to these GATA motifs in the GATA-2  locus, which inhibits correspondence: Xin hu school of life sciences, Jilin University,  2699 Qianjin road, changchun 130012,  People’s republic of china Tel +86 186 4311 9899 Fax +86 431 8451 5118 email huxinjilin@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Guo et al Running head recto: LSD1 represses GATA-2  in erythropoiesis DOI: http://dx.doi.org/10.2147/DDDT.S81911",Non-OADS,/arxiv_data1/oa_pdf/4d/76/dddt-9-3153.PMC4482369.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4d/76/dddt-9-3153.PMC4482369.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/76/dddt-9-3153.PMC4482369.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/53/ott-8-1543.PMC4482370.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 1543–1552OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1543Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7737 3roles of dopamine receptors and their antagonist  thioridazine in hepatoma metastasis Meiling lu1,* Jinghua li1,* Zaili luo2,3,* shuai Zhang3 shaobo Xue1 Kesheng Wang1 Yan shi4 cunzhen Zhang3 haiyang chen3 Zhong li1,5 1central laboratory, The 10th  People’s hospital, T ongji University,   shanghai, People’s republic of  china; 2international cooperation  laboratory on signal Transduction,   eastern hepatobiliary surgery  institute/ hospital, The second Military  Medical University, shanghai, People’s  republic of china; 3institution of  Biomedical sciences, Fudan University,   shanghai, People’s republic of china;    4Department of gastroenterology,   The 10th People’s hospital, Tongji  University, shanghai, People’s republic  of china; 5Zhangjiang center for  Translational Medicine, shanghai,   People’s republic of china *These authors contributed equally  to this workAbstract:  Tumor metastasis is the most common cause of death and poor prognosis for cancer  patients.",Non-OADS,/arxiv_data1/oa_pdf/9c/53/ott-8-1543.PMC4482370.pdf
"In  the case of advanced tumor, the drug is widely used for the treatment of tumor-linked  sweating and depression.4,5 Studies have revealed that antipsychotics have antiprolif - erative activity and promote apoptosis in gastric cancer, cervical cancer, endometrial  cancer, breast cancer, neuroblastoma, glioma, leukemia, and ovarian cancer.6–11  Further research disclosed that THIO induced cell cycle (G0/G1) arrest and served as  an inhibitor of PI3K/AKT signaling to downregulate the cell cycle regulator Cyclin  D1 and CDK4 and upregulate p21, p16, and p-CDC25A in ovarian cancer.11 Studies correspondence: Zhong li central laboratory, The 10th People’s  hospital, Tongji University, 301 Middle  Yanchang road, shanghai 200072,  People’s republic of china Tel +86 21 3605 0164 email lizhongsh@yahoo.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Lu et al Running head recto: Thioridazine inhibits proliferation and migration of HCC cells DOI: http://dx.doi.org/10.2147/OTT.S77373",Non-OADS,/arxiv_data1/oa_pdf/9c/53/ott-8-1543.PMC4482370.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9c/53/ott-8-1543.PMC4482370.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/53/ott-8-1543.PMC4482370.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/5e/dddt-9-3183.PMC4482371.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 3183–3190Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3183Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8203 5combination of erlotinib and a P arP inhibitor  inhibits growth of a2780 tumor xenografts due  to increased autophagy hongying sui caixia shi Zhipeng Yan hucheng li Department of gynecological  Oncology, hunan cancer hospital,   The affiliated cancer hospital  of Xiangya school of Medicine,   central south University, changsha  city, People’s republic of chinaBackground:  Ovarian cancer is the leading cause of death in women with gynecological  malignancy worldwide.",Non-OADS,/arxiv_data1/oa_pdf/71/5e/dddt-9-3183.PMC4482371.pdf
"The epidermal growth factor receptor (EGFR) has been suggested as a promising  target since up to 70% of ovarian cancers are EGFR-positive, and overexpression of correspondence: hongying sui Department of gynecological Oncology,  Hunan Cancer Hospital, The Affiliated  cancer hospital of Xiangya school  of Medicine, central south University,  Tongzipo road 283, changsha city,  hunan Province, People’s republic  of china email hongyingsui26@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Sui et al Running head recto: EGFR and PARP inhibition in ovarian cancer DOI: http://dx.doi.org/10.2147/DDDT.S82035",Non-OADS,/arxiv_data1/oa_pdf/71/5e/dddt-9-3183.PMC4482371.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/71/5e/dddt-9-3183.PMC4482371.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/5e/dddt-9-3183.PMC4482371.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/e1/dddt-9-3163.PMC4482372.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3163–3178Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3163Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8095 8Therapeutic effects of c-28 methyl ester of  2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid  (cDDO-Me; bardoxolone methyl) on radiation- induced lung inflammation and fibrosis in mice Yan-Yang Wang,1,* cui-Ying  Zhang,2,* Ya-Qiong Ma,3  Zhi-Xu he,4 hong Zhe,1  shu-Feng Zhou5 1Department of radiation Oncology,   general hospital of ningxia Medical  University, 2graduate school, ningxia  Medical University, 3Department  of Pathology, general hospital of  ningxia Medical University, 4guizhou  Provincial Key laboratory for  regenerative Medicine, stem cell  and Tissue engineering research  center and sino-U s Joint laboratory  for Medical sciences, guizhou  Medical University, guiyang, People’s  republic of china;  5Department of  Pharmaceutical sciences, college of  Pharmacy, University of south Florida,   Fl, Usa *These authors contributed equally  to this workAbstract:  The C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me),  one of the synthetic triterpenoids, has been found to have potent anti-inflammatory and anticancer  properties in vitro and in vivo.",Non-OADS,/arxiv_data1/oa_pdf/10/e1/dddt-9-3163.PMC4482372.pdf
"Clinically significant RILI occurs in up to 30% of  patients irradiated for lung cancer and in about 10%–15% of other thoracic cancers,  eg, mediastinal lymphoma patients, depending on the method of assessment.5–10 A far  greater proportion of patients will have subclinical effects of radiation on the lung,  identifiable by imaging and/or physiological testing.8,10–12 The exact mechanisms of  RILI are not fully understood, but previous studies indicate that the process starts  with energy deposition and generation of reactive oxygen species (ROS), followed correspondence: hong Zhe Department of radiation Oncology,  general hospital of ningxia Medical  University, 804 shengli street, Yinchuan,  ningxia 750004, People’s republic  of china Tel +86 951 674 3315 Fax +86 951 674 6101 email nxzh1961@hotmail.co m  shu-Feng Zhou Department of Pharmaceutical sciences,  college of Pharmacy, University of south  Florida, 12901 Bruce B Down Boulevard,  Tampa, Fl 33612, Usa Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: Therapeutic effect of CDDO-Me in RILI DOI: http://dx.doi.org/10.2147/DDDT.S80958",Non-OADS,/arxiv_data1/oa_pdf/10/e1/dddt-9-3163.PMC4482372.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/10/e1/dddt-9-3163.PMC4482372.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/e1/dddt-9-3163.PMC4482372.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/f2/ijn-10-4081.PMC4482373.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4081–4098International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4081OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7587 7Oral administration of iron-saturated bovine  lactoferrin–loaded ceramic nanocapsules for  breast cancer therapy and influence on iron  and calcium metabolism ganesh Mahidhara rupinder K Kanwar Kislay roy Jagat r Kanwar Nanomedicine-laboratory  of Immunology and Molecular  Biomedical research, school  of Medicine, Molecular and Medical  research strategic research centre,   Faculty of health, Deakin University,   Waurn Ponds, VIc , australiaAbstract:  We determined the anticancer efficacy and internalization mechanism of our  polymeric–ceramic nanoparticle system (calcium phosphate nanocores, enclosed in biode - gradable polymers chitosan and alginate nanocapsules/nanocarriers [ACSC NCs]) loaded with  iron-saturated bovine lactoferrin (Fe-bLf) in a breast cancer xenograft model.",Non-OADS,/arxiv_data1/oa_pdf/09/f2/ijn-10-4081.PMC4482373.pdf
"It is established that milk and colostrum are a rich source of  potential health-enhancing proteins, and bovine lactoferrin (bLf) in particular has been correspondence: Jagat r Kanwar Nanomedicine-laboratory of Immunology  and Molecular Biomedical research,  school of Medicine, Molecular  and Medical research strategic research  centre, Faculty of health, Deakin  University, locked Bag 20000, geelong,  VIc 3220, australia Tel +61 3 5227 1148 Fax +61 3 5227 3402 email jagat.kanwar@deakin.edu.a u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Mahidhara et al Running head recto: Fe-bLf NCs for breast cancer therapy DOI: http://dx.doi.org/10.2147/IJN.S75877",Non-OADS,/arxiv_data1/oa_pdf/09/f2/ijn-10-4081.PMC4482373.pdf
The miRNAs  gene-specific stem-loop RT primer for reverse transcription  was designed according to miRNAs sequences listed in the  Sanger miRBase ( http://microrna.sanger.ac.uk/sequences /)  (Applied Biosystems).,Non-OADS,/arxiv_data1/oa_pdf/09/f2/ijn-10-4081.PMC4482373.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/09/f2/ijn-10-4081.PMC4482373.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/f2/ijn-10-4081.PMC4482373.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/9c/dddt-9-3191.PMC4482374.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3191–3198Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3191Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7879 2characterization of renal biomarkers for use  in clinical trials: effect of preanalytical processing  and qualification using samples from subjects  with diabetes David a Brott1 stephen T Furlong1 scott h adler1 James W hainer2 ramin B arani2 Mark Pinches3 Peter rossing4–6 nish chaturvedi7 On behalf of the Direc T Programme  steering committee 1enabling safety sciences, 2astraZeneca  Pharmaceuticals, Wilmington, De,  Usa; 3Drug safety and Metabolism,  astraZeneca Pharmaceuticals, alderley  Park, UK; 4steno Diabetes center,  gentofte, Denmark; 5aarhus University,  aarhus, Denmark, 6University  of copenhagen, Denmark; 7institute  of cardiovascular sciences, University  college london, london, UKBackground:  Identifying the potential for drug-induced kidney injury is essential for the  successful research and development of new drugs.",Non-OADS,/arxiv_data1/oa_pdf/14/9c/dddt-9-3191.PMC4482374.pdf
"Keywords:  drug development, healthy volunteers, kidney Introduction The shortcomings of traditional renal function laboratory biomarkers are illustrated  by the fact that kidney function can decrease by more than 50% without any notable  elevation in serum creatinine.1–4 Newer and potentially more sensitive and informative  assays are now available, many of which have been qualified by regulatory agencies  (European Medicines Agency, US Food and Drug Administration, and Pharmaceuticals  and Medical Devices Agency) for preclinical/rat studies.5–7 Given the high level of correspondence: David a Brott enabling safety sciences, astraZeneca  Pharmaceuticals, 1 Medimmune Way,  gaithersburg, MD 20878, Usa Tel +1 301 398 0275 email david.brott@astrazeneca.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Brott et al Running head recto: Clinical renal biomarkers DOI: http://dx.doi.org/10.2147/DDDT.S78792",Non-OADS,/arxiv_data1/oa_pdf/14/9c/dddt-9-3191.PMC4482374.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/14/9c/dddt-9-3191.PMC4482374.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/9c/dddt-9-3191.PMC4482374.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/d2/ahmt-6-115.PMC4482375.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdolescent Health, Medicine and Therapeutics 2015:6 115–131Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  115Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S3731 6Promoting family meals: a review of existing  interventions and opportunities for future  research Laura Dwyer1 April Oh2 Heather Patrick1,3 erin Hennessy4 1Health Behaviors Research Branch,   Behavioral Research Program,   Division of Cancer Control and  Population Sciences, National Cancer  institute, Bethesda, MD, USA; 2Health  Communication and informatics  Research Branch, Behavioral Research  Program, Division of Cancer Control  and Population Sciences, National  Cancer institute,  Bethesda, MD,   USA; 3Live Healthier, Bethesda,  MD,   USA; 4Clinical Research Directorate/ Clinical Monitoring Research Program,   Leidos Biomedical Research, inc.,   Frederick National Laboratory for  Cancer Research, Frederick, MD, USA Correspondence: erin Hennessy   Clinical Research Directorate/Clinical  Monitoring Research Program, Leidos  Biomedical Research, inc., Frederick  National Laboratory for Cancer  Research, 5705 industry Lane, Frederick,  MD 21704, USA   Tel +1 240 529 4268   Fax +1 240 276 7907  email erin.hennessy@fnlcr.nih.go vAbstract:  Evidence suggests that regular family meals protect against unhealthy eating and  obesity during childhood and adolescence.",Non-OADS,/arxiv_data1/oa_pdf/7a/d2/ahmt-6-115.PMC4482375.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/7a/d2/ahmt-6-115.PMC4482375.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/d2/ahmt-6-115.PMC4482375.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/5d/ott-8-1533.PMC4482376.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1533–1541OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1533Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8493 8Detection of epidermal growth factor receptor  mutation in lung cancer by droplet digital  polymerase chain reaction Qing Xu1,* Yazhen Zhu2,*  Yali Bai1 Xiumin Wei1 Xirun Zheng2 Mao Mao1 guangjuan Zheng2 1Translational Bioscience and  Diagnostics, WuXi appT ec, shanghai,   2Department of Pathology, guangdong  Provincial hospital of TcM,   guangzhou University of chinese  Medicine, guangdong Provincial  academy of chinese Medical sciences,   guangzhou, People’s republic  of china *These authors contributed equally  to this workBackground:  Two types of epidermal growth factor receptor ( EGFR ) mutations in exon 19  and exon 21 (ex19del and L858R) are prevalent in lung cancer patients and sensitive to targeted  EGFR  inhibition.",Non-OADS,/arxiv_data1/oa_pdf/c2/5d/ott-8-1533.PMC4482376.pdf
"Adenocarcinoma and squamous cell  carcinoma are the two major subtypes of non-small cell lung cancer, comprising 50%  and 40% of cases, respectively.1 Genomic studies such as next-generation sequenc - ing and other high-throughput profiling platforms have identified genetic alterations  common to both adenocarcinoma and squamous cell carcinoma, including in KRAS,  BRAF, epidermal growth factor receptor ( EGFR ), and ALK.1 Among these mutations  or fusion genes, alterations in the EGFR  have been identified in about 12%–13% of  cases examined so far worldwide,1,2 and are much more frequent in Asian populations  (~50%).3 EGFR  is a member of the ERBB family of receptor tyrosine kinases involved correspondence: guangjuan Zheng Department of Pathology, guangdong  Provincial hospital of TcM, guangzhou  University of chinese Medicine,  guangdong Provincial academy  of chinese Medical sciences, 111 Dade  road, guangzhou 510120, People’s  republic of china email zhengguangjuan@163.co m  Mao Mao Translational Bioscience and Diagnostics,  WuXi appTec, 288 Fute Zhong road,  shanghai 200131, People’s republic of china Tel +86 21 5046 5237 email mao_m@yahoo.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xu et al Running head recto: EGFR  mutation detection by ddPCR DOI: http://dx.doi.org/10.2147/OTT.S84938",Non-OADS,/arxiv_data1/oa_pdf/c2/5d/ott-8-1533.PMC4482376.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c2/5d/ott-8-1533.PMC4482376.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5d/ott-8-1533.PMC4482376.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/9f/dddt-9-3125.PMC4482377.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3125–3139Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3125Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8293 5gamma scintigraphic study of the hydrodynamically  balanced matrix tablets of Metformin hcl  in rabbits Mahboubeh razavi1 hamed Karimian1 chai hong Yeong2 sazilah ahmad sarji2 lip Y ong chung1 shaik nyamathulla1,3 Mohamed ibrahim  noordin1,3 1Department of Pharmacy, Faculty  of Medicine, 2Department of  Biomedical imaging and University  of Malaya research imaging  centre, Faculty of Medicine,   3Department of chemistry, centre  for natural Products and Drug  Discovery ( cenar ), Faculty of  science, University of Malaya, Kuala  lumpur,  MalaysiaAbstract:  The purpose of this study is to evaluate the in vitro and in vivo performance of  gastro-retentive matrix tablets having Metformin HCl as model drug and combination of natural  polymers.",Non-OADS,/arxiv_data1/oa_pdf/ef/9f/dddt-9-3125.PMC4482377.pdf
"The  controlled oral drug delivery systems reduce the frequency of drug administration  and avoid drug fluctuations in blood plasma levels, which are often associated with  an unwanted side effect.2 Gastro-retentive drug delivery systems are designed to release drug at the upper  part of the GI tract for a prolonged and predictable period of time in order to improve  its bioavailability.3 Excipients are “inert” materials added to the drug formulations  for further processing of the materials into its final dosage form and to achieve an  optimum absorption and therapeutic effect.4 They can be used as diluents, binders, correspondence: Mahboubeh razavi;  Mohamed ibrahim noordin Department of Pharmacy, Faculty  of Medicine, University of Malaya,  50603 Kuala lumpur, Malaysia Tel +60 3 7967 3194 Fax +60 3 7967 4964 email mahbobehrazavi@gmail.co m;  ibrahimn@um.edu.m yJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Razavi et al Running head recto: Gamma scintigraphic study of gastroretentive matrix tablet in rabbits DOI: http://dx.doi.org/10.2147/DDDT.S82935",Non-OADS,/arxiv_data1/oa_pdf/ef/9f/dddt-9-3125.PMC4482377.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ef/9f/dddt-9-3125.PMC4482377.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/9f/dddt-9-3125.PMC4482377.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/98/ijn-10-4071.PMC4482378.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4071–4080International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4071OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8248 6sustained release of Vh and rhBMP-2 from  nanoporous magnesium–zinc–silicon xerogels  for osteomyelitis treatment and bone repair Fengqian li1,* Wen Wu2,* li Xiang1 gan Weng1 hua hong3 hong Jiang4 Jun Qian3 1Department of Pharmacy, shanghai  Xuhui Dahua hospital, 2Department  of Orthopaedics, Ninth People’s  hospital, school of Medicine, shanghai  Jiaotong University, 3Key laboratory  for Ultrafine Materials of Ministry of  education, east china University of  science and T echnology, 4school of  Materials science and  engineering,   University of  shanghai for science  and Technology, shanghai, People’s  republic of china *co-first authors contributed equally  to this workAbstract:  Nanoporous magnesium–zinc–silicon (n-MZS) xerogels with a pore size of ~4 nm,  a surface area of 718 cm2/g, and a pore volume of 1.24 cm3/g were synthesized by a sol–gel  method.",Non-OADS,/arxiv_data1/oa_pdf/20/98/ijn-10-4071.PMC4482378.pdf
"Thus, local antibiotic  administration has been developed to improve the treatment effects.16–18 In order to  achieve a sustained antibiotic concentration at the site of bone infection, different kinds correspondence: hua hong; Jun Qian Key Laboratory for Ultrafine Materials  of Ministry of education, east china  University of science and Technology,  130 Meilong road, shanghai 200237,  People’s republic of china Tel +86 21 6453 5555 email biomaterbone@163.co m;   qianjun@ecust.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Li et al Running head recto: Sustained release of VH and rhBMP-2 DOI: http://dx.doi.org/10.2147/IJN.S82486",Non-OADS,/arxiv_data1/oa_pdf/20/98/ijn-10-4071.PMC4482378.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/20/98/ijn-10-4071.PMC4482378.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/98/ijn-10-4071.PMC4482378.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/90/oajsm-6-201.PMC4482379.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 201–208Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  201OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S8109 6Suture locking of isolated internal locking knotless  suture anchors is not affected by bone quality Jarret M Woodmass1 graeme Matthewson1 Y ohei Ono1,2 Aaron J Bois1 richard S Boorman1 ian KY lo1 gail M Thornton1,3 1Department of Surgery, Section  of Orthopaedic Surgery, Mc caig  institute for Bone and Joint health,  University of calgary, calgary, AB,  canada;  2Department of Orthopaedic  Surgery, nagoya University graduate  School of Medicine, nagoya, Japan;   3Department of Orthopaedics,  University of British columbia,  Vancouver, Bc, canada correspondence: gail M Thornton   Mccaig institute for Bone and Joint  health, Department of Surgery,  University of calgary,  3A18 health  research innovation centre,   3280 hospital Drive nW, calgary,   AB, T2n  4Z6, canada   Tel +1 403 220 2296  Fax +1 403 210 8197  email gail.thornton@ucalgary.c aPurpose:  The purpose of this study was to evaluate the mechanical performance of different  suture locking mechanisms including: i) interference fit between the anchor and the bone (eg,   4.5 mm PushLock,  5.5 mm SwiveLock), ii) internal locking mechanism within the anchor itself  (eg, 5.5 mm SpeedScrew), or iii) a combination of interference fit and internal locking (eg,   4.5 mm MultiFIX P ,  5.5 mm MultiFIX S).",Non-OADS,/arxiv_data1/oa_pdf/76/90/oajsm-6-201.PMC4482379.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/76/90/oajsm-6-201.PMC4482379.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/90/oajsm-6-201.PMC4482379.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/25/dddt-9-3179.PMC4482380.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3179–3182Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3179Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8210 0The impact of lipocalin-type-prostaglandin- D-synthase as a predictor of kidney disease  in patients with type 2 diabetes Marcelo Rodrigues Bacci1 Marina Romera Cavallari1 Ross Martin de  Rozier-Alves2 Beatriz da Costa Aguiar  Alves2 Fernando Luiz Affonso  Fonseca2,3 1General Practice Department,   2Clinical Analysis Laboratory, ABC  Medical School, 3Biological Sciences  Department, Federal University of São  Paulo, São Paulo, BrazilAbstract:  Hypertension and diabetes are clinical conditions which contribute to the development  of chronic  kidney disease  as well as risk factors for cardiovascular events.",Non-OADS,/arxiv_data1/oa_pdf/1c/25/dddt-9-3179.PMC4482380.pdf
"However, given the limitations of creatinine as a biomarker  of this GFR, and therefore of renal function, new alternative biomarkers are being  investigated, such as low molecular weight proteins.3 Lipocalin-type-prostaglandin-D-synthase (or, beta trace protein, BTP) can be  considered a protein with a double function: first, BTP acts as an enzyme in the  production of PGD2; and second, after being secreted, BTP acts as an extracellular Correspondence: Marcelo Rodrigues  Bacci General Practice Department,  ABC Medical School, Av Principe de  Gales, 821, Santo Andre, São Paulo  09060-650, Brazil Tel +55 11 981937005 email mrbacci@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Bacci et al Running head recto: Lipocalin-type-prostaglandin-D-synthase in patients with type 2 diabetes DOI: http://dx.doi.org/10.2147/DDDT.S82100",Non-OADS,/arxiv_data1/oa_pdf/1c/25/dddt-9-3179.PMC4482380.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1c/25/dddt-9-3179.PMC4482380.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/25/dddt-9-3179.PMC4482380.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/f9/ott-8-1553.PMC4482381.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1553–1559OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1553Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8261 6enhanced nK cell adoptive antitumor effects  against breast cancer in vitro via blockade of the  transforming growth factor- β signaling pathway Yue Zhao1,* Jinyue hu2,* rongguo li1 Jian song1 Yujuan Kang1 si liu1 Dongwei Zhang1 1Department of general surgery,   second affiliated hospital of  harbin Medical University, harbin,  2Department of Breast and Thyroid  surgery, The Third hospital of  Zhengzhou, Zhengzhou, People’s  republic of china *These authors contributed equally  to this workAbstract:  Natural killer (NK) cells have great potential for improving cancer immunotherapy.",Non-OADS,/arxiv_data1/oa_pdf/96/f9/ott-8-1553.PMC4482381.pdf
"They exert their effector function via direct killing of virally  infected cells and tumor cells and via production of immunoregulatory cytokines and  chemokines, thereby effecting adaptive immune responses.2–4 However, the adoptive correspondence: Dongwei Zhang Department of general surgery,  Second Affiliated Hospital of Harbin  Medical University, 246 Xuefu road,  nangang District, harbin 150086,  People’s republic of china Tel +86 135 0484 5465 email mugong0@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhao et al Running head recto: Enhanced NK cell adoptive antitumor effects DOI: http://dx.doi.org/10.2147/OTT.S82616",Non-OADS,/arxiv_data1/oa_pdf/96/f9/ott-8-1553.PMC4482381.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/96/f9/ott-8-1553.PMC4482381.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/f9/ott-8-1553.PMC4482381.pdf
"Circ Cardiovasc Interv is available at http://circinterventions.ahajournals.org DOI: 10.1161/CIRCINTERVENTIONS.114.002369Received September 24, 2014; accepted April 13, 2015.From the Departments of Interventional Cardiology (A.K., N.V .M., N.v.D., C.F., J.D., Y .O., R.D., M.V ., F.K., P.d.J., F.Z., R.-J.v.G., E.R.)",Non-OADS,/arxiv_data1/oa_pdf/0f/4b/hcv-8-e002369.PMC4482452.pdf
"The Data Supplement is available at http://circinterventions.ahajournals.org/lookup/suppl/doi:10.1161/CIRCINTERVENTIONS.114.002369/-/DC1.Correspondence to Evelyn Regar, MD, PhD, Thoraxcenter, BA-585, Erasmus MC, ‘s Gravendijkwal 230, 3015CE Rotterdam, The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/0f/4b/hcv-8-e002369.PMC4482452.pdf
2014. https://clinicaltrials.gov/ct2/show/NCT00740610?term=GS-9450& rank=2.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/cogas-31-175.PMC4482455.pdf
2015. https://clinicaltrials.gov/ct2/show/NCT0169 4849?term=GFT-505&rank=4.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/cogas-31-175.PMC4482455.pdf
2014. https://clinicaltrials.gov/ct2/show/NCT02217475?term=cenicriviroc&rank =5.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/cogas-31-175.PMC4482455.pdf
2013. https://clinicaltrials.gov/ct2/show/ NCT01237119?term=liraglutide+NAFLD&rank=3.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/cogas-31-175.PMC4482455.pdf
2013. https://clinicaltrials.gov/ct2/show/ NCT01963845?term=sitagliptin+NASH&rank=2.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/cogas-31-175.PMC4482455.pdf
2014. https://clinicaltrials.gov/ct2/show/NCT0167 2879?term=simtuzumab+NASH&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/cogas-31-175.PMC4482455.pdf
2014. https://clinicaltrials.gov/ct2/ show/NCT01672866?term=simtuzumab+NASH&rank=2.,Non-OADS,/arxiv_data1/oa_pdf/6b/2f/cogas-31-175.PMC4482455.pdf
DOI: http://dx.doi.org/10.1016/S0140-6736(14)61933-4.,OADS,/arxiv_data1/oa_pdf/6b/2f/cogas-31-175.PMC4482455.pdf
J Gastrointest Surg 2014. doi: http://dx.doi.org/10.1007/s11605-014-2678-y.,OADS,/arxiv_data1/oa_pdf/6b/2f/cogas-31-175.PMC4482455.pdf
Available: http://www.raosoft.com/samplesize.html  (accessed 25 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/43/6c/pharmpract-13-506.PMC4482839.pdf
Available:  http://dsc.gov.ae/EN/Publications/Pages/Publicat ionsList.aspx?PublicationId=1&Year=2013  (accessed 12 July 2014).,OADS,/arxiv_data1/oa_pdf/43/6c/pharmpract-13-506.PMC4482839.pdf
Available: http://www-01.ibm.com/support/docview.wss?uid=swg27021213   (accessed 27 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/43/6c/pharmpract-13-506.PMC4482839.pdf
Available:  http://www.economy.gov.ae/Arabic/DoingB usinessUAE/Pages/FederalLaw-1984-8.aspx  (accessed 22 July 2014).,Non-OADS,/arxiv_data1/oa_pdf/43/6c/pharmpract-13-506.PMC4482839.pdf
Available: http://www.gcu.edu.pk/Library/NI_Feb07.htm  (accessed 3  Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/43/6c/pharmpract-13-506.PMC4482839.pdf
"Available at: http://www.alz.co.uk/research/statistics  (accessed  February 4, 2009).",OADS,/arxiv_data1/oa_pdf/f9/25/pharmpract-13-521.PMC4482840.pdf
"Available in:  http://www.fundacionalzheimeresp.org/index.php  (accessed September 4, 2012).",Non-OADS,/arxiv_data1/oa_pdf/f9/25/pharmpract-13-521.PMC4482840.pdf
"Available in: http://www.alzheimer-europe.org/Alzheimer-Europe/Our-work/Completed-AE- projects/2006-Dementia-Carers-Survey  (accessed September 4, 2012).",Non-OADS,/arxiv_data1/oa_pdf/f9/25/pharmpract-13-521.PMC4482840.pdf
"http://chfs.ky.gov/NR/rdonlyres/85989824-1030-4AA6-91E1- 7F9E3EF68827/0/KASPEREvaluationPDMPStatusFinalReport6242010.pdf  (accessed September 12, 2013).",OADS,/arxiv_data1/oa_pdf/9a/d4/pharmpract-13-540.PMC4482842.pdf
"http://chfs.ky.gov/NR/rdonlyres/BDC0DFC9-924B-4F11-A10A- 5EB17933FDDB/0/2010KASPERSatisfactionSurveyExecutiveSummary.pdf  (accessed July 12, 2013).",OADS,/arxiv_data1/oa_pdf/9a/d4/pharmpract-13-540.PMC4482842.pdf
"http://chfs.ky.gov/NR/rdonlyres/7607D456-68C5-4C86-BF32- BACE738B0B4B/0/2006KASPERSatisfactionSurveySummary.pdf  (accessed July 12, 2013).",OADS,/arxiv_data1/oa_pdf/9a/d4/pharmpract-13-540.PMC4482842.pdf
"http://chfs.ky.gov/NR/rdonlyres/2DA936B2-C5E2-4A9C-B5BB- 4483FF9DB9D3/0/2004KASPERSatisfactionSurveySummaryReport.pdf  (accessed July 12, 2013).",OADS,/arxiv_data1/oa_pdf/9a/d4/pharmpract-13-540.PMC4482842.pdf
"http://www.simeoneassociates.com/simeone3.pdf  (accessed August 8, 2013).",Non-OADS,/arxiv_data1/oa_pdf/9a/d4/pharmpract-13-540.PMC4482842.pdf
"“One year  in, landmark prescription  drug bill shows huge impact.” http://migration.kentucky.gov/newsroom/governor/20130725hb1.htm  (accessed March 24,  2015).",Non-OADS,/arxiv_data1/oa_pdf/9a/d4/pharmpract-13-540.PMC4482842.pdf
"“Prescription drug abuse: untangling the harm.” http://www.altustimes.com/news/opinion/2400269/Prescription-drug- abuse:-Untangling-the-harm  (accessed March 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/9a/d4/pharmpract-13-540.PMC4482842.pdf
"https://fas.org/sgp/crs/misc/R42593.pdf  (accessed March 24, 2015).",Non-OADS,/arxiv_data1/oa_pdf/9a/d4/pharmpract-13-540.PMC4482842.pdf
"http://www.chfs.ky.gov/NR/rdonlyres/24493B2E-B1A1-4399-89AD- 1625953BAD43/0/KASPEREvaluationFinalReport10152010.pdf  (accessed September 12, 2013).",Non-OADS,/arxiv_data1/oa_pdf/9a/d4/pharmpract-13-540.PMC4482842.pdf
"Accessed at  https://portal.pharmacist.com/AM/Temp late.cfm?Section=News_Releases2&template=/CM/ContentDisplay.cfm&Conten tID=18987  (accessed January 23, 2014).",Non-OADS,/arxiv_data1/oa_pdf/9a/d4/pharmpract-13-540.PMC4482842.pdf
Available from:  http://www.ukppg.org.uk/supplementary-prescribing-statement-2003.pdf  (accessed 1 August 2007).,Non-OADS,/arxiv_data1/oa_pdf/ae/70/pharmpract-13-553.PMC4482843.pdf
Available from:  http://www.cqc.org.uk/aboutcqc/howwedoi t/involvingpeoplewhouseservices/patient surveys/communitymentalhealthservi ces.cfm  (accessed 24 September 2010).,Non-OADS,/arxiv_data1/oa_pdf/ae/70/pharmpract-13-553.PMC4482843.pdf
Available at: http://www.ccs.neu.edu/course/is4800s p12/resources/qualmethods.pdf  (accessed 3 May  2015).,Non-OADS,/arxiv_data1/oa_pdf/8c/56/pharmpract-13-559.PMC4482844.pdf
Available from: http://crisispregnancy.ie/wp- content/uploads/2012/06/ICCP-2010_REPORT.pdf  (accessed 2013 Oct 28).,Non-OADS,/arxiv_data1/oa_pdf/58/12/pharmpract-13-565.PMC4482845.pdf
Available from: http://www.ama- assn.org/assets/meeting/2013a/a13-refcomm-e-annotated.pdf  (accessed 2013 Oct 28).,OADS,/arxiv_data1/oa_pdf/58/12/pharmpract-13-565.PMC4482845.pdf
Available from: http://www.fsrh.org/pdfs/CEUGuidanc eCombinedHormonalContraception.pdf  (accessed 2013 Oct 28).,OADS,/arxiv_data1/oa_pdf/58/12/pharmpract-13-565.PMC4482845.pdf
Available from: http://www.dohc.ie/about_us/divisi ons/whc_menopause/menopause_info rmation_in_Ireland.pdf?direct=1  (accesed 2013  Oct 28).,Non-OADS,/arxiv_data1/oa_pdf/58/12/pharmpract-13-565.PMC4482845.pdf
Avalaibale from:  http://www.cdc.gov/drugov erdose/epidemic/index.html  (accessed 8 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/1e/8f/pharmpract-13-566.PMC4482846.pdf
Available at  http://www.napra.ca/Content_Files/Files/weekly.pdf  (accessed 12 December 2011).,Non-OADS,/arxiv_data1/oa_pdf/1e/8f/pharmpract-13-566.PMC4482846.pdf
Available from:  http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf  (accessed 6 May 2015).,OADS,/arxiv_data1/oa_pdf/1e/8f/pharmpract-13-566.PMC4482846.pdf
Statistisk sentralbyr å (Eng: Statistics Norway) Available from: URL: http://www.ssb.no/   (accessed 2010 Jul 13).,OADS,/arxiv_data1/oa_pdf/d6/f3/pharmpract-13-575.PMC4482847.pdf
Available from: URL: http://www.sign.ac.uk/  (accessed 2010 Jul 13).,Non-OADS,/arxiv_data1/oa_pdf/d6/f3/pharmpract-13-575.PMC4482847.pdf
Available from: URL: http://www.nice.org.uk/  (accessed 2010 Jul  13).,Non-OADS,/arxiv_data1/oa_pdf/d6/f3/pharmpract-13-575.PMC4482847.pdf
National Institute of  Clinical Expertice (NICE) 2011Available from: URL:  http://guidance.nice.org.uk/Topic/Cardiovascular  (accessed 2010 Jul 13).,Non-OADS,/arxiv_data1/oa_pdf/d6/f3/pharmpract-13-575.PMC4482847.pdf
"http://www.escardio.org/Policy/Pages/EuroAction.aspx   (accessed November 7, 2011).",Non-OADS,/arxiv_data1/oa_pdf/d6/f3/pharmpract-13-575.PMC4482847.pdf
Available from: URL:  http://www.helse-nord.no/befolkning-pr-helseforetak/category22368.html  (accessed 2010 Jul 13).,OADS,/arxiv_data1/oa_pdf/d6/f3/pharmpract-13-575.PMC4482847.pdf
"Clinicaltrials gov 2011 May 19 Available from: URL: http://clinicaltrials.gov/ct2/show/NCT00811772  (accessed  November 7, 2011).",Non-OADS,/arxiv_data1/oa_pdf/d6/f3/pharmpract-13-575.PMC4482847.pdf
"http://www.ntnu.edu/dmf/akf/randomisering   (accessed November 7, 2011).",Non-OADS,/arxiv_data1/oa_pdf/d6/f3/pharmpract-13-575.PMC4482847.pdf
"http://www.bhsoc.org/blood_pressure_list.stm   (accessed November 7, 2011).",Non-OADS,/arxiv_data1/oa_pdf/d6/f3/pharmpract-13-575.PMC4482847.pdf
"http://www.merriam-webster.com/dictionary/hawthorne%20effect  (accessed November 7, 2011).",Non-OADS,/arxiv_data1/oa_pdf/d6/f3/pharmpract-13-575.PMC4482847.pdf
"Available at: http://www.fda.gov/OHRMS/DOCKETS/98fr/06-545.pdf  (accessed March 20, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c4/4a/pharmpract-13-605.PMC4482848.pdf
"Available at: http://www.cdc.gov/pregnancy/meds/treatingfortwo/data.html  (accessed March 20, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c4/4a/pharmpract-13-605.PMC4482848.pdf
"Available at: http://www.fda.gov/downloads/ForCons umers/ConsumerUpdates/UCM322886.pdf  (accessed March  20, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c4/4a/pharmpract-13-605.PMC4482848.pdf
"Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm425317.htm  (accessed:  March 20, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c4/4a/pharmpract-13-605.PMC4482848.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/9d/nou159.PMC4483092.pdf
"Image Preprocessing DWIs were realigned to remove eddy current distortions using eddy correct (FMRIB Software Library, http://www.fmrib.ox.ac.",OADS,/arxiv_data1/oa_pdf/d7/9d/nou159.PMC4483092.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, providedthe original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/ee/nou368.PMC4483107.pdf
http://www.nccn.org/professionals/physician_gls/pdf/ cns.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/ee/nou368.PMC4483107.pdf
"GEFOS has released summary data from their 2012 meta-analyses onfemoral neck and lumbar spine bone mineral density tested in 32,961 subjects included from 17 studies ( http://www.gefos.",Non-OADS,/arxiv_data1/oa_pdf/c8/4c/198_2015_Article_3087.PMC4483183.pdf
"The B2AR gene is highly evolutionary conserved; the mouse and human genesare 88 % similar (comparison based on amino acids), and this also applies to the region surrounding the polymorphisms (http://genome.ucsc.edu/cgi-bin/hgTracks?db= hg19&position=chr5%3A148206156-148208197&hgsid= 406908755_GVOKV49jJeWv 0lNk5TyiXyon0z8p ).",Non-OADS,/arxiv_data1/oa_pdf/c8/4c/198_2015_Article_3087.PMC4483183.pdf
"National osteoporosis society, URL: http://www.nos.org.uk/page.",Non-OADS,/arxiv_data1/oa_pdf/0c/b6/198_2015_Article_3098.PMC4483189.pdf
"URL: https://www.rcplondon.ac.uk/sites/default/files/ national_report.pdf , assessed 25 Jan 2015 25.",Non-OADS,/arxiv_data1/oa_pdf/0c/b6/198_2015_Article_3098.PMC4483189.pdf
The protocol was published on PROSPERO ( http://www.crd.,Non-OADS,/arxiv_data1/oa_pdf/68/10/134_2015_Article_3899.PMC4483251.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/68/10/134_2015_Article_3899.PMC4483251.pdf
"In fact, RGC death occurs Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> Received 3 February 2015 | Accepted 26 June 2015 | Published 29 June 2015© 2015 Molecular Vision 718Intravitreal injection of forskolin, homotaurine, and L-carnosine  affords neuroprotection to retinal ganglion cells following retinal  ischemic injury Rossella Russo,1 Annagrazia Adornetto,1 Federica Cavaliere,1 Giuseppe Pasquale Varano,1 Dario Rusciano,3  Luigi Antonio Morrone,1,2 Maria Tiziana Corasaniti,4 Giacinto Bagetta,1,2 Carlo Nucci5 1Department of Pharmacy and Health and Nutritional Sciences, Section of Preclinical and Translational Pharmacology,  University of Calabria, Arcavacata di Rende, Italy; 2University Consortium for Adaptive Disorders and Head Pain (UCHAD),  Section of Neuropharmacology of Normal and Pathological Neuronal Plasticity, University of Calabria, Arcavacata di Rende,  Italy; 3Sooft Italia SpA, Via Salvatore Quasimodo,Roma; 4Department of Health Sciences, University “Magna Graecia” of  Catanzaro, 88100 Catanzaro, Italy; 5Ophtalmology Unit, Department of Experimental Medicine and Surgery, University of Rome  “Tor Vergata” Rome, Italy Purpose:  Retinal ganglion cell (RGC) death is the final event leading to visual impairment in glaucoma; therefore,  identification of neuroprotective strategies able to slow down or prevent the process is one of the main challenges for  glaucoma research.",Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  719through a complex series of pathological events and involves  several pathways.,Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  720(2 mM; 3 μl/eye; corresponding to about 100 μM as the final  concentration in the vitreous) was performed 75 min before  the ischemia was induced.,Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
"Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  721(FG)-labeled RGCs was observed, 7 days following the insult,  in the retina undergone ischemia/reperfusion compared to the  contralateral, non-ischemic retina (Figure 1A-B).",Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
"Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  722It has been previously shown that forskolin is able to  decrease aqueous humor production and therefore reduce  IOP in rabbits, monkeys, and humans [ 11].",Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  723 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  724leads to a transitory ischemia that mimics the hypoxic stress  that RGCs may undergo in glaucoma [ 38].,Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
"Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  725In our experimental setting, the decrease in RGC loss  observed at 7 days following the insult was preceded by an  increased activation of calpain during the 1 h of reperfusion.",Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
"Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  726GSK-3β is one of the Akt downstream substrates, and its  activity is inversely correlated to PI3K/Akt pathway activa - tion [ 36].",Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  727REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
"Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  728G, Morrone LA.",Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
Molecular Vision  2015; 21:718-729 <http://www.molvis.org/molvis/v 21/718> © 2015 Molecular Vision  729s i gnaling path wa ys.,Non-OADS,/arxiv_data1/oa_pdf/ee/47/mv-v21-718.PMC4483367.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/50/b6/jpts-27-1283.PMC4483379.pdf
http://motorgrowth.canchild.ca/en/GMFCS/ resources/GMFCS-ER.pdf.,Non-OADS,/arxiv_data1/oa_pdf/50/b6/jpts-27-1283.PMC4483379.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/77/12/jpts-27-1287.PMC4483380.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ef/0a/jpts-27-1291.PMC4483381.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/8e/3a/jpts-27-1295.PMC4483382.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e3/bf/jpts-27-1299.PMC4483383.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ef/1d/jpts-27-1303.PMC4483384.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e2/bc/jpts-27-1309.PMC4483385.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/52/d3/jpts-27-1313.PMC4483386.pdf
REFERENCES 1) American Psychiatric Association: http://www.psychiatry.org/autism (Ac - cessed Apr.,Non-OADS,/arxiv_data1/oa_pdf/52/d3/jpts-27-1313.PMC4483386.pdf
4) Saudi Autistic Society: http://saudiautism.com/english/index (Accessed Apr.,Non-OADS,/arxiv_data1/oa_pdf/52/d3/jpts-27-1313.PMC4483386.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ba/f9/jpts-27-1317.PMC4483387.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/64/4f/jpts-27-1319.PMC4483388.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/36/f2/jpts-27-1323.PMC4483389.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/94/5c/jpts-27-1329.PMC4483390.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/fe/9b/jpts-27-1333.PMC4483391.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/98/50/jpts-27-1337.PMC4483392.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a2/50/jpts-27-1341.PMC4483393.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/36/c9/jpts-27-1347.PMC4483394.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ad/0e/jpts-27-1353.PMC4483395.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/18/ca/jpts-27-1357.PMC4483396.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/83/60/jpts-27-1361.PMC4483397.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/c1/47/jpts-27-1365.PMC4483398.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/12/41/jpts-27-1369.PMC4483399.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/bf/d3/jpts-27-1373.PMC4483400.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/57/d2/jpts-27-1377.PMC4483401.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/4c/ac/jpts-27-1379.PMC4483402.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/58/37/jpts-27-1383.PMC4483403.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e7/ff/jpts-27-1387.PMC4483404.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/01/e8/jpts-27-1391.PMC4483405.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/21/86/jpts-27-1397.PMC4483406.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/92/95/jpts-27-1401.PMC4483407.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/de/80/jpts-27-1407.PMC4483408.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/48/c4/jpts-27-1411.PMC4483409.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f3/5f/jpts-27-1417.PMC4483410.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/b1/dd/jpts-27-1421.PMC4483411.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/05/bc/jpts-27-1429.PMC4483412.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a4/53/jpts-27-1435.PMC4483413.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f2/fa/jpts-27-1441.PMC4483414.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/3e/3d/jpts-27-1445.PMC4483415.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/6a/8e/jpts-27-1451.PMC4483416.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/bb/b4/jpts-27-1455.PMC4483417.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/00/6b/jpts-27-1459.PMC4483418.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/63/5d/jpts-27-1463.PMC4483419.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ce/e1/jpts-27-1467.PMC4483420.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c6/dd/jpts-27-1473.PMC4483421.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/5c/48/jpts-27-1477.PMC4483422.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c6/10/jpts-27-1481.PMC4483423.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a8/fc/jpts-27-1485.PMC4483424.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/e9/49/jpts-27-1491.PMC4483425.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/64/9a/jpts-27-1495.PMC4483426.pdf
Available: http://www.seniam.org/.,Non-OADS,/arxiv_data1/oa_pdf/64/9a/jpts-27-1495.PMC4483426.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/59/ac/jpts-27-1499.PMC4483427.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f3/08/jpts-27-1503.PMC4483428.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/cc/d8/jpts-27-1507.PMC4483429.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/89/13/jpts-27-1511.PMC4483430.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ac/b3/jpts-27-1515.PMC4483431.pdf
"REFERENCES 1) Statics Korea: http://kostat.go.kr/portal/korea, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ac/b3/jpts-27-1515.PMC4483431.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/18/2e/jpts-27-1519.PMC4483432.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d3/e8/jpts-27-1523.PMC4483433.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a6/aa/jpts-27-1527.PMC4483434.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/df/46/jpts-27-1529.PMC4483435.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jpts-27-1533.PMC4483436.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0e/1f/jpts-27-1539.PMC4483437.pdf
"http://stats.oecd.org/index.aspx?queryid   =58524 (Accessed Aug. 29, 2014) 9) Granick S, Kleban MH, Weiss AD: Relationships between hearing loss  and cognition in normally hearing aged persons.",OADS,/arxiv_data1/oa_pdf/0e/1f/jpts-27-1539.PMC4483437.pdf
http://www.who.int/pbd/deafness/,Non-OADS,/arxiv_data1/oa_pdf/0e/1f/jpts-27-1539.PMC4483437.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/80/1c/jpts-27-1543.PMC4483438.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/18/e2/jpts-27-1549.PMC4483439.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jpts-27-1555.PMC4483440.pdf
[Medline] 7)  Internet Site: http://www.ncmedical.com/wp-ntent/uploads/2011/07/Touch-   Test- Sensory-Evaluator_11_web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/c4/jpts-27-1555.PMC4483440.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/93/08/jpts-27-1559.PMC4483441.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/98/20/jpts-27-1565.PMC4483442.pdf
Data	were	obtained	 through	“confirmation	 of	plan	for	raw	data	use”	from	the	 Korean	Centers	for	Disease	Control	and	Prevention	 through	 the	KNHANES	 website	(http://knhanes.cdc.go.kr)	 with	 permission.,OADS,/arxiv_data1/oa_pdf/98/20/jpts-27-1565.PMC4483442.pdf
Revised	Nov	2005.	http://www.ipaq.ki.se/scoring.htm.,Non-OADS,/arxiv_data1/oa_pdf/98/20/jpts-27-1565.PMC4483442.pdf
"http://knhanes.cdc.go.kr	(Accessed	Nov.	1,	2013) 12)	 Korean	 Society	for	the	Study	of	Obesity:	Obesity	diagnostic	 criteria.",Non-OADS,/arxiv_data1/oa_pdf/98/20/jpts-27-1565.PMC4483442.pdf
"Seoul,	2007.	http://www.kosso.or.kr/.",Non-OADS,/arxiv_data1/oa_pdf/98/20/jpts-27-1565.PMC4483442.pdf
"2004.	 http://www.who.int/substance_abuse 	/publications/global_status_re - port_2004_overview.pdf	(Accessed	Dec.	10,	2011) 25)	 Kim	 DH:	Relation	of	body	mass	index,	waist	and	visceral	fat	area	with	 alcohol	consumption	 habits	in	Korea.",OADS,/arxiv_data1/oa_pdf/98/20/jpts-27-1565.PMC4483442.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d6/a8/jpts-27-1571.PMC4483443.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/jpts-27-1577.PMC4483444.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/37/14/jpts-27-1581.PMC4483445.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/04/10/jpts-27-1585.PMC4483446.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f8/8d/jpts-27-1589.PMC4483447.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/05/13/jpts-27-1593.PMC4483448.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/48/eb/jpts-27-1597.PMC4483449.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/79/f9/jpts-27-1603.PMC4483450.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/6c/df/jpts-27-1609.PMC4483451.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/1e/99/jpts-27-1613.PMC4483452.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review Article,Non-OADS,/arxiv_data1/oa_pdf/32/54/jpts-27-1617.PMC4483453.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review Article,Non-OADS,/arxiv_data1/oa_pdf/60/24/jpts-27-1621.PMC4483454.pdf
http://colleges.ksu.edu.sa/appliedmedicalsciences/healthrehabilitation.,Non-OADS,/arxiv_data1/oa_pdf/60/24/jpts-27-1621.PMC4483454.pdf
[Medline]    [CrossRef] 10) King Saud University: http://cams.ksu.edu.sa/en/students/students-statis - tics.,Non-OADS,/arxiv_data1/oa_pdf/60/24/jpts-27-1621.PMC4483454.pdf
11) Umm al Qura University: https://uqu.edu.sa/page/en/1290.,Non-OADS,/arxiv_data1/oa_pdf/60/24/jpts-27-1621.PMC4483454.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/38/32/jpts-27-1625.PMC4483455.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/f8/e1/jpts-27-1629.PMC4483456.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Technical Note,Non-OADS,/arxiv_data1/oa_pdf/e8/19/jpts-27-1633.PMC4483457.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/6e/main.PMC4483485.pdf
http://dx.doi.org/10.1016/j.fob.2015.06.004 2211-5463/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/6e/main.PMC4483485.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: GLFG repeat, Gly-Leu-Phe-Gly repeat; NE, nuclear envelope; NPC, nuclear pore complex ⇑Corresponding authors at: Graduate School of Frontier Biosciences, Osaka University, 1-3 Yamadaoka, Suita 565-0871, Japan.",Non-OADS,/arxiv_data1/oa_pdf/2a/6e/main.PMC4483485.pdf
"Original Article J Vet Sci 2015, 16(2), 135-143 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.135 JVS Received 5 Nov. 2014, Revised 19 Jan. 2015, Accepted 29 Jan. 2015 *Corresponding author: Tel: +82-53-580-5931; Fax: +82-53-588-5233; E-mail: yckim@kmu.ac.kr Journal of Veterinary Science ㆍⓒ 2015 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/f5/ce/jvs-16-135.PMC4483495.pdf
"Original Article J Vet Sci 2015, 16(2), 145-150 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.145 JVS Received 8 Jul.",Non-OADS,/arxiv_data1/oa_pdf/61/14/jvs-16-145.PMC4483496.pdf
"Original Article J Vet Sci 2015, 16(2), 151-156 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.151 JVS Received 28 May 2014, Revised 7 Oct. 2014, Accepted 12 Nov. 2014 *Corresponding author: Tel: +86-514-87991448; Fax: +86-514-87972218; E-mail: liuzongping@yzu.edu.cn †The first two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/96/67/jvs-16-151.PMC4483497.pdf
"Original Article J Vet Sci 2015, 16(2), 157-164 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.157 JVS Received 29 Aug. 2014, Revised 24 Nov. 2014, Accepted 30 Dec. 2014 *Corresponding author: Tel/Fax:+86-20-85281204; E-mail: zlzeng@scau.edu.cn †The first two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/ae/65/jvs-16-157.PMC4483498.pdf
"Original Article J Vet Sci 2015, 16(2), 165-171 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.165 JVS Received 6 Aug. 2014, Revised 8 Jan. 2015, Accepted 29 Jan. 2015 *Corresponding author: Tel: +82-41-580-2721; Fax: +82-41-580-2932; E-mail: kang@nsu.ac.kr Journal of Veterinary Science ㆍCopyright ⓒ 2015 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/a0/1a/jvs-16-165.PMC4483499.pdf
"Original Article J Vet Sci 2015, 16(2), 173-177 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.173 JVS Received 13 Oct. 2014, Revised 7 Nov. 2014, Accepted 12 Nov. 2014 *Corresponding author: Tel: +82-53-850-3737; Fax: +82-53-850-3736; E-mail: yheo@cu.ac.kr Journal of Veterinary Science ㆍCopyright ⓒ 2015 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/06/9a/jvs-16-173.PMC4483500.pdf
"Original Article J Vet Sci 2015, 16(2), 179-186 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.179 JVS Received 5 Sep. 2014, Revised 23 Oct. 2014, Accepted 5 Nov. 2014 *Corresponding author: Tel: +1-5093353882; Fax: +1-5093358328; E-mail: rohana1@vetmed.wsu.edu Journal of Veterinary Science ㆍCopyright ⓒ 2015 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/5c/ba/jvs-16-179.PMC4483501.pdf
"Original Article J Vet Sci 2015, 16(2), 187-194 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.187 JVS Received 20 Jun.",Non-OADS,/arxiv_data1/oa_pdf/bd/fe/jvs-16-187.PMC4483502.pdf
"Original Article J Vet Sci 2015, 16(2), 195-201 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.195 JVS Received 29 Aug. 2014, Revised 16 Dec. 2014, Accepted 30 Dec. 2014 *Corresponding author: Tel: +1-402-314-2255; Fax: +1-402-472-1693; E-mail: jgneto84@huskers.unl.edu †The first two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/82/ae/jvs-16-195.PMC4483503.pdf
"Original Article J Vet Sci 2015, 16(2), 203-211 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.203 JVS Received 28 Apr.",Non-OADS,/arxiv_data1/oa_pdf/e1/84/jvs-16-203.PMC4483504.pdf
"Original Article J Vet Sci 2015, 16(2), 213-219 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.213 JVS Received 27 Feb. 2014, Revised 26 Sep. 2014, Accepted 12 Nov. 2014 *Corresponding author: Tel: +90-362-3121919/1546; Fax: +90-362-4576922; E-mail: nilgung@omu.edu.tr  †Present address: Department of Obstetrics and Gynecology, Faculty of Veterinary Medicine, Near East University, Nicosia, Cyprus Journal of Veterinary Science ㆍCopyright ⓒ 2015 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/88/52/jvs-16-213.PMC4483505.pdf
"Original Article J Vet Sci 2015, 16(2), 221-224 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.221 JVS Received 6 Nov. 2014, Revised 13 Jan. 2015, Accepted 29 Jan. 2015 *Corresponding author: Tel: +82-2-880-1265; Fax: +82-2-880-8662; E-mail: heeyoon@snu.ac.kr Journal of Veterinary Science ㆍCopyright ⓒ 2015 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/54/48/jvs-16-221.PMC4483506.pdf
"Original Article J Vet Sci 2015, 16(2), 225-231 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.225 JVS Received 8 Oct. 2014, Revised 11 Jan. 2015, Accepted 29 Jan. 2015 *Corresponding author: Tel/Fax:+86-01062733621; E-mail: csama@sina.com Journal of Veterinary Science ㆍCopyright ⓒ 2015 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/d7/b2/jvs-16-225.PMC4483507.pdf
"Short Communication J Vet Sci 2015, 16(2), 233-235 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.233 JVS Received 18 Jun.",Non-OADS,/arxiv_data1/oa_pdf/2b/32/jvs-16-233.PMC4483508.pdf
"Short Communication J Vet Sci 2015, 16(2), 237-240 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.237 JVS Received 18 Aug. 2014, Revised 3 Nov. 2014, Accepted 5 Nov. 2014 *Corresponding author: Tel: +82-31-467-1807; Fax: +82-31-467-1814; E-mail: leeyj700@korea.kr Journal of Veterinary Science ㆍCopyright ⓒ 2015 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/28/73/jvs-16-237.PMC4483509.pdf
"Case Report J Vet Sci 2015, 16(2), 241-244 ㆍhttp://dx.doi.org/10.4142/jvs.2015.16.2.241 JVS Received 12 Aug. 2014, Revised 12 Dec. 2014, Accepted 30 Dec. 2014 *Corresponding author: Tel: +82-2-880-1269; Fax: +82-2-873-1269; E-mail: bclee@snu.ac.kr Journal of Veterinary Science ㆍCopyright ⓒ 2015 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/a7/e8/jvs-16-241.PMC4483510.pdf
"Associate Editor of JKAOMS Department of Dentistry, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Koreahttp://dx.doi.org/10.5125/jkaoms.2015.41.3.117 pISSN 2234-7550 ·eISSN 2234-5930 Fig.",Non-OADS,/arxiv_data1/oa_pdf/25/8c/jkaoms-41-117.PMC4483523.pdf
"J Korean Assoc Oral Maxillofac Surg 2015% Accepted35 3025 20 15 10 5 0 Rejected Accepted Rejected Case reports Original articlesSimilarity index Won Lee Dental Clinic, Department of Dentistry, The Catholic University of Korea,  Uijeongbu St. Mary’s Hospital, 271 Cheonbo-ro, Uijeongbu 480-717, Korea TEL: +82-31-820-3574   FAX: +82-31-847-2894 E-mail: cmfs21@catholic.ac.kr ORCID: http://orcid.org/0000-0002-6383-8754    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2015 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/25/8c/jkaoms-41-117.PMC4483523.pdf
"Moreover, a variety of factors, including trauma and ORIGINAL ARTICLE Shahriar Ahmadpour Department of Anatomical Sciences, Medicine Faculty, North Khorasan  University of Medical Sciences, Bojnurd 9414953536, Iran TEL: +98-9157682132   FAX: +98-5842296764 E-mail: shahahmadpour@gmail.com ORCID: http://orcid.org/0000-0002-7744-3358    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Effects of fresh mineralized dentin and cementum on socket healing:   a preliminary study in dogs Mahdi Kadkhodazadeh1, Majid Ghasemianpour2, Negar Soltanian3, Gholam Reza Sultanian4,   Shahriar Ahmadpour5, Reza Amid1 1Dental Research Center, Department of Periodontics, Dental School, Shahid Beheshti University of Medical Sciences,   2Endodontic Research Center, Shahid Beheshti University of Medical Sciences, 3Dental School, International Branch of Shahid Beheshti  University of Medical Sciences, 4Iran Veterinary Organization, Tehran, 5Department of Anatomical Sciences, Medicine Faculty,   North Khorasan University of Medical Sciences, Bojnurd, Iran Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:119-123) Objectives:  Dentin is composed of many minerals and growth factors.",Non-OADS,/arxiv_data1/oa_pdf/bc/d7/jkaoms-41-119.PMC4483524.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.3.119 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/bc/d7/jkaoms-41-119.PMC4483524.pdf
"ORCID In-Woong Um, http://orcid.org/0000-0002-4628-3662 Woo-Jin Cho, http://orcid.org/0000-0003-2952-2921 Referenc es 1.",Non-OADS,/arxiv_data1/oa_pdf/02/20/jkaoms-41-124.PMC4483525.pdf
"This article encourages  researchers to investigate new methods to manufacture bone  graft material for dental patients with alveolar bone defects.DISCUSSION In-Woong Um R&D Institute, Korea Tooth Bank, 622 Eonju-ro, Gangnam-gu, Seoul 135-832,  Korea TEL: +82-2-548-2055   FAX: +82-2-548-2228 E-mail: h-bmp@hanmail.net ORCID: http://orcid.org/0000-0002-4628-3662    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2015 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/02/20/jkaoms-41-124.PMC4483525.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.3.124 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/02/20/jkaoms-41-124.PMC4483525.pdf
"ORIGINAL ARTICLE Seung-Il Song Division of Oral and Maxillofacial Surgery, Department of Dentistry, Ajou  University School of Medicine, 164 WorldCup-ro, Yeongtong-gu, Suwon 443- 380, Korea TEL: +82-31-219-5328   FAX: +82-31-219-5329 E-mail: seungilsong@daum.net ORCID: http://orcid.org/0000-0001-9504-6471    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Correlation between clinical symptoms and magnetic resonance imaging  findings in patients with temporomandibular joint internal derangement Young-Wook Jung1, Sung-Hoon Park2, Sung-Woon On1, Seung-Il Song1 1Division of Oral and Maxillofacial Surgery, Department of Dentistry, Ajou University School of Medicine,  2Department of Radiology, Ajou University School of Medicine, Suwon, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:125-132) Objectives:  The purpose of this study was to clarify which findings in magnetic resonance imaging (MRI) are good predicators of pain and mouth  opening limitation in patients with temporomandibular joint (TMJ) internal derangement (ID).",Non-OADS,/arxiv_data1/oa_pdf/a2/29/jkaoms-41-125.PMC4483526.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.3.125 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/a2/29/jkaoms-41-125.PMC4483526.pdf
"ORCID Young-Wook Jung, http://orcid.org/0000-0002-7920-2697 Sung-Hoon Park, http://orcid.org/0000-0003-0844-0521 Sung-Woon On, http://orcid.org/0000-0001-6192-1530 Seung-Il Song, http://orcid.org/0000-0001-9504-6471 Refer ences 1.",Non-OADS,/arxiv_data1/oa_pdf/a2/29/jkaoms-41-125.PMC4483526.pdf
"The  osteotomy technique suggested by Epker4 was widely accept-ORIGINAL ARTICLE Sergio Olate Department of Oral and Maxillofacial Surgery, Universidad de La Frontera,  Claro Solar 115, Oficina 414-A, Temuco 4780000, Chile TEL: +56-45-2325000   FAX: +56-45-2325001 E-mail: sergio.olate@ufrontera.cl ORCID: http://orcid.org/0000-0001-8153-0676    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC An in vitro  comparison between two different designs of   sagittal split ramus osteotomy Valdir Cabral Andrade1, Leonardo Flores Luthi2, Fabio Loureiro Sato1, Leandro Pozzer1, Sergio Olate3,4,   Jose Ricardo Albergaria-Barbosa1 1Department of Oral and Maxillofacial Surgery, 2Department of Oral Rehabilitation and Periodontics,   State University of Campinas, São Paulo, Brazil,   3Department of Oral and Maxillofacial Surgery, Universidad de La Frontera,   4Center for Biomedical Research, Universidad Autónoma de Chile, Temuco, Chile Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:133-138) Objectives:  To evaluate the influence of the type of osteotomy in the inferior aspect of the mandible on the mechanical performance.",Non-OADS,/arxiv_data1/oa_pdf/2a/db/jkaoms-41-133.PMC4483527.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.3.133 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/2a/db/jkaoms-41-133.PMC4483527.pdf
"ORCID Valdir Cabral Andrade, http://orcid.org/0000-0002-1680-2855 Leonardo Flores Luthi, http://orcid.org/0000-0003-1398-6529 Fabio Loureiro Sato, http://orcid.org/0000-0003-2842-5150 Leandro Pozzer, http://orcid.org/0000-0003-2109-1450 Sergio Olate, http://orcid.org/0000-0001-8153-0676 Jose Ricardo Albergaria-Barbosa, http://orcid.org/0000- 0002-6433-4080 References 1.",Non-OADS,/arxiv_data1/oa_pdf/2a/db/jkaoms-41-133.PMC4483527.pdf
"Etiologically, the aforemen- tioned lesions may affect the pathogenesis of odontogenic CASE REPORT Il-Kyu Kim Division of Oral and Maxillofacial Surgery, Department of Dentistry, Inha  University Hospital, 27 Inhang-ro, Jung-gu, Incheon 400-711, Korea TEL: +82-32-890-2470   FAX: +82-32-890-2475 E-mail: kik@inha.ac.kr ORCID: http://orcid.org/0000-0003-3930-766X    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Odontogenic carcinosarcoma of the mandible: a case report and review Il-Kyu Kim1, Sang-Pill Pae1, Hyun-Young Cho1, Hyun-Woo Cho1, Ji-Hoon Seo1, Dong-Hwan Lee1, In-Shu Park2 1Department of Oral and Maxillofacial Surgery, Section of Dentistry, Inha University School of Medicine,   2Department of Pathology, Inha University School of Medicine, Incheon, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:139-144) Odontogenic carcinosarcoma is an extremely rare malignant odontogenic tumor with only a few reported cases.",Non-OADS,/arxiv_data1/oa_pdf/b5/f9/jkaoms-41-139.PMC4483528.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.3.139 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/b5/f9/jkaoms-41-139.PMC4483528.pdf
"New York: Springer; 1992.ORCID Il-Kyu Kim, http://orcid.org/0000-0003-3930-766X Sang-Pill Pae, http://orcid.org/0000-0002-8931-2267 Hyun-Young Cho, http://orcid.org/0000-0003-3055-0591 Hyun-Woo Cho, http://orcid.org/0000-0002-0062-5217 Ji-Hoon Seo, http://orcid.org/0000-0003-3618-6380 Dong-Hwan Lee, http://orcid.org/0000-0002-1091-2543 In-Shu Park, http://orcid.org/0000-0002-9415-2923 Refer ences 1.",Non-OADS,/arxiv_data1/oa_pdf/b5/f9/jkaoms-41-139.PMC4483528.pdf
"CASE REPORT Elluru Venkatesh Department of Oral Medicine and Radiology, College of Dentistry, Qaseem  Private College, Western Ring Road, Buraidah 156, Kingdom of Saudi Arabia TEL: +966-16-3260111   FAX: +966-16-3260666 E-mail: dr_eva1@yahoo.com ORCID: http://orcid.org/0000-0002-6723-2514    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Stafne bone cavity and cone-beam computed tomography:   a report of two cases Elluru Venkatesh Department of Oral Medicine and Radiology, College of Dentistry, Qaseem Private College, Buraidah, Kingdom of Saudi Arabia Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:145-148) In 1942 Stafne reported 35 asymptomatic, radiolucent cavities that were unilaterally located in the posterior region of the mandible between the man- dibular angle and the third molar, and below the mandibular canal.",Non-OADS,/arxiv_data1/oa_pdf/b7/03/jkaoms-41-145.PMC4483529.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.3.145 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/b7/03/jkaoms-41-145.PMC4483529.pdf
"In women, the CASE REPORT Moon-Gi Choi Department of Oral and Maxillofacial Surgery, Wonkwang University Dental  Hospital, 895 Muwang-ro, Iksan 570-711, Korea TEL: +82-63-859-2926   FAX: +82-63-857-4002 E-mail: omschoi@wonkwang.ac.kr ORCID: http://orcid.org/0000-0003-3502-7652    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Transmasseteric antero-parotid facelift approach for open reduction and  internal fixation of condylar fractures Moon-Gi Choi Department of Oral and Maxillofacial Surgery, Wonkwang University School of Dentistry, Iksan, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:149-155) Surgical approaches to the condylar fracture include intraoral, preauricular, submandibular, and retromandibular approaches.",Non-OADS,/arxiv_data1/oa_pdf/be/bf/jkaoms-41-149.PMC4483530.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.3.149 pISSN 2234-7550 ·eISSN 2234-5930 This paper was supported by Wonkwang University in 2015.,Non-OADS,/arxiv_data1/oa_pdf/be/bf/jkaoms-41-149.PMC4483530.pdf
"Performing SSO  on bilateral mandibular rami (bilateral SSO, BSSO) to re- duce unexpected stress or torsion in the temporomandibular  joint (TMJ) is considered a standard technique in mandibular CASE REPORT Bong-Wook Park Department of Oral and Maxillofacial Surgery, School of Medicine and Institute  of Health Science, Gyeongsang National University, 79 Gangnam-ro, Jinju 660- 702, Korea TEL: +82-55-750-8264   FAX: +82-55-761-7024 E-mail: parkbw@gnu.ac.kr ORCID: http://orcid.org/0000-0002-2699-9188 Stability of unilateral sagittal split ramus osteotomy for correction of  facial asymmetry: long-term case series and literature review Seong-Geun Lee1,2, Young-Hoon Kang3, June-Ho Byun3, Uk-Kyu Kim4, Jong-Ryoul Kim5, Bong-Wook Park3 1Ilsan Ye Dental Clinic, Goyang, 2Graduate School of Clinical Dentistry, Ewha Womans University, Seoul,   3Department of Oral and Maxillofacial Surgery, School of Medicine and Institute of Health Science, Gyeongsang National University, Jinju,   4Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University, Yangsan,   5Department of Oral and Maxillofacial Surgery, Jaw and Face Surgery Center, On General Hospital, Busan, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:156-164) Bilateral sagittal split ramus osteotomy is considered a standard technique in mandibular orthognathic surgeries to reduce unexpected bilateral stress in  the temporomandibular joints.",Non-OADS,/arxiv_data1/oa_pdf/72/e2/jkaoms-41-156.PMC4483531.pdf
"16]    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2015 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/72/e2/jkaoms-41-156.PMC4483531.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.3.156 pISSN 2234-7550 ·eISSN 2234-5930 This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2014R1A1A2058807)  and a Gyeongsang National University Hospital Research Foundation grant (GNUHBIF-2014-0006).,Non-OADS,/arxiv_data1/oa_pdf/72/e2/jkaoms-41-156.PMC4483531.pdf
"ORCID Seong-Geun Lee, http://orcid.org/0000-0002-1028-0849 Young-Hoon Kang, http://orcid.org/0000-0002-7245-2773 June-Ho Byun, http://orcid.org/0000-0003-2962-6632 Uk-Kyu Kim, http://orcid.org/0000-0003-1251-7843 Jong-Ryoul Kim, http://orcid.org/0000-0002-7737-7127 Bong-Wook Park, http://orcid.org/0000-0002-2699-9188 References 1.",Non-OADS,/arxiv_data1/oa_pdf/72/e2/jkaoms-41-156.PMC4483531.pdf
"ABDM is typically considered to be bilaterally symmetri-TECHNICAL NOTE Matthew J. Zdilla Department of Natural Sciences and Mathematics, West Liberty University,  CSC 139, PO Box 295, West Liberty, WV 26074, USA TEL: +1-304-336-8631   FAX: +1-304-336-8266 E-mail: mzdilla@westliberty.edu ORCID: http://orcid.org/0000-0002-2578-1128    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Screening for variations in anterior digastric musculature prior to  correction of post-traumatic anterior open bite by injection of   botulinum toxin type A: a technical note Matthew J. Zdilla Department of Natural Sciences and Mathematics, West Liberty University, West Liberty, WV, USA Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:165-167) It has recently been reported that long-standing post-traumatic open bite can be successfully corrected with botulinum toxin type A (BTX-A) injection  into the anterior belly of the digastric muscle (ABDM).",Non-OADS,/arxiv_data1/oa_pdf/d8/44/jkaoms-41-165.PMC4483532.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.3.165 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/d8/44/jkaoms-41-165.PMC4483532.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/ec/TOORTHJ-9-94.PMC4483534.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/4f/TOORTHJ-9-157.PMC4483535.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/ba/TOORTHJ-9-179.PMC4483536.pdf
"Available from: http://hab.hrsa.gov/deliverhivaidscare/habperform measures.html [19] Catherine P, Nicholas M, Jennie P. Synthesising qualitative and quantitative health evidence: a guide to methods: a guide to methods.",Non-OADS,/arxiv_data1/oa_pdf/37/cb/TOAIDJ-9-45.PMC4483537.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/cb/TOAIDJ-9-45.PMC4483537.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/5d/TOORTHJ-9-89.PMC4483538.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/d0/TOORTHJ-9-129.PMC4483539.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/2c/TOORTHJ-9-163.PMC4483540.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
"Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:177-187 The Role of Glucagon-Like Peptide-1 Receptor  Agonists in Type 2 Diabetes: Understanding How Data  Can Inform Clinical Practice in Korea Seungjoon Oh1, Suk Chon1, Kyu Jeong Ahn1, In-Kyung Jeong1, Byung-Joon Kim2, Jun Goo Kang3 1Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul,  2Department of Endocrinology, Gachon University College of Medicine, Incheon,  3Department of Endocrinology and Metabolism, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea Glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce glycosylated hemoglobin (HbA1c, 0.5% to 1.0%), and are associ - ated with moderate weight loss and a relatively low risk of hypoglycemia.",Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
"Recent research in  Korea has, however, revealed differences between both gender  and age groups: prevalence had decreased amongst women aged  30 to 59 years (6.9% in 2001 to 4.5% in 2010), but increased  amongst males aged 60 years or more (15.9% in 2001 to 21.6% Review Clinical Care/Education http://dx.doi.org/10.4093/dmj.2015.39.3.177 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
Diabetes Metab J 2015;39:177-187 http://e-dmj.orgin 2010) [4].,Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
"179Informing GLP-1RA clinical practice in Korea Diabetes Metab J 2015;39:177-187 http://e-dmj.orgtion of increased risk of CV disease: for example, exenatide CV  disease-extended events, relative risk (RR) 0.69 (95% CI, 0.46  to 1.04) [16]; liraglutide major adverse CV events, incidence  ratio 0.73 (95% CI, 0.38 to 1.41) [17].",Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
"Diabetes Metab J 2015;39:177-187 http://e-dmj.orgat dinner (1.01 mmol/L, P<0.0005) [20,39].",Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
181Informing GLP-1RA clinical practice in Korea Diabetes Metab J 2015;39:177-187 http://e-dmj.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
"Diabetes Metab J 2015;39:177-187 http://e-dmj.orgStudy DesignProportion  Korean  patientsGLP-1RAMean change in Discontinu - ation due to  TEAE, n (%)Proportion of patients with HbA1c  from base - line,  %Bodyweight  from  baseline,  kgFPG level  from  baseline,  mmol/LMorning  2-hr PPG  level from  baseline,  mmol/LGI adverse events, % Hypoglyce - mia, %Nausea Vomiting Diarrhea Shin et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
183Informing GLP-1RA clinical practice in Korea Diabetes Metab J 2015;39:177-187 http://e-dmj.orgthere were none in the liraglutide groups.,Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
Diabetes Metab J 2015;39:177-187 http://e-dmj.orgT2DM are obese (when defined as a BMI ≥25.0 kg/m2 and a  waist circumference >90 cm in men and >85 cm in women)  with data showing the highest prevalence of obesity (63.6%)  and abdominal obesity (57.6%) amongst those aged 40 to 49  years [5].,Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
"185Informing GLP-1RA clinical practice in Korea Diabetes Metab J 2015;39:177-187 http://e-dmj.orgtice Guidelines, Korean Diabetes Association.",Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
http://dx.doi.org/10.1007/s00592-014-0710-z.,Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
Diabetes Metab J 2015;39:177-187 http://e-dmj.org29.,Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
"187Informing GLP-1RA clinical practice in Korea Diabetes Metab J 2015;39:177-187 http://e-dmj.orgcombination with metformin) and reduces body weight and  systolic blood pressure in Asian population with type 2 diabetes  from China, South Korea and India: a 16-week, randomized,  double-blind, active control trial(*).",Non-OADS,/arxiv_data1/oa_pdf/d5/0f/dmj-39-177.PMC4483602.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
"Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:188-197 Pyruvate Dehydrogenase Kinases: Therapeutic Targets  for Diabetes and Cancers Nam Ho Jeoung Department of Pharmaceutical Science and Technology, Catholic University of Daegu College of Medical Sciences, Gyeongsan, Korea Impaired glucose homeostasis is one of the risk factors for causing metabolic diseases including obesity, type 2 diabetes, and can - cers.",Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
"In  starved state, PDC in peripheral tissues is inactive to inhibit  the glucose oxidation and to spare the three carbon compounds  (lactate, alanine, and pyruvate), which are substrates for gluco - neogenesis, leading to maintain the euglycemia in fasting con -Review Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2015.39.3.188 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
189PDK inhibitors Diabetes Metab J 2015;39:188-197 http://e-dmj.orgdition [6].,Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
"190Jeong NH  Diabetes Metab J 2015;39:188-197 http://e-dmj.orgter the publication of this report, studies regarding the expres - sional regulation of PDK1 and its effect on the regulation of  PDC activity have dramatically increased [20-23].",Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
191PDK inhibitors Diabetes Metab J 2015;39:188-197 http://e-dmj.orgliorates the insulin resistance and hyperglycemia induced by  high fat diet (unpublished data).,Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
192Jeong NH  Diabetes Metab J 2015;39:188-197 http://e-dmj.orgEFFECTS OF THE SMALL MOLECULAR PDK  INHIBITORS ON METABOLIC DISEASES Up-regulation of PDKs plays a pivotal role in the development  of various metabolic diseases.,Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
193PDK inhibitors Diabetes Metab J 2015;39:188-197 http://e-dmj.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
"194Jeong NH  Diabetes Metab J 2015;39:188-197 http://e-dmj.orgLipoamide-binding domain In the N-terminal of PDKs, there is a lipoamide-binding site(s)  that allows PDKs to bind to the PDC-E2 subunit for their activ - ity.",Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
195PDK inhibitors Diabetes Metab J 2015;39:188-197 http://e-dmj.orgLactate production and pyruvate dehydrogenase activity in fat  and skeletal muscle from diabetic rats.,Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
196Jeong NH  Diabetes Metab J 2015;39:188-197 http://e-dmj.org33.,Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
197PDK inhibitors Diabetes Metab J 2015;39:188-197 http://e-dmj.orgvivo.,Non-OADS,/arxiv_data1/oa_pdf/40/11/dmj-39-188.PMC4483603.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/75/dmj-39-198.PMC4483604.pdf
"Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:198-203 Gut Microbiota and Metabolic Disorders Kyu Y eon Hur1, Myung-Shik Lee2 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine,   Seoul;  2Severance Biomedical Research Institute and Department of Internal Medicine, Y onsei University College of Medicine, Seoul, Korea Gut microbiota plays critical physiological roles in the energy extraction and in the control of local or systemic immunity.",Non-OADS,/arxiv_data1/oa_pdf/63/75/dmj-39-198.PMC4483604.pdf
Most Sulwon Lecture 2014 Pathophysiology http://dx.doi.org/10.4093/dmj.2015.39.3.198 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/63/75/dmj-39-198.PMC4483604.pdf
199Gut microbiota and host metabolism Diabetes Metab J 2015;39:198-203 http://e-dmj.orgbacterial species in the mouse and human gut belong to the  phyla Bacteroidetes and Firmicutes.,Non-OADS,/arxiv_data1/oa_pdf/63/75/dmj-39-198.PMC4483604.pdf
Diabetes Metab J 2015;39:198-203 http://e-dmj.orgsubsequently preventing fat accumulation [15].,Non-OADS,/arxiv_data1/oa_pdf/63/75/dmj-39-198.PMC4483604.pdf
201Gut microbiota and host metabolism Diabetes Metab J 2015;39:198-203 http://e-dmj.orgported the direct beneficial actions of Lactobacilli  on the epithe - lial cells and on the enteric nervous system regulating gut con - tractility [32].,Non-OADS,/arxiv_data1/oa_pdf/63/75/dmj-39-198.PMC4483604.pdf
Diabetes Metab J 2015;39:198-203 http://e-dmj.org464:59-65.,Non-OADS,/arxiv_data1/oa_pdf/63/75/dmj-39-198.PMC4483604.pdf
203Gut microbiota and host metabolism Diabetes Metab J 2015;39:198-203 http://e-dmj.org24.,Non-OADS,/arxiv_data1/oa_pdf/63/75/dmj-39-198.PMC4483604.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/64/dmj-39-204.PMC4483605.pdf
Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:204-206 Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart  Failure Caused by a Class Effect?,Non-OADS,/arxiv_data1/oa_pdf/09/64/dmj-39-204.PMC4483605.pdf
In Vildagliptin in Ventricu -Editorial Others http://dx.doi.org/10.4093/dmj.2015.39.3.204 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/09/64/dmj-39-204.PMC4483605.pdf
"205DPP4 inhibitors and heart failure Diabetes Metab J 2015;39:204-206 http://e-dmj.orglar Dysfunction Diabetes (VIVIDD) trial, 254 subjects with  type 2 diabetes and New Y ork Heart Association functional  classes I through III heart failure were randomized to vilda - gliptin or placebo for 12 months [10].",Non-OADS,/arxiv_data1/oa_pdf/09/64/dmj-39-204.PMC4483605.pdf
206Lee YH Diabetes Metab J 2015;39:204-206 http://e-dmj.orgWhite WB; EXAMINE Investigators.,Non-OADS,/arxiv_data1/oa_pdf/09/64/dmj-39-204.PMC4483605.pdf
http://dx.doi.org/  10.1016/S0140-6736(14)62225-X .,OADS,/arxiv_data1/oa_pdf/09/64/dmj-39-204.PMC4483605.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Diabetes Metab J 2015;39:207-217 Copyright © 2015 Korean Diabetes Association http://e-dmj.org A Smartphone Application Signif icantly Improved  Diabetes Self-Care Activities with High User Satisfaction Yu Jin Kim1, Sang Y oul Rhee1, Jong Kyu Byun1, So Y oung Park1, Soo Min Hong1, Sang Ouk Chin2, Suk Chon1, Seungjoon Oh1,  Jeong-taek Woo1, Sung Woon Kim1, Y oung Seol Kim1 1Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, 2Division of Endocrinology and Metabolism, Department of Internal Medicine, Jeju National University Hospital, Jeju National University College of Medicine,    Jeju, Korea  Background:  We developed for the first time a smartphone application designed for diabetes self-management in Korea and  registered a patent for the relevant algorithm.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
"Therefore, in -Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2015.39.3.207 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
http://e-dmj.org208 Diabetes Metab J 2015;39:207-217conveniences related to diabetes self-management such as blood  glucose measurement and diabetes journaling can be effectively  improved by utilizing smartphone applications [13].,Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
Diabetes self-care via a smartphone application http://e-dmj.org209 Diabetes Metab J 2015;39:207-217 A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
"http://e-dmj.org210 Diabetes Metab J 2015;39:207-217 The Wilcoxon signed rank test was used for the comparison  of SDSCA items before and after the use of the diabetes appli - cation, and a Mann-Whitney U test was performed for the  comparison of changes in SDSCA between the group with high  satisfaction and the group with low satisfaction with using the  application.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
"Diabetes self-care via a smartphone application http://e-dmj.org211 Diabetes Metab J 2015;39:207-217points to disagree, and (4) 1 point to strongly disagree.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
http://e-dmj.org212 Diabetes Metab J 2015;39:207-217Table 3.,Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
Diabetes self-care via a smartphone application http://e-dmj.org213 Diabetes Metab J 2015;39:207-217CharacteristicHave there been pos - itive changes in the  clinical course of dia - betes after the use of  the application?Are you satisfied  with the structure  and completeness of  the application?Is the application  easy to use?Are you willing to  actively recommend  the application to  others?Will you keep using  the application to  manage diabetes?,Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
http://e-dmj.org214 Diabetes Metab J 2015;39:207-217Table 5.,Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
Diabetes self-care via a smartphone application http://e-dmj.org215 Diabetes Metab J 2015;39:207-217ΔVariableΔBlood  sugar testingΔDiet ΔAlcohol ΔSmoking ΔExercise ΔMedicationΔWeight  measurementΔComply  with regular  lifestyle Comorbidities    None ( n=38) 1.50±2.69 0.87±1.54 –0.08±1.44 –0.38±1.45 1.07±2.32 0.63±2.03 0.70±1.54 1.28±1.86    Hypertension ( n=13) 3.08±2.66 0.38±1.76 –0.46±2.57 –0.77±1.96 1.46±2.18 1.00±2.13 1.46±1.56 2.15±2.30    Dyslipidemia ( n=12) 2.75±2.99 0.50±0.67 –0.42±1.17 –0.83±2.13 1.17±2.48 2.00±2.76 1.08±1.62 0.75±0.75    Other ( n=4) 2.25±3.30 0.50±1.29 –0.25±0.50 –0.75±1.50 0.25±0.50 1.50±3.00 0.50±0.58 2.50±1.92    P value 0.165 0.936 0.674 0.500 0.766 0.430 0.420 0.280 Values are presented as mean±standard deviation.,Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
http://e-dmj.org216 Diabetes Metab J 2015;39:207-217tions [13].,Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
Available from: http://www.kpcb.com/blog/2013-internet-trends  (updated 2013 May 29).,Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
Diabetes self-care via a smartphone application http://e-dmj.org217 Diabetes Metab J 2015;39:207-21738:204-10.,Non-OADS,/arxiv_data1/oa_pdf/b7/45/dmj-39-207.PMC4483606.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Diabetes Metab J 2015;39:218-229 Copyright © 2015 Korean Diabetes Association http://e-dmj.org Prevalence of Depression and Glucose Abnormality in  an Urbanizing Rural Population of Bangladesh Khurshid Natasha1,2, Akhtar Hussain1, A. K. Azad Khan2, Bishwajit Bhowmik1,2 1Institute of Health and Society, Section for International Health, University of Oslo, Oslo, Norway, 2Bangladesh University of Health Sciences, Diabetic Association of Bangladesh, Dhaka, Bangladesh Background:  Depression and glucose abnormality are increasing in Bangladesh including its rural area.",Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
"Because of its widespread  prevalence and potentially debilitating impact, glucose abnor - mality has become an international and national priority area of  health concern.Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2015.39.3.218 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
"Depression and diabetes prevalence in Bangladesh http://e-dmj.org219 Diabetes Metab J 2015;39:218-229 Depression has been found to be associated with lower qual - ity of life, poorer diabetes self-care, impaired glycaemic control  and an increased risk of developing diabetes-related complica - tions [4].",Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
"http://e-dmj.org220 Diabetes Metab J 2015;39:218-229Diagnostics Ltd., Camberley, UK) on the same day.",Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
Depression and diabetes prevalence in Bangladesh http://e-dmj.org221 Diabetes Metab J 2015;39:218-229tiple logistic regression analyses were also used to study the as - sociations.,Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
http://e-dmj.org222 Diabetes Metab J 2015;39:218-229level may have some relationship with depression and glucose  abnormality which was not very clear (Tables 5 and 7).,Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
Depression and diabetes prevalence in Bangladesh http://e-dmj.org223 Diabetes Metab J 2015;39:218-229Table 3.,Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
http://e-dmj.org224 Diabetes Metab J 2015;39:218-229Table 5.,Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
Depression and diabetes prevalence in Bangladesh http://e-dmj.org225 Diabetes Metab J 2015;39:218-229Table 6.,Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
http://e-dmj.org226 Diabetes Metab J 2015;39:218-229Table 7.,Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
Depression and diabetes prevalence in Bangladesh http://e-dmj.org227 Diabetes Metab J 2015;39:218-229group had lower mean BMI in comparison with both healthy  and diseased.,Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
http://e-dmj.org228 Diabetes Metab J 2015;39:218-229REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
Available  from: http://www.who.int/diabetes/en (updated 2011 Sep 30).,Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
"Depression and diabetes prevalence in Bangladesh http://e-dmj.org229 Diabetes Metab J 2015;39:218-229pression, and quality of life: a population study.",Non-OADS,/arxiv_data1/oa_pdf/33/5c/dmj-39-218.PMC4483607.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Diabetes Metab J 2015;39:230-239 Copyright © 2015 Korean Diabetes Association http://e-dmj.org Serum Ceruloplasmin Level as a Predictor for the  Progression of Diabetic Nephropathy in Korean Men  with Type 2 Diabetes Mellitus Min Jung Lee*, Chang Hee Jung*, Yu Mi Kang, Jung Eun Jang, Jaechan Leem, Joong-Y eol Park, Woo Je Lee  Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Background:  Oxidative stress is known to be associated with progression of diabetic kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
"However, in  conditions of elevated oxidative stress, it may act as a pro-oxi -Original Article Complications http://dx.doi.org/10.4093/dmj.2015.39.3.230 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
"Ceruloplasmin and diabetic nephropathy http://e-dmj.org231 Diabetes Metab J 2015;39:230-239dant by donating of free copper ions, which induces reactive  oxygen species (ROS) formation and low density lipoprotein  (LDL) oxidation [5].",Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
"http://e-dmj.org232 Diabetes Metab J 2015;39:230-239Serum ceruloplasmin level was measured using a nephelomet - ric method (BN II System; Siemens, Marburg, Germany).",Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
Ceruloplasmin and diabetic nephropathy http://e-dmj.org233 Diabetes Metab J 2015;39:230-239Table 1.,Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
"http://e-dmj.org234 Diabetes Metab J 2015;39:230-239Values are presented as mean±standard deviation, median (range) unless otherwise indicated.",Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
Ceruloplasmin and diabetic nephropathy http://e-dmj.org235 Diabetes Metab J 2015;39:230-239Table 2.,Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
http://e-dmj.org236 Diabetes Metab J 2015;39:230-239Table 4.,Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
Ceruloplasmin and diabetic nephropathy http://e-dmj.org237 Diabetes Metab J 2015;39:230-239up period might affect this outcome.,Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
http://e-dmj.org238 Diabetes Metab J 2015;39:230-239REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
Ceruloplasmin and diabetic nephropathy http://e-dmj.org239 Diabetes Metab J 2015;39:230-239age and gender on reference ranges in healthy adults.,Non-OADS,/arxiv_data1/oa_pdf/25/f6/dmj-39-230.PMC4483608.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/29/dmj-39-240.PMC4483609.pdf
"Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:240-246 The Relationship between Anemia and the Initiation of  Dialysis in Patients with Type 2 Diabetic Nephropathy Sun Hee Kim, Kyung Ae Lee, Heung Y ong Jin, Hong Sun Baek, Tae Sun Park  Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine of Chonbuk National University-Chonbuk  National University Hospital, Chonbuk National University Medical School, Jeonju, Korea Background:  Anemia is associated with various poor clinical outcomes in chronic kidney disease patients.",Non-OADS,/arxiv_data1/oa_pdf/93/29/dmj-39-240.PMC4483609.pdf
"Previously, anemia affected over two-thirds (68%) of CKD pa -Original Article Complications http://dx.doi.org/10.4093/dmj.2015.39.3.240 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/93/29/dmj-39-240.PMC4483609.pdf
Anemia & diabetic nephropathy requiring dialysis http://e-dmj.org241 Diabetes Metab J 2015;39:240-246tients starting dialysis.,Non-OADS,/arxiv_data1/oa_pdf/93/29/dmj-39-240.PMC4483609.pdf
"http://e-dmj.org242 Diabetes Metab J 2015;39:240-246fore, Cr was measured in a total 87 patients for 10 years.",Non-OADS,/arxiv_data1/oa_pdf/93/29/dmj-39-240.PMC4483609.pdf
Anemia & diabetic nephropathy requiring dialysis http://e-dmj.org243 Diabetes Metab J 2015;39:240-246(Table 2).,Non-OADS,/arxiv_data1/oa_pdf/93/29/dmj-39-240.PMC4483609.pdf
http://e-dmj.org244 Diabetes Metab J 2015;39:240-246tion in patients with diabetic nephropathy.,Non-OADS,/arxiv_data1/oa_pdf/93/29/dmj-39-240.PMC4483609.pdf
"Anemia & diabetic nephropathy requiring dialysis http://e-dmj.org245 Diabetes Metab J 2015;39:240-246that anemia is due to hypoxia which increases oxidative stress,  thus enhancing tissue injury [15].",Non-OADS,/arxiv_data1/oa_pdf/93/29/dmj-39-240.PMC4483609.pdf
http://e-dmj.org246 Diabetes Metab J 2015;39:240-246Toto RD.,Non-OADS,/arxiv_data1/oa_pdf/93/29/dmj-39-240.PMC4483609.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/2f/dmj-39-247.PMC4483610.pdf
"Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:247-252 Increased Risk of Hospitalization for Heart Failure with  Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors  and Pioglitazone Using the Korean Health Insurance  Claims Database Sunghwan Suh1, Gi Hyeon Seo2, Chang Hee Jung3, Mee-Kyoung Kim4, Sang-Man Jin5, Y ou-Cheol Hwang6, Byung-Wan Lee7,   Jae Hyeon Kim5 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Dong-A Medical Center, Dong-A University College of Medicine, Busan,  2Health Insurance Review and Assessment Service, Seoul,  3Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  4Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul,  5Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  6Division of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul,  7Division of Endocrinology and Metabolism, Department of Internal Medicine, Y onsei University College of Medicine, Seoul, Korea Background:  We assessed the association of dipeptidyl peptidase 4 inhibitors (DPP4i) with hospitalization for heart failure (HF)  using the Korean Health Insurance claims database.",Non-OADS,/arxiv_data1/oa_pdf/4f/2f/dmj-39-247.PMC4483610.pdf
New types of glucose-lowering agents are required for type 2 Original Article Others http://dx.doi.org/10.4093/dmj.2015.39.3.247 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/4f/2f/dmj-39-247.PMC4483610.pdf
"http://e-dmj.org248 Diabetes Metab J 2015;39:247-252diabetes mellitus (T2DM) because a multivariable mix of genetic  and environmental factors combine to create a progressive and  highly heterogeneous natural history, with at least eight major or - gan systems being implicated [5].",Non-OADS,/arxiv_data1/oa_pdf/4f/2f/dmj-39-247.PMC4483610.pdf
"DPP-4 inhibitors and heart failure  http://e-dmj.org249 Diabetes Metab J 2015;39:247-252years (mean of 59.4 years) with prescriptions from January 1,  2009 to December 31, 2012 (mean follow-up of 336.8 days).",Non-OADS,/arxiv_data1/oa_pdf/4f/2f/dmj-39-247.PMC4483610.pdf
http://e-dmj.org250 Diabetes Metab J 2015;39:247-252risk of hospitalization for HF in 30 days even though doctors  may not have prescribed the drug to patients at high risk for HF  because TZD is well known risk factor.,Non-OADS,/arxiv_data1/oa_pdf/4f/2f/dmj-39-247.PMC4483610.pdf
"DPP-4 inhibitors and heart failure  http://e-dmj.org251 Diabetes Metab J 2015;39:247-252fore, we await the results of the ongoing trials with CVD as a  main endpoint.",Non-OADS,/arxiv_data1/oa_pdf/4f/2f/dmj-39-247.PMC4483610.pdf
http://e-dmj.org252 Diabetes Metab J 2015;39:247-25216.,Non-OADS,/arxiv_data1/oa_pdf/4f/2f/dmj-39-247.PMC4483610.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
"Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:253-263 Optimal Waist Circumference Cutoff Value Based on  Insulin Resistance and Visceral Obesity in Koreans  with Type 2 Diabetes Jung Soo Lim1, Y oung Ju Choi2, Soo-Kyung Kim3, Byoung Wook Huh2, Eun Jig Lee4, Kap Bum Huh2 1Division of Endocrinology, Department of Internal Medicine, Y onsei University Wonju College of Medicine, Wonju,  2Huh’s Diabetes Center and the 21C Diabetes and Vascular Research Institute, Seoul,  3Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam,  4Division of Endocrinology, Department of Internal Medicine, Y onsei University College of Medicine, Seoul, Korea Background:  Visceral obesity is the most powerful contributor to the development of metabolic syndrome (MetS) and cardio - vascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
One study reported that as many as  86% of patients with diabetes aged 50 years and older had MetS Original Article Others http://dx.doi.org/10.4093/dmj.2015.39.3.253 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
"http://e-dmj.org254 Diabetes Metab J 2015;39:253-263[4], indicating that these two conditions have a close relation - ship.",Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
Waist circumference in type 2 diabetes  http://e-dmj.org255 Diabetes Metab J 2015;39:253-263among the three listed above.,Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
"http://e-dmj.org256 Diabetes Metab J 2015;39:253-263ity of WC for identifying two or more metabolic risk factors, as  well as the presence of IR and visceral obesity.",Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
Waist circumference in type 2 diabetes  http://e-dmj.org257 Diabetes Metab J 2015;39:253-263those who were insulin-sensitive (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
http://e-dmj.org258 Diabetes Metab J 2015;39:253-263prevalence of MetS is 15.8% in men and 11.6% in women [25].,Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
"Waist circumference in type 2 diabetes  http://e-dmj.org259 Diabetes Metab J 2015;39:253-263Some investigators have demonstrated metabolic disturbances  in metabolically obese normal-weight (MONW) [28] or meta - bolically healthy obese (MHO) individuals [29]; the MONW- like phenotype showed an increased risk for incident diabetes  or CVD, whereas the MHO-like phenotype did not confer a  markedly increased risk [30].",Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
http://e-dmj.org260 Diabetes Metab J 2015;39:253-263tween the points for men and women is similar [14].,Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
"Waist circumference in type 2 diabetes  http://e-dmj.org261 Diabetes Metab J 2015;39:253-263Donato KA, Fruchart JC, James WP , Loria CM, Smith SC Jr;  International Diabetes Federation Task Force on Epidemiology  and Prevention; Hational Heart, Lung, and Blood Institute;  American Heart Association; World Heart Federation; Interna - tional Atherosclerosis Society; International Association for the  Study of Obesity.",Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
http://e-dmj.org262 Diabetes Metab J 2015;39:253-26322.,Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
Waist circumference in type 2 diabetes  http://e-dmj.org263 Diabetes Metab J 2015;39:253-263Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/78/72/dmj-39-253.PMC4483611.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/35/dmj-39-264.PMC4483612.pdf
"Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:264-267 Effect of Low Frequency Neuromuscular Electrical  Stimulation on Glucose Profile of Persons with Type 2  Diabetes: A Pilot Study Georges Jabbour1, Lise Belliveau2, David Probizanski3, Ian Newhouse2, Jim McAuliffe2, Jennifer Jakobi4, Michel Johnson1 1School of Kinesiology and Leisure, Faculty of Health and Community Services, University of Moncton, Moncton, NB,  2Lakehead University School of Kinesiology, Thunder Bay, ON,  3Northern Ontario School of Medicine, Thunder Bay, ON, 4Human Kinetics, University of British Columbia Okanagan, Kelowna, BC, Canada The purpose of this study was to examine the effect of low-frequency neuromuscular electrical stimulation (NMES) on glucose  profile in persons with type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/29/35/dmj-39-264.PMC4483612.pdf
The purpose of this study was to determine the acute influ - ence of low-frequency NMES (8 Hz) on glucose metabolism Brief Report Others http://dx.doi.org/10.4093/dmj.2015.39.3.264 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/29/35/dmj-39-264.PMC4483612.pdf
Low frequency NMES and type 2 diabetes http://e-dmj.org265 Diabetes Metab J 2015;39:264-267in middle-aged mobile patients with T2DM.,Non-OADS,/arxiv_data1/oa_pdf/29/35/dmj-39-264.PMC4483612.pdf
http://e-dmj.org266 Diabetes Metab J 2015;39:264-267cose in the NMES than in the control sessions at times 60 ( P<  0.01).,Non-OADS,/arxiv_data1/oa_pdf/29/35/dmj-39-264.PMC4483612.pdf
Low frequency NMES and type 2 diabetes http://e-dmj.org267 Diabetes Metab J 2015;39:264-267cal muscle stimulation acutely mimics exercise in neurological - ly intact individuals but has limited clinical benefits in patients  with type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/29/35/dmj-39-264.PMC4483612.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/ac/dmj-39-268.PMC4483613.pdf
"Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:268-269 Normal Glucose Tolerance with a High 1-Hour  Postload Plasma Glucose Level Exhibits Decreased  β-Cell Function Similar to Impaired Glucose Tolerance  (Diabetes Metab J  2015;39:147-53) Hee Kyung Kim Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea Corresponding author: Hee Kyung Kim Department of Internal Medicine, Chonnam National University Hwasun  Hospital, Chonnam National University Medical School, 322 Seoyang-ro,  Hwasun 519-763, Korea E-mail: albeppy@jnu.ac.krA 75-g oral glucose tolerance test (OGTT) is a sensitive test in  most populations for diagnosis of type 2 diabetes mellitus  (T2DM) and commonly used to identify high-risk individuals  of T2DM [1].",Non-OADS,/arxiv_data1/oa_pdf/61/ac/dmj-39-268.PMC4483613.pdf
"In this study, insulin sensitivity Letter http://dx.doi.org/10.4093/dmj.2015.39.3.268 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/61/ac/dmj-39-268.PMC4483613.pdf
"2691-Hour postload glucose levels and β-cell function Diabetes Metab J 2015;39:268-269 http://e-dmj.organd resistance of NGT 1-hour high groups were similar with  that of IGT subjects, but this study did not determine the differ - ences between NGT 1-hour high group and IFG subjects.",Non-OADS,/arxiv_data1/oa_pdf/61/ac/dmj-39-268.PMC4483613.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/1f/dmj-39-270.PMC4483614.pdf
"Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:270-271 Normal Glucose Tolerance with a High 1-Hour  Postload Plasma Glucose Level Exhibits Decreased  β-Cell Function Similar to Impaired Glucose Tolerance  (Diabetes Metab J  2015;39:147-53) Tae Jung Oh, Se Hee Min, Chang Ho Ahn, Eun Ky Kim, Soo Heon Kwak, Hye Seung Jung, Kyong Soo Park, Y oung Min Cho Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Corresponding author: Y oung Min Cho Department of Internal Medicine, Seoul National University College of  Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea E-mail: ymchomd@snu.ac.krWe appreciate Dr. Hee Kyung Kim’s comments on our study  entitled “Normal glucose tolerance with a high 1-hour postload  plasma glucose level exhibits decreased β-cell function similar  to impaired glucose tolerance, ” which was published in Diabe - tes and Metabolism Journal [1].",Non-OADS,/arxiv_data1/oa_pdf/c6/1f/dmj-39-270.PMC4483614.pdf
CONFLICTS OF INTEREST  No potential conflict of interest relevant to this article was re - ported.Response http://dx.doi.org/10.4093/dmj.2015.39.3.270 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/c6/1f/dmj-39-270.PMC4483614.pdf
2711-Hour postload glucose levels and β-cell function Diabetes Metab J 2015;39:270-271 http://e-dmj.orgREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c6/1f/dmj-39-270.PMC4483614.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/cc/dmj-39-272.PMC4483615.pdf
"Copyright © 2015 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2015;39:272Corrigendum http://dx.doi.org/10.4093/dmj.2015.39.3.272 pISSN 2233-6079 · eISSN 2233-6087 Increasing Prevalence of Type 2 Diabetes in a  Rural Bangladeshi Population: A Population Based  Study for 10 Y ears Bishwajit Bhowmik1, Faria Afsana2, Lien My Diep1,3, Sanjida Binte Munir4, Erica Wright5, Sharif Mahmood6,   A. K. Azad Khan2, Akhtar Hussain1 1Department of Community Medicine, Institute of Health and Society, University of Oslo Faculty of Medicine, Oslo, Norway, 2Department of Endocrinology, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM),    Dhaka, Bangladesh, 3Unit for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway, 4Executive Diabetes Care Centre, NHN, Diabetic Association of Bangladesh, Dhaka, Bangladesh, 5ACT Diabetes Service, Division of Medicine, Canberra Hospital, Canberra, Australia, 6Institutes of Statistical Research and Training, University of Dhaka, Dhaka, Bangladesh Diabetes Metab J 2013;37:46-53. http://dx.doi.org/10.4093/dmj.2013.37.1.46 With regard to the paper by Bhowmik et al.",Non-OADS,/arxiv_data1/oa_pdf/36/cc/dmj-39-272.PMC4483615.pdf
"- 103 -Imaging Science in Dentistry 2015; 45: 103-8 http://dx.doi.org/10.5624/isd.2015.45.2.103 Bony ankylosis of the temporomandibular joint (TMJ)  is a fusion between the condyle and the temporal bone,  which partially or completely obliterates the articular space and causes joint deformity.",Non-OADS,/arxiv_data1/oa_pdf/3e/c7/isd-45-103.PMC4483616.pdf
"(Imaging Sci Dent 2015; 45: 103-8) Key wordS : Temporomandibular Joint; Ankylosis; Arthroplasty; Mouth Rehabilitation Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/c7/isd-45-103.PMC4483616.pdf
"- 109 -Imaging Science in Dentistry 2015; 45: 109-15 http://dx.doi.org/10.5624/isd.2015.45.2.109 Central odontogenic fibroma (COF) is an extremely rare  benign ectomesenchymal neoplasm that accounts for 0.1%  of all odontogenic tumors.1-4 It has two major types: (1)  the simple type and (2) the World Health Organization  (WHO) type.3,5,6 This tumor appears in both the mandible and maxilla (55  % and 45%, respectively).",Non-OADS,/arxiv_data1/oa_pdf/63/48/isd-45-109.PMC4483617.pdf
"(Imaging Sci Dent 2015; 45: 109-15) Key woRds : Fibroma; Odontogenic Tumors; Cone-Beam Computed Tomography Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/48/isd-45-109.PMC4483617.pdf
"- 117 -Imaging Science in Dentistry 2015; 45: 117-22 http://dx.doi.org/10.5624/isd.2015.45.2.117 Introduction With edentulous patients, it is difficult to secure suitable  positioning when taking panoramic radiographs and also  it is hard to assess the positioning by means of inspecting  anatomical structures such as the occlusal plane, ante - ro-posterior position of the anterior teeth, and symmetry  in their panoramic radiographs after taken.",Non-OADS,/arxiv_data1/oa_pdf/cd/6e/isd-45-117.PMC4483618.pdf
"(Imaging Sci Dent 2015; 45: 117-22) Key words : Panoramic, Radiography; Bite Block; Reproducibility of Results Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/6e/isd-45-117.PMC4483618.pdf
- 123 -Imaging Science in Dentistry 2015; 45: 123-31 http://dx.doi.org/10.5624/isd.2015.45.2.123 Vascular anomalies are the most common congenital  deformities observed in infants and children.,Non-OADS,/arxiv_data1/oa_pdf/9e/0c/isd-45-123.PMC4483619.pdf
"(Imaging Sci Dent 2015;  45: 123-31) Key words : Hemangioma; Vascular Malformation; Classification; Neck Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non­Commercial License (http://creativecommons.org/licenses/by­nc/3.0)   which permits unrestricted non­commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/0c/isd-45-123.PMC4483619.pdf
Available  from: http://www.issva.org/content.aspx?page_id=22&club_id=298433&module_id=152904.,Non-OADS,/arxiv_data1/oa_pdf/9e/0c/isd-45-123.PMC4483619.pdf
"- 133 -Imaging Science in Dentistry 2015; 45: 133-5 http://dx.doi.org/10.5624/isd.2015.45.2.133 Dear Editor, The selection of appropriate diagnostic techniques is an  important step in the treatment of disease.",Non-OADS,/arxiv_data1/oa_pdf/35/a3/isd-45-133.PMC4483620.pdf
"Table 1 summarizes the reasons provided Level of knowledge of dental practitioners in Isfahan, Iran about cone-beam computed  tomography and digital radiography Mojdeh Mehdizadeh1, Sahar Goli Booshehri2, Farimah Kazemzadeh2, Parisa Soltani2,   Mahmood Reza Kalantar Motamedi3,* 1Department of Oral and Maxillofacial Radiology, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran   2Dental Students Research Center, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran   3Department of Research, School of Dentistry, Isfahan Branch, Islamic Azad University, Isfahan, Iran Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/a3/isd-45-133.PMC4483620.pdf
"- 137 -Imaging Science in Dentistry 2015; 45: 137-8 http://dx.doi.org/10.5624/isd.2015.45.2.137 Dear Editor: The article by Lee et al., “Glandular odontogenic cyst  mimicking ameloblastoma in a 78-year-old female: A case  report,” caught our attention as we were doing a literature search for rare cases.",Non-OADS,/arxiv_data1/oa_pdf/ce/62/isd-45-137.PMC4483621.pdf
"İnci Rana Karaca1,*, Dilara Nur Öztürk1, Hacer Ulutürk1 1Gazi University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Ankara, Turkey Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/62/isd-45-137.PMC4483621.pdf
- 139 -Imaging Science in Dentistry 2015; 45: 139-40 http://dx.doi.org/10.5624/isd.2015.45.2.139 Thank you for your attention to our study and wonder - ful questions.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/isd-45-139.PMC4483622.pdf
"Imaging Science in Dentistry   2014; 44(3): 249-52.” Byung-Do Lee1,* 1Department of Oral and Maxillofacial Radiology and Wonkwang Dental Research Institute, College of Dentistry, Wonkwang University,  Iksan, Korea Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/d0/isd-45-139.PMC4483622.pdf
- 73 -Imaging Science in Dentistry 2015; 45: 73-80 http://dx.doi.org/10.5624/isd.2015.45.2.73 Introduction Treatment of edentulous areas with dental implants is  becoming a popular choice for patients and a reliable met­ hod for dentists.,Non-OADS,/arxiv_data1/oa_pdf/fb/47/isd-45-73.PMC4483623.pdf
"(Imaging Sci Dent 2015; 45: 73-80) KEy words : Cone ­Beam Computed Tomography; Dental Implants; Patient Positioning; Dimensional Measurement Accuracy Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non­Commercial License (http://creativecommons.org/licenses/by­nc/3.0)   which permits unrestricted non­commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/47/isd-45-73.PMC4483623.pdf
- 81 -Imaging Science in Dentistry 2015; 45: 81-7 http://dx.doi.org/10.5624/isd.2015.45.2.81 Introduction Intraoral digital radiography has been used widely in  the field of dentistry.,Non-OADS,/arxiv_data1/oa_pdf/21/02/isd-45-81.PMC4483624.pdf
"(Imaging Sci Dent 2015; 45: 81-7) Key words : Dental Caries; Dental Digital Radiography; Image Enhancement Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by­nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/02/isd-45-81.PMC4483624.pdf
- 89 -Imaging Science in Dentistry 2015; 45: 89-94 http://dx.doi.org/10.5624/isd.2015.45.2.89 Introduction Temporomandibular disorder (TMD) is a clinical term  used to describe musculoskeletal disorders affecting the  temporomandibular joints (TMJs) and their associated  musculature.1 Pain in the TMJ and/or jaw muscles is one  of the defining features of TMD and the primary reason  for seeking care.,Non-OADS,/arxiv_data1/oa_pdf/82/c3/isd-45-89.PMC4483625.pdf
"(Imaging Sci Dent 2015; 45: 89-94 ) Keywords : Sphenoid Bone; Cone-Beam Computed Tomography; Facial Pain; Temporomandibular Joint Disorders Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/c3/isd-45-89.PMC4483625.pdf
"- 95 -Imaging Science in Dentistry 2015; 45: 95-101 http://dx.doi.org/10.5624/isd.2015.45.2.95 Introduction  The main goal of endodontic treatment is the thorough  cleaning and shaping of the root canal system and its  complete obturation with an inert filling material.1 How- ever, in order to ensure successful treatment, prior knowl-edge of the root canal anatomy is necessary, based on the careful interpretation of angled radiographs, proper access  preparation, and a detailed exploration of the interior of the tooth, as incomplete or untreated canals may cause the treatment to fail.",Non-OADS,/arxiv_data1/oa_pdf/75/a2/isd-45-95.PMC4483626.pdf
"(Imaging Sci Dent  2015; 45: 95-101) Key words : Anatomy; Cone -Beam Computed Tomography; Molar; Dental Pulp Cavity Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/a2/isd-45-95.PMC4483626.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comNeurosurgery Concepts Neurosurgery Concepts: Key perspectives on C2 nerve root  transection following C1 lateral mass screw fixation, choroid  plexus cauterization in infants with hydrocephalus, quality of life  following treatment of vestibular schwannoma, dynamic magnetic  resonance imaging for glioblastoma pseudoprogression,   cost-utility analysis of lumbar spinal stenosis treatment Johnathan H. Sherman, Nader S. Dahdaleh1, Panayiotis Pelargos2, Sandi Lam3, Winward Choy1,  Isaac Yang2, Zachary A. Smith1 Departments of Neurosurgery, George Washington University School of Medicine and Health Sciences, Washington, D.C, 1Department of Neurosurgery,  Northwestern University Feinberg School of Medicine, Chicago, IL, 2Department of Neurosurgery, University of California Los Angeles, David Geffen School of  Medicine, Los Angeles, CA, 3Department of Neurosurgery, Baylor College of Medicine, T exas Children’s Hospital, Houston, TX, USA  E‑mail:  Johnathan H Sherman ‑ jsherman@mfa.gwu.edu; Nader S. Dahdaleh ‑ nader.dahdaleh@northwestern.edu; Panayiotis Pelargos‑ ppelargo@uci.edu;   Sandi Lam ‑sandilam@gmail.com; Winward Choy ‑ winward.choy@northwestern.edu; Isaac Yang ‑iyang@mednet.ucla.edu; *Zachary A. Smith ‑ zsmith@nmff.org   *Corresponding author Received: 08 February 15  Accepted: 16 February 15  Published: 17 June 15 Key Words:  C2 nerve root, hydrocephalus, lumbar spinal stenosis,  pseudoprogression, vestibular schwannoma EVALUATION OF PSEUDOPROGRESSION  IN PATIENTS WITH GLIOBLASTOMA  MULTIFORME USING DYNAMIC  MAGNETIC RESONANCE IMAGING WITH  FERUMOXYTOL CALLS RANO CRITERIA  INTO QUESTION.",Non-OADS,/arxiv_data1/oa_pdf/2a/29/SNI-6-108.PMC4483780.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/108/158981 Copyright: © 2015 Sherman JH.,Non-OADS,/arxiv_data1/oa_pdf/2a/29/SNI-6-108.PMC4483780.pdf
"Surgical Neurology International 2015, 6:108  http://www.surgicalneurologyint.com/content/6/1/108conventional MRI findings concerning for progression of  disease.",Non-OADS,/arxiv_data1/oa_pdf/2a/29/SNI-6-108.PMC4483780.pdf
"Surgical Neurology International 2015, 6:108  http://www.surgicalneurologyint.com/content/6/1/108LONG‑TERM QUALITY OF LIFE IN PATIENTS  WITH VESTIBULAR SCHWANNOMA:  AN INTERNATIONAL MULTICENTER  CROSS‑SECTIONAL STUDY COMPARING  MICROSURGERY , STEREOTACTIC  RADIOSURGERY , OBSERVATION, AND  NONTUMOR CONTROLS.",Non-OADS,/arxiv_data1/oa_pdf/2a/29/SNI-6-108.PMC4483780.pdf
"Surgical Neurology International 2015, 6:108  http://www.surgicalneurologyint.com/content/6/1/108suggesting that the effect of CPC may have a dose– response effect.",Non-OADS,/arxiv_data1/oa_pdf/2a/29/SNI-6-108.PMC4483780.pdf
"Surgical Neurology International 2015, 6:108  http://www.surgicalneurologyint.com/content/6/1/1084.",Non-OADS,/arxiv_data1/oa_pdf/2a/29/SNI-6-108.PMC4483780.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comASSESSING HEALTH‑RELATED QUALITY OF  LIFE IN CHILDREN WITH SPINA BIFIDA[4] Study Question:  How do chronic health issues of spina  bifida affect physical/psychosocial function and pediatric  patients’ health‑related quality of life?",Non-OADS,/arxiv_data1/oa_pdf/91/9a/SNI-6-110.PMC4483781.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/110/159075 Copyright: © 2015 Lam S.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/91/9a/SNI-6-110.PMC4483781.pdf
"Surgical Neurology International 2015, 6:110  http://www.surgicalneurologyint.com/content/6/1/110patients with VP shunts had lower HRQOL scores  than those without shunts (0.47 vs 0.74,  P < 0.001),  even after taking into account age, history of Chiari II  decompression, and number of shunt revisions.",Non-OADS,/arxiv_data1/oa_pdf/91/9a/SNI-6-110.PMC4483781.pdf
"Surgical Neurology International 2015, 6:110  http://www.surgicalneurologyint.com/content/6/1/110The authors[3] conducted a retrospective analysis  of consecutive patients presenting with intracranial  metastatic disease with ≤4 lesions from a known primary  malignancy.",Non-OADS,/arxiv_data1/oa_pdf/91/9a/SNI-6-110.PMC4483781.pdf
"Surgical Neurology International 2015, 6:110  http://www.surgicalneurologyint.com/content/6/1/110To assess patient perspectives on lumbar spondylosis, the  authors administered a survey comprising multiple choice  questions to 121 new patients referred to neurosurgery  clinic with chief complaint of back pain in the absence  of leg pain.",Non-OADS,/arxiv_data1/oa_pdf/91/9a/SNI-6-110.PMC4483781.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Tumoral calcinosis (TC) is a disease of unknown etiology  characterized by the presence of calcified masses in the juxta‑articular regions  of the extremities.",Non-OADS,/arxiv_data1/oa_pdf/33/a9/SNI-6-109.PMC4483782.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/109/159074 Copyright: © 2015 Sasaki O.,Non-OADS,/arxiv_data1/oa_pdf/33/a9/SNI-6-109.PMC4483782.pdf
"Surgical Neurology International 2015, 6:109  http://www.surgicalneurologyint.com/content/6/1/109the juxta‑articular regions of the extremities, and  involvement of the cervical spine is very rare, with only  seven cases having been reported (including ours).",Non-OADS,/arxiv_data1/oa_pdf/33/a9/SNI-6-109.PMC4483782.pdf
"Surgical Neurology International 2015, 6:109  http://www.surgicalneurologyint.com/content/6/1/109The seven reported patients (five females and two males)  ranged in age from 1.4 to 90 years.",Non-OADS,/arxiv_data1/oa_pdf/33/a9/SNI-6-109.PMC4483782.pdf
"Surgical Neurology International 2015, 6:109  http://www.surgicalneurologyint.com/content/6/1/109masses may progress and that the bone around the mass  may become involved within several years.",Non-OADS,/arxiv_data1/oa_pdf/33/a9/SNI-6-109.PMC4483782.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comReview Article A paradigm for the evaluation and management of spinal  coccidioidomycosis Nikolay L. Martirosyan, Jesse M. Skoch, Orel Zaninovich, Carmine Zoccali, John N. Galgiani1, Ali A. Baaj Division of Neurosurgery, University of Arizona, 1Valley Fever Center for Excellence, University of Arizona Medical Center, University of Arizona College of  Medicine, Tucson, Arizona, USA  E‑mail:  Nikolay L. Martirosyan ‑ nmartirosyan@email.arizona.edu; Jesse M. Skoch ‑ jesse@seekaltroute.com; Orel Zaninovich ‑ ozaninovich@gmail.com;   Carmine Zoccali ‑ carminezoccali@libero.it; John N. Galgiani ‑ spherule@email.arizona.edu; *Ali A. Baaj ‑ abaaj@surgery.arizona.edu   *Corresponding author Received: 01 February 15  Accepted: 24 April 15  Published: 17 June 15 Abstract Background:  Coccidioidomycosis is a fungal infection that is endemic to parts of  the Southwestern United States.",Non-OADS,/arxiv_data1/oa_pdf/87/2c/SNI-6-107.PMC4483783.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/107/158979 Copyright: © 2015 Martirosyan NL.,Non-OADS,/arxiv_data1/oa_pdf/87/2c/SNI-6-107.PMC4483783.pdf
"Surgical Neurology International 2015, 6:107  http://www.surgicalneurologyint.com/content/6/1/107which commonly manifests as a community‑acquired  pneumonia or fever with fatigue.",Non-OADS,/arxiv_data1/oa_pdf/87/2c/SNI-6-107.PMC4483783.pdf
"Surgical Neurology International 2015, 6:107  http://www.surgicalneurologyint.com/content/6/1/10711.",Non-OADS,/arxiv_data1/oa_pdf/87/2c/SNI-6-107.PMC4483783.pdf
"Surgical Neurology International 2015, 6:107  http://www.surgicalneurologyint.com/content/6/1/107Surgery In patients with mechanical instability, neurologic deficit,  medically intractable pain or disease progression surgical  debridement, decompression of neural elements and  stabilization was often necessary.",Non-OADS,/arxiv_data1/oa_pdf/87/2c/SNI-6-107.PMC4483783.pdf
"Surgical Neurology International 2015, 6:107  http://www.surgicalneurologyint.com/content/6/1/107vertebral body and disc space involvement, and minimal  epidural involvement [Figure 2].",Non-OADS,/arxiv_data1/oa_pdf/87/2c/SNI-6-107.PMC4483783.pdf
"Surgical Neurology International 2015, 6:107  http://www.surgicalneurologyint.com/content/6/1/107coccidioidomycosis were radiculopathy, sensory  disturbances, paraparesis (often progressive), and most  frequently back/neck pain.",Non-OADS,/arxiv_data1/oa_pdf/87/2c/SNI-6-107.PMC4483783.pdf
"Surgical Neurology International 2015, 6:107  http://www.surgicalneurologyint.com/content/6/1/107responded poorly to azoles alone.",Non-OADS,/arxiv_data1/oa_pdf/87/2c/SNI-6-107.PMC4483783.pdf
"Surgical Neurology International 2015, 6:107  http://www.surgicalneurologyint.com/content/6/1/10710.",Non-OADS,/arxiv_data1/oa_pdf/87/2c/SNI-6-107.PMC4483783.pdf
"Surgical Neurology International 2015, 6:107  http://www.surgicalneurologyint.com/content/6/1/10761.",Non-OADS,/arxiv_data1/oa_pdf/87/2c/SNI-6-107.PMC4483783.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ To cite Lawlor M, Perry R, Plant G T. J Neurol Neurosurg Psychiatry 2015; 86:818 –820.",Non-OADS,/arxiv_data1/oa_pdf/51/57/jnnp-2014-308812.PMC4483785.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Stenger M, Bauer NE, Licht PB.",Non-OADS,/arxiv_data1/oa_pdf/ab/18/acupmed-2014-010700.PMC4483786.pdf
http://www.nice.org.uk/about/ what-we-do/accreditation 4 BSG guidelines advice document.,Non-OADS,/arxiv_data1/oa_pdf/89/78/gutjnl-2014-308956.PMC4483788.pdf
http://www.bsg.org.,Non-OADS,/arxiv_data1/oa_pdf/89/78/gutjnl-2014-308956.PMC4483788.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Fischer H, Holst E, Karlsson F, et al .Gut 2015; 64:1185 –1186.",Non-OADS,/arxiv_data1/oa_pdf/89/78/gutjnl-2014-308956.PMC4483788.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 United Nations Children ’s Fund, World Health Organization, The World Bank, UNICEF-WHO-World Bank Joint Child Malnutrition Estimates.",Non-OADS,/arxiv_data1/oa_pdf/db/d5/archdischild-2014-308017.PMC4483790.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/jech- 2014-205103).,OADS,/arxiv_data1/oa_pdf/d6/56/jech-2014-205103.PMC4483791.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Kawachi I, Adler N, Dow W. Money, schooling, and health: mechanisms and causal evidence.",Non-OADS,/arxiv_data1/oa_pdf/d6/56/jech-2014-205103.PMC4483791.pdf
Crisis squeezes income and puts pressure on inequality and poverty: Organization for Economic Cooperation and Development 2013. http://www.oecd.,Non-OADS,/arxiv_data1/oa_pdf/d6/56/jech-2014-205103.PMC4483791.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Black N. Why we need observational studies to evaluate the effectiveness of health care.,Non-OADS,/arxiv_data1/oa_pdf/85/35/jech-2014-205389.PMC4483792.pdf
2015. http://www.aihw.gov.au/burden-of-disease/ 10 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/85/35/jech-2014-205389.PMC4483792.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/85/35/jech-2014-205389.PMC4483792.pdf
http://www.campbellcollaboration.org/ about_us/index.php (accessed Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/85/35/jech-2014-205389.PMC4483792.pdf
2014. https://www.nhmrc.gov.au/grants/research- funding-statistics-and-data/national-health-priority-areas-nhpas-datasets (accessed Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/85/35/jech-2014-205389.PMC4483792.pdf
"2014. http://report.nih.gov/categorical_spending.aspx (accessed Sep 2014).30 Man J, Weinkauf J, Tsang M, et al.",OADS,/arxiv_data1/oa_pdf/85/35/jech-2014-205389.PMC4483792.pdf
2012. http://pregnancy.cochrane.org/node/69 (accessed Sep 2014).,OADS,/arxiv_data1/oa_pdf/85/35/jech-2014-205389.PMC4483792.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ heartjnl-2014-307288).,Non-OADS,/arxiv_data1/oa_pdf/dc/84/heartjnl-2014-307288.PMC4484040.pdf
"1Bournemouth University, Centre of Postgraduate MedicalResearch & Education, Faculty of Health and Social Sciences, UK 2Poole Hospital NHS Foundation Trust, Dorset, UK 3Emergency Department, Royal Brisbane and Women ’s Hospital, Queensland, Australia 4Emergency Department, Christchurch Hospital, New Zealand 5Department of Cardiology, John Radcliffe Hospital, Oxford, UK 6Sunshine Coast Hospital and Health Services, University ofthe Sunshine Coast, Queensland, Australia Correspondence to Dr Edward Carlton,Department of Cardiology,Poole Hospital NHS Foundation Trust, Long ﬂeet Road, Poole, Dorset BH15 2JB, UK;eddcarlton@gmail.com Received 4 December 2014 Revised 22 January 2015 Accepted 25 January 2015Published Online First17 February 2015 ▸http://dx.doi.org/10.1136/ heartjnl-2015-307555 To cite: Carlton EW, Cullen L, Than M, et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/84/heartjnl-2014-307288.PMC4484040.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Goodacre S, Cross E, Arnold J, et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/84/heartjnl-2014-307288.PMC4484040.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/jech- 2014-204801).,OADS,/arxiv_data1/oa_pdf/75/49/jech-2014-204801.PMC4484041.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Cohen AJ, Ross Anderson H, Ostro B, et al.",Non-OADS,/arxiv_data1/oa_pdf/75/49/jech-2014-204801.PMC4484041.pdf
See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Patient safety: the checklist effect.,Non-OADS,/arxiv_data1/oa_pdf/a5/d8/bmjqs-2015-003957.PMC4484042.pdf
"Retrieved 24 October 2014. http://www.who.int/patientsafety/implementation/checklists/background/en/ 2 Dixon-W oods M, Leslie M, T arrant C, et al.",Non-OADS,/arxiv_data1/oa_pdf/a5/d8/bmjqs-2015-003957.PMC4484042.pdf
"http://www.who.int/patientsafety/safesurgery/endorsements_received/en/8 Degani A, Wiener EL.",Non-OADS,/arxiv_data1/oa_pdf/a5/d8/bmjqs-2015-003957.PMC4484042.pdf
Retrieved 24 October 2014. https://www.osha.gov/dts/osta/anestheticgases/index.html —Appendix2.,OADS,/arxiv_data1/oa_pdf/a5/d8/bmjqs-2015-003957.PMC4484042.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Leen SL, Singh N. Pathology of primary and metastatic mucinous ovarian neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/0d/c8/jclinpath-2015-202951.PMC4484043.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/c8/83/JAIM-6-121.PMC4484047.pdf
Available from: http://www.aiims.edu/aiims/departments/ccm/Rural%20health%20Program.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/d3/JAIM-6-139.PMC4484049.pdf
Available from: http://www.mgims.ac.in/index.,Non-OADS,/arxiv_data1/oa_pdf/49/d3/JAIM-6-139.PMC4484049.pdf
Available from: http://www.ccimindia.,Non-OADS,/arxiv_data1/oa_pdf/49/d3/JAIM-6-139.PMC4484049.pdf
Available from: http://www.ccimindia.,Non-OADS,/arxiv_data1/oa_pdf/49/d3/JAIM-6-139.PMC4484049.pdf
Available from: http://www.planningcommission.nic.in/ aboutus/committee/strgrp12/st_ayush0903.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/d3/JAIM-6-139.PMC4484049.pdf
Available from: http://www.mohfw.nic.in/showfile.,Non-OADS,/arxiv_data1/oa_pdf/49/d3/JAIM-6-139.PMC4484049.pdf
"International Committee of   Medical Journal Editors offers guidance for conduct,  reporting, editing, and publication (http://www.icmje.org).",Non-OADS,/arxiv_data1/oa_pdf/3f/29/JAIM-6-73.PMC4484051.pdf
http://www.unipune.ac.in/ uop_files/Report‑Guidelines_20‑5‑15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3f/29/JAIM-6-73.PMC4484051.pdf
Available  from: https://www.nachc.com/client/Key%20HIT%20 Terms%20Definitions%20Final_April_2008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/60/bb/JAIM-6-89.PMC4484054.pdf
Available from:  http://www.ncbi.nlm.nih.gov/pubmed/21383365.,Non-OADS,/arxiv_data1/oa_pdf/60/bb/JAIM-6-89.PMC4484054.pdf
Available from: http://www.hdl.handle.net/1944/1568.,Non-OADS,/arxiv_data1/oa_pdf/60/bb/JAIM-6-89.PMC4484054.pdf
Available from:  http://www.cdac.in/html/press/1q06/spot561.aspx.,Non-OADS,/arxiv_data1/oa_pdf/60/bb/JAIM-6-89.PMC4484054.pdf
Available from: http://www.ncpa.org/pdfs/st27.pdf.,Non-OADS,/arxiv_data1/oa_pdf/60/bb/JAIM-6-89.PMC4484054.pdf
Available from: http://www.ahrq.gov/professionals/ quality‑patient‑safety/patient‑safety‑resources/resources/ advances‑in‑patient‑safety‑2/vol4/Advances‑Campbell_47.,Non-OADS,/arxiv_data1/oa_pdf/60/bb/JAIM-6-89.PMC4484054.pdf
Available from: http://www.unapcict.org/ecohub/resources/ improving‑health‑connecting‑people‑the‑role‑of‑icts‑in‑the‑  health‑sector‑of‑developing‑countries‑1.,Non-OADS,/arxiv_data1/oa_pdf/60/bb/JAIM-6-89.PMC4484054.pdf
Available from: https://www.frost.com  /prod/servlet/press‑release.pag?docid=36543439.,Non-OADS,/arxiv_data1/oa_pdf/60/bb/JAIM-6-89.PMC4484054.pdf
Available from:  http://www.unarv.com/.,Non-OADS,/arxiv_data1/oa_pdf/60/bb/JAIM-6-89.PMC4484054.pdf
"Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021548s031,022116s015lbl.pdf.",Non-OADS,/arxiv_data1/oa_pdf/96/a2/TOAIDJ-9-38.PMC4484231.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/a2/TOAIDJ-9-38.PMC4484231.pdf
Available from: https://www.drmp.jp/data.shtml [Accessed 9 September 2014].,OADS,/arxiv_data1/oa_pdf/27/e4/TODENTJ-9-159.PMC4484232.pdf
Available from: http://www.jrmp.jp/ data.html [Accessed 9 September 2014].,OADS,/arxiv_data1/oa_pdf/27/e4/TODENTJ-9-159.PMC4484232.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/02/TOORTHJ-9-98.PMC4484233.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/82/TOORTHJ-9-107.PMC4484235.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/dd/TOORTHJ-9-126.PMC4484237.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/be/TOORTHJ-9-139.PMC4484238.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/fc/TOOPHTJ-9-49.PMC4484240.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2014-206016).,Non-OADS,/arxiv_data1/oa_pdf/c4/8b/annrheumdis-2014-206016.PMC4484251.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Hiepe F, Dorner T, Hauser AE, et al.",Non-OADS,/arxiv_data1/oa_pdf/c4/8b/annrheumdis-2014-206016.PMC4484251.pdf
"Technology, cognition and error Enrico Coiera Correspondence to Professor Enrico Coiera, Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie University, Sydney,NSW 2109, Australia; enrico.coiera@mq.edu.au Received 14 August 2014 Revised 10 February 2015 Accepted 26 February 2015 ▸http://dx.doi.org/10.1136/ bmjqs-2014-003483 ▸http://dx.doi.org/10.1136/ bmjqs-2014-003492▸http://dx.doi.org/10.1136/ bmjqs-2014-003482 To cite: Coiera E. BMJ Qual Saf2015; 24:417–422.INTRODUCTION Our information machines exist to make us faster, more powerful decision-makers.",Non-OADS,/arxiv_data1/oa_pdf/25/87/bmjqs-2014-003484.PMC4484254.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ford KM, Glymour C, Hayes PJ.",Non-OADS,/arxiv_data1/oa_pdf/25/87/bmjqs-2014-003484.PMC4484254.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ heartjnl-2015-307821) For numbered af ﬁliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
The website http://www.gmc-uk.org/guidance/ethical_guidance/consent_guidance_index.asp providesthe Gemeral Medical Council (GMC) guidance ‘Consent: patients and doctors making decisions together ’.,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
"WHO checklist In addition to ward-based checklists, the National PatientSafety Agency has asked all hospitals in England and W alesto implement a ﬁve-stage checklist for all interventional proce- dures based on the WHO safe surgery checklist (http://www.nrls.npsa.nhs.uk/resources/collections/10-for-2010/ ﬁve-steps-to- safer-surgery/?entryid45=92901).",Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
"19The complete document can be accessed on the websites of all three societies(http://www.bcis.org.uk, http://www.bcs.com and http://www.scts.org).",Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
The MHRA is a centre of the Medicines and Healthcare Products Regulatory Agency whichalso includes the National Institute for Biological Standards andControl (http://www.nibsc.org/) and the Clinical PracticeResearch Datalink (http://www.cprd.com/).,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
The website http://www.crncc.nihr.ac.uk provides the criteria governing eligibilityof studies for Network support.,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/REFERENCES 1 Windecker S, Kolh P, Alfonso F, et al.",Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
12 http://www.bcis.org.uk/pages/page_box_contents.asp?pageid=780&navcatid=11 (accessed 17 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
18 http://www.bcis.org.uk/pages/page_box_contents.asp?PageID=736 (accessed 22 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
19 http://www.bcis.org.uk/resources/MDT_joint_document_ ﬁnal_version.pdf (accessed 23 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
21 http://www.bcis.org.uk/pages/page_box_contents.asp?pageid=697&navcatid=11 (accessed 22 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
22 http://www.bcis.org.uk/pages/page_box_contents.asp?pageid=678&navcatid=25 (accessed 23 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
23 https://www.gov.uk/government/uploads/system/uploads/attachment_data/ ﬁle/ 213823/dh_117794.pdf (accessed 23 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
24 https://www.gov.uk/government/uploads/system/uploads/attachment_data/ ﬁle/ 217118/9387-2900853-CVD-Outcomes_web1.pdf (accessed 23 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
25 https://www.rcplondon.ac.uk/sites/default/ ﬁles/consultant_physicians_revised_5th_ ed_full_text_ ﬁnal.pdf (accessed 23 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/35/a6/heartjnl-2015-307821.PMC4484255.pdf
"In the meantime, these recommendationsremain valid.T o help users clearly identify areas of overlap between the two guidelines, an annotated version of the BTS CAP Guidelinehas been produced and is available on the BTS website: http://www.brit-thoracic.org.uk FUTURE DIRECTIONS The BTS Standards of Care Committee will, at a later date,decide on the timing and scope of a future update of the BTSCAP Guideline building on the excellence of the NICEPneumonia Guideline.",Non-OADS,/arxiv_data1/oa_pdf/3a/a2/thoraxjnl-2015-206881.PMC4484256.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Lim WS, Baudouin SV, George RC, et al., Pneumonia Guidelines Committee of the BTS Standards of Care Committee.",Non-OADS,/arxiv_data1/oa_pdf/3a/a2/thoraxjnl-2015-206881.PMC4484256.pdf
2014. http://www.nice.org.uk/guidance/cg191 3 BTS Care Bundles for CAP and COPD.,Non-OADS,/arxiv_data1/oa_pdf/3a/a2/thoraxjnl-2015-206881.PMC4484256.pdf
2014. https://www.brit-thoracic.org.uk/audit- and-quality-improvement/bts-care-bundles-for-cap-and-copd/ 4 Department of Health.,Non-OADS,/arxiv_data1/oa_pdf/3a/a2/thoraxjnl-2015-206881.PMC4484256.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ heartjnl-2014-307205).,Non-OADS,/arxiv_data1/oa_pdf/df/aa/heartjnl-2014-307205.PMC4484257.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Watkins H, Rosenzweig A, Hwang DS, et al.",Non-OADS,/arxiv_data1/oa_pdf/df/aa/heartjnl-2014-307205.PMC4484257.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Newton JN, Young N, Verne J, et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/d2/jech-2015-205917.PMC4484260.pdf
▸http://dx.doi.org/10.1136/ jech-2015-205708 ▸http://dx.doi.org/10.1136/ jech-2014-204971J Epidemiol Community Health 2015; 69:617–618.,Non-OADS,/arxiv_data1/oa_pdf/a4/d2/jech-2015-205917.PMC4484260.pdf
"2015. http://www.hscic.gov.uk/ catalogue/PUB17137 (accessed 13 Apr 2015) 2 Shepherd MA, Nadanovsky P, Sheiham A.",Non-OADS,/arxiv_data1/oa_pdf/a4/d2/jech-2015-205917.PMC4484260.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/heartjnl-2014-306868).,Non-OADS,/arxiv_data1/oa_pdf/9d/a3/heartjnl-2014-306868.PMC4484264.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ To cite Wang Y, Dong L, Shu X.",Non-OADS,/arxiv_data1/oa_pdf/9d/a3/heartjnl-2014-306868.PMC4484264.pdf
"Correspondence to Dr N Daneman, Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview, G106, Toronto, ON M4N 3M5,Canada; nick.daneman@sunnybrook.ca Received 11 December 2014 Revised 1 April 2015 Accepted 8 April 2015Published Online First 24 April 2015 ▸http://dx.doi.org/10.1136/ bmjqs-2015-004344 To cite: Daneman N, Guttmann A, Wang X, et al.",Non-OADS,/arxiv_data1/oa_pdf/10/d7/bmjqs-2014-003863.PMC4484271.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Kwong JC, Ratnasingham S, Campitelli MA, et al.",Non-OADS,/arxiv_data1/oa_pdf/10/d7/bmjqs-2014-003863.PMC4484271.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Mountjoy M, Armstrong N, Bizzini L, et al .",Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
2007. http://www.athleticinsight.com/ Vol8Iss3/YouthSports.htm (accessed 28 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
http://www.olympic.org/ documents/olympic_charter_en.pdf (accessed 28 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
http://www.olympic.org/news/ make-sure-your-body-is-ready-for-exercise-with-get-set/235461 (accessed 28 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
http://www.olympic.org/HBI (accessed 28 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
http://sha.olympic.org (accessed 28 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
"Geneva: World Health Organisation, 2002. http://www.who.int/violence_injury_prevention/violence/ world_report/en/ (accessed 28 Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
http://www.ohchr.org/en/professionalinterest/ pages/crc.aspx (accessed 28 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
http://www.olympic.org/news/ioc-disquali ﬁes-athlete-for-violating- anti-doping-rules-at-the-summer-youth-olympic-games/240150 (accessed 28 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
http://www.olympic.org/content/press-release/press-release- pr65-2010/ (accessed 28 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
http://www.bbc.com/sport/0/commonwealth-games/28541211 (accessed28 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
https://www.wada-ama.org/en/what-we-do/ the-code (accessed 28 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/bc/41/bjsports-2015-094619.PMC4484277.pdf
"Journal of  Preventive Medicine  & Public Health 142 Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:142-150    •  http://dx.doi.org/10.3961/jpmph.14.027 Patterns of Alcohol Consumption and Suicidal Behavior:  Findings From the Fourth and Fifth Korea National Health  and Nutritional Examination Survey (2007–2011) Hong-Chul Bae1,2, Seri Hong3, Sung-In Jang1,2, Kwang-Sig Lee1,2, Eun-Cheol Park1,2 1Department of Preventive Medicine, Yonsei University College of Medicine, Seoul; 2Institute of Health Services Research, Yonsei University College of  Medicine, Seoul; 3Department of Preventive Medicine, Graduate School of Public Health, Yonsei University, Seoul, KoreaOriginal Article Objectives: The purpose of this study was to investigate the association between suicidal behavior and patterns of alcohol consump - tion in Korean adults.",Non-OADS,/arxiv_data1/oa_pdf/9b/39/jpmph-48-3-142.PMC4484278.pdf
"Key words:  Alcohol consumption, Suicidal ideation, Suicide, Attempted  Received:  June 30, 2014 Accepted:  April 27, 2015 Corresponding author:  Eun-Cheol Park, MD, PhD 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea  Tel: +82-2-2228-1862, Fax:  +82-2-392-8133 E-mail:  ecpark@yuhs.ac This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Suicide is a common cause of death in most developed coun - tries.",Non-OADS,/arxiv_data1/oa_pdf/9b/39/jpmph-48-3-142.PMC4484278.pdf
Available from: http://kostat.go.kr (Korean).,Non-OADS,/arxiv_data1/oa_pdf/9b/39/jpmph-48-3-142.PMC4484278.pdf
Available from: http://www.oecd-ili - brary.org/economics/oecd-factbook-2013_factbook-2013-en.,Non-OADS,/arxiv_data1/oa_pdf/9b/39/jpmph-48-3-142.PMC4484278.pdf
Available from: http://www.cdc.gov/injury/wisqars/ index.html.,OADS,/arxiv_data1/oa_pdf/9b/39/jpmph-48-3-142.PMC4484278.pdf
"Journal of  Preventive Medicine  & Public Health 132 Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:132-141    •  http://dx.doi.org/10.3961/jpmph.15.006 Exposure to Cerium Oxide Nanoparticles Is Associated With  Activation of Mitogen-activated Protein Kinases Signaling  and Apoptosis in Rat Lungs Kevin M. Rice1-4, Siva K. Nalabotu1,5, Nandini D.P .K.",Non-OADS,/arxiv_data1/oa_pdf/ef/95/jpmph-48-3-132.PMC4484279.pdf
"Key words:  Cerium oxide nanoparticles, Lung, Inflammation, Mitogen-activated protein kinases Received:  January 30, 2015 Accepted:  April 22, 2015 Corresponding author:  Kevin M. Rice, MS Room #241 D, 1700 3rd Avenue, Huntington, WV 25755-1090, USA Tel: +1-304-638-2982, Fax:  +1-304-696-3766 E-mail:  rice9@marshall.edu This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Cerium is a lanthanide metal that can undergo redox cycling  depending on the partial pressure of oxygen in the surround - ing environment [1].",Non-OADS,/arxiv_data1/oa_pdf/ef/95/jpmph-48-3-132.PMC4484279.pdf
Journal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health 119J Prev Med Public Health 2015;48:119-131    •  http://dx.doi.org/10.3961/jpmph.15.039 Joint Statement of the Ad-hoc Committee of the Korean  Society for Preventive Medicine and the Korean Society  of Epidemiology on Tobacco Lawsuits on the Causal Link  Between Tobacco Smoking and Lung Cancer  Ad-hoc Committee of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on Tobacco  LawsuitsSpecial Article This article is also being simultaneously published in Epidemiology and Health by  the Korean Society of Epidemiology.,Non-OADS,/arxiv_data1/oa_pdf/06/d2/jpmph-48-3-119.PMC4484280.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.PROCESS AND BACKGROUND The National Health Insurance Service (NHIS) has filed a dam - age suit against tobacco producers KT&G, Philip Morris Korea,  and BAT Korea (hereafter referred to as “Tobacco Lawsuit”).",Non-OADS,/arxiv_data1/oa_pdf/06/d2/jpmph-48-3-119.PMC4484280.pdf
"Journal of  Preventive Medicine  & Public Health 151 Copyright © 2015  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:151-169    •  http://dx.doi.org/10.3961/jpmph.15.014 Physical Activity- and Alcohol-dependent Association   Between Air Pollution Exposure and Elevated Liver Enzyme  Levels: An Elderly Panel Study Kyoung-Nam Kim1, Hyemi Lee1, Jin Hee Kim2, Kweon Jung3, Youn-Hee Lim4,5, Yun-Chul Hong1,4,5 1Department of Preventive Medicine, Seoul National University College of Medicine, Seoul; 2Department of Environmental Health, Graduate School  of Public Health, Seoul National University, Seoul; 3Seoul Metropolitan Institute of Public Health and Environment, Seoul; 4Institute of Environmental  Medicine, Seoul National University Medical Research Center, Seoul; 5Environmental Health Center, Seoul National University College of Medicine,  Seoul, KoreaOriginal Article Objectives: The deleterious effects of air pollution on various health outcomes have been demonstrated.",Non-OADS,/arxiv_data1/oa_pdf/06/58/jpmph-48-3-151.PMC4484281.pdf
"Key words:  Air pollution, Liver, Nitrogen dioxide, Ozone, Particulate matter Received:  February 23, 2015 Accepted:  April 30, 2015 Corresponding author:  Yun-Chul Hong, MD, PhD  103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea Tel: +82-2-740-8394, Fax:  +82-2-747-4830 E-mail:  ychong1@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Air pollution has been associated with increased morbidity  and mortality [1-5], insulin resistance [6], systemic inflamma - tion and immune injury [7], and symptoms of depression [8].",Non-OADS,/arxiv_data1/oa_pdf/06/58/jpmph-48-3-151.PMC4484281.pdf
"All analyses were performed using SAS version 9.4 (SAS Insti - tute Inc., Cary, NC, USA) and R version 3.1.0 (Comprehensive R  Archive Network [http://cran.r-project.org]).",OADS,/arxiv_data1/oa_pdf/06/58/jpmph-48-3-151.PMC4484281.pdf
"Journal of  Preventive Medicine  & Public Health 170 Copyright © 2015  The Korean Society for Preventive MedicineJ Prev Med Public Health 2015;48:170-177    •  http://dx.doi.org/10.3961/jpmph.15.002 Association of Demographic and Socioeconomic Factors  With Risk Factors for Chronic Kidney Disease Tae Hyun Kim1,2, Min-Jee Lee3, Ki-Bong Yoo4, Euna Han5, Jae-Woo Choi1,6 1Institute of Health Services Research, Yonsei University College of Medicine, Seoul; 2Department of Hospital Administration, Graduate School of  Public Health, Yonsei University, Seoul, Korea; 3Department of Health Services Policy and Management, Arnold School of Public Health, University of  South Carolina, Columbia, SC, USA; 4Department of Healthcare Administration, Eulji University, Daejeon; 5School of Pharmacy, Yonsei University,  Seoul; 6Department of Public Health, Graduate School, Yonsei University, Seoul, Korea Original Article Objectives: The goal of this study was to examine the association of various demographic and socioeconomic factors with risk factors  for chronic kidney disease (CKD).",Non-OADS,/arxiv_data1/oa_pdf/80/cb/jpmph-48-3-170.PMC4484282.pdf
"Key words:  Chronic kidney disease, Prevention, Demographic factors, Socioeconomic factors Received:  January 16, 2015 Accepted:  May 4, 2015 Corresponding author:  Jae-Woo Choi, MPH 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: +82-2-2228-1889, Fax:  +82-2-392-8133 E-mail:  jwchoi2695@yuhs.ac This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Chronic kidney disease (CKD) is a global problem, and its  prevalence is increasing dramatically.",Non-OADS,/arxiv_data1/oa_pdf/80/cb/jpmph-48-3-170.PMC4484282.pdf
"e-ultrasonography.org Ultrasonography 34(3), July 2015211Ultrasonographic differentiation of bezoar  from feces in small bowel obstruction Kyung Hoon Lee1, Hyun Young Han1, Hee Jin Kim1, Hee Kyung Kim1, Moon Soo Lee2 Departments of 1Radiology and 2Surgery, Eulji University Hospital, Daejeon, Korea http://dx.doi.org/10.14366/usg.14070 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:211-216Purpose: To evaluate ultrasonographic accuracy in the differentiation of a bezoar from feces in  a small bowel obstruction showing feces-like material just proximal to the transitional zone in  abdominal computed tomography (CT).Methods: This study included 14 patients who showed feces-like material just proximal to the  transitional zone, among 302 patients diagnosed with small bowel obstruction on abdominal CT.",Non-OADS,/arxiv_data1/oa_pdf/41/d1/usg-14070.PMC4484283.pdf
"+82-42-611-3590 E-mail: hyhan@eulji.ac.krORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/41/d1/usg-14070.PMC4484283.pdf
ORCID: Kyung Hoon Lee: http://orcid.org/0000-0002-4818-2937; Hyun Young Han:  http://orcid.org/0000-0002-9557-3957; Hee Jin Kim: http://orcid.org/0000-0002-6747-664X; Hee Kyung Kim: http://orcid.org/0000-0001-7400-1311; Moon Soo Lee: http://orcid.org/0000-0002-3286-0385 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/41/d1/usg-14070.PMC4484283.pdf
"e-ultrasonography.org Ultrasonography 34(3), July 2015153Characteristics of breast cancer  detected by supplementary screening ultrasonography Hee Jung Moon, Eun-Kyung Kim Department of Radiology, Severance Hospital, Research Institute of Radiological Science,  Yonsei University College of Medicine, Seoul, Koreahttp://dx.doi.org/10.14366/usg.15029 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:153-156 Received: May 17, 2015 Revised: May 24, 2015Accepted: May 24, 2015 Correspondence to: Hee Jung Moon, MD, PhD, Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea  Tel.",Non-OADS,/arxiv_data1/oa_pdf/c6/43/usg-15029.PMC4484284.pdf
"+82-2-393-3035 E-mail: artemis4u@yuhs.acPERSPECTIVE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/43/usg-15029.PMC4484284.pdf
ORCID: Hee Jung Moon: http://orcid.org/0000-0002-5643-5885; Eun-Kyung Kim:  http://orcid.org/0000-0002-3368-5013 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/c6/43/usg-15029.PMC4484284.pdf
http://dx.doi.org/10.1055/s-0034-1366288.,Non-OADS,/arxiv_data1/oa_pdf/c6/43/usg-15029.PMC4484284.pdf
"226  Ultrasonography 34(3), July 2015 e-ultrasonography.orgUltrasonography of the healing process  during a 3-month follow-up after a splenic injury Vasileios Rafailidis1, Dimitrios Apostolou2, Christodoulos Kaitartzis2, Dimitrios Rafailidis2 1Postgraduate Programme in Medical Research Methodology,  Aristotle University of  Thessaloniki, Thessaloniki; 2Department of Radiology, G. Gennimatas Hospital, Thessaloniki,  Greecehttp://dx.doi.org/10.14366/usg.14057 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:226-230 We present a 14-year-old boy with a grade III splenic injury due to a bicycle accident, who was  treated conservatively.",Non-OADS,/arxiv_data1/oa_pdf/af/aa/usg-14057.PMC4484285.pdf
"+30-2310-213-070 E-mail: billraf@hotmail.comCASE REPORT This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/af/aa/usg-14057.PMC4484285.pdf
ORCID: Vasileios Rafailidis: http://orcid.org/0000-0002-0284-4106; Dimitrios Apostolou:  http://orcid.org/0000-0002-0440-8885; Chritsodoulos Kaitartzis: http://orcid.org/0000-0001-6943-4542; Dimitrios Rafailidis: http://orcid.org/0000-0002-8279-5710 Conflict of Interest No potential conflict of interest relevant to this article was reported.References  1.,Non-OADS,/arxiv_data1/oa_pdf/af/aa/usg-14057.PMC4484285.pdf
"206  Ultrasonography 34(3), July 2015 e-ultrasonography.orgLong-term assessment of clinical outcomes  of ultrasound-guided steroid injections in patients with piriformis syndrome Hee Seok Jeong, Guen Young Lee, Eu Gene Lee, Eu Gene Joe, Joon Woo Lee,  Heung Sik Kang Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Koreahttp://dx.doi.org/10.14366/usg.14039 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:206-210 Purpose: The purpose of this study was to evaluate the long-term efficacy of ultrasound (US)- guided steroid injections in patients with piriformis syndrome.",Non-OADS,/arxiv_data1/oa_pdf/c1/a4/usg-14039.PMC4484286.pdf
"+82-31-787-4011 E-mail: netty0523@gmail.comORIGINAL ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/a4/usg-14039.PMC4484286.pdf
ORCID: Hee Seok Jeong: http://orcid.org/0000-0002-8459-1260; Guen Young Lee:  http://orcid.org/0000-0002-6906-5182; Eu Gene Lee: http://orcid.org/0000-0003-4205-2362; Eu Gene Joe: http://orcid.org/0000-0001-6604-5787; Joon Woo Lee: http://orcid.org/0000-0002-7106-5229; Heung Sik Kang: http://orcid.org/0000-0002-7024-388X Conflict of Interest No potential conflict of interest relevant to this article was reported.Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c1/a4/usg-14039.PMC4484286.pdf
"e-ultrasonography.org Ultrasonography 34(3), July 2015165Current status of automated breast  ultrasonography Hee Jung Shin, Hak Hee Kim, Joo Hee Cha Department of Radiology and Research Institute of Radiology, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, Korea http://dx.doi.org/10.14366/usg.15002 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:165-172 Breast ultrasonography (US) is currently considered the first-line examination in the detection  and characterization of breast lesions.",Non-OADS,/arxiv_data1/oa_pdf/36/02/usg-15002.PMC4484287.pdf
"+82-2-476-4719 E-mail: hhkim@amc.seoul.krREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/36/02/usg-15002.PMC4484287.pdf
ORCID: Hee Jung Shin: http://orcid.org/0000-0002-3398-1074; Hak Hee Kim:  http://orcid.org/0000-0002-2956-9212; Joo Hee Cha: http://orcid.org/0000-0002-1446-8195 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/36/02/usg-15002.PMC4484287.pdf
Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/ Recently-ApprovedDevices/ucm320724.htm.,Non-OADS,/arxiv_data1/oa_pdf/36/02/usg-15002.PMC4484287.pdf
Available from: http://www.acr.org/%7E/media/52D58307E93E45898B09D4C4D407DD76.,Non-OADS,/arxiv_data1/oa_pdf/36/02/usg-15002.PMC4484287.pdf
Available  from: http://www.somoinsightstudy.org.,Non-OADS,/arxiv_data1/oa_pdf/36/02/usg-15002.PMC4484287.pdf
"e-ultrasonography.org Ultrasonography 34(3), July 2015195Postoperative ultrasonography of the  musculoskeletal system Kyung Ah Chun1, Kil-Ho Cho2 1Department of Radiology, Catholic Kwandong University International St. Mary’s Hospital,  Incheon; 2Department of Radiology, Yeungnam University Medical Center, Daegu, Korea http://dx.doi.org/10.14366/usg.15006 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:195-205Ultrasonography of the postoperative musculoskeletal system plays an important role in the  accurate diagnosis of abnormal lesions in the bone and soft tissues.",Non-OADS,/arxiv_data1/oa_pdf/92/50/usg-15006.PMC4484288.pdf
"+82-32-290-3090 E-mail: ka1000@cku.ac.krREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/92/50/usg-15006.PMC4484288.pdf
ORCID: Kyung Ah Chun: http://orcid.org/0000-0003-3576-0264; Kil-Ho Cho: http://orcid.,Non-OADS,/arxiv_data1/oa_pdf/92/50/usg-15006.PMC4484288.pdf
"e-ultrasonography.org Ultrasonography 34(3), July 2015231Multiple hemangiomas of the urinary  bladder in a child with gross hematuria Yeun Yoon Kim1, Myung-Joon Kim1, Mi-Jung Lee1, Ji-Ye Kim2 1Department of Radiology and Research Institute of Radiological Science, Severance  Children's Hospital, Yonsei University College of Medicine, Seoul; 2Department of Pathology,  Severance Hospital, Yonsei University College of Medicine, Seoul, Korea http://dx.doi.org/10.14366/usg.14056 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:231-234 We report a case of multiple hemangiomas involving the urinary bladder in a 4-year-old boy  who presented with recurrent episodes of gross hematuria.",Non-OADS,/arxiv_data1/oa_pdf/0c/49/usg-14056.PMC4484289.pdf
"+82-2-393-3035 E-mail: mjl1213@yuhs.acCASE REPORT This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/49/usg-14056.PMC4484289.pdf
ORCID: Yeun Yoon Kim: http://orcid.org/0000-0003-2018-5332; Myung-Joon Kim:  http://orcid.org/0000-0002-4608-0275; Mi-Jung Lee: http://orcid.org/0000-0003-3244-9171; Ji-Ye Kim: http://orcid.org/0000-0003-4291-2967Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/0c/49/usg-14056.PMC4484289.pdf
"e-ultrasonography.org  Ultr asonography 34(3), July 2015217Ultrasonography of soft tissue  “oops lesions” Hye Won Chung1, Kil-Ho Cho2 1Department of Radiology and Research Institute of Radiology, University of Ulsan College  of Medicine, Asan Medical Center, Seoul, 2Department of Radiology, Yeungnam University  College of Medicine, Daegu, Korea http://dx.doi.org/10.14366/usg.14068 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:217-225 In this article, I would like to define “oops lesions” as soft tissue mass-like lesions that  involve surprise or embarrassment for radiologists following the final diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/b9/99/usg-14068.PMC4484290.pdf
"+82-2-476-4719E-mail: chung@amc.seoul.krPICTORIAL ESSAY This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/99/usg-14068.PMC4484290.pdf
ORCID: Hye Won Chung: http://orcid.org/0000-0001-5597-8143; Kil-Ho Cho:  http://orcid.org/0000-0002-5782-6028 Conflict of Interest  No potential conflict of interest relevant to this article is reported.,Non-OADS,/arxiv_data1/oa_pdf/b9/99/usg-14068.PMC4484290.pdf
"e-ultrasonography.org Ultrasonography 34(3), July 2015157Ultrasound elastography for evaluation of  cervical lymph nodes Young Jun Choi, Jeong Hyun Lee, Jung Hwan Baek Department of Radiology and Research Institute of Radiology, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, Korea http://dx.doi.org/10.14366/usg.15007 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:157-164Ultrasound (US) elastography has been introduced as a noninvasive imaging technique for  evaluating cervical lymph nodes.",Non-OADS,/arxiv_data1/oa_pdf/4b/55/usg-15007.PMC4484291.pdf
"+82-2-476-4719 E-mail: jehee23@gmail.comREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/55/usg-15007.PMC4484291.pdf
"US elastography for cervical LN e-ultrasonography.org Ultrasonography 34(3), July 2015163ORCID: Young Jun Choi: http://orcid.org/0000-0001-7098-5042; Jeong Hyun Lee:  http://orcid.org/0000-0002-0021-4477; Jung Hwan Baek: http://orcid.org/0000-0003-0480-4754 Conflict of Interest No potential conflict of interest relevant to this article was reported.",Non-OADS,/arxiv_data1/oa_pdf/4b/55/usg-15007.PMC4484291.pdf
The color of the elasticity changes with vascular pulsation   (http://dx.doi.org/10.14366/usg.15007.v001).,OADS,/arxiv_data1/oa_pdf/4b/55/usg-15007.PMC4484291.pdf
"e-ultrasonography.org Ultrasonography 34(3), July 2015183Ultrasonography of intrauterine devices Kristina M. Nowitzki1, Matthew L. Hoimes1,2, Byron Chen1, Larry Z. Zheng1, Young H. Kim1 1Department of Radiology, UMass Memorial Medical Center, University of Massachusetts  Medical School, Worcester, MA; 2Newton Wellesley Radiology Associates, Newton Wellesley  Hospital, Newton, MA, USA http://dx.doi.org/10.14366/usg.15010 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:183-194The intrauterine device (IUD) is gaining popularity as a reversible form of contraception.",Non-OADS,/arxiv_data1/oa_pdf/d6/4d/usg-15010.PMC4484292.pdf
"+1-508-856-1860 E-mail: kimy@ummhc.orgREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/4d/usg-15010.PMC4484292.pdf
ORCID: Kristina M. Nowitzki: http://orcid.org/0000-0001-8344-1845; Matthew L.  Hoimes: http://orcid.org/0000-0002-3116-3422; Byron Chen: http://orcid.org/0000-0001-5642-7618; Larry Z. Zheng: http://orcid.org/0000-0003-2995-111X; Young H. Kim: http://orcid.org/0000-0002-0206-5663 Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/d6/4d/usg-15010.PMC4484292.pdf
Available from: http://www.un.org/esa/population/ publications/contraceptive2011contraceptive2011.htm.,Non-OADS,/arxiv_data1/oa_pdf/d6/4d/usg-15010.PMC4484292.pdf
"e-ultrasonography.org Ultrasonography 34(3), July 2015173Ultrasonography of ovarian masses using  a pattern recognition approach Sung Il Jung Department of Radiology, Research Institute of Medical Science, Konkuk University School of  Medicine, Seoul, Korea http://dx.doi.org/10.14366/usg.15003 pISSN: 2288-5919 • eISSN: 2288-5943 Ultrasonography 2015;34:173-182As a primary imaging modality, ultrasonography (US) can provide diagnostic information for  evaluating ovarian masses.",OADS,/arxiv_data1/oa_pdf/b3/cf/usg-15003.PMC4484293.pdf
"+82-2-2030-5549 E-mail: radsijung@kuh.ac.krREVIEW ARTICLE This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/cf/usg-15003.PMC4484293.pdf
ORCID: Sung Il Jung : http://orcid.org/0000-0002-4588-209X Conflict of Interest No potential conflict of interest relevant to this article was reported.,Non-OADS,/arxiv_data1/oa_pdf/b3/cf/usg-15003.PMC4484293.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/a9/TOORTHJ-9-168.PMC4484343.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/e4/TOORTHJ-9-120.PMC4484344.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/licenses/   by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/57/TOBIOCJ-9-34.PMC4484347.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/c5/TOORTHJ-9-143.PMC4484348.pdf
Available at: http://www.who.int/mediacentre/factshee ts/smallpox/en/.,Non-OADS,/arxiv_data1/oa_pdf/5a/52/TOORTHJ-9-114.PMC4484349.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/TOORTHJ-9-114.PMC4484349.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ bjsports-2015-094807).,Non-OADS,/arxiv_data1/oa_pdf/04/4b/bjsports-2015-094807.PMC4484360.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Table 2 The various terms used to describe the diagnoses for case 2 First diagnosis (n=23) N (%)Second diagnosis (n=10) N (%)Third diagnosis (n=4) N (%) Inguinal-related groin pain 9 (39) Sportsman ’s hernia 3 (13) Incipient hernia 2 (9)Inguinal disruption 2 (9)Posterior wall weakness 1 (4) 1 (4)Gilmore ’s groin 1 (4) Inguinal canal aponeurosis strain 1 (4)Inguinal ligament enthesopathy 1 (4)Pubic bone fibrocartilage separation1 (4) Hip chondral surface damage 1 (4) Core muscle injury 1 (4)Hip labral tear 2 (9)Adductor tendinopathy 1 (4)Femoroacetabular impingement 1 (4)Pubic symphysis pathology 1 (4)Conjoined tendon enthesopathy 1 (4)Superficial inguinal ring insufficiency1 (4) Rectus abdominis strain 1 (4) Combination of multiple diagnoses 1 (4) 1 (4)Public cleft arthritis 1 (4)Transversus abdominis strain 1 (4)Posterior wall tear 1 (4) Weir A, et al.Br J Sports Med 2015; 49:825 –827.",Non-OADS,/arxiv_data1/oa_pdf/04/4b/bjsports-2015-094807.PMC4484360.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ bjsports-2015-094602).,Non-OADS,/arxiv_data1/oa_pdf/8a/80/bjsports-2015-094602.PMC4484362.pdf
"METHODS This review followed the PRISMA guidelines and the protocol was registered on the PROSPERO International prospective re gister for systematic reviews website (http://www.crd.york.ac.uk/PROSPERO) on 9April 2014, with the following registrationnumber: CRD42014007416.",Non-OADS,/arxiv_data1/oa_pdf/8a/80/bjsports-2015-094602.PMC4484362.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Orchard J, Seward H. Epidemiology of injuries in the Australian Football League, seasons 1997 –2000.",Non-OADS,/arxiv_data1/oa_pdf/8a/80/bjsports-2015-094602.PMC4484362.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Orchard JW.,Non-OADS,/arxiv_data1/oa_pdf/5d/47/bjsports-2015-094839.PMC4484363.pdf
13 http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/ clinical-trial-registration.html (accessed Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/5d/47/bjsports-2015-094839.PMC4484363.pdf
14 http://www.who.int/ictrp/en/ (accessed Apr 2015).15 https://clinicaltrials.gov (accessed Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/5d/47/bjsports-2015-094839.PMC4484363.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 http://www.jrcptb.org.uk/trainingandcert/ST3-SpR/Documents/ 2010%20(AUC)%20Gastroenterology%20curriculum(amendments%202013).pdf 2 Laffan TA, Horton KM, Klein AP ,et al.",Non-OADS,/arxiv_data1/oa_pdf/34/3b/flgastro-2014-100502.PMC4484365.pdf
"7 http://www.bsg.org.uk/clinical/news/ercp-%E2%80% 93-the-way-forward-a-standards-framework.htmlPANCREATOBILIARY Hart A, et al.Frontline Gastroenterology 2015; 6:175 –177.",Non-OADS,/arxiv_data1/oa_pdf/34/3b/flgastro-2014-100502.PMC4484365.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ bjsports-2015-094869).,Non-OADS,/arxiv_data1/oa_pdf/95/c1/bjsports-2015-094869.PMC4484366.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Serner A, van Eijck CH, Beumer BR, et al.",Non-OADS,/arxiv_data1/oa_pdf/95/c1/bjsports-2015-094869.PMC4484366.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/oemed-2014-102496).,Non-OADS,/arxiv_data1/oa_pdf/11/9e/oemed-2014-102496.PMC4484367.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Liberty Mutual Research Institute for Safety.,Non-OADS,/arxiv_data1/oa_pdf/11/9e/oemed-2014-102496.PMC4484367.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/e9/82/fetalneonatal-2014-308082.PMC4484369.pdf
http://www.childinfo.org/ ﬁles/ Child_Mortality_Report_2013.pdf (accessed 9 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/e9/82/fetalneonatal-2014-308082.PMC4484369.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ bjsports-2014-094256).,OADS,/arxiv_data1/oa_pdf/84/a9/bjsports-2014-094256.PMC4484372.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Bradshaw C, McCrory P, Bell S, et al.",Non-OADS,/arxiv_data1/oa_pdf/84/a9/bjsports-2014-094256.PMC4484372.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Williams SGJ, W estaby D. Management of variceal bleeding.",Non-OADS,/arxiv_data1/oa_pdf/62/8e/flgastro-2013-100428.PMC4484373.pdf
"http://www.thieme-connect.de/ journals/toc/endoscopy/29237 16 Binmoeller KF , W eilert F , Shah JN, et al.",Non-OADS,/arxiv_data1/oa_pdf/62/8e/flgastro-2013-100428.PMC4484373.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Messner AH, Lalakea ML, Aby J, et al .",Non-OADS,/arxiv_data1/oa_pdf/2d/b2/fetalneonatal-2014-307503.PMC4484383.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.188193.114.© 2015 Lubliner et al.",OADS,/arxiv_data1/oa_pdf/1f/a8/1008.PMC4484384.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/1f/a8/1008.PMC4484384.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 4.0 In- ternational), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 1008 Genome Research 25:1008 –1017 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/1f/a8/1008.PMC4484384.pdf
Data access Raw and processed expression data from this study have been sub- mitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE68168.,OADS,/arxiv_data1/oa_pdf/1f/a8/1008.PMC4484384.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.185033.114.© 2015 Levo et al.",OADS,/arxiv_data1/oa_pdf/9e/22/1018.PMC4484385.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/9e/22/1018.PMC4484385.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Method 1018 Genome Research 25:1018 –1029 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/9e/22/1018.PMC4484385.pdf
A detailed experimental protocol for BunDLE-seq is available as Supplemental Material and at http://genie.weizmann.ac.il/data/factor_binding.html.,OADS,/arxiv_data1/oa_pdf/9e/22/1018.PMC4484385.pdf
Binding scores obtained with BunDLE-seq are available as Supplemental Material and at http://genie.weizmann.ac.il/data/factor_binding.html.,OADS,/arxiv_data1/oa_pdf/9e/22/1018.PMC4484385.pdf
Data access Raw and processed data from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih .gov/geo/) under accession number GSE66143.,OADS,/arxiv_data1/oa_pdf/9e/22/1018.PMC4484385.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.186379.114.",OADS,/arxiv_data1/oa_pdf/1a/2d/1030.PMC4484386.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Method 1030 Genome Research 25:1030 –1042 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/1a/2d/1030.PMC4484386.pdf
"Results Genome-wide identification of CRISPR targets To assist in the design of CRISPR targets in zebrafish, we produced a browser extensible data (BED) track computationally predicting18,367,469 CRISPR 20-mers in the zebrafish reference genome(http://genome.ucsc.edu/cgi-bin/hgHubConnect, “CRISPRs ”track on the ZebrafishGenomics track hub).",OADS,/arxiv_data1/oa_pdf/1a/2d/1030.PMC4484386.pdf
This track is designed to be a useful first-pass resource for identifying potential CRISPR targets and iscomplementary to other tools such as http://crispr.mit.edu/(Supplemental Fig.,OADS,/arxiv_data1/oa_pdf/1a/2d/1030.PMC4484386.pdf
The sequences were processed using ampliconDIVider for the identification ofinsertions and deletions induced by CRISPR/Cas9 (http://research.nhgri.nih.gov/CRISPRz).Zebrafish mutagenesis with CRISPR/Cas9 Genome Research 1033 www.genome.org,OADS,/arxiv_data1/oa_pdf/1a/2d/1030.PMC4484386.pdf
"At least three mismatches in the full 20-mer, relative to all possible off-targets The 18,367,469 CRISPR targets identified in this man- ner are viewable in the University of California, Santa Cruz(UCSC) Genome Browser in the “CRISPRs ”track of the “ZebrafishGenomics ”data hub at http://genome.ucsc.edu/cgi- bin/hgHubConnect, or in the Ensembl genome browser by upload-ing http://research.nhgri.nih.gov/manuscripts/Burgess/zebrafish/downloads/NHGRI-1/hub.txt as a TrackHub (Kent et al.",OADS,/arxiv_data1/oa_pdf/1a/2d/1030.PMC4484386.pdf
"Deletion/insertion variant identification We identified the deletion and insertion variants (DIVs) using ampliconDIVider v.1.0.0 (http://research.nhgri.nih.gov/CRISPRz).This software uses cutadapt v.1.3 (Martin 2011) to trim nonge- nomic DNA from the reads, NovoAlign v.3.02.07 (http://www.",OADS,/arxiv_data1/oa_pdf/1a/2d/1030.PMC4484386.pdf
"2013), bam2mpg andmpg2vcf.pl (http://research.nhgri.nih.gov/software/bam2mpg/) (Teer et al.",OADS,/arxiv_data1/oa_pdf/1a/2d/1030.PMC4484386.pdf
"2010) to identify samples with DIVs, sam2pairwise v.1.0.0 to (https://github.com/mlafave/sam2pairwise) visualizeDIV-containing reads as pairwise alignments, and SAMtoolsv.0.1.19 (Li et al.",Non-OADS,/arxiv_data1/oa_pdf/1a/2d/1030.PMC4484386.pdf
http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/1a/2d/1030.PMC4484386.pdf
2007) and the GEBA-Root Nodulating Bacteria (GEBA-RNB; http://jgi.doe.gov/)initiatives are providing reference genomes necessary for under- standing the role of microorganisms in specific habitats.,Non-OADS,/arxiv_data1/oa_pdf/e4/b6/1043.PMC4484387.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.186072.114.",OADS,/arxiv_data1/oa_pdf/e4/b6/1043.PMC4484387.pdf
"This article, published in Genome Research , is available un- der a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Method 25:1043 –1055 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 1043 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/e4/b6/1043.PMC4484387.pdf
"Genes were aligned with HMMER v3.1b1 (http://hmmer.janelia.org), and gene trees inferred with FastTree v2.1.3 (Price et al.",OADS,/arxiv_data1/oa_pdf/e4/b6/1043.PMC4484387.pdf
"Pfam annotations are assigned using the same methodology as the Sanger Institute and IMG, which accounts for homologous relationships betweenPfam clans (see pfam_scan.pl on the Sanger Institute FTP site, https://www.sanger.ac.uk/).",OADS,/arxiv_data1/oa_pdf/e4/b6/1043.PMC4484387.pdf
"(2013) studies were downloaded from ggKbase (http://ggkbase.berkeley.edu/) on March 31, 2014.",OADS,/arxiv_data1/oa_pdf/e4/b6/1043.PMC4484387.pdf
(2013) study can be obtained from http://ecogenomic.org/checkm/public-data.,OADS,/arxiv_data1/oa_pdf/e4/b6/1043.PMC4484387.pdf
"For posterity, the reference genomes analyzed in this paper have been archived at http://ecogenomic.org/checkm/public-data.",OADS,/arxiv_data1/oa_pdf/e4/b6/1043.PMC4484387.pdf
Software availability CheckM is open source software available at http://ecogenomics.github.io/CheckM.,OADS,/arxiv_data1/oa_pdf/e4/b6/1043.PMC4484387.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.180596.114.© 2015 Balbin et al.",OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
"After six months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Resource 1068 Genome Research 25:1068 –1079 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
The Cancer Genome Atlas(TCGA) project has generated data from more than 6000 RNA- seq analyses (http://cancergenome.nih.gov/).,OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
"Transcript structure, CpG islands (green boxes), and H3K27ac (light blue) tracksare obtained from the UCSC Genome Browser (https://genome.ucsc.edu/) (Karolchik et al.",OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
OncoNAT is provided as aset of tables for the use by the researchcommunity (Supplemental Data S11 – S15 and https://github.com/oabalbin/ OncoNAT).,OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
"Finally, we created OncoNAT, a catalog of cancer-related genes with significant antisense expression (Supplemental Data S11–S15 and https://github.com/oabalbin/OncoNAT).",OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
"Then, asummarized transcriptome was built by reconstructing the longestannotation for each gene, using transcript and exon informationprovided in the Ensembl v69 assembly (http://www.ensembl.org) (Flicek et al.",OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
"The pipeline aggregates tumorsuppressor and oncogenes with significant antisense expressioninto a single catalog, OncoNAT (Supplemental Data S4 –S6, S11 – S15 and https://github.com/oabalbin/OncoNAT).",OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
"Seventy- two hours post transfection, cells were plated on 24-wellplates in triplicate, and cell proliferation was monitored using IncuCyte live-cell imaging system (http://www.essenbioscience.",OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
Data access Therawsequencingdatafromthisstudyhavebeensubmittedtothe NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) and dbGaP (http://www.ncbi.nlm.nih.gov/gap) under acces- sion numbers SRP048484 and phs000937.v1.p1.,OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under acces- sion number GSE66729.,Non-OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
"The source code for the analyses presented in this study and the OncoNAT catalog are available in the Supple-mental Material and at https://github.com/oabalbin/OncoNAT, and https://github.com/oabalbin/OncoNAT/tree/master/onconat, respectively.",OADS,/arxiv_data1/oa_pdf/67/aa/1068.PMC4484389.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.192278.115.",OADS,/arxiv_data1/oa_pdf/ce/75/927.PMC4484390.pdf
"This article, published in Genome Research , is available un- der a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 25:927 –936 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 927 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/ce/75/927.PMC4484390.pdf
"2013; TheGTEx Consortium 2015), summarized in Supplemental Table S1.The GTEx data are in dbGaP (http://www.ncbi.nlm.nih.gov/ gap) under accessions phs000424.v3.p1, phs000424.v5.p1, and phs000424.v6.p1.",OADS,/arxiv_data1/oa_pdf/ce/75/927.PMC4484390.pdf
The GenCord data are available in the European Genome-phenome Archive (https://www.ebi.ac.,OADS,/arxiv_data1/oa_pdf/ce/75/927.PMC4484390.pdf
doi: http://dx.doi.org/10.1101/016097.,Non-OADS,/arxiv_data1/oa_pdf/ce/75/927.PMC4484390.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.191247.115.© 2015 Weckselblatt et al.",OADS,/arxiv_data1/oa_pdf/ad/fc/937.PMC4484391.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ad/fc/937.PMC4484391.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 25:937 –947 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org Genome Research 937 www.genome.org",OADS,/arxiv_data1/oa_pdf/ad/fc/937.PMC4484391.pdf
We de- signed custom 4×180K oligonucleotide arrays with ∼200-bp probe spacing using eArray from Agilent Technologies (https://earray.chem.agilent.com/earray/).,OADS,/arxiv_data1/oa_pdf/ad/fc/937.PMC4484391.pdf
"Sanger sequencing was performed by Beckman Coulter Genomics, and the reads were aligned to the human ge-nome reference assembly (GRC37/hg19) using the BLAT tool on the UCSC Genome Browser (http://genome.ucsc.edu/).",OADS,/arxiv_data1/oa_pdf/ad/fc/937.PMC4484391.pdf
"To identify discordant read pairs, we converted reads and mappings flagged as structural variant candi- dates to SAM format with the map2sam command in CGATools1.7.1 (http://cgatools.sourceforge.net/).",OADS,/arxiv_data1/oa_pdf/ad/fc/937.PMC4484391.pdf
5) by analyzing cDNA sequencefrom Ensembl 75 with ScanProsite (http://prosite.expasy.org/scanprosite/).,Non-OADS,/arxiv_data1/oa_pdf/ad/fc/937.PMC4484391.pdf
Data access Agilent array CGH data have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE68019.,OADS,/arxiv_data1/oa_pdf/ad/fc/937.PMC4484391.pdf
Breakpoint junction sequenc- es have been submitted to GenBank (http://www.ncbi.nlm.nih.gov/genbank/) under accession numbers KR072894 –KR072971.,Non-OADS,/arxiv_data1/oa_pdf/ad/fc/937.PMC4484391.pdf
"Illumina sequencing data have been submitted to the NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) under accession number SRP057518, and Complete Genomics whole genome sequencing data have been submitted to the data-base of Genotypes and Phenotypes (dbGaP; http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/ad/fc/937.PMC4484391.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.186882.114.© 2015 Fairfield et al.",OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Research 948 Genome Research 25:948 –957 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
"To test the idea that these could be false callsarising from the underlying genome reference assembly, we com-pared the variant positions to the coordinates of known assembly issues cataloged by the Genome Reference Consortium (GRC) inci- dent database (http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/index.shtml; data available for FTP at ftp://ftp.ncbi.nlm.nih.gov/pub/grc/).",OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
"Todetermineif our datacould be usedto inform unsolved human exome projects, we used the GeneMatcher tool(http://www.genematcher.org/) to compare our gene list to candi-date gene lists from unsolved human exome sequencing projects.This search resulted in a corresponding match (1/73 genes) for Ap3b2 /AP3B2 , where a splice site variant (NM_004644.3: c.588 + 1G > T, Chr 15: 83349863 C > A, in hg19) was found in two indi-viduals from a consanguineous family.",OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
"Using an optimized pipeline for analysis of mouse exome data and a database that integrates sample and vari- ant data across strains (http://mmrdb.jax.org), we nominated andvalidated putative pathogenic mutations for 91 (53%) of our se-quenced strains and these mutations were in 73 genes.",OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
"To compare our data to un- published human exome variant data, we used a publicly availableexome data sharing resource for Mendelian disease (i.e.,GeneMatcher, http://www.genematcher.org), and we were able toidentify a match between our relatively short list of new mouse al- leles lacking previous human disease associations and candidate genes from unsolved human exome projects.",OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
The resulting alignment was sorted by coordi- nates and further converted to binary alignment map (BAM)format by Picard v1.95 SortSam utility (http://picard.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
2010) and dbSNP data obtainedfrom the Mouse Phenome Database (MPD) (http://phenome.jax.,OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
The web application is accessible on the Internet athttps://mmrdb.jax.org.,OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
Data access The raw sequencing data for all of the mutant and inbred strains reported here have been submitted to the NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) under accession number SRP053040.,Non-OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
"Variant data are available through the Mouse Mutant Resource Database (https://mmrdb.jax.org); allstrains are available through The Jackson Laboratory Mouse Mutant Resource (www.jax.org), and mutant allele/phenotype in- formation is available through the Mouse Genome Database (search by allele, www.informatics.jax.org).",OADS,/arxiv_data1/oa_pdf/37/c6/948.PMC4484392.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.187039.114.© 2015 Bosse et al.",OADS,/arxiv_data1/oa_pdf/a0/57/970.PMC4484394.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date(see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a0/57/970.PMC4484394.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 970 Genome Research 25:970 –981 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/a0/57/970.PMC4484394.pdf
The tree was visualized using FigTree (http://tree.bio.ed.ac.uk/software/figtree/).,OADS,/arxiv_data1/oa_pdf/a0/57/970.PMC4484394.pdf
Data access The data from this study have been submitted to the European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena/) underPopulation management and coancestry in pigs Genome Research 979 www.genome.org,OADS,/arxiv_data1/oa_pdf/a0/57/970.PMC4484394.pdf
Source codes together with starting and final data are available in the Supplemental Material and have been deposited in https://github.com/angelesdecara.,OADS,/arxiv_data1/oa_pdf/a0/57/970.PMC4484394.pdf
http://animalgene.umn.edu/pedigraph/.,Non-OADS,/arxiv_data1/oa_pdf/a0/57/970.PMC4484394.pdf
Version 2013.1. http://www.iucnredlist.org/.,Non-OADS,/arxiv_data1/oa_pdf/a0/57/970.PMC4484394.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.186783.114.© 2015 Ragle et al.",OADS,/arxiv_data1/oa_pdf/73/5e/982.PMC4484395.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/73/5e/982.PMC4484395.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Research 982 Genome Research 25:982 –994 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/15; www.genome.org www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/73/5e/982.PMC4484395.pdf
A consensus motif was created online withWebLogo (http://weblogo.threeplusone.com/create.cgi).,OADS,/arxiv_data1/oa_pdf/73/5e/982.PMC4484395.pdf
Data access FASTQ files of raw reads from five high-throughput RNA-seq librar- ies and a table of genes with tissue-specific alternative 3′splice sites have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo) under accession num-ber GSE64672.,OADS,/arxiv_data1/oa_pdf/73/5e/982.PMC4484395.pdf
http://www.wormbook.org.,Non-OADS,/arxiv_data1/oa_pdf/73/5e/982.PMC4484395.pdf
"http://www.wormbook.org.Zhang H, Blumenthal T. 1996.",Non-OADS,/arxiv_data1/oa_pdf/73/5e/982.PMC4484395.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Carr KE.,Non-OADS,/arxiv_data1/oa_pdf/b0/8a/bjsports-2014-094436.PMC4484496.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
"Waterloo, Ontario, Canada: University of Waterloo, 2012. http://www.itcproject.org/ ﬁles/ITC_CrossCountry-Price-Tax_Apr20-v11-web.pdf (accessed 17 Sep 2014).",Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
ITIC ’s Asia -11 Illicit Tobacco Indicator 2012: More Myth than Fact A Critique by SEATCA 2014. http://seatca.org/ dmdocuments/ITIC%20report_More%20Myth%20than%20Fact_2%20July%202014.pdf (accessed 22 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
"Hong Kong, 2014. http://www.customs.gov.hk/tc/publication_press/ publication/departmental_reviews/index.html (accessed 14 Oct 2014).",Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
"Hong Kong, 2008. http://www.statistics.gov.hk/pub/ B11302362008XXXXB0100.pdf (accessed 20 Dec 2013).",Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
"Hong Kong, 2013. http://www.censtatd.gov.hk/hkstat/sub/sp140.",Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
2013. http://www.gov.hk/en/about/abouthk/factsheets/docs/tourism.pdf (accessed 15 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
"Hong Kong, 2013. http://partnernet.hktb.com/ ﬁlemanager/pressrelease/ Tourism%20Stat%2012%202012.pdf (accessed 20 Dec 2013).",Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
"Canberra, 2011. http://www.aihw.gov.au/WorkArea/ DownloadAsset.aspx?id=10737420455.",Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
2013. http://ash.org.uk/ ﬁles/documents/ASH_106.pdf (accessed 27 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
2012. http://www.statistics.gov.hk/pub/ B1120015052012XXXXB0100.pdf (accessed 17 Sep 2014).,OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
2013. https://www.gov.uk/government/uploads/system/uploads/ attachment_data/ ﬁle/249537/131010_Measuring_Tax_Gaps_ACCESS_2013.pdf (accessed 4 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
"Lyon Cedex: International Agency for Research on Cancer, 2011. http://www.iarc.fr/en/publications/pdfs-online/prev/handbook14/ handbook14-0.pdf (accessed 15 Apr 2014).",Non-OADS,/arxiv_data1/oa_pdf/a0/53/tobaccocontrol-2014-051937.PMC4484498.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/ To cite Stillman FA, Soong A, Zheng L Y, et al.Tob Control 2015; 24:417–418.",Non-OADS,/arxiv_data1/oa_pdf/6b/3b/tobaccocontrol-2013-051514.PMC4484500.pdf
"Although technological improvements in terms of specimen acquisi- tion and processing have been made, much work remains to be done toEBioMedicine 2 (2015) 192 –193 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.02.005 .",Non-OADS,/arxiv_data1/oa_pdf/9e/02/main.PMC4484505.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.02.010 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/02/main.PMC4484505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/02/main.PMC4484505.pdf
"Furthermore, it isEBioMedicine 2 (2015) 105 –106 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2014.12.004 .",Non-OADS,/arxiv_data1/oa_pdf/80/d1/main.PMC4484514.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.01.016 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/80/d1/main.PMC4484514.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/d1/main.PMC4484514.pdf
EBioMedicine 2015. http://dx.doi.org/10.1016/j.ebiom.2014.,OADS,/arxiv_data1/oa_pdf/80/d1/main.PMC4484514.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.04.007,Non-OADS,/arxiv_data1/oa_pdf/b9/15/main.PMC4484541.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,3 1–32 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/b9/15/main.PMC4484541.pdf
"Antibiotic susceptibility testing per- formed on Mueller-Hinton agar by standard disk diffusion method as recommended by the European Committee on Antimicrobial Susceptibility Testing (EUCAST; http://www.euca st.org/ ), showed that the isolate was resistant to almost all an- tibiotics, including β-lactams, as well as ﬂuoroquinolones and rifampicin, but remained susceptible to aminoglycosides and colistin.",Non-OADS,/arxiv_data1/oa_pdf/ea/ac/main.PMC4484542.pdf
"Multilocus sequence typing, performed as previously described ( http://pubmlst.org/paeruginosa ), showed a novel sequence type (ST1797) and thus a novel clone of P. aeruginosa.",OADS,/arxiv_data1/oa_pdf/ea/ac/main.PMC4484542.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.05.004,Non-OADS,/arxiv_data1/oa_pdf/ea/ac/main.PMC4484542.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,2 6 –27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ea/ac/main.PMC4484542.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.05.002,Non-OADS,/arxiv_data1/oa_pdf/06/1e/main.PMC4484543.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,2 8 –30 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/06/1e/main.PMC4484543.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,2 8 –30 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/06/1e/main.PMC4484543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.05.007 2213-2317/ &2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ANS, autonomous nervous system; BMI, body mass index; CVS, cardiovascular system; ECG, electrocardiogram; FBG, fasting blood glucose; HBA 1c, glycated hemoglobin; HF, the power of high frequency oscillations; HOMA, homeostatic model assessment; HR, heart rate; HRV, heart rate variability; HSS, hea lthy sedentary subjects; IR, insulin resistance; LF, the power of low frequency oscillations; OT, orthostatic test; pNN50, percentage of differences between adja cent normal RR intervals exceeding 50 milliseconds; RMSSD, square root of the mean squared differences of successive RR intervals; SAN, sinoatrial node; SDNN, standard devi ation of normal RR intervals; TP, total power of RR-intervals oscillations; VLF, the power of very low frequency oscillations nCorresponding author at: Knyagyni Olgy St. 1, Lviv, 79044, Ukraine.",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"The questionnaireused in the study was adapted from “The General Practice Physical Activity Questionnaire ”(translated into Ukrainian), developed by the London School of Hygiene and Tropical Medicine as a validated shortmeasure of physical activity available online at http://www.patient.co.",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"Public Health 12 (1) (2012) 41, http://dx.doi.org/10.1186/1471-2458-12-41 .",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"[3] WHO, Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks, 2009 〈http://www.who.int/healthinfo/global_burden_ disease/GlobalHealthRisks_report_full.pdf 〉.. [4] A. Bauman, F. Bull, T. Chey, et al., The International Prevalence Study on Physical Activity: results from 20 countries, Int.",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"6 (1)(2009) 21, http://dx.doi.org/10.1186/1479-5868-6-21 19335883 .",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"[5] A.S. Kishabongo, P. Katchunga, E.H. Van Aken, et al., Glycation of nail proteins: from basic biochemical ﬁndings to a representative marker for diabetic gly- cation-associated target organ damage, PLOS One 10 (3) (2015) , http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"33 (8) (2013)2026 –2031, http://dx.doi.org/10.1161/ATVBAHA.113.301587 .",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"3 (2)(2009) 293 –307, http://dx.doi.org/10.1556/CEMED.3.2009.2.9 .",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"118 (2) (2012) 47 –57,http://dx.doi.org/10.3109/ 13813455.2012.659259 22393897 .",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"57 (2) (2010) 199 –208 〈http://www.ncbi.nlm.nih.gov/pubmed/ 20532252 〉(accessed 10.01.15, Pubmed: 20532252 ).",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
Hypothesis 2 (1) (2014) 1 –8 〈http://www.oapublishinglondon.com/ images/article/pdf/1415968823.pdf 〉.,Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"[12] O. Abrahamovych, A. Cherkas, U. Abrahamovych, M. Abrahamovych, V. Serhiyenko, Heart Rate Variability: Physiological Bases, Clinical Importanceand Peculiarities in Patients with Peptic Ulcer and after Resection of Stomach,Danylo Halytskyi Lviv National Medical University, Lviv (2014) http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"Matthews, Use and abuse of HOMA modeling, Diabetes Care 27 (6) (2004) , http://dx.doi.org/10.2337/diacare.27.6.1487 .",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"98 (6) (2013) 2318 –2325, http://dx.doi.org/10.1210/ jc.2012-4253 23559087 .",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"A population-based analysis in the Spanish population, PLOS One 9 (9) (2014) e106641, http://dx.doi.org/ 10.1371/journal.pone.0106641 25198070 .",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"55 (3) (2012) 321 –331, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"5 (2015) 71 –79,http://dx.doi.org/ 10.1016/j.redox.2015.03.004 .",OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"1)(2013) S39 –S48, http://dx.doi.org/10.3109/10715762.2013.789136 23521622 .",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
": r e v i e w ,T u r k i y eK l i n .JM e d .S c i .2 9( 1 ) (2009) 189 –193 〈http://www.turkiyeklinikleri.com /article/en-lipid-peroxidation- and-age-associated-diseases-cause-o r-consequence-review-53453.html 〉.",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
"[23] N. Poliakova, J.P. Després, J. Bergeron, N. Alméras, A. Tremblay, P. Poirier, In- ﬂuence of obesity indices, metabolic parameters and age on cardiac auto- nomic function in abdominally obese men, Metabolism 61 (9) (2012)1270 –1279, http://dx.doi.org/10.1016/j.metabol.2012.02.006 22444779 .A.",Non-OADS,/arxiv_data1/oa_pdf/05/e5/main.PMC4484544.pdf
New Microbe and New Infect 2015; 6:49–52 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ) http://dx.doi.org/10.1016/j.nmni.2014.12.002,Non-OADS,/arxiv_data1/oa_pdf/69/f1/main.PMC4484545.pdf
"Bilateral iterstitiel and alveolar interstitial with lower right lobar alveolar consolidation.50 New Microbes and New Infections , Volume 6 Number C, --- 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,4 9–52 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ )",Non-OADS,/arxiv_data1/oa_pdf/69/f1/main.PMC4484545.pdf
"Outcome of mucormycosis 51 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,4 9–52 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ )",Non-OADS,/arxiv_data1/oa_pdf/69/f1/main.PMC4484545.pdf
"Surv Ophtalmol 1994;39:3 –22.52 New Microbes and New Infections , Volume 6 Number C, --- 2015 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,6,4 9–52 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ )",Non-OADS,/arxiv_data1/oa_pdf/69/f1/main.PMC4484545.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1016/j.nicl.2015.06.001 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1002/hbm.2256124938993 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1007/s00441-004-0956-915338272 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1016/j.pneurobio.2011.08.00921896306 .,OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.06.018 .,OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1093/ cercor/bhs13622645252 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1093/brain/aws21122961551 .558 A. Rieckmann et al.,OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1002/ mds.2150717542011 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1093/brain/114.5.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1016/S0896- 6273(02)00569-X11832223 .,OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1002/1098- 2396(20010315)39:4 b332::AID-SYN1017 N3.0.CO;2-X11169784 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1371/journal.pone.007733624204812 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
"Neuroimage 48 (1), 63 –72.http://dx.doi.org/10.1016/j.neuroimage.",OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1093/brain/aws28123195207 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
"Neuropsychopharmacology 39 (4), 1020– 1030. http://dx.doi.org/10.1038/npp.2013.30524165885 .",Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1136/jnnp.55.3.181 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1093/brain/awt01523370091 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1006/nimg.2002.113212377157 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0810-09.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1073/ pnas.93.17.92358799184 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1038/jcbfm.1990.1272384545 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
"Therapy 6 (5 –8), 52. http://dx.doi.org/10.1186/s13195-014-0052-7 .",Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
"http://dx.doi.org/ 10.1212/01.wnl.0000187889.17253.b116237129 .Meltzer, C.C., Leal, J.P., Mayberg, H.S., Wagner, H.N., Frost, J.J., 1990.",Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1097/ 00004728-199007000-000112370355 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1001/archneur.61.6.91915210531 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/ 10.1212/WNL.000000000000102025355821.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
"6 (1), 53 –62.http://dx.doi.org/10.1080/ 13854049208404117 .",Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.08.05222926292 .,OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
"Psychiatry 74 (2), 84 –89.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1093/cercor/bhs38223242198 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1002/mds.2342921069833 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1152/ jn.00783.200919889849 .,Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2011.07.04421810475 .,OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.05.00519442749 .,OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
"524 (1), 55 –59.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
http://dx.doi.org/10.1371/journal.pone.005971723555758 .559 A. Rieckmann et al.,OADS,/arxiv_data1/oa_pdf/4e/af/main.PMC4484547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.nicl.2015.06.002 2213-1582/© 2015 Academic Center for Epileptology Kempenhaeghe & Maastrich UMC+.,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
"The preprocessing of EEG and fMRI is indicated in columns 1 and 3, with the subsequent GLM analysis that results in an EEG –fMRI correlation pattern (column 2) using Brain Imaging Analysis Package ( http://demunck.info/ software/ ).",OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
Brain ex- traction was then performed in FSL ( http://www.fmrib.ox.ac.uk/fsl/ )t o exclude voxels outside the brain from the analysis.,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1006/nimg.1998.,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
"67 (1), 64 –73.http://dx.doi.org/10.1002/ana.2180620186859 .",Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1002/hbm.2002415195285 .,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1109/TMI.2003.82282114964560 .,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1002/mrm.19103404098524021 .,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/ 10.1073/pnas.091185510720176931 .,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.08.,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
"Neuroimage 78, 59 –67.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
"4, 8. http://dx.doi.org/ 10.3389/fnsys.2010.0000820407579 .",Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
Cortex 1 –13http://dx.doi.org/ 10.1093/cercor/bhu01224532319 .,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
"98 (3), 302 –315.http://dx.doi.org/10.1016/j.pneurobio.",OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1002/hbm.2126521391283 .,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1002/hbm.2064718726909 .,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
"Neuroimage 29 (1), 54 –66.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1002/hbm.2255724862742 .,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.08.,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
"Magma 23 (5 –6), 309– 316. http://dx.doi.org/10.1007/s10334-009-0196- 920101434.",Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
"7, 1 –8.http://dx.doi.org/10.3389/fnhum.2013.",Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.brainres.2006.02.09816678803 .,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1046/j.1528-1157.2003.60602.x12887435 .,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1093/cercor/bhr09921616982 .,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.neuron.2014.03.02024811386 .,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.10.01318042495 .,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.mri.2010.03.02220471191 .,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.02.02322369995 .,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
http://dx.doi.org/10.1093/brain/awm14117586868 .571 K. Hermans et al.,OADS,/arxiv_data1/oa_pdf/20/c5/main.PMC4484549.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/b9/opth-9-1129.PMC4484645.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1129–1134Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1129Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8502 0incidence of retinal detachment associated with  atopic dermatitis in Japan: review of cases from  1992 to 2011 Mikio sasoh1,2 hitoshi Mizutani3 hisashi Matsubara1 Motoyasu Furuta4 Y oshitsugu Matsui1 Kei-ichi Yamanaka3 Mineo Kondo1 1Department of Ophthalmology,   graduate school of Medicine, Mie  University, Tsu, 2local independent  administrative institution, Mie  Prefectural general Medical  Center, Y okkaichi, 3Department  of Dermatology, graduate school  of Medicine, Mie University, Tsu,   4Japanese red Cross ise hospital,   ise, Mie, JapanPurpose:  The present study aims to investigate the number and characteristics of retinal  detachment with atopic dermatitis (AD) in these 20 years, and the number of the first visit AD  outpatients in almost the same period.",Non-OADS,/arxiv_data1/oa_pdf/22/b9/opth-9-1129.PMC4484645.pdf
"The prevalence of adolescent AD markedly increased from 1967 to 1996 in Japan.8  After 2000, AD therapies improved by introduction of new therapeutic tools including  the topical and systemic calcineurin inhibitors, and new therapeutic strategy: proactive Correspondence: Mikio sasoh Department of Ophthalmology, graduate  school of Medicine, Mie University, 2-174  edobashi, Tsu, Mie 514-8507, Japan Tel +81 59 231 5027 Fax +81 59 231 3036 email sasoh8521@yahoo.co.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Sasoh et al Running head recto: Changes in retinal detachment with atopic dermatitis DOI: http://dx.doi.org/10.2147/OPTH.S85020",Non-OADS,/arxiv_data1/oa_pdf/22/b9/opth-9-1129.PMC4484645.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/22/b9/opth-9-1129.PMC4484645.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/b9/opth-9-1129.PMC4484645.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3247–3255Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3247Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7521 9Development of biosimilars in an era of oncologic  drug shortages edward Li1 Janakiraman Subramanian2 Scott Anderson3 Dolca Thomas4 Jason McKinley5 ira A Jacobs4 1University of New england College  of Pharmacy, Portland, M e, USA;   2Hanna Cancer Associates, Knoxville,   TN, USA; 3Pfizer inc, La Jolla, CA,  USA;  4Pfizer inc, New Y ork, NY,  USA;   5Pfizer inc, Groton, CT, USAAbstract:  Acute and chronic shortages of various pharmaceuticals and particularly of sterile  injectable products are being reported on a global scale, prompting evaluation of more effective  strategies to manage current shortages and development of new, high-quality pharmaceutical  products to mitigate the risk of potential future shortages.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"As of the third quarter of 2013, 294 active drug shortages had been Correspondence: edward Li  University of New england College  of Pharmacy, 716 Stevens Avenue,  Portland, Me 04103, USA  Tel +1 207 221 4120  Fax +1 207 523 1927 email eli@une.ed uJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Li et al Running head recto: Drug shortages and biosimilars DOI: http://dx.doi.org/10.2147/DDDT.S75219",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.fda.gov/downloads/aboutfda/centersoffices/ officeofmedicalproductsandtobacco/cder/ manualofpoliciesprocedures / ucm079936.pd f. Accessed September 15, 2014.",OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.fda.gov/downloads/ AboutFDA/ReportsManualsForms/Reports/UCM277755.pd f. Accessed  September 15, 2014.",OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from:  http://www.aha.org/content/11/drugshortagesurvey.pd f. Accessed  September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/Other/2012/11/WC500135113.pd f. Accessed September 15,  2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.hc-sc.gc.ca/ahc-asc/media/ nr-cp/_2013/2013-125fs-eng.ph p. Accessed September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from:  http://www.ispe.org/drug-shortages-initiativ e. Accessed September 15,  2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.fda.gov/downloads/Drugs/Drug - Safety/DrugShortages/UCM372566.pd f. Accessed September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.fda.gov/downloads/ biologicsbloodvaccines/guidancecomplianceregulatoryinformation/ proceduressopps/ucm299324.pd f. Accessed September 15, 2014.36.",OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.fda.gov/downloads/aboutfda/centersof - fices/officeofmedicalproductsandtobacco/cder/ manualofpoliciesprocedures / ucm079936.pd f. Accessed September 15, 2014.",OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.asco.org/advocacy/asco-comments- gao-report-drug-shortage s. Accessed September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.asco.org/advocacy/asco- nccr-support-fda-proposed-rule-drug-manufacturing-interruption s.  Accessed  September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from:  http://www.house.gov/legcoun/Comps/PHSA_CMD.pd f. Accessed  September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/UCM216146.pd f.  Accessed September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.fda.go v. Accessed September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.fda.go v. Accessed September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/ Scientific_guideline /2012/06/WC500128686.pd f. Accessed  September 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/61/c2/dddt-9-3247.PMC4484646.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/cf/amep-6-459.PMC4484647.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 459–467Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  459PErsPEctivEsopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S8101 6toward a more professional and practical medical  education: a novel central European approach Heinz Drexel1–4,* Alexander vonbank1–3,* Peter Fraunberger3,5 Walter F riesen3 christoph H saely1–3 1vorarlberg institute for vascular  investigation and treatment,   2Department of Medicine and  cardiology, Academic teaching  Hospital Feldkirch, Feldkirch,   Austria;  3Private University of the  Principality of Liechtenstein, triesen,   Liechtenstein;  4Drexel University  college of Medicine, Philadelphia, PA,   UsA;  5Medical central Laboratories,   Feldkirch, Austria *these authors contributed equally   to this work correspondence: Heinz Drexel   Department of Medicine and cardiology,  Academic teaching Hospital Feldkirch,  carinagasse  47, A-6807 Feldkirch, Austria   tel +43 5522 303 2670  Fax +43 5522 303 7533  Email vivit@lkhf.a tAbstract : We here present an innovative curriculum for a complete medical education that  conforms to the current European Bologna system of academic training.",Non-OADS,/arxiv_data1/oa_pdf/c6/cf/amep-6-459.PMC4484647.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/c6/cf/amep-6-459.PMC4484647.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/cf/amep-6-459.PMC4484647.pdf
"Available from: http://europa.eu/ legislation_summaries /education_training_youth/lifelong_learning/ c11088_en.ht m. Accessed February  10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c6/cf/amep-6-459.PMC4484647.pdf
"Available from: http://www.ufl.l i. Accessed February  21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c6/cf/amep-6-459.PMC4484647.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/18/opth-9-1117.PMC4484648.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1117–1120Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1117Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8121 8an outbreak of Ralstonia pickettii  endophthalmitis  following intravitreal methotrexate injection Himadri Choudhury1 animesh Jindal1 avinash Pathengay1 Harry W Flynn Jr2 1LV Prasad eye institute, GM r  Varalakshmi Campus, Visakhapatnam,   india; 2Department of Ophthalmology,   Bascom Palmer eye institute, Miller  school of Medicine, University of  Miami, Miami, FL, UsaPurpose:  To report an outbreak of endophthalmitis in three eyes of two patients following  intravitreal methotrexate, caused by Ralstonia pickettii .",Non-OADS,/arxiv_data1/oa_pdf/83/18/opth-9-1117.PMC4484648.pdf
"Separate sterile drape, speculum, topical Correspondence: avinash Pathengay LV Prasad eye institute, GMr Varalakshmi  Campus, 11-113/1 Hanumanthawaka  Junction, Visakhapatnam, 530 040,  andhra Pradesh, india Tel +91 891 3989 2020 Fax +91 891 398 4444 email avinash@lvpei.or g Journal name: Clinical Ophthalmology Article Designation: Case Series Y ear: 2015 Volume: 9 Running head verso: Choudhury et al Running head recto: R. pickettii  endophthalmitis outbreak after intravitreal methotrexate injection  DOI: http://dx.doi.org/10.2147/OPTH.S81218",Non-OADS,/arxiv_data1/oa_pdf/83/18/opth-9-1117.PMC4484648.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/83/18/opth-9-1117.PMC4484648.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/18/opth-9-1117.PMC4484648.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/6c/dddt-9-3239.PMC4484649.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3239–3245Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3239Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8328 8Sphingosine kinase 1 as an anticancer therapeutic  target Ying Gao1,* Fei Gao2,* Kan Chen3,* Mei-li Tian1 Dong-li Zhao1 1Department of Radiotherapy  Oncology, First Affiliated Hospital  of Xi’an Jiaotong University,   2Department of Neurology, First  Affiliated Hospital of Xi’an Medical  University, Xi’an, 3School of Life  Sciences, Zhejiang Sci-T ech University,   Hangzhou, People’s Republic of China *These authors contributed equally   to this workAbstract:  The development of chemotherapeutic resistance is a major challenge in oncology.",Non-OADS,/arxiv_data1/oa_pdf/fb/6c/dddt-9-3239.PMC4484649.pdf
"S1P  released into the extracellular milieu engages with sphingosine-1-phosphate receptors Correspondence: Ying Gao; Dong-li Zhao Department of Radiotherapy Oncology,   First Affiliated Hospital of Xi’an  Jiaotong University, 277 Yan Ta  west Road, Xi’an city, Xi’an 710061,  People’s Republic of China Tel +86 029 8532 4029 email togaoying@163.co m;  jdyfy223@163.comJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Gao et al Running head recto: Sphingosine kinase 1 as an anticancer therapeutic target DOI: http://dx.doi.org/10.2147/DDDT.S83288",Non-OADS,/arxiv_data1/oa_pdf/fb/6c/dddt-9-3239.PMC4484649.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fb/6c/dddt-9-3239.PMC4484649.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/6c/dddt-9-3239.PMC4484649.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/98/dddt-9-3199.PMC4484650.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3199–3215Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3199Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8088 6Disposition and metabolism of [14c]- levomilnacipran, a serotonin and norepinephrine  reuptake inhibitor, in humans, monkeys, and rats Valérie Brunner1 Bernadette Maynadier2 laishun chen3 louise roques2 isabelle hude2 sébastien séguier2 laurence Barthe1 Philippe hermann1 1Pierre Fabre Médicament, centre de  r&D, T oulouse, 2centre experimental  Preclinque, campans, France; 3Forest  research institute inc., an affiliate  of actavis inc., Jersey city, nJ, UsaAbstract:  Levomilnacipran is approved in the US for the treatment of major depressive disorder  in adults.",Non-OADS,/arxiv_data1/oa_pdf/dd/98/dddt-9-3199.PMC4484650.pdf
"Results of the World Health Organization World Mental  Health survey, which analyzed data from 18 countries using the Composite International  Diagnostic Interview1 for the Diagnostic and Statistical Manual of Mental Disorders ,  fourth edition,2 estimated that the average lifetime and 12-month prevalence of major  depressive disorder was 14.6% and 5.5% in ten high-income countries and 11.1%  and 5.9% in eight low- to middle-income countries, respectively.3 Current therapies  used to treat major depressive disorder include selective serotonin reuptake inhibitors,  dopamine–norepinephrine reuptake inhibitors, and serotonin–norepinephrine reuptake  inhibitors (SNRIs), among others.4 Levomilnacipran is an SNRI, and its antidepressant action is thought to be related  to potentiation of norepinephrine and serotonin in the central nervous system through correspondence: Valérie Brunner Department of Pharmacokinetic  Development, centre de r&D Pierre  Fabre, 3 avenue hubert curien, 31035  Toulouse, France Tel +33 5 34 50 63 89 Fax +33 5 34 50 33 89 email v alerie.brunner@pierre-fabre.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Brunner et al Running head recto: Disposition and metabolism of [14C]-levomilnacipran DOI: http://dx.doi.org/10.2147/DDDT.S80886",Non-OADS,/arxiv_data1/oa_pdf/dd/98/dddt-9-3199.PMC4484650.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/dd/98/dddt-9-3199.PMC4484650.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/98/dddt-9-3199.PMC4484650.pdf
Available from: http://psychiatryonline.org/guidelines.,Non-OADS,/arxiv_data1/oa_pdf/dd/98/dddt-9-3199.PMC4484650.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7d/a2/ijn-10-4111.PMC4484651.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4111–4124International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4111OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8126 3enzyme-responsive nanocomposites for wound  infection prophylaxis in burn management: in vitro  evaluation of their compatibility with healing  processes Verena grützner1 ronald e Unger1 grit Baier2 lars choritz3 christian Freese1 Thomas Böse1 Katharina landfester2 c James Kirkpatrick1 1rePaIr-lab, Institute of Pathology,   University Medical center, Mainz,   2Max Planck Institute for Polymer  research, Mainz, germany;   3Department of Ophthalmology,   University clinic, Magdeburg,   germanyAbstract:  Responsive, theranostic nanosystems, capable of both signaling and treating wound  infections, is a sophisticated approach to reduce the most common and potentially traumatizing  side effects of burn wound treatment: slowed wound healing due to prophylactic anti-infective  drug exposure as well as frequent painful dressing changes.",Non-OADS,/arxiv_data1/oa_pdf/7d/a2/ijn-10-4111.PMC4484651.pdf
"Predispos - ing factors including the condition and extent of burn wounds make them particularly correspondence: Verena grützner rePaIr-lab, Institute of Pathology,  University Medical center,  langenbeckstraße 1, 55131 Mainz,  germany email vgruetzn@uni-mainz.d eJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Grützner et al Running head recto: Enzyme-responsive nanocomposites for wound infection prophylaxis DOI: http://dx.doi.org/10.2147/IJN.S81263",Non-OADS,/arxiv_data1/oa_pdf/7d/a2/ijn-10-4111.PMC4484651.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7d/a2/ijn-10-4111.PMC4484651.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/a2/ijn-10-4111.PMC4484651.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/bc/ijn-10-4009.PMC4484652.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4009–4027International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4009OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8335 7Influence of nanotopography on periodontal  ligament stem cell functions and cell sheet  based periodontal regeneration hui gao1–3,* Bei li1,2,* Lingzhou Zhao4 Yan Jin1,2 1State Key Laboratory of  Military Stomatology, Center for  Tissue Engineering, School of  Stomatology, The Fourth Military  Medical University, 2Research and  Development center for Tissue  Engineering, The Fourth Military  Medical University, Xi’an, Shaanxi,   3Department of Stomatology, PLA  309th Hospital, Beijing, 4State Key  Laboratory of Military Stomatology,   Department of Periodontology,   School of Stomatology, Fourth  Military Medical University, Xi’an,   Shaanxi, People’s Republic of China *These authors contributed equally  to this workAbstract:  Periodontal regeneration is an important part of regenerative medicine, with great clini - cal significance; however, the effects of nanotopography on the functions of periodontal ligament  (PDL) stem cells (PDLSCs) and on PDLSC sheet based periodontal regeneration have never been  explored.",Non-OADS,/arxiv_data1/oa_pdf/96/bc/ijn-10-4009.PMC4484652.pdf
"Though various regenerative therapies, such as  guided tissue regeneration, have been routinely utilized in clinical practice, the outcomes  are limited, with poor clinical predictability.3 Stem cell–based tissue engineering is  believed to be a promising approach to generate more predictable and efficient periodontal  tissue restoration.4 Tissue-engineered tooth regeneration is believed to be a more ideal  approach for missing tooth restoration, and successful periodontal tissue regeneration  is an essential part of this.5,6 For successful tissue-engineered tooth regeneration, use correspondence: Yan Jin State Key Laboratory of Military  Stomatology, Center for Tissue  Engineering, School of Stomatology,  The Fourth Military Medical University,  Number 145 West Changle Road,  Xincheng District, Xi’an 710032,   Shaanxi, People’s Republic of China Tel +86 29 8477 6147 Fax +86 29 8321 8039 email yanjin@fmmu.edu.c n Lingzhou Zhao State Key Laboratory of Military  Stomatology, Department of  Periodontology, School of Stomatology,  The Fourth Military Medical University,  Number 145 West Changle Road,  Xincheng District, Xi’an 710032,   Shaanxi, People’s Republic of China Tel +86 29 8477 6093 Fax +86 29 8477 6096 email zhaolingzhou1983@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Gao et al Running head recto: Role of nanotopography on PDL regeneration DOI: http://dx.doi.org/10.2147/IJN.S83357",Non-OADS,/arxiv_data1/oa_pdf/96/bc/ijn-10-4009.PMC4484652.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/96/bc/ijn-10-4009.PMC4484652.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/bc/ijn-10-4009.PMC4484652.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/0a/ijnrd-8-065.PMC4484653.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 65–75International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  65ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S8072 3successful creation of an anemia management  algorithm for hemodialysis patients Kazuhiro hara Yasuhide Mizutani hitoshi Kodera Masato Miyake Y oshiki Yasuda sanae Ohara Department of Nephrology, Yokkaichi  social Insurance hospital, Y okkaichi,   Mie Prefecture, Japan correspondence: Kazuhiro hara   Department of Nephrology,   Yokkaichi social Insurance hospital,   10-8, hazuyama-chou, Yokkaichi,   Mie Prefecture, 510-0016, Japan   Tel +81 59 331 2000   Fax +81 59 331 0354   email yokkaichialgorithm@ba2.so-net.",Non-OADS,/arxiv_data1/oa_pdf/18/0a/ijnrd-8-065.PMC4484653.pdf
"Available from: http://www.usrds.org/adr.asp x.  Accessed March 29, 2015.",OADS,/arxiv_data1/oa_pdf/18/0a/ijnrd-8-065.PMC4484653.pdf
"Available from: http://www.fda.gov/ Drugs/DrugSafety/ucm259639.ht m. Accessed March 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/18/0a/ijnrd-8-065.PMC4484653.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/18/0a/ijnrd-8-065.PMC4484653.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/0a/ijnrd-8-065.PMC4484653.pdf
Available  from: http://journals.plos.org/plosone/article?id=10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/18/0a/ijnrd-8-065.PMC4484653.pdf
Available  from: http://www.ncbi.nlm.nih.gov/books/NBK143610 /.,Non-OADS,/arxiv_data1/oa_pdf/18/0a/ijnrd-8-065.PMC4484653.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/ae/opth-9-1109.PMC4484654.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1109–1116Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1109Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8420 7Efficacy and tolerability of bilateral sustained- release dexamethasone intravitreal implants for  the treatment of noninfectious posterior uveitis  and macular edema secondary to retinal vein  occlusion steven J ryder1 Danilo iannetta1 swetangi D Bhaleeya2 szilárd Kiss1 1Department of Ophthalmology,   Weill Cornell Medical College,   new Y ork, nY, Usa; 2Department of  Ophthalmology, University of south  Florida, Tampa, Fl, UsaPurpose:  To report our experience with bilateral placement of dexamethasone 0.7 mg (DEX)  sustained-release intravitreal implant in the management of noninfectious posterior uveitis or  macular edema secondary to retinal vein occlusion.",Non-OADS,/arxiv_data1/oa_pdf/ae/ae/opth-9-1109.PMC4484654.pdf
"The various routes include oral, intravenous, topical, periocular, and intravitreal, Correspondence: steven J ryder Weill Cornell Medical College, 1305  York avenue, 11th Floor, new York,  nY 10021, Usa Tel +1 646 962 2540 Fax +1 646 962 0602 email sjr9005@med.cornell.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ryder et al Running head recto: Bilateral sustained-release dexamethasone intravitreal implants DOI: http://dx.doi.org/10.2147/OPTH.S84207",Non-OADS,/arxiv_data1/oa_pdf/ae/ae/opth-9-1109.PMC4484654.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2014/022315s010lbl.pd f. Accessed January 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/ae/opth-9-1109.PMC4484654.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ae/ae/opth-9-1109.PMC4484654.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/ae/opth-9-1109.PMC4484654.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/15/copd-10-1173.PMC4484655.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1173–1178International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1173OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8422 5Impact of direct substitution of arm span length  for current standing height in elderly COPD Chaicharn Pothirat Warawut Chaiwong nittaya Phetsuk Division of Pulmonary, Critical Care  and allergy, Department of Internal  Medicine, Faculty of Medicine, Chiang  Mai University, Chiang Mai, ThailandBackground:  Arm span length is related to standing height and has been studied as a substitute  for current standing height for predicting lung function parameters.",Non-OADS,/arxiv_data1/oa_pdf/f0/15/copd-10-1173.PMC4484655.pdf
"Keywords:  chronic obstructive pulmonary disease, arm span, standing height, spirometry,  severity Introduction Pulmonary function tests use standardized reference values based on ethnic and  anthropometric characteristics, including age, sex, and height.1 It has become increas - ingly necessary to measure pulmonary function in patients who are unable to stand, as  their current standing height cannot be accurately measured.2,3 The American Thoracic  Society (ATS) and the European Respiratory Society (ERS) jointly recommend other  options, including stated height or estimating from arm span when height cannot be  measured.4 Substitution of standing height measurements can be estimated from arm span  measurements using the appropriate regression equations and might be an alterna - tive method to use for subjects in whom current standing height cannot be measured Correspondence: Chaicharn Pothirat Division of Pulmonary, Critical Care  and allergy, Department of Internal  Medicine, Faculty of Medicine, Chiang  Mai University, 110 Inthavaroros road  sriphum, Maung Chiang Mai District,  Chiang Mai 50200, Thailand Tel +66 53 946 228 Fax +66 53 895 117 email cpothira@med.cmu.ac.t h;  chaicharn.p@cmu.ac.t hJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Pothirat et al Running head recto: Substitution of arm span for height in elderly COPD DOI: http://dx.doi.org/10.2147/COPD.S84225",Non-OADS,/arxiv_data1/oa_pdf/f0/15/copd-10-1173.PMC4484655.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f0/15/copd-10-1173.PMC4484655.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/15/copd-10-1173.PMC4484655.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/87/cia-10-1003.PMC4484656.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1003–1008Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1003OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8156 8randomized comparative study of left versus  right radial approach in the setting of primary  percutaneous coronary intervention for  sT -elevation myocardial infarction Qiang Fu hongyu hu Dezhao Wang Wei Chen Zhixu Tan Qun li Buxing Chen Department of Cardiology, Beijing  Titantan hospital, Capital Medical  University, Beijing, People’s republic  of ChinaBackground:  Growing evidence suggests that the left radial approach (LRA) is related to  decreased coronary procedure duration and fewer cerebrovascular complications as compared  to the right radial approach (RRA) in elective percutaneous coronary intervention (PCI).",Non-OADS,/arxiv_data1/oa_pdf/3a/87/cia-10-1003.PMC4484656.pdf
"However,  several observations have revealed that the left radial approach (LRA) is thought Correspondence: Buxing Chen Department of Cardiology, Beijing  Titantan hospital, Capital Medical  University, no 6 Tiantanxili, Dongcheng  District, Beijing 100050, People’s  republic of China Tel +86 10 6709 6572 Fax +86 10 6709 6572 email chbux@126.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Fu et al Running head recto: Transradial primary PCI in STEMI DOI: http://dx.doi.org/10.2147/CIA.S81568",Non-OADS,/arxiv_data1/oa_pdf/3a/87/cia-10-1003.PMC4484656.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3a/87/cia-10-1003.PMC4484656.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3a/87/cia-10-1003.PMC4484656.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/6a/copd-10-1207.PMC4484657.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1207–1212International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1207OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8208 2relationship between nutritional risk and exercise  capacity in severe chronic obstructive pulmonary  disease in male patients Xizheng shan1 Jinming liu2 Yanrong luo1 Xiaowen Xu1 Zhiqing han1 hailing li1 1Department of respiratory Medicine,   Yangpu hospital, Tongji University  school of Medicine, shanghai, People’s  republic of China; 2Department  of Pulmonary Circulation, Pulmonary  hospital, Tongji University school  of Medicine, shanghai, People’s  republic of ChinaObjective:  The nutritional status of chronic obstructive pulmonary disease (COPD) patients is  associated with their exercise capacity.",Non-OADS,/arxiv_data1/oa_pdf/d0/6a/copd-10-1207.PMC4484657.pdf
"Keywords:  nutritional risk, exercise capacity, chronic obstructive pulmonary disease, conven - tional pulmonary function testing, cardiopulmonary exercise testing Introduction Chronic obstructive pulmonary disease (COPD), as a common problem in the elderly,  is a major cause of chronic morbidity and mortality throughout the world.1 It is char - acterized by chronic obstruction of expiratory flow affecting peripheral airways, and  is often associated with chronic bronchitis and emphysema, thereby accelerating the  decline in lung function.2,3 Previous studies have found that nutritional status is the prognostic factor that is  associated with the mortality in COPD.4–6 Weight loss is the major characteristic of  malnutrition in COPD.7 In 2002, “nutritional risk” was defined by the European Society  for Parenteral and Enteral Nutrition (ESPEN).8 Recently, nutritional risk was found to  be associated with the exacerbation of COPD in the patients who were hospitalized  because of COPD.9 Meanwhile, it has been reported that nutritional risk is related to  the development of COPD in male smokers.10 In addition, the exercise capacity is also another factor related to mortality in  COPD.11 Limitation of the exercise capacity seriously affects the quality of life in COPD  patients.12 Therefore, many studies have aimed at strategies for improving the exercise Correspondence: Jinming liu Department of Pulmonary Circulation,  Pulmonary hospital, Tongji University  school of Medicine, Zhengmin road 507,   Yangpu District, shanghai 200433,  People’s republic of China Tel +86 21 6511 5006 email jinmingliujml@126.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Shan et al Running head recto: Nutritional risk and exercise capacity in COPD DOI: http://dx.doi.org/10.2147/COPD.S82082",Non-OADS,/arxiv_data1/oa_pdf/d0/6a/copd-10-1207.PMC4484657.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/d0/6a/copd-10-1207.PMC4484657.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/6a/copd-10-1207.PMC4484657.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/68/ndt-11-1511.PMC4484658.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1511–1521Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1511OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8589 1The social functional outcome of being  naturalistically treated with paliperidone  extended-release in patients with schizophrenia ryoko Nakagawa1 Takashi Ohnishi1 hisanori Kobayashi1 akihide Wakamatsu2 ai Tanimura3 Kazuo Morita3 T oshio Yamaoka3 hideo Usui3 Y oshimasa Ogawa3 akiko Fujino3 Kazutake Y oshizawa1 1evidence generation Department,   Medical affairs Division, 2Medical  affairs strategy Department, Medical  affairs Division, 3Drug safety  surveillance Department, Japan safety  and surveillance Division, Janssen  Pharmaceutical K.K., T okyo, JapanBackground:  Social functioning is an important outcome for patients with schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/75/68/ndt-11-1511.PMC4484658.pdf
"Actually, the guideline on the clinical investigation of antipsychotics  by the European Medical Agency mentioned that primary efficacy measures should be  presented as the numerical change in schizophrenia symptom score from baseline to study  end point.1 Nevertheless, the most important treatment goal in patients with schizophrenia correspondence: Takashi Ohnishi evidence generation Department,  Medical affairs Division, Janssen  Pharmaceutical K.K., 5-2, Nishi-kanda  3-chome chiyoda-ku, Tokyo 101-0065,  Japan Tel +81 3 4411 5009 Fax +81 3 4411 5086 email tohnish8@its.jnj.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Nakagawa et al Running head recto: Social functional outcome with paliperidone ER DOI: http://dx.doi.org/10.2147/NDT.S85891",Non-OADS,/arxiv_data1/oa_pdf/75/68/ndt-11-1511.PMC4484658.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2012/10/WC500133437.pd f.  Accessed January 22, 2015.",Non-OADS,/arxiv_data1/oa_pdf/75/68/ndt-11-1511.PMC4484658.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/75/68/ndt-11-1511.PMC4484658.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/68/ndt-11-1511.PMC4484658.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/a4/dddt-9-3231.PMC4484659.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3231–3238Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3231Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8645 8Design of a gelatin microparticle-containing self- microemulsifying formulation for enhanced oral  bioavailability of dutasteride in-hwan Baek1,* eun-sol ha2,* Jin-Wook Y oo2 Yunjin Jung2 Min-soo Kim2 1college of Pharmacy, Kyungsung  University, 2college of Pharmacy,   Pusan national University, Busan,   republic of Korea *These authors contributed equally  to this workAbstract:  In this study, a gelatin microparticle-containing self-microemulsifying formulation  (SMF) was developed using a spray-drying method to enhance the oral delivery of the poorly  water-soluble therapeutic dutasteride.",Non-OADS,/arxiv_data1/oa_pdf/cb/a4/dddt-9-3231.PMC4484659.pdf
"However, the oral bioavailability of the correspondence: Min-soo Kim college of Pharmacy, Pusan national  University, 2 Busandaehak-ro 63beon-gil,  geumjeong-gu, Busan 609-735,   republic of Korea Tel +82 51 510 2813 Fax +82 51 513 6754 email minsookim@pusan.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Baek et al Running head recto: Dutasteride-loaded gelatin microparticles DOI: http://dx.doi.org/10.2147/DDDT.S86458",Non-OADS,/arxiv_data1/oa_pdf/cb/a4/dddt-9-3231.PMC4484659.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/cb/a4/dddt-9-3231.PMC4484659.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/a4/dddt-9-3231.PMC4484659.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/27/ndt-11-1493.PMC4484660.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1493–1503Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1493OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8246 8T elomere length in blood cells is related  to the chronicity, severity, and recurrence  rate of schizophrenia T omasz Pawelczyk1 Bozena szymanska2 Marta grancow-grabka3 Magdalena Kotlicka- antczak1 agnieszka Pawelczyk1 1Department of affective and  Psychotic Disorders, Medical  University of lodz, czechoslowacka,   lodz, Poland; 2central scientific  laboratory, Medical University of  lodz, Mazowiecka, lodz, Poland;   3central Teaching hospital, Medical  University of lodz, czechoslowacka,   lodz, PolandIntroduction:  Telomere shortening is strongly associated with higher mortality rates and has  been shown in a number of age-related diseases, such as cardiovascular disorders, diabetes  mellitus, Alzheimer’s disease, and psychiatric disorders.",Non-OADS,/arxiv_data1/oa_pdf/f0/27/ndt-11-1493.PMC4484660.pdf
"Although on the one hand, this obligatory telomere loss provides a tumor  suppressor mechanism that limits cell proliferation, it eventually results in replicative  senescence and contributes to aging and cellular apoptosis.2 In 2009, The Nobel Prize  in Physiology or Medicine was awarded to Elizabeth H Blackburn, Carol W Greider, correspondence: Tomasz Pawelczyk Department of affective and Psychotic  Disorders Medical University of lodz,  czechoslowacka 8/10, 92-216 lodz,  Poland   Tel +48 4 2675 7214   Fax +48 4 2675 7403   email tomasz.pawelczyk@umed.lodz.p l;  tomasz.pawelczyk@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Pawelczyk et al Running head recto: Telomere shortening related to schizophrenia chronicity DOI: http://dx.doi.org/10.2147/NDT.S82468",Non-OADS,/arxiv_data1/oa_pdf/f0/27/ndt-11-1493.PMC4484660.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f0/27/ndt-11-1493.PMC4484660.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/27/ndt-11-1493.PMC4484660.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/bb/dddt-9-3257.PMC4484661.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3257–3266Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3257Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8773 8improving dissolution and oral bioavailability of   pranlukast hemihydrate by particle surface  modification with surfactants and homogenization eun-sol ha1 in-hwan Baek2 Jin-Wook Y oo1 Yunjin Jung1 Min-soo Kim1 1college of Pharmacy, Pusan national  University, 2college of Pharmacy,   Kyungsung University, Busan, republic  of KoreaAbstract:  The present study was carried out to develop an oral formulation of pranlukast  hemihydrate with improved dissolution and oral bioavailability using a surface-modified  microparticle.",Non-OADS,/arxiv_data1/oa_pdf/cb/bb/dddt-9-3257.PMC4484661.pdf
"Recently, novel solid dispersion systems for APIs have been correspondence: Min-soo Kim college of Pharmacy, Pusan national  University, 2, Busandaehak-ro 63beon-gil,  geumjeong-gu, Busan 609-735, republic  of Korea Tel +82 51 510 2813 Fax +82 51 513 6754 email minsookim@pusan.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ha et al Running head recto: Surface-modified pranlukast hemihydrate microparticles DOI: http://dx.doi.org/10.2147/DDDT.S87738",Non-OADS,/arxiv_data1/oa_pdf/cb/bb/dddt-9-3257.PMC4484661.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/cb/bb/dddt-9-3257.PMC4484661.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/bb/dddt-9-3257.PMC4484661.pdf
The trial is registered at http://www.ClinicalTrials.gov as NCT01001221.,Non-OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
"The most frequent AEs ofany grade were typical of cytotoxic chemotherapies and included fatigue (66.7%), decr eased appetite (50%), diarrhea (44.4%), and nausea (38.9%; see Table 1, Supplementaldigital content 1, http://links.lww.com/ACD/A110 ,w h i c hs h o w s the most frequent nonhemato logic AEs).",Non-OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
"As a result of AEs, 11 patients (61.1%) required a dose delay and 13 patients (72.2%) required a dose reduction, which in both cases were most frequently due to neu- tropenia (38.9% for each; see Table 2, Supplemental digital content 1, http://links.lww.com/ACD/A110 , which shows AEs leading to dose delay or reduction).",Non-OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
"1, and the descriptive statistics for cabazitaxel PK parameters are reported in Table 3 of Supplemental digital content 1 ( http://links.lww.com/ACD/ A110 ).",OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
"Descriptive statistics for gemcitabine and dFdU PK parameters are reported in Table 4 of Supplemental digital content 1 ( http://links.lww.com/ACD/A110 ), and the mean plasma concentration –time curves for gemcitabine and dFdU are shown in Fig.",OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
1 of Supplemental digital content 1 ( http://links.lww.com/ACD/A110 ).,Non-OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
"Efficacy Disease control (SD or better for at least 12 weeks) was achieved in 11 patients (61.1%; see Table 5, Supplemental digital content 1, http://links.lww.com/ACD/ A110 , which shows antitumor responses).",Non-OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/002018/WC500104764.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
Available at: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2010/201023lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
Available at: http://pi.lilly.com/us/gemzar.pdf [Accessed 1 August 2014].,Non-OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
Available at: http://ctep.cancer.gov/ protocolDevelopment/electronic_applications/docs/ctcaev3.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c1/80/cad-26-785.PMC4484664.pdf
"S1, Supplemental digital content 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S1, Supplemental digital content 1, http://links.lww.com/ACD/ A105).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S2 (Supplemental digital con- tent 1, http://links.lww.com/ACD/A105 ) relative quantification of G0/G1-phase, S-phase and G2/M-phase populations of monolayer cell cultures in t he log phase by DNA content (7AAD labelling) was performed after 48 h incubation withAPG101 or APG293.",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S6 A and B, Supplemental digital content 1, http://links.lww.com/ACD/A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S5, Supplemental digital content 1, http://links.lww.com/ACD/A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S6 A and B, Supplemental digital content 1, http://links.lww.com/ACD/A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S6 B, Supplemental digital content 1,http://links.lww.com/ACD/A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S3, Supplemental digital content 1, http://links.lww.com/ ACD/A105).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"A ss h o w ni nF i g .5 ,[ C D 9 5 L ] knockdown spheroids from both cell lines show only limite d invasion into the Matrigel (see also Supplementary Fi g. S8A and B, Supplemental digital content 1, http://links.lww.com/ACD/A105 for quantifi- cation).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S8 A and B, Supplemental digital content 1, http://links.lww.com/ACD/ A105).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S9, Supplemental digital content 1, http://links.lww.com/ACD/A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"[13] (for details see Supplementary Methods, Supplemental digital content 1, http://links.lww.com/ACD/ A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S4 (Supplemental digitalcontent 1, http://links.lww.com/ACD/A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S10, Supplemental digital content 1, http://links.lww.com/ACD/ A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S10,Supplemental digital content 1, http://links.lww.com/ACD/ A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S4, Supplemental digital content 1, http://links.lww.com/ACD/A105 and S10, Supplementary digital content 1, http://links.lww.com/ACD/A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S4,Supplemental digital content 1, http://links.lww.com/ACD/ A105 and S10, Supplemental digital content 1, http://links.",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S4, Supplementaldigital content 1, http://links.lww.com/ACD/A105 and S10, Supplemental digital content 1, http://links.lww.com/ACD/ A105 ).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
"S4, Supplemental digital content 1, http://links.lww.com/ ACD/A105 and S10, Supplemental digital content 1, http:// links.lww.com/ACD/A105 ), corroborating the notion that the ex-vivo assay recapitulates the in-vitro observations in a more complex physiological context.",Non-OADS,/arxiv_data1/oa_pdf/a3/43/cad-26-716.PMC4484665.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/52/dddt-9-3217.PMC4484667.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3217–3229Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3217Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8643 1simvastatin prevents isoproterenol-induced  cardiac hypertrophy through modulation of the   JaK/sT aT pathway nouf M al-rasheed1 Maha M al-Oteibi1 reem Z al-Manee1 sarah a al-shareef1 nawal M al-rasheed1 iman h hasan1 raeesa a Mohamad2 ayman M Mahmoud3 1Department of Pharmacology,   Faculty of Pharmacy, 2Department of  anatomy, college of Medicine, King  saud University, riyadh, saudi arabia;   3Physiology Division, Department  of Zoology, Faculty of science,   Beni-suef University, egyptAbstract:  Simvastatin (SIM) is a lipid-soluble inhibitor of hydroxy-3-methylglutaryl coenzyme A   reductase with multiple reported therapeutic benefits.",Non-OADS,/arxiv_data1/oa_pdf/85/52/dddt-9-3217.PMC4484667.pdf
"edu.e g Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Al-Rasheed et al Running head recto: SIM prevents ISO-induced cardiac hypertrophy via JAK/STAT pathway DOI: http://dx.doi.org/10.2147/DDDT.S86431",Non-OADS,/arxiv_data1/oa_pdf/85/52/dddt-9-3217.PMC4484667.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/85/52/dddt-9-3217.PMC4484667.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/52/dddt-9-3217.PMC4484667.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/26/jmdh-8-291.PMC4484669.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 291–298Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  291Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S5052 9A multidisciplinary approach to therapeutic   risk management of the suicidal patient Cynthia L Grant1,2  Jaimie L Lusk3 1Arapahoe/Douglas Mental Health  Network, englewood, CO,  2School of  education and Human Development,   University of Colorado Denver,   Denver, CO,  3Mental Health Service,   vA Portland Health Care System,   Portland, OR, USA Correspondence: Cynthia L Grant   Arapahoe/Douglas Mental Health  Network, 155 inverness Dr west,  englewood, CO  80112, USA   email cgrant@admhn.or gAbstract:  As health care trends toward a system of care approach, providers from various  disciplines strive to collaborate to provide optimal care for their patients.",Non-OADS,/arxiv_data1/oa_pdf/18/26/jmdh-8-291.PMC4484669.pdf
Available from: http://med-ed-online.net/index.,OADS,/arxiv_data1/oa_pdf/18/26/jmdh-8-291.PMC4484669.pdf
Available from: http://dx.doi.org/10.1016/j.hjdsi.2014.06.00 2  18.,OADS,/arxiv_data1/oa_pdf/18/26/jmdh-8-291.PMC4484669.pdf
"Available from:  http://www.qprinstitute.com/pdfs/PCP%20SLTB%20Word%20F_ SLTB9_24.pd f. Accessed December  13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/18/26/jmdh-8-291.PMC4484669.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/18/26/jmdh-8-291.PMC4484669.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/26/jmdh-8-291.PMC4484669.pdf
"Available from: http://www.sprc.org/bpr/section-III/safety- plan- treatment -manual-reduce-suicide-risk-veteran-versio n. Accessed  December  13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/18/26/jmdh-8-291.PMC4484669.pdf
"Available from: http://www.mentalhealth.va.gov/docs/ V A_Safety_planning_manual.pd f. Accessed December  13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/18/26/jmdh-8-291.PMC4484669.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/65/dddt-9-3267.PMC4484670.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3267–3278Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3267Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8156 4a meta-analysis for cXcr4 as a prognostic marker  and potential drug target in non-small cell lung  cancer changyuan Zhang1,* Jie li2,* Yi han3 Jian Jiang4 1Department of cardiothoracic  surgery, inner Mongolia autonomous  region People’s hospital, inner  Mongolia; 2Department of Oncology,  3Department of Thoracic surgery,   Beijing chest hospital, 4Department  of Thoracic surgery, Beijing T ongren  hospital, capital Medical University,   Beijing, People’s republic of china *These authors contributed equally  to this workBackground:  Recent reports have shown that C-X-C chemokine receptor type 4 (CXCR4)  is a candidate oncogene in several types of human tumors, including non-small cell lung can - cer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/7c/65/dddt-9-3267.PMC4484670.pdf
"Chemokines  can interact with G-protein-coupled receptors, which play critical roles in  the immune system and in the cellular proliferation, migration, invasion, angiogenesis,  evasion of the immune response, and inflammatory microenvironment of tumors.1–3  C-X-C chemokine receptor type 4 (CXCR4), also known as fusin or CD184, is an  alpha-chemokine receptor specific for stromal cell-derived factor 1 (SDF-1; also called  CXCL12).4,5 CXCR4 belongs to the superfamily of seven-transmembrane domain,  heterotrimeric G-protein-coupled receptors and is functionally expressed on the cell sur - face in a wide range of malignant tumors as well as implicated in the cell proliferation  and migration of these cells.6–8 Recently, CXCR4 has been reported to be overexpressed  and to play an important role in cell survival, proliferation, migration, and metastasis of correspondence: Yi han Department of Thoracic surgery,  Beijing chest hospital, capital Medical  University, 97 Machang, Tongzhou  District, Beijing 101149, People’s  republic of china email yihan78@126.co m  Jian Jiang Department of Thoracic surgery, Beijing  Tongren hospital, capital Medical  University, 2 chongwenmennei street,  Dongcheng District, Beijing 100730,  People’s republic of china email jianjiangmd@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: Association of CXCR4 expression with the incidence of NSCLC DOI: http://dx.doi.org/10.2147/DDDT.S81564",Non-OADS,/arxiv_data1/oa_pdf/7c/65/dddt-9-3267.PMC4484670.pdf
"Briefly, CXCR4  gene  was entered into the database ( http://kmplot.com/analysis/ index.php?p =service&cancer =lung) to obtain Kaplan–Meier  survival plots, where the number at risk is indicated below the  main plot.",Non-OADS,/arxiv_data1/oa_pdf/7c/65/dddt-9-3267.PMC4484670.pdf
"The clinical relevance of CXCR4 was further corrobo - rated in a patient survival analysis using an online database  containing the expression of 22,277 genes and 20-year  survival information of 1,809 patients.49 The database has  recently been updated to include survival information of  1,432 NSCLC patients ( http://www.kmplot.com/analysis /).",OADS,/arxiv_data1/oa_pdf/7c/65/dddt-9-3267.PMC4484670.pdf
"Notes:  The database has recently been updated to include survival information  of 1,432 nsclc patients ( http://www.kmplot.com/analysis /).",Non-OADS,/arxiv_data1/oa_pdf/7c/65/dddt-9-3267.PMC4484670.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/7c/65/dddt-9-3267.PMC4484670.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/65/dddt-9-3267.PMC4484670.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/88/ott-8-1561.PMC4484671.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1561–1565OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1561STudy Pr OTO cOlopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8144 7role of integrin-linked kinase in drug resistance  of lung cancer Zhiyang Jia department of Imaging and Nuclear  Medicine, The First Affiliated Hospital  of Zhengzhou university, Zhengzhou  city, People’s republic of chinaObjective:  The objective of the present investigation was to investigate the role of  integrin-linked kinase (ILK) in the gemcitabine-resistant lung cancer cell line A549 and explore  the underlying mechanism.",Non-OADS,/arxiv_data1/oa_pdf/e5/88/ott-8-1561.PMC4484671.pdf
"Dubecco’s Modified Eagle’s Medium correspondence: Zhiyang Jia department of Imaging and Nuclear  Medicine, The First Affiliated Hospital  of Zhengzhou university, Zhengzhou city  420052, People’s republic of china Tel +86 136 3383 2898 Email zhiyangjiababy@163.co m Journal name: OncoTargets and Therapy Article Designation: Study Protocol Y ear: 2015 Volume: 8 Running head verso: Jia Running head recto: Role of integrin-linked kinase in drug resistance of lung cancer DOI: http://dx.doi.org/10.2147/OTT.S81447",Non-OADS,/arxiv_data1/oa_pdf/e5/88/ott-8-1561.PMC4484671.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/88/ott-8-1561.PMC4484671.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/88/ott-8-1561.PMC4484671.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/28/29/ijn-10-4125.PMC4484672.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4125–4136International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4125OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8294 5Degradability, bioactivity, and osteogenesis  of biocomposite scaffolds of lithium-containing  mesoporous bioglass and mPeg-Plga- b-Pll  copolymer Yanrong cai1 lieping guo2 hongxing shen2 Xiaofei an2 hong Jiang3 Fang Ji2 Yunfei Niu2 1The college of Basic science  of Medicine, hunan University  of Traditional chinese Medicine,   changsha, 2Department of  Orthopaedics, changhai hospital,   second Military Medical University,   3school of Materials science and  engineering, University of shanghai  for science and T echnology, shanghai,   People’s republic of chinaAbstract:  Biocomposite scaffolds of lithium (Li)-containing mesoporous bioglass and  monomethoxy poly(ethylene glycol)-poly( d,l-lactide- co-glycolide)-poly( l-lysine) (mPEG- PLGA -b-PLL) copolymer were fabricated in this study.",Non-OADS,/arxiv_data1/oa_pdf/28/29/ijn-10-4125.PMC4484672.pdf
"Keywords:  MBG, copolymer, degradability, bioactivity, osteogenesis, cell proliferation, bone repair Introduction Some biodegradable polymers have been applied as biomedical materials for tis - sue repair and drug delivery, such as polylactide, poly( d,l-lactide- co-glycolide)  (PLGA), polycaprolactone, and monomethoxy poly(ethylene glycol)-poly( d,l- lactide- co-glycolide) (mPEG-PLGA).1–4 Recently, an amphiphilic block copolymer  of monomethoxy (polyethylene glycol)-poly( d,l-lactide- co-glycolide)-poly( l-lysine)  (mPEG-PLGA- b-PLL) was synthesized,5,6 and the studies indicated that mPEG- PLGA- b-PLL with good biocompatibility and degradability would be a promising  and effective carrier for the delivery of drugs and genes.7,8 In the past few years, the applications of mesoporous bioglasses (MBGs) for bone  tissue regeneration have been proposed, because their large surface area and high pore  volume may enhance their bioactivity and promote new bone formation.9,10 The large  surface area and high pore volume of MBG result in higher surface chemical reactivity  compared with normal bioglasses (BGs) without mesopores.11,12 Lithium (Li) has been  widely used as a long-term mood stabilizer in the treatment of bipolar and depressive  disorders for 50 years.13 Li+ ions can stimulate the osteogenic differentiation of bone  mesenchymal stem cells (BMSCs) through activation of the canonical Wnt signal - ing pathway in vitro.14 Previous studies suggested that Li + ions can protect cartilage  correspondence: Fang Ji; Yunfei Niu Department of Orthopaedics, changhai  hospital, second Military Medical  University, changhai road 168, shanghai  200433, People’s republic of china Tel +86 21 3116 6666 email 7 29817837@qq.co m;   niuyf2015@sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Cai et al Running head recto: Biocomposite scaffolds of l-MBG and mPEG-PLGA- b-PLL copolymer DOI: http://dx.doi.org/10.2147/IJN.S82945",Non-OADS,/arxiv_data1/oa_pdf/28/29/ijn-10-4125.PMC4484672.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/28/29/ijn-10-4125.PMC4484672.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/29/ijn-10-4125.PMC4484672.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/90/cia-10-1009.PMC4484673.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1009–1015Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1009OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8596 0Outcomes of vaginal hysterectomy and constricting  colporrhaphy with concurrent levator myorrhaphy  and high perineorrhaphy in women older than   75 years of age emrah Töz Aykut Özcan Nesin Apaydın I˙brahim Uyar Betül Kocakaya gülin Okay Department of gynecology  and Obstetrics, Tepecik education  and research hospital, I ˙zmir, T urkeyObjectives:  We performed constricting anterior and posterior colporrhaphy, levator  myorrhaphy, and high perineorrhaphy with concurrent hysterectomy, and investigated the  intraoperative complications, and short-term outcomes of these constricting procedures in  patients aged 75 years or older.",Non-OADS,/arxiv_data1/oa_pdf/2d/90/cia-10-1009.PMC4484673.pdf
"Although pessaries are offered as ﬁrst-line  therapy to such patients,4,5 surgery may be indicated for patients who have failed or  do not desire the lifelong use of a pessary.Correspondence: emrah Töz Department of gynecology and  Obstetrics, Tepecik education and  research hospital, gaziler cad,   no 468, I ˙zmir 35330, Turkey Tel +90 50 5259 5629 Fax +90 23 2261 7351 email emrahtoz79@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Töz et al Running head recto: Outcomes of prolapse surgery in women older than 75 years of age DOI: http://dx.doi.org/10.2147/CIA.S85960",Non-OADS,/arxiv_data1/oa_pdf/2d/90/cia-10-1009.PMC4484673.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/2d/90/cia-10-1009.PMC4484673.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/2d/90/cia-10-1009.PMC4484673.pdf
Available from: http://www.nami.org 4.,Non-OADS,/arxiv_data1/oa_pdf/46/e2/abc-104-06-0431.PMC4484674.pdf
Disponível  em: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/cnv/obt10uf.def 5.,OADS,/arxiv_data1/oa_pdf/29/73/abc-104-06-0433.PMC4484675.pdf
Available from: <http://www.who.int/cardiovascular_ diseases/about_cvd/en> 2.,Non-OADS,/arxiv_data1/oa_pdf/2b/a4/abc-104-06-0468.PMC4484679.pdf
Available from: < http://www.who.int/mediacentre/factsheets/fs355/en/ index.html> 3.,Non-OADS,/arxiv_data1/oa_pdf/2b/a4/abc-104-06-0468.PMC4484679.pdf
Disponível  em: <http://tabnet.datasus.gov.br/cgi/idb2012/matriz.htm> 4.,Non-OADS,/arxiv_data1/oa_pdf/2b/a4/abc-104-06-0468.PMC4484679.pdf
Disponível em: <http://portal.saude.gov.br/portal/aplicacoes/ noticias/default.cfm?pg=dspDetalheNoticia&id_area=124&CO_ NOTICIA=11994> 5.,Non-OADS,/arxiv_data1/oa_pdf/2b/a4/abc-104-06-0468.PMC4484679.pdf
Available from: http://apps.who.int/isis/bitstream/10665/79059/who/_dco .,OADS,/arxiv_data1/oa_pdf/e7/d4/abc-104-06-0487.PMC4484681.pdf
Available from: http://www.ursds.org/2012/pdf/ v2_ch4_12.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/48/8b/abc-104-06-0493.PMC4484682.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/05/tcrm-11-979.PMC4484687.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 979–990Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  979Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7355 9A critical appraisal of ibrutinib in the treatment  of mantle cell lymphoma and chronic lymphocytic  leukemia David L T ucker Simon A Rule Department of Haematology,   Plymouth Hospitals NHS Trust,   Plymouth, UKAbstract:  Although chemo-immunotherapy remains at the forefront of first-line treatment for  mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL), small molecules, such  as ibrutinib, are beginning to play a significant role, particularly in patients with multiply relapsed  or chemotherapy-refractory disease and where toxicity is an overriding concern.",Non-OADS,/arxiv_data1/oa_pdf/34/05/tcrm-11-979.PMC4484687.pdf
"This review provides an overview of Correspondence: Simon A Rule Department of Haematology, Plymouth  Hospitals NHS Trust, Derriford Road,  Plymouth PL6 8DH, Devon, UK Tel +44 1752 432595 Fax +44 1752 792400 email simon.rule@nhs.ne t Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Tucker and Rule Running head recto: Ibrutinib for MCL and CLL DOI: http://dx.doi.org/10.2147/TCRM.S73559",Non-OADS,/arxiv_data1/oa_pdf/34/05/tcrm-11-979.PMC4484687.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/34/05/tcrm-11-979.PMC4484687.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/05/tcrm-11-979.PMC4484687.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/0a/ndt-11-1505.PMC4484694.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1505–1509Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1505OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8223 2Validity and reliability of the T urkish version of  craFFT substance abuse screening T est among  adolescents hasan Kandemir1 Ömer aydemir2 suat ekinci3 salih selek4 sultan B Kandemir5 hüseyin Bayazit6 1Department of child and adolescent  Psychiatry, school of Medicine, harran  University, sanliurfa, 2Department of  Psychiatry, school of Medicine, celal  Bayar University, Manisa, 3Balıklı Rum  hospital, i.stanbul, 4Department of  Psychiatry and Behavioral sciences,   University of Texas health science  center, houston, T exas, Usa;   5Department of Psychiatry, Balikligol  state hospital, sanliurfa, 6Department  of Psychiatry, school of Medicine,   harran University, sanliurfa, T urkeyAim:  This study aimed to validate the CRAFFT diagnostic test, against the Diagnostic and  Statistical Manual of Mental Disorders – Fourth Edition,  Axis 1-based diagnostic inventory in  a Turkish population of adolescents.",Non-OADS,/arxiv_data1/oa_pdf/d1/0a/ndt-11-1505.PMC4484694.pdf
"Recent estimates are  that in 2008, 155–250 million people, or 3.5%–5.7% of the world’s population, aged  15–64 years used other psychoactive substances, such as cannabis, amphetamines,  cocaine, opioids, and nonprescribed psychoactive prescription medication.1 The use of  psychoactive substances causes significant health and social problems for the people  who use them, as well as for others in their families and communities.1 It is reported  that use of drugs by at least one parent/guardian is independently associated with  higher odds of mental health problems.2–5 Background Alcohol and drug use typically begins during adolescence and it is associated with  increased risk of addictive disorders in later life.6,7 Data from the 2005 National  Survey on Drug Use and Health indicated that all levels of drinking, from use to  binge drinking to heavy drinking, increase with increasing age during adolescence.8  Alcohol dependence typically emerges during late adolescence or early adulthood.9  One study in Turkey showed that high school students (aged 15–17 years) had ever correspondence: hasan Kandemir Department of child and adolescent  Psychiatry, harran University, school  of Medicine, Yenisehir, sanliurfa 63100,  Turkey Tel +90 414 318 3000 Fax +90 414 318 3190 email kandemirhsn@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kandemir et al Running head recto: Validity and reliability of the Turkish version of CRAFFT DOI: http://dx.doi.org/10.2147/NDT.S82232",Non-OADS,/arxiv_data1/oa_pdf/d1/0a/ndt-11-1505.PMC4484694.pdf
Available from: http://www.who.int/substance_abuse/facts/en /  2.,Non-OADS,/arxiv_data1/oa_pdf/d1/0a/ndt-11-1505.PMC4484694.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d1/0a/ndt-11-1505.PMC4484694.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/0a/ndt-11-1505.PMC4484694.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/cb/ndt-11-1483.PMC4484695.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1483–1492Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1483OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8176 0Efficacy and safety of flexibly dosed paliperidone  palmitate in chinese patients with acute  schizophrenia: an open-label, single-arm,  prospective, interventional study Tianmei si1 Kerang Zhang2 Jisheng Tang3 Maosheng Fang4 Keqing Li5 Jianmin Zhuo6 Yu Feng6 1Peking University Institute of Mental  Health, Key Laboratory of Mental  Health, Ministry of Health, Beijing,   People’s Republic of China; 2shanxi  Medical University First Hospital,   Shanxi, People’s Republic of China;   3Mental Health Center of Shandong  Province, Shandong, People’s Republic  of China; 4Mental Health Center,   Tongji Medical College, Huazhong  University of Science and T echnology,   Hubei, People’s Republic of China;   5Mental Health Center of Hebei  Province, Hebei, People’s Republic  of China; 6Janssen research and  Development, Beijing, People’s  Republic of ChinaAbstract:  This open-label, single-arm, multicenter, 13-week, prospective study explored the  efficacy, safety, and tolerability of paliperidone palmitate (150 milligram equivalents [mg eq]  [day 1], 100 mg eq [day 8], both deltoid injections; 75–150 mg eq, deltoid/gluteal injection) in  Chinese patients with acute schizophrenia (Positive and Negative Syndrome Scale [PANSS]  total score 70), who previously had unsatisfactory therapeutic effect following oral antip - sychotic treatment (without washout period).",Non-OADS,/arxiv_data1/oa_pdf/66/cb/ndt-11-1483.PMC4484695.pdf
"Keywords:  antipsychotic, long-acting injectable, PANSS Introduction Though second generation oral antipsychotics are a critical modality in the treatment  of schizophrenia, partial or total nonadherence to oral antipsychotics is known to  cause treatment failure, relapse, and hospitalization.1 Long-acting injectable (LAI)  antipsychotics enhance adherence, maximize pharmacokinetic coverage, and mini - mize antipsychotic withdrawal symptoms, potentially enhancing treatment outcomes  in patients with schizophrenia.2–4 Paliperidone palmitate (PP), an LAI antipsychotic, is approved for acute and main - tenance treatment of schizophrenia in adults in the United States, Europe, People’s  Republic of China, Korea, and several other countries.5,6 An earlier study with PP  demonstrated that once-monthly treatment with PP is rapid-acting in the acute phase  and effectively prevents relapse during long-term maintenance.6 Most of these stud - ies were performed using fixed dosages of PP to treat well-defined groups of patients  with schizophrenia and typically included an initial washout period.7–10 A few of  these studies were performed using flexible dosing of PP, which better reflects how Correspondence: Yu Feng Janssen Research and Development, 19 F,  Tower 3, China Central Place, 77 Jianguo  Road, Chaoyang District, Beijing 100025,  People’s Republic of China Tel +86 10 5821 8307 email yfeng23@its.jnj.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Si et al Running head recto: Flexibly dosed paliperidone palmitate in acute schizophrenia patients DOI: http://dx.doi.org/10.2147/NDT.S81760",Non-OADS,/arxiv_data1/oa_pdf/66/cb/ndt-11-1483.PMC4484695.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/66/cb/ndt-11-1483.PMC4484695.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/cb/ndt-11-1483.PMC4484695.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/54/ppa-9-831.PMC4484696.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 831–835Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  831PersPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/PPA.S8197 5Measuring the quality of patient-centered care:  why patient-reported measures are critical to  reliable assessment Flora tzelepis robert W sanson-Fisher Alison c Zucca elizabeth A Fradgley Priority research centre for Health  Behaviour, University of Newcastle  and Hunter Medical research  institute, Newcastle, N sW, AustraliaPurpose:  The Institute of Medicine (IOM) identified patient-centeredness as crucial to quality  health care.",Non-OADS,/arxiv_data1/oa_pdf/ea/54/ppa-9-831.PMC4484696.pdf
"Keywords:  patient-centered care, quality of care, quality assessment, patient-reported  measures Measuring the quality of patient-centered care The Institute of Medicine (IOM) recommended that to achieve high quality health  care, improvements were needed to the delivery of patient-centered care.1 Patient- centered care is responsive to patients’ values and needs and patient preferences guide  decision-making.1 The IOM endorsed six dimensions of patient-centered care which  stated that care must be: 1) respectful to patients’ values, preferences, and expressed  needs; 2) coordinated and integrated; 3) provide information, communication, and  education; 4) ensure physical comfort; 5) provide emotional support – relieving fear correspondence: Flora tzelepis Priority research centre for Health  Behaviour, University of Newcastle,  University Drive, callaghan, NsW 2308,  Australia tel +61 2 4924 6275 Fax +61 2 4924 6490 email flora.tzelepis@newcastle.edu.a u Journal name: Patient Preference and Adherence Article Designation: Perspectives Y ear: 2015 Volume: 9 Running head verso: Tzelepis et al Running head recto: Measuring the quality of patient-centered care DOI: http://dx.doi.org/10.2147/PPA.S81975",Non-OADS,/arxiv_data1/oa_pdf/ea/54/ppa-9-831.PMC4484696.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ea/54/ppa-9-831.PMC4484696.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/70/cmar-7-189.PMC4484697.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 189–198Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  189Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S7182 1Treatment of metastatic colorectal cancer:   focus on panitumumab Rebecca Y Tay1 Rachel wong1–3 eliza A Hawkes1,3,4 1Department of Medical Oncology,   eastern Health, Box Hill, viC,   Australia; 2walter and eliza Hall  institute of Medical Research,   Parkville, viC, Australia; 3Faculty  of Medicine, Nursing and Health  Sciences, Monash University,   Melbourne, viC, Australia;   4Department of Oncology, Olivia  Newton John Cancer and wellness  Centre, Austin Hospital, Heidelberg,   viC, Australia Correspondence: eliza A Hawkes,   Department of Oncology, Level 4,  Olivia Newton John Cancer and wellness  Centre, Austin Hospital, Heidelberg,   viC 3084, Australia   Tel +61 39 496 5763   email eliza.hawkes@onjcri.org.a uAbstract:  Targeted agents are an important therapeutic option in the treatment of metastatic  colorectal cancer (mCRC).",Non-OADS,/arxiv_data1/oa_pdf/23/70/cmar-7-189.PMC4484697.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/23/70/cmar-7-189.PMC4484697.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/70/cmar-7-189.PMC4484697.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/cb/main.PMC4484717.pdf
"Till date, ~4636 com- plete metazoan mitogenomes have been sequenced and deposited in the NCBI organellar genome database ( http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/09/cb/main.PMC4484717.pdf
http://dx.doi.org/10.1016/j.mgene.2015.06.004 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/cb/main.PMC4484717.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/cb/main.PMC4484717.pdf
"The annotation of the best assembled mitogenome was carried out using Mitoannotator ( Iwasaki et al., 2013 )a n df u r t h e rv e r i - ﬁed by NCBI ORF ﬁnder ( http://www.ncbi.nlm.nih.gov/projects/gorf/ ).",OADS,/arxiv_data1/oa_pdf/09/cb/main.PMC4484717.pdf
5. http://dx.doi.org/10.1371/currents.tol.,OADS,/arxiv_data1/oa_pdf/09/cb/main.PMC4484717.pdf
http://www.clcbio.com .,Non-OADS,/arxiv_data1/oa_pdf/09/cb/main.PMC4484717.pdf
http://bioinfogp.cnb.csic.es/tools/venny/index.html .,Non-OADS,/arxiv_data1/oa_pdf/09/cb/main.PMC4484717.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/5f/main.PMC4484718.pdf
http://dx.doi.org/10.1016/j.mgene.2015.06.002 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/5f/main.PMC4484718.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/5f/main.PMC4484718.pdf
Graphical abstract This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/61/nihms702337.PMC4484736.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four figures, and two tables and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2015.04.034 .",OADS,/arxiv_data1/oa_pdf/0a/61/nihms702337.PMC4484736.pdf
"http://dx.doi.org/10.1016/j.gendis.2015.02.001 2352-3042/Copyright ª2015, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/34/2e/main.PMC4484766.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2015) 2, 152e163",Non-OADS,/arxiv_data1/oa_pdf/34/2e/main.PMC4484766.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/2e/main.PMC4484766.pdf
"Keywords Allergy; Asthma; Cytokines; Fungi; Innate lymphoid cells Introduction After the initial discovery and characterization of Th1- and Th2-type CD4+ T cells  approximately 25 years ago, T cells were thought to play a central role in regulation of  immune responses and pathophysiology of diseases by producing a repertoire of cytokines.1  However, the recent discovery of innate lymphoid cells (ILCs) added another layer of  complexity and provided a major shift in this paradigm.2 ILCs have emerged as important  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/de/12/nihms696342.PMC4484772.pdf
2015. http://dx.doi.org/10.1016/j.jaci.2014.11.037 93.,OADS,/arxiv_data1/oa_pdf/de/12/nihms696342.PMC4484772.pdf
"94, 758 –766.EBioMedicine 2 (2015) 188 –189 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.01.015 .",Non-OADS,/arxiv_data1/oa_pdf/30/ea/main.PMC4484815.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.02.0112352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/30/ea/main.PMC4484815.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/ea/main.PMC4484815.pdf
Commensal Neisseria species have also been suggestedEBioMedicine 2 (2015) 186 –187 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.01.004 .,Non-OADS,/arxiv_data1/oa_pdf/41/86/main.PMC4484816.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.02.001 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/41/86/main.PMC4484816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/86/main.PMC4484816.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/10/main.PMC4484817.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.01.006 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/99/10/main.PMC4484817.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/10/main.PMC4484817.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/d0/main.PMC4484819.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.01.015 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/d0/main.PMC4484819.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/d0/main.PMC4484819.pdf
"Transmitted drug resistance was predicted using the 2009 WHO list (Bennett et al., 2009 )(http://cpr.stanford.edu/cpr.cgi ).",OADS,/arxiv_data1/oa_pdf/4a/d0/main.PMC4484819.pdf
"For transmission cluster analysis, polsequences were pooled with a) all other available Cuban sequences at IPK; b) the 30 most similar se- quences to each of the study sequences retrieved from NCBI ( http:// blast.ncbi.nlm.nih.gov/Blast.cgi ); and c) all sequences retrieved from the Los Alamos database ( http://www.hiv.lanl.gov in December 2013) by using the search term “Cuba ”and duplicates were removed.",OADS,/arxiv_data1/oa_pdf/4a/d0/main.PMC4484819.pdf
D) Mosaic structure of the CRF19_cpx genome as taken from the Los Alamos HIV Sequence Database ( http://www.hiv.lanl.gov/content/sequence/HIV/CRFs/breakpoints.html#CRF19 ).249 V. Kouri et al.,OADS,/arxiv_data1/oa_pdf/4a/d0/main.PMC4484819.pdf
http://www.daignet.de/site-content/ hiv-therapie/leitlinien-1/Empfehlungen%20zur%20Bestimmung%20des%20HIV_1_Korezeptor_Gebrauchs.pdf (last accessed 2/3/2015).,Non-OADS,/arxiv_data1/oa_pdf/4a/d0/main.PMC4484819.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.01.018 2352-3964/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/22/f1/main.PMC4484823.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/f1/main.PMC4484823.pdf
http://dx.doi.org/10.1016/j.ebiom.2015.02.005 2352-3964/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/b1/main.PMC4484825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/b1/main.PMC4484825.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/b1/main.PMC4484825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/12/6e/main.PMC4484882.pdf
E-mail address: galvinj@health.fau.edu http://dx.doi.org/10.1016/j.dadm.2015.03.003 2352-8729/ /C2112015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/12/6e/main.PMC4484882.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/6e/main.PMC4484882.pdf
"http://dx.doi.org/10.1371/ journal.pbio.1001972 Behnke, O.",Non-OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1016/ S0022-5320(70)90145-0 Conde, C., and A. Cáceres.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1038/nrn2631 Diagouraga, B., A. Grichine, A. Fertin, J. Wang, S. Khochbin, and  K. Sadoul.",Non-OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1083/jcb.201306085 Harris, J.J., R. Jolivet, and D. Attwell.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1016/j.neuron .2012.08.019 Heidelberger, R. 1998.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1085/jgp.111.2.225 Heidelberger, R., and G. Matthews.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1113/ jphysiol.1992.sp019000 Heidelberger, R., P. Sterling, and G. Matthews.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1016/j.cub.2003 .12.053 Ji, J., Y.Y.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi .org/10.1089/neu.2010.1602 Job, C., and L. Lagnado.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1083/ jcb.143.6.1661observed in many neural systems (Kurshan et al., 2014).",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1183-  14.2014 Lagnado, L. 2003.",Non-OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"17:957– 967. http://dx.doi.org/10.1016/S0896-6273(00)80226-3 Larson, B.T., K.A.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi .org/10.1091/mbc.E14-02-0771 Lazarides, E. 1987.",Non-OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1016/0092-8674(87)90631-3 Lukinavičius, G., L. Reymond, E. D’Este, A. Masharina, F. Göttfert,  H. Ta, A. Güther, M. Fournier, S. Rizzo, H. Waldmann, et al.",Non-OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1038/nmeth.2972 Magiera, M.M., and C. Janke.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/ 10.1016/j.cub.2014.03.032 Masland, R.H. 2012.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1016/j.neuron.2012.10.002 Matthews, G., and P. Fuchs.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"11:812– 822. http://dx.doi.org/10.1038/nrn2924 Paysan, J., W.G.",Non-OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1002/1096- 9861(20000918)425:2<284::AID-CNE10>3.0.CO;2-N Pfeifer, C.R., A. Shomorony, M.A.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1016/j.jsb.2014.10.013 Rangaraju, V., N. Calloway, and T.A.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1016/j.cell.2013.12.042 Roos, J., T. Hummel, N. Ng, C. Klämbt, and G.W.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)00159-8 Sheng, Z.H., and Q. Cai.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1002/ aja.1001210213 Tachibana, M., and A. Kaneko.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1016/ S0896-6273(00)80634-0 Wilhelm, B.G., S. Mandad, S. Truckenbrodt, K. Kröhnert, C. Schäfer,  B. Rammner, S.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1126/science.1252884 Zenisek, D., and G. Matthews.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80885-5 Zenisek, D., J.A.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1038/35022500 Zenisek, D., N.K.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2886-  04.2004 Zhao, S., D. Studer, X. Chai, W. Graber, N. Brose, S. Nestel, C.  Young, E.P.",OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
http://dx.doi.org/10.1002/cne.23040,Non-OADS,/arxiv_data1/oa_pdf/e4/82/JGP_201511396.PMC4485018.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"Online supplemental material A zip file with the application and information to run the CaBuf   program is available at http://www.jgp.org/cgi/content/full/jgp.201411339/DC1.M A T E R I A L S  A N D  M E T H O D S Cell culture and heterologous expressionHEK293T cells stably overexpressing the mouse TRPM32 vari-ant (HEK-M3 cells) or human TRPM8 (HEK-M8 cells) were gen-erated and cultured as described before (Mahieu et al., 2010; Vriens et al., 2011; Drews et al., 2014).",Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"To determine the free Mg 2+ concentrations,  we used the CaBuf program (available as Supplemental material http://perswww.kuleuven.be/~u0032053/CaBuf.zip), which takes into account the K d values for Mg2+ of the various Mg2+-chelating  compounds, including ATP, EGTA, and aspartate.",Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1111/bph.12521 Gamper, N., and M.S.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1038/nrn2257 Grimm, C., R. Kraft, S. Sauerbruch, G. Schultz, and C. Harteneck.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1074/jbc.M300945200 Halaszovich, C.R., D.N.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1074/jbc.M803543200 Hilgemann, D.W., S. Feng, and C. Nasuhoglu.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1074/jbc.M112.350686 Horowitz, L.F., W. Hirdes, B.C.",Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1085/jgp.200509309 Hossain, M.I., H. Iwasaki, Y. Okochi, M. Chahine, S. Higashijima,  K. Nagayama, and Y. Okamura.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1073/ pnas.0803936105 Julius, D., and A.I.",Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1038/35093019 Karashima, Y., J. Prenen, V. Meseguer, G. Owsianik, T. Voets, and  B. Nilius.",Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1007/s00424- 008-0493-6 Knight, Z.A., B. Gonzalez, M.E.",Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1085/jgp.201210806 Leitner, M.G., C.R.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1124/mol.110.068130 Liu, B., and F. Qin.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.3632-04.2005 Lukacs, V., B. Thyagarajan, P. Varnai, A. Balla, T. Balla, and   T. Rohacs.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1523/JNEUROSCI .1866-07.2007 Lukacs, V., Y. Yudin, G.R.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10 .1038/35082088 Collins, M.D., and S.E.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"105:2485– 2494. http://dx.doi.org/10.1016/j.bpj.2013.09.035 Czech, M.P.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1016/S0092- 8674(00)80696-0 Drews, A., F. Mohr, O. Rizun, T.F.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi .org/10.1523/JNEUROSCI.5637-12.2013 Mahieu, F., A. Janssens, M. Gees, K. Talavera, B. Nilius, and T. Voets.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi .org/10.1113/jphysiol.2009.183582 Murata, Y., and Y. Okamura.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1113/jphysiol.2007.134775 Murata, Y., H. Iwasaki, M. Sasaki, K. Inaba, and Y. Okamura.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1038/ nature03650 Nilius, B., F. Mahieu, J. Prenen, A. Janssens, G. Owsianik, R. Vennekens,  and T. Voets.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1038/sj.emboj.7600963 Nilius, B., G. Owsianik, and T. Voets.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1038/emboj.2008.217 Oberwinkler, J., and S.E.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1007/s00424-007-0275-6 Rohács, T., J. Chen, G.D. Prestwich, and D.E.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi .org/10.1074/jbc.274.51.36065 Rohács, T., C.M.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1038/nn1451 Runnels, L.W., L. Yue, and D.E.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1126/science.1058519 Sakata, S., M.I.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1113/jphysiol.2011.208165 Straub, I., U. Krügel, F. Mohr, J. Teichert, O. Rizun, M. Konrad,   J. Oberwinkler, and M. Schaefer.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1124/mol.113.086843 Suh, B.C., and B. Hille.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1085/jgp.200709821 Suh, B.C., and B. Hille.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1083/ jcb.200607116 Voets, T., and B. Nilius.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1113/jphysiol.2007.132522 Vriens, J., G. Owsianik, T. Hofmann, S.E.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1016/j .neuron.2011.02.051 Vriens, J., K. Held, A. Janssens, B.I.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1038/nchembio.1428 Wagner, T.F., S. Loch, S. Lambert, I. Straub, S. Mannebach,  I. Mathar, M. Düfer, A. Lis, V. Flockerzi, S.E.",Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1038/ncb1801 Wagner, T.F., A. Drews, S. Loch, F. Mohr, S.E.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1007/s00424-010-0838-9 Xie, J., B.",Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"Rep. 1:146. http://dx.doi.org/10.1038/srep00146 Yudin, Y., V. Lukacs, C. Cao, and T. Rohacs.",Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
"http://dx.doi.org/10.1113/jphysiol.2011.220228 Zakharian, E., C. Cao, and T. Rohacs.",OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
http://dx.doi.org/10.1096/fj.11-184630,Non-OADS,/arxiv_data1/oa_pdf/e5/63/JGP_201411339.PMC4485019.pdf
This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
Online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201411336/DC1.,Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"105:2485– 2494. http://dx.doi.org/10.1016/j.bpj.2013.09.035 Decher, N., T. Gonzalez, A.K.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi .org/10.1038/emboj.2008.231 Du, X., H. Zhang, C. Lopes, T. Mirshahi, T. Rohacs, and D.E.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"135:99– 114. http://dx.doi.org/10.1085/jgp.200910345 Frühwald, J., J. Camacho Londoño, S. Dembla, S. Mannebach, A.  Lis, A. Drews, U. Wissenbach, J. Oberwinkler, and S.E.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/ 10.1074/jbc.M112.396663 Gabriel, T.E., and D. Günzel.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1016/j.abb.2006 .07.007 Gordon-Shaag, A., W.N.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.4161/chan.2.2.6026 Grimm, C., R. Kraft, S. Sauerbruch, G. Schultz, and C. Harteneck.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"278:21493– 21501. http://dx.doi.org/10.1074/jbc.M300945200 Grubbs, R.D.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1023/ A:1016026831789 Hammond, G.R., M.J. Fischer, K.E.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1126/science.1222483 Hilgemann, D.W. 1997.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1146/annurev .physiol.59.1.193 Hilgemann, D.W. 2012.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1085/jgp .201210874 Hilgemann, D.W., and R. Ball.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"273:956– 959. http://dx.doi.org/10.1126/science.273.5277.956 Holakovska, B., L. Grycova, M. Jirku, M. Sulc, L. Bumba, and  J. Teisinger.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1074/jbc.M112.350686 Horowitz, L.F., W. Hirdes, B.C.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1085/jgp.200509309 Hossain, M.I., H. Iwasaki, Y. Okochi, M. Chahine, S. Higashijima,  K. Nagayama, and Y. Okamura.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10 .1152/physrev.00028.2012 Bennett, T.M., D.S.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1371/journal.pone.0104000 Bojjireddy, N., J. Botyanszki, G. Hammond, D. Creech, R. Peterson,  D.C. Kemp, M. Snead, R. Brown, A. Morrison, S. Wilson, et al.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/ 10.1074/jbc.M113.531426 Cao, C., E. Zakharian, I. Borbiro, and T. Rohacs.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/ 10.1074/jbc.M112.409482 Cao, E., J.F.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1126/science.1094113 Rohacs, T. 2013.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10 .1007/978-3-319-05161-1_18 Rohacs, T. 2015.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1007/s00424-015-1695-3 Rohács, T., C. Lopes, T. Mirshahi, T. Jin, H. Zhang, and D.E.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1038/nn1451 Runnels, L.W., L. Yue, and D.E.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1074/ jbc.M114.553180 Stein, A.T., C.A.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1085/ jgp.200609576 Suh, B.C., and B. Hille.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1126/science.1131163 Sui, J.L., J. Petit-Jacques, and D.E.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1530/JME-12-0237 Tóth, B., and L. Csanády.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1074/ jbc.M110.192526 Varnai, P., B. Thyagarajan, T. Rohacs, and T. Balla.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1083/ jcb.200607116 Vriens, J., G. Owsianik, T. Hofmann, S.E.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1074/jbc.M706184200 Hughes, S., C.A.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1074/jbc.M801912200 Kruse, M., G.R.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1085/jgp.201210806 Li, Y., N. Gamper, D.W. Hilgemann, and M.S.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1146/ annurev-physiol-021113-170358 Lopes, C.M., H. Zhang, T. Rohacs, T. Jin, J. Yang, and D.E.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1523/JNEUROSCI| .1866-07.2007 Lukacs, V., J.M.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/ 10.1074/jbc.M113.520288 Mercado, J., A. Gordon-Shaag, W.N.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.2108-10.2010 Nilius, B., F. Mahieu, J. Prenen, A. Janssens, G. Owsianik, R. Vennekens,  and T. Voets.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1038/sj.emboj.7600963 Oberwinkler, J., and S.E.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1016/ j.neuron.2011.02.051 Wagner, T.F., S. Loch, S. Lambert, I. Straub, S. Mannebach,  I. Mathar, M. Düfer, A. Lis, V. Flockerzi, S.E.",OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1038/ ncb1801 Wu, L.J., T.B.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"62:381– 404. http://dx.doi.org/10.1124/pr.110.002725Xie, J., B.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"Rep.  1:146. http://dx.doi.org/10.1038/srep00146 Zakharian, E., C. Cao, and T. Rohacs.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
"http://dx.doi.org/10.1096/ fj.11-184630 Zhang, H., L.C.",Non-OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
http://dx.doi.org/10.1016/S0896- 6273(03)00125-9,OADS,/arxiv_data1/oa_pdf/df/2b/JGP_201411336.PMC4485020.pdf
© 2015 Gonzalez-Gutierrez and Grosman  This article is distributed under the terms of an  Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"After six months it is avail- able under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Un- ported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1016/S0006-3495 (99)77089-X Charnet, P., C. Labarca, R.J. Leonard, N.J. Vogelaar, L. Czyzyk, A.  Gouin, N. Davidson, and H.A.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10 .1016/0896-6273(90)90445-L Chen, J., Y. Zhang, G. Akk, S. Sine, and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1016/S0006-3495 (95)79959-3 Conway, B.E., R.E.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1039/tf9666202738 Cuevas, J., and D.J.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi .org/10.1038/nature04293 Davies, P.A., M. Pistis, M.C.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1038/16941 Davies, P.A., W. Wang, T.G.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1021/ ed047p261 Elenes, S., Y. Ni, G.D. Cymes, and C. Grosman.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"133:151– 169. http://dx.doi.org/10.1085/jgp.200810089 Emsley, P., B. Lohkamp, W.G.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
http://dx.doi.org/10.1107/S0907444910007493our mechanistic understanding of the pLGICs from ver- tebrate animals.,Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1107/S0907444909052925 Adler, M., A.C. Oliveira, E.X.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi .org/10.1085/jgp.74.1.129 Akk, G., and J.H.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1113/jphysiol.2003.043885 Alberola-Die, A., J. Martinez-Pinna, J.M.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1085/jgp.200609639 Beg, A.A., and E.M. Jorgensen.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi .org/10.1038/nn1136 Beg, A.A., G.G.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1016/j.cell.2007 .10.058 Bianchi, M.T., and R.L.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
http://dx.doi.org/10.1016/S0006-8993(01)02806-2,OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1038/376514a0 Leonard, R.J., C.G.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1126/science.2462281 Marabelli, A., R. Lape, and L. Sivilotti.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1085/jgp .201411234 Marshall, J., S.D.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi .org/10.1038/nature07923 Neher, E., and J.H.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1113/jphysiol.1978.sp012267 Ogden, D.C., and D. Colquhoun.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10 .1523/JNEUROSCI.5105-13.2014 Parikh, R.B., M. Bali, and M.H.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi .org/10.1074/jbc.M111.221895 Purohit, P., and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1085/jgp.200509437 Putnam, N.H., M. Srivastava, U. Hellsten, B. Dirks, J. Chapman, A.  Salamov, A. Terry, H. Shapiro, E. Lindquist, V.V.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10 .1038/353846a0Etter, A., D.F.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1021/bi0354334 Hansen, S.B., G. Sulzenbacher, T. Huxford, P. Marchot, P. Taylor,  and Y. Bourne.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"474:54– 60. http://dx.doi.org/10.1038/nature10139 Hilf, R.J.C., and R. Dutzler.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1038/nature06717 Hilf, R.J.C., C. Bertozzi, I. Zimmermann, A. Reiter, D. Trauner, and  R. Dutzler.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1038/nsmb.1933 Houtani, T., Y. Munemoto, M. Kase, S. Sakuma, T. Tsutsumi, and  T. Sugimoto.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"15:181– 191. http://dx.doi.org/10.1016/0896-6273(95)90075-6 Juneja, P., R. Horlacher, D. Bertrand, R. Krause, F. Marger, and W.  Welte.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80252-4 Kosolapov, A.V., G.N.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1038/emboj.2013.17 Schnizler, K., B. Saeger, C. Pfeffer, A. Gerbaulet, U. Ebbinghaus- Kintscher, C. Methfessel, E.-M. Franken, K. Raming, C.H.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi .org/10.1046/j.1471-4159.2003.01872.x Shen, X.-M., J.M.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi .org/10.1172/JCI63415 Sine, S.M., and J.H.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1186/ gb-2004-6-1-r4 Thompson, S.A., M.Z.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1038/sj.bjp.0702687Thompson, A.J., M. Alqazzaz, C. Ulens, and S.C.R.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1016/j .neuropharm.2012.05.027 Ue, M. 1994.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1149/ 1.2059336 Velisetty, P., and S. Chakrapani.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"287:18467– 18477. http://dx.doi.org/10.1074/jbc.M112.348045 Wang, D.-S., R. Buckinx, H. Lecorronc, J.-M. Mangin, J.-M. Rigo,  and P. Legendre.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1074/jbc.M701502200 Wyllie, D.J., P. Béhé, and D. Colquhoun.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"96:1177– 1198. http://dx.doi.org/10.1085/jgp.96.6.1177 Yoluk, O., T. Brömstrup, E.J.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1016/j.bpj.2013.06.037 Zhang, Y., J. Chen, and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1113/jphysiol.1995.sp020802 Zhou, Z., and E. Neher.",OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1007/ BF00374879 Zimmermann, I., and R. Dutzler.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
"http://dx.doi.org/10.1371/journal.pbio.1001101 Zimmermann, I., A. Marabelli, C. Bertozzi, L.G.",Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
http://dx.doi.org/10.1371/journal.pbio.1001429,Non-OADS,/arxiv_data1/oa_pdf/d3/65/JGP_201411333.PMC4485021.pdf
This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
The online supplemental material is available at http://www.jgp .org/cgi/content/full/jgp.201411329/DC1.,Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80143-9 Alabi, A.A., M.I.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1038/ nature06266 Bandell, M., A.E.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1038/ nn1665 Bohlen, C.J., A. Priel, S. Zhou, D. King, J. Siemens, and D. Julius.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1016/j.cell.2010.03.052 Boukalova, S., L. Marsakova, J. Teisinger, and V. Vlachova.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1371/journal.pcbi .1000392 Brauchi, S., P. Orio, and R. Latorre.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1523/JNEUROSCI .5080-05.2006 Cai, X.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
http://dx.doi.org/10.1093/ molbev/msn0772013).,Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1096/fj.02-0238hyp Labro, A.J., A.L.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/ 10.1085/jgp.200810048 Lacroix, J.J., H.C. Hyde, F.V.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1371/journal.pbio.1000047 Liao, M., E. Cao, D. Julius, and Y. Cheng.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1038/nature12822 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/ 10.1038/nature06265 Lu, Z., A.M. Klem, and Y. Ramu.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1085/jgp.20028696 Marti-Renom, M.A., M.S.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1110/ps.03379804 Matsuura, H., T. Sokabe, K. Kohno, M. Tominaga, and T. Kadowaki.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"9:228. http://dx.doi.org/10.1186/1471- 2148-9-228 Morcos, F., A. Pagnani, B. Lunt, A. Bertolino, D.S.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1016/j.neuron .2008.04.012 Narsky, I., and F.C.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1007/s10254-005-0006-0 Palovcak, E., L. Delemotte, M.L.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1085/ jgp.201311103 Paulsen, C.E., J.-P. Armache, Y. Gao, Y. Cheng, and D. Julius.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1038/nature14367 Payandeh, J., T. Scheuer, N. Zheng, and W.A.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1038/nature10238Cao, E., M. Liao, Y. Cheng, and D. Julius.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1038/nature12823 Cao, Z., and J.U.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1016/j.cell.2014.07.026 Clapham, D.E.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1038/nature02196 Crooks, G.E., G. Hon, J.-M. Chandonia, and S.E.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1101/gr.849004 Doñate-Macián, P., and A. Perálvarez-Marín.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1371/journal.pone.0110715 Eddy, S.R.",Non-OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi.org/10.1093/bioinformatics/14.9.755 Efron, B., and R.J. Tibshirani.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
"http://dx.doi .org/10.1007/978-1-4899-4541-9 Ekeberg, M., C. Lövkvist, Y. Lan, M. Weigt, and E. Aurell.",OADS,/arxiv_data1/oa_pdf/32/46/JGP_201411329.PMC4485022.pdf
